HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 9.4 Linux 07DEC21:22:31:4607DEC21:22:31:46 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SE SASDATA 9.4 Linux 07DEC21:22:31:4607DEC21:22:31:46 Subject Elements HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000001200000000000000000000 STUDYID Study Identifier DOMAIN Domain Abbreviation USUBJID Unique Subject Identifier SESEQ Sequence Number ETCD Element Code (ELEMENT Description of Element 0TAETORD Planned Order of Element within Arm DEPOCH Epoch L SESTDTC Start Date/Time of Element ` SEENDTC End Date/Time of Element s SESTDY Study Day of Start of Observation  SEENDY Study Day of End of Observation HEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 C4591001SEC4591001 1005 10051317ASCRN Screening ASCREENING 2020-10-20 2020-10-20T09:35:00AAC4591001SEC4591001 1005 10051317A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-20T09:35:002020-12-15 AB9C4591001SEC4591001 1005 10051317A0FUP Follow-up A0FOLLOW-UP 2020-12-15 2021-05-13 B9BC4591001SEC4591001 1005 10051328ASCRN Screening ASCREENING 2020-10-20 2020-10-20T12:31:00AAC4591001SEC4591001 1005 10051328A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-20T12:31:002020-12-11 AB5C4591001SEC4591001 1005 10051328A0FUP Follow-up A0FOLLOW-UP 2020-12-11 2021-05-13 B5BC4591001SEC4591001 1005 10051339ASCRN Screening ASCREENING 2020-10-21 2020-10-21T11:41:00AAC4591001SEC4591001 1005 10051339A VAXP Placebo A VACCINATION 2020-10-21T11:41:002020-12-09 AB2C4591001SEC4591001 1005 10051339A0FUP Follow-up A0FOLLOW-UP 2020-12-09 2021-05-17 B2BC4591001SEC4591001 1005 10051339A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T15:00:00BBC4591001SEC4591001 1005 10051339APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T15:00:002021-07-07 BC@C4591001SEC4591001 1005 10051339A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 C@C@C4591001SEC4591001 1005 10051410ASCRN Screening ASCREENING 2020-12-09 2020-12-09T16:46:00AAC4591001SEC4591001 1005 10051410A VAXP Placebo A VACCINATION 2020-12-09T16:46:002021-01-27 AB2C4591001SEC4591001 1005 10051410A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-19 B2BC4591001SEC4591001 1005 10051410A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T14:59:00BBC4591001SEC4591001 1005 10051410APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T14:59:002021-07-07 BBC4591001SEC4591001 1005 10051410A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1005 10051412ASCRN Screening ASCREENING 2020-12-14 2020-12-14T09:49:00AAC4591001SEC4591001 1005 10051412A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T09:49:002021-02-09 AB:C4591001SEC4591001 1005 10051412A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-06-30 B:BC4591001SEC4591001 1005 10051413ASCRN Screening ASCREENING 2020-12-14 2020-12-14T09:32:00AAC4591001SEC4591001 1005 10051413A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T09:32:002021-02-01 AB2C4591001SEC4591001 1005 10051413A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-07-26 B2BC4591001SEC4591001 1005 10051414ASCRN Screening ASCREENING 2020-12-14 2020-12-14T11:36:00AAC4591001SEC4591001 1005 10051414A VAXP Placebo A VACCINATION 2020-12-14T11:36:002021-02-01 AB2C4591001SEC4591001 1005 10051414A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-25 B2BC4591001SEC4591001 1005 10051414A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T16:51:00BBC4591001SEC4591001 1005 10051414APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T16:51:002021-07-23 BBC4591001SEC4591001 1005 10051414A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-23 2021-07-23 BBC4591001SEC4591001 1005 10051415ASCRN Screening ASCREENING 2020-12-14 2020-12-14T16:26:00AAC4591001SEC4591001 1005 10051415A VAXP Placebo A VACCINATION 2020-12-14T16:26:002021-02-01 AB2C4591001SEC4591001 1005 10051415A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-20 B2BC4591001SEC4591001 1005 10051415A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T14:11:00BBC4591001SEC4591001 1005 10051415APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T14:11:002021-07-08 BBC4591001SEC4591001 1005 10051415A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1005 10051417ASCRN Screening ASCREENING 2020-12-16 2020-12-16T12:25:00AAC4591001SEC4591001 1005 10051417A VAXP Placebo A VACCINATION 2020-12-16T12:25:002021-02-10 AB9C4591001SEC4591001 1005 10051417A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-20 B9BC4591001SEC4591001 1005 10051417A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-20 2021-07-20T12:18:00BBC4591001SEC4591001 1005 10051417APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-20T12:18:002021-08-14 BBC4591001SEC4591001 1005 10051418ASCRN Screening ASCREENING 2020-12-16 2020-12-16T12:30:00AAC4591001SEC4591001 1005 10051418A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T12:30:002021-02-10 AB9C4591001SEC4591001 1005 10051418A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-16 B9BC4591001SEC4591001 1005 10051419ASCRN Screening ASCREENING 2020-12-16 2020-12-16T15:57:00AAC4591001SEC4591001 1005 10051419A VAXP Placebo A VACCINATION 2020-12-16T15:57:002021-02-01 AB0C4591001SEC4591001 1005 10051419A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-02-24 B0BGC4591001SEC4591001 1005 10051419A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-24 2021-02-24T15:21:00BGBGC4591001SEC4591001 1005 10051419APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-24T15:21:002021-04-14 BGBxC4591001SEC4591001 1005 10051419A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-14 2021-04-14 BxBxC4591001SEC4591001 1005 10051420ASCRN Screening ASCREENING 2020-12-16 2020-12-16T15:50:00AAC4591001SEC4591001 1005 10051420A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T15:50:002021-02-01 AB0C4591001SEC4591001 1005 10051420A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-07-19 B0BC4591001SEC4591001 1005 10051421ASCRN Screening ASCREENING 2020-12-17 2020-12-17T15:48:00AAC4591001SEC4591001 1005 10051421A VAXP Placebo A VACCINATION 2020-12-17T15:48:002021-02-08 AB6C4591001SEC4591001 1005 10051421A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-18 B6BC4591001SEC4591001 1005 10051421A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T16:13:00BBC4591001SEC4591001 1005 10051421APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T16:13:002021-07-19 BBC4591001SEC4591001 1005 10051421A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-19 BBC4591001SEC4591001 1005 10051422ASCRN Screening ASCREENING 2020-12-17 2020-12-17T15:56:00AAC4591001SEC4591001 1005 10051422A VAXP Placebo A VACCINATION 2020-12-17T15:56:002021-02-08 AB6C4591001SEC4591001 1005 10051422A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-18 B6BC4591001SEC4591001 1005 10051422A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T16:14:00BBC4591001SEC4591001 1005 10051422APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T16:14:002021-07-19 BBC4591001SEC4591001 1005 10051422A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-19 BBC4591001SEC4591001 1005 10051424ASCRN Screening ASCREENING 2020-12-18 2020-12-18T09:36:00AAC4591001SEC4591001 1005 10051424A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T09:36:002021-02-12 AB9C4591001SEC4591001 1005 10051424A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-12 B9BC4591001SEC4591001 1005 10051425ASCRN Screening ASCREENING 2020-12-18 2020-12-18T12:13:00AAC4591001SEC4591001 1005 10051425A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T12:13:002021-02-09 AB6C4591001SEC4591001 1005 10051425A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-07-08 B6BC4591001SEC4591001 1005 10051427ASCRN Screening ASCREENING 2020-12-21 2020-12-21T11:11:00AAC4591001SEC4591001 1005 10051427A VAXP Placebo A VACCINATION 2020-12-21T11:11:002021-02-08 AB2C4591001SEC4591001 1005 10051427A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-17 B2BC4591001SEC4591001 1005 10051427A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T12:32:00BBC4591001SEC4591001 1005 10051427APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T12:32:002021-07-08 BBC4591001SEC4591001 1005 10051427A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1005 10051428ASCRN Screening ASCREENING 2020-12-21 2020-12-21T14:37:00AAC4591001SEC4591001 1005 10051428A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T14:37:002021-02-10 AB4C4591001SEC4591001 1005 10051428A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-14 B4BC4591001SEC4591001 1005 10051429ASCRN Screening ASCREENING 2020-12-21 2020-12-21T15:09:00AAC4591001SEC4591001 1005 10051429A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T15:09:002021-02-15 AB9C4591001SEC4591001 1005 10051429A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-16 B9BC4591001SEC4591001 1005 10051430ASCRN Screening ASCREENING 2020-12-22 2020-12-22T08:48:00AAC4591001SEC4591001 1005 10051430A VAXP Placebo A VACCINATION 2020-12-22T08:48:002021-02-09 AB2C4591001SEC4591001 1005 10051430A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-04-22 B2BzC4591001SEC4591001 1005 10051430A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-22 2021-04-22T09:43:00BzBzC4591001SEC4591001 1005 10051430APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-22T09:43:002021-06-14 BzBC4591001SEC4591001 1005 10051430A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-14 2021-07-19 BBC4591001SEC4591001 1005 10051431ASCRN Screening ASCREENING 2020-12-22 2020-12-22T09:40:00AAC4591001SEC4591001 1005 10051431A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T09:40:002021-02-09 AB2C4591001SEC4591001 1005 10051431A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-07-20 B2BC4591001SEC4591001 1005 10051436ASCRN Screening ASCREENING 2020-12-22 2020-12-22T12:26:00AAC4591001SEC4591001 1005 10051436A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T12:26:002021-02-15 AB8C4591001SEC4591001 1005 10051436A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-08 B8BC4591001SEC4591001 1005 10051437ASCRN Screening ASCREENING 2020-12-22 2020-12-22T12:20:00AAC4591001SEC4591001 1005 10051437A VAXP Placebo A VACCINATION 2020-12-22T12:20:002021-02-15 AB8C4591001SEC4591001 1005 10051437A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-27 B8BC4591001SEC4591001 1005 10051437A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-27 2021-05-27T10:24:00BBC4591001SEC4591001 1005 10051437APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-27T10:24:002021-07-19 BBC4591001SEC4591001 1005 10051437A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-19 BBC4591001SEC4591001 1005 10051438ASCRN Screening ASCREENING 2020-12-22 2020-12-22T12:13:00AAC4591001SEC4591001 1005 10051438A VAXP Placebo A VACCINATION 2020-12-22T12:13:002021-02-15 AB8C4591001SEC4591001 1005 10051438A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-27 B8BC4591001SEC4591001 1005 10051438A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-27 2021-05-27T10:22:00BBC4591001SEC4591001 1005 10051438APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-27T10:22:002021-07-19 BBC4591001SEC4591001 1005 10051438A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-26 BBC4591001SEC4591001 1005 10051439ASCRN Screening ASCREENING 2020-12-22 2020-12-22T15:07:00AAC4591001SEC4591001 1005 10051439A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T15:07:002021-02-09 AB2C4591001SEC4591001 1005 10051439A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-07-12 B2BC4591001SEC4591001 1005 10051440ASCRN Screening ASCREENING 2020-12-22 2020-12-22T15:10:00AAC4591001SEC4591001 1005 10051440A VAXP Placebo A VACCINATION 2020-12-22T15:10:002021-02-09 AB2C4591001SEC4591001 1005 10051440A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-05-19 B2BC4591001SEC4591001 1005 10051440A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T12:17:00BBC4591001SEC4591001 1005 10051440APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T12:17:002021-07-07 BBC4591001SEC4591001 1005 10051440A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1005 10051441ASCRN Screening ASCREENING 2020-12-22 2020-12-22T15:00:00AAC4591001SEC4591001 1005 10051441A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T15:00:002021-02-10 AB3C4591001SEC4591001 1005 10051441A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-08-05 B3BC4591001SEC4591001 1005 10051444ASCRN Screening ASCREENING 2020-12-22 2020-12-22T16:23:00AAC4591001SEC4591001 1005 10051444A VAXP Placebo A VACCINATION 2020-12-22T16:23:002021-02-09 AB2C4591001SEC4591001 1005 10051444A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-05-20 B2BC4591001SEC4591001 1005 10051444A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T15:17:00BBC4591001SEC4591001 1005 10051444APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T15:17:002021-07-08 BBC4591001SEC4591001 1005 10051444A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1005 10051445ASCRN Screening ASCREENING 2020-12-22 2020-12-22T16:50:00AAC4591001SEC4591001 1005 10051445A VAXP Placebo A VACCINATION 2020-12-22T16:50:002021-02-09 AB2C4591001SEC4591001 1005 10051445A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-05-26 B2BC4591001SEC4591001 1005 10051445A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T09:09:00BBC4591001SEC4591001 1005 10051445APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T09:09:002021-07-15 BBC4591001SEC4591001 1005 10051445A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-15 2021-07-15 BBC4591001SEC4591001 1005 10051447ASCRN Screening ASCREENING 2021-01-11 2021-01-11T10:48:00AAC4591001SEC4591001 1005 10051447A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T10:48:002021-03-01 AB2C4591001SEC4591001 1005 10051447A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-26 B2BC4591001SEC4591001 1005 10051448ASCRN Screening ASCREENING 2021-01-11 2021-01-11T12:59:00AAC4591001SEC4591001 1005 10051448A VAXP Placebo A VACCINATION 2021-01-11T12:59:002021-03-01 AB2C4591001SEC4591001 1005 10051448A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-05-26 B2BC4591001SEC4591001 1005 10051448A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T09:40:00BBC4591001SEC4591001 1005 10051448APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T09:40:002021-07-19 BBC4591001SEC4591001 1005 10051448A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-19 BBC4591001SEC4591001 1005 10051449ASCRN Screening ASCREENING 2021-01-11 2021-01-11T12:48:00AAC4591001SEC4591001 1005 10051449A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T12:48:002021-03-01 AB2C4591001SEC4591001 1005 10051449A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-08-02 B2BC4591001SEC4591001 1005 10051450ASCRN Screening ASCREENING 2021-01-11 2021-01-11T14:54:00AAC4591001SEC4591001 1005 10051450A VAXP Placebo A VACCINATION 2021-01-11T14:54:002021-03-01 AB2C4591001SEC4591001 1005 10051450A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-05-24 B2BC4591001SEC4591001 1005 10051450A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T16:01:00BBC4591001SEC4591001 1005 10051450APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T16:01:002021-07-19 BBC4591001SEC4591001 1005 10051450A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-19 BBC4591001SEC4591001 1005 10051451ASCRN Screening ASCREENING 2021-01-12 2021-01-12T14:32:00AAC4591001SEC4591001 1005 10051451A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T14:32:002021-03-03 AB3C4591001SEC4591001 1005 10051451A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-08-09 B3BC4591001SEC4591001 1006 10061183ASCRN Screening ASCREENING 2020-11-30 2020-11-30T09:24:00AAC4591001SEC4591001 1006 10061183A VAXP Placebo A VACCINATION 2020-11-30T09:24:002021-02-09 ABHC4591001SEC4591001 1006 10061183A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-05-20 BHBC4591001SEC4591001 1006 10061183A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T10:22:00BBC4591001SEC4591001 1006 10061183APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T10:22:002021-07-12 BBC4591001SEC4591001 1006 10061183A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1006 10061184ASCRN Screening ASCREENING 2020-11-30 2020-11-30T12:03:00AAC4591001SEC4591001 1006 10061184A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-11-30T12:03:002021-01-22 AB6C4591001SEC4591001 1006 10061184A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-06-14 B6BC4591001SEC4591001 1006 10061188ASCRN Screening ASCREENING 2020-12-01 2020-12-01T17:24:00AAC4591001SEC4591001 1006 10061188A VAXP Placebo A VACCINATION 2020-12-01T17:24:002021-01-19 AB2C4591001SEC4591001 1006 10061188A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-05-18 B2BC4591001SEC4591001 1006 10061188A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T17:04:00BBC4591001SEC4591001 1006 10061188APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T17:04:002021-07-12 BBC4591001SEC4591001 1006 10061188A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1006 10061189ASCRN Screening ASCREENING 2020-12-01 2020-12-01T17:24:00AAC4591001SEC4591001 1006 10061189A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-01T17:24:002021-01-19 AB2C4591001SEC4591001 1006 10061189A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-06-15 B2BC4591001SEC4591001 1006 10061190ASCRN Screening ASCREENING 2020-12-02 2020-12-02T08:52:00AAC4591001SEC4591001 1006 10061190A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T08:52:002021-01-20 AB2C4591001SEC4591001 1006 10061190A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-17 B2BC4591001SEC4591001 1006 10061191ASCRN Screening ASCREENING 2020-12-02 2020-12-02T11:09:00AAC4591001SEC4591001 1006 10061191A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T11:09:002021-01-19 AB1C4591001SEC4591001 1006 10061191A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-06-18 B1BC4591001SEC4591001 1006 10061196ASCRN Screening ASCREENING 2020-12-02 2020-12-02T18:00:00AAC4591001SEC4591001 1006 10061196A VAXP Placebo A VACCINATION 2020-12-02T18:00:002021-01-20 AB2C4591001SEC4591001 1006 10061196A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-05-19 B2BC4591001SEC4591001 1006 10061196A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T14:04:00BBC4591001SEC4591001 1006 10061196APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T14:04:002021-07-06 BBC4591001SEC4591001 1006 10061196A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1006 10061200ASCRN Screening ASCREENING 2020-12-03 2020-12-03T14:59:00AAC4591001SEC4591001 1006 10061200A VAXP Placebo A VACCINATION 2020-12-03T14:59:002021-01-28 AB9C4591001SEC4591001 1006 10061200A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-03-16 B9BhC4591001SEC4591001 1006 10061200A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-16 2021-03-16T17:01:00BhBhC4591001SEC4591001 1006 10061200APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-16T17:01:002021-05-11 BhBC4591001SEC4591001 1006 10061200A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-11 2021-08-26 BCC4591001SEC4591001 1006 10061201ASCRN Screening ASCREENING 2020-12-03 2020-12-03T14:58:00AAC4591001SEC4591001 1006 10061201A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-03T14:58:002021-01-28 AB9C4591001SEC4591001 1006 10061201A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-07-07 B9BC4591001SEC4591001 1006 10061203ASCRN Screening ASCREENING 2020-12-03 2020-12-03T17:14:00AAC4591001SEC4591001 1006 10061203A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-03T17:14:002021-01-19 AB0C4591001SEC4591001 1006 10061203A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-06-17 B0BC4591001SEC4591001 1006 10061206ASCRN Screening ASCREENING 2020-12-04 2020-12-04T09:16:00AAC4591001SEC4591001 1006 10061206A VAXP Placebo A VACCINATION 2020-12-04T09:16:002021-01-22 AB2C4591001SEC4591001 1006 10061206A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-05-18 B2BC4591001SEC4591001 1006 10061207ASCRN Screening ASCREENING 2020-12-04 2020-12-04T09:17:00AAC4591001SEC4591001 1006 10061207A VAXP Placebo A VACCINATION 2020-12-04T09:17:002021-01-22 AB2C4591001SEC4591001 1006 10061207A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-05-18 B2BC4591001SEC4591001 1006 10061209ASCRN Screening ASCREENING 2020-12-04 2020-12-04T12:09:00AAC4591001SEC4591001 1006 10061209A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-04T12:09:002021-01-26 AB6C4591001SEC4591001 1006 10061209A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-06-22 B6BC4591001SEC4591001 1006 10061212ASCRN Screening ASCREENING 2020-12-04 2020-12-04T14:24:00AAC4591001SEC4591001 1006 10061212A VAXP Placebo A VACCINATION 2020-12-04T14:24:002021-01-22 AB2C4591001SEC4591001 1006 10061212A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-05-18 B2BC4591001SEC4591001 1006 10061212A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T11:02:00BBC4591001SEC4591001 1006 10061212APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T11:02:002021-07-08 BBC4591001SEC4591001 1006 10061212A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1006 10061213ASCRN Screening ASCREENING 2020-12-04 2020-12-04T14:23:00AAC4591001SEC4591001 1006 10061213A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-04T14:23:002021-01-22 AB2C4591001SEC4591001 1006 10061213A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-06-16 B2BC4591001SEC4591001 1006 10061214ASCRN Screening ASCREENING 2020-12-04 2020-12-04T15:54:00AAC4591001SEC4591001 1006 10061214A VAXP Placebo A VACCINATION 2020-12-04T15:54:002021-01-22 AB2C4591001SEC4591001 1006 10061214A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-05-18 B2BC4591001SEC4591001 1006 10061214A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T16:07:00BBC4591001SEC4591001 1006 10061214APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T16:07:002021-07-19 BBC4591001SEC4591001 1006 10061214A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-19 BBC4591001SEC4591001 1006 10061219ASCRN Screening ASCREENING 2020-12-07 2020-12-07T09:55:00AAC4591001SEC4591001 1006 10061219A VAXP Placebo A VACCINATION 2020-12-07T09:55:002021-01-25 AB2C4591001SEC4591001 1006 10061219A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-06-15 B2BC4591001SEC4591001 1006 10061219A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-15 2021-06-15T09:50:00BBC4591001SEC4591001 1006 10061219APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-15T09:50:002021-09-01 BCC4591001SEC4591001 1006 10061219A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-09-01 2021-09-01 CCC4591001SEC4591001 1006 10061220ASCRN Screening ASCREENING 2020-12-07 2020-12-07T10:58:00AAC4591001SEC4591001 1006 10061220A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T10:58:002021-01-29 AB6C4591001SEC4591001 1006 10061220A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-06-23 B6BC4591001SEC4591001 1006 10061221ASCRN Screening ASCREENING 2020-12-07 2020-12-07T12:09:00AAC4591001SEC4591001 1006 10061221A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T12:09:002021-01-29 AB6C4591001SEC4591001 1006 10061221A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-08-02 B6BC4591001SEC4591001 1006 10061223ASCRN Screening ASCREENING 2020-12-07 2020-12-07T13:48:00AAC4591001SEC4591001 1006 10061223A VAXP Placebo A VACCINATION 2020-12-07T13:48:002021-02-02 AB:C4591001SEC4591001 1006 10061223A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-17 B:BC4591001SEC4591001 1006 10061223A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T08:45:00BBC4591001SEC4591001 1006 10061223APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T08:45:002021-07-08 BBC4591001SEC4591001 1006 10061223A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1006 10061224ASCRN Screening ASCREENING 2020-12-07 2020-12-07T15:10:00AAC4591001SEC4591001 1006 10061224A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T15:10:002021-01-29 AB6C4591001SEC4591001 1006 10061224A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-07-08 B6BC4591001SEC4591001 1006 10061226ASCRN Screening ASCREENING 2020-12-07 2020-12-07T16:29:00AAC4591001SEC4591001 1006 10061226A VAXP Placebo A VACCINATION 2020-12-07T16:29:002021-01-25 AB2C4591001SEC4591001 1006 10061226A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-05-14 B2BC4591001SEC4591001 1006 10061226A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T11:19:00BBC4591001SEC4591001 1006 10061226APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T11:19:002021-07-08 BBC4591001SEC4591001 1006 10061226A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1006 10061227ASCRN Screening ASCREENING 2020-12-07 2020-12-07T16:30:00AAC4591001SEC4591001 1006 10061227A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T16:30:002021-01-25 AB2C4591001SEC4591001 1006 10061227A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-06-21 B2BC4591001SEC4591001 1006 10061228ASCRN Screening ASCREENING 2020-12-08 2020-12-08T10:56:00AAC4591001SEC4591001 1006 10061228A VAXP Placebo A VACCINATION 2020-12-08T10:56:002021-01-28 AB4C4591001SEC4591001 1006 10061228A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-05-14 B4BC4591001SEC4591001 1006 10061228A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T11:19:00BBC4591001SEC4591001 1006 10061228APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T11:19:002021-07-08 BBC4591001SEC4591001 1006 10061228A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1006 10061229ASCRN Screening ASCREENING 2020-12-08 2020-12-08T13:00:00AAC4591001SEC4591001 1006 10061229A VAXP Placebo A VACCINATION 2020-12-08T13:00:002021-02-01 AB8C4591001SEC4591001 1006 10061229A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-02-18 B8BIC4591001SEC4591001 1006 10061229A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-18 2021-02-18T16:38:00BIBIC4591001SEC4591001 1006 10061229APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-18T16:38:002021-04-08 BIBzC4591001SEC4591001 1006 10061229A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-08 2021-06-23 BzBC4591001SEC4591001 1006 10061230ASCRN Screening ASCREENING 2020-12-08 2020-12-08T17:08:00AAC4591001SEC4591001 1006 10061230A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T17:08:002021-02-02 AB9C4591001SEC4591001 1006 10061230A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-08-10 B9BC4591001SEC4591001 1006 10061231ASCRN Screening ASCREENING 2020-12-08 2020-12-08T17:33:00AAC4591001SEC4591001 1006 10061231A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T17:33:002021-01-26 AB2C4591001SEC4591001 1006 10061231A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-08-16 B2BC4591001SEC4591001 1006 10061232ASCRN Screening ASCREENING 2020-12-08 2020-12-08T17:56:00AAC4591001SEC4591001 1006 10061232A VAXP Placebo A VACCINATION 2020-12-08T17:56:002021-01-27 AB3C4591001SEC4591001 1006 10061232A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-18 B3BC4591001SEC4591001 1006 10061232A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T17:52:00BBC4591001SEC4591001 1006 10061232APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T17:52:002021-07-08 BBC4591001SEC4591001 1006 10061232A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1006 10061233ASCRN Screening ASCREENING 2020-12-08 2020-12-08T17:51:00AAC4591001SEC4591001 1006 10061233A VAXP Placebo A VACCINATION 2020-12-08T17:51:002021-01-27 AB3C4591001SEC4591001 1006 10061233A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-18 B3BC4591001SEC4591001 1006 10061233A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T17:53:00BBC4591001SEC4591001 1006 10061233APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T17:53:002021-07-08 BBC4591001SEC4591001 1006 10061233A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1006 10061234ASCRN Screening ASCREENING 2020-12-09 2020-12-09T08:59:00AAC4591001SEC4591001 1006 10061234A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T08:59:002021-01-27 AB2C4591001SEC4591001 1006 10061234A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-23 B2BC4591001SEC4591001 1006 10061235ASCRN Screening ASCREENING 2020-12-09 2020-12-09T09:00:00AAC4591001SEC4591001 1006 10061235A VAXP Placebo A VACCINATION 2020-12-09T09:00:002021-01-27 AB2C4591001SEC4591001 1006 10061235A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-19 B2BC4591001SEC4591001 1006 10061235A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T14:20:00BBC4591001SEC4591001 1006 10061235APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T14:20:002021-07-06 BBC4591001SEC4591001 1006 10061235A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-14 BBC4591001SEC4591001 1006 10061236ASCRN Screening ASCREENING 2020-12-09 2020-12-09T11:20:00AAC4591001SEC4591001 1006 10061236A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T11:20:002021-01-25 AB0C4591001SEC4591001 1006 10061236A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-06-21 B0BC4591001SEC4591001 1006 10061237ASCRN Screening ASCREENING 2020-12-09 2020-12-09T11:39:00AAC4591001SEC4591001 1006 10061237A VAXP Placebo A VACCINATION 2020-12-09T11:39:002021-01-27 AB2C4591001SEC4591001 1006 10061237A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-14 B2BC4591001SEC4591001 1006 10061237A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T15:09:00BBC4591001SEC4591001 1006 10061237APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T15:09:002021-06-30 BBC4591001SEC4591001 1006 10061237A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-30 2021-06-30 BBC4591001SEC4591001 1006 10061239ASCRN Screening ASCREENING 2020-12-09 2020-12-09T12:26:00AAC4591001SEC4591001 1006 10061239A VAXP Placebo A VACCINATION 2020-12-09T12:26:002021-01-27 AB2C4591001SEC4591001 1006 10061239A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-17 B2BC4591001SEC4591001 1006 10061239A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T17:44:00BBC4591001SEC4591001 1006 10061239APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T17:44:002021-07-09 BBC4591001SEC4591001 1006 10061239A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1006 10061241ASCRN Screening ASCREENING 2020-12-09 2020-12-09T14:21:00AAC4591001SEC4591001 1006 10061241A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T14:21:002021-01-27 AB2C4591001SEC4591001 1006 10061241A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-22 B2BC4591001SEC4591001 1006 10061242ASCRN Screening ASCREENING 2020-12-09 2020-12-09T16:24:00AAC4591001SEC4591001 1006 10061242A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T16:24:002021-01-29 AB4C4591001SEC4591001 1006 10061242A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-07-06 B4BC4591001SEC4591001 1006 10061243ASCRN Screening ASCREENING 2020-12-10 2020-12-10T10:07:00AAC4591001SEC4591001 1006 10061243A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T10:07:002021-01-26 AB0C4591001SEC4591001 1006 10061243A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-06-29 B0BC4591001SEC4591001 1006 10061244ASCRN Screening ASCREENING 2020-12-10 2020-12-10T12:10:00AAC4591001SEC4591001 1006 10061244A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T12:10:002021-01-26 AB0C4591001SEC4591001 1006 10061244A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-06-22 B0BC4591001SEC4591001 1006 10061245ASCRN Screening ASCREENING 2020-12-10 2020-12-10T12:11:00AAC4591001SEC4591001 1006 10061245A VAXP Placebo A VACCINATION 2020-12-10T12:11:002021-01-26 AB0C4591001SEC4591001 1006 10061245A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-05-18 B0BC4591001SEC4591001 1006 10061245A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T16:50:00BBC4591001SEC4591001 1006 10061245APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T16:50:002021-07-08 BBC4591001SEC4591001 1006 10061245A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1006 10061247ASCRN Screening ASCREENING 2020-12-10 2020-12-10T18:19:00AAC4591001SEC4591001 1006 10061247A VAXP Placebo A VACCINATION 2020-12-10T18:19:002021-01-28 AB2C4591001SEC4591001 1006 10061247A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-05-14 B2BC4591001SEC4591001 1006 10061247A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T17:44:00BBC4591001SEC4591001 1006 10061247APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T17:44:002021-07-12 BBC4591001SEC4591001 1006 10061247A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1006 10061248ASCRN Screening ASCREENING 2020-12-11 2020-12-11T09:11:00AAC4591001SEC4591001 1006 10061248A VAXP Placebo A VACCINATION 2020-12-11T09:11:002021-01-29 AB2C4591001SEC4591001 1006 10061248A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-05-19 B2BC4591001SEC4591001 1006 10061248A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T11:40:00BBC4591001SEC4591001 1006 10061248APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T11:40:002021-07-09 BBC4591001SEC4591001 1006 10061248A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1006 10061249ASCRN Screening ASCREENING 2020-12-11 2020-12-11T11:00:00AAC4591001SEC4591001 1006 10061249A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-11T11:00:002021-02-04 AB8C4591001SEC4591001 1006 10061249A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-06-25 B8BC4591001SEC4591001 1006 10061250ASCRN Screening ASCREENING 2020-12-11 2020-12-11T11:03:00AAC4591001SEC4591001 1006 10061250A VAXP Placebo A VACCINATION 2020-12-11T11:03:002021-02-04 AB8C4591001SEC4591001 1006 10061250A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-20 B8BC4591001SEC4591001 1006 10061250A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T09:16:00BBC4591001SEC4591001 1006 10061250APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T09:16:002021-07-27 BBC4591001SEC4591001 1006 10061250A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-27 2021-07-27 BBC4591001SEC4591001 1006 10061252ASCRN Screening ASCREENING 2020-12-11 2020-12-11T12:42:00AAC4591001SEC4591001 1006 10061252A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-11T12:42:002021-01-28 AB1C4591001SEC4591001 1006 10061252A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-07-12 B1BC4591001SEC4591001 1006 10061253ASCRN Screening ASCREENING 2020-12-11 2020-12-11T14:15:00AAC4591001SEC4591001 1006 10061253A VAXP Placebo A VACCINATION 2020-12-11T14:15:002021-02-01 AB5C4591001SEC4591001 1006 10061253A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-17 B5BC4591001SEC4591001 1006 10061253A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T08:58:00BBC4591001SEC4591001 1006 10061253APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T08:58:002021-07-08 BBC4591001SEC4591001 1006 10061253A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1006 10061254ASCRN Screening ASCREENING 2020-12-11 2020-12-11T14:00:00AAC4591001SEC4591001 1006 10061254A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-11T14:00:002021-02-02 AB6C4591001SEC4591001 1006 10061254A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-07-06 B6BC4591001SEC4591001 1006 10061256ASCRN Screening ASCREENING 2020-12-11 2020-12-11T17:55:00AAC4591001SEC4591001 1006 10061256A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-11T17:55:002021-02-01 AB5C4591001SEC4591001 1006 10061256A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-07-07 B5BC4591001SEC4591001 1006 10061257ASCRN Screening ASCREENING 2020-12-11 2020-12-11T17:50:00AAC4591001SEC4591001 1006 10061257A VAXP Placebo A VACCINATION 2020-12-11T17:50:002021-01-28 AB1C4591001SEC4591001 1006 10061257A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-02-19 B1BGC4591001SEC4591001 1006 10061257A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-19 2021-02-19T16:57:00BGBGC4591001SEC4591001 1006 10061257APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-19T16:57:002021-04-09 BGBxC4591001SEC4591001 1006 10061257A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-09 2021-04-09 BxBxC4591001SEC4591001 1006 10061258ASCRN Screening ASCREENING 2020-12-14 2020-12-14T09:15:00AAC4591001SEC4591001 1006 10061258A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T09:15:002021-02-08 AB9C4591001SEC4591001 1006 10061258A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-09 B9BC4591001SEC4591001 1006 10061259ASCRN Screening ASCREENING 2020-12-14 2020-12-14T10:42:00AAC4591001SEC4591001 1006 10061259A VAXP Placebo A VACCINATION 2020-12-14T10:42:002021-02-02 AB3C4591001SEC4591001 1006 10061259A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-03-19 B3B`C4591001SEC4591001 1006 10061259A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-19 2021-03-19T09:39:00B`B`C4591001SEC4591001 1006 10061259APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-19T09:39:002021-05-11 B`BC4591001SEC4591001 1006 10061259A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-11 2021-05-11 BBC4591001SEC4591001 1006 10061260ASCRN Screening ASCREENING 2020-12-14 2020-12-14T10:44:00AAC4591001SEC4591001 1006 10061260A VAXP Placebo A VACCINATION 2020-12-14T10:44:002021-02-02 AB3C4591001SEC4591001 1006 10061260A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-17 B3BC4591001SEC4591001 1006 10061260A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T09:39:00BBC4591001SEC4591001 1006 10061260APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T09:39:002021-07-09 BBC4591001SEC4591001 1006 10061260A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1006 10061261ASCRN Screening ASCREENING 2020-12-14 2020-12-14T15:52:00AAC4591001SEC4591001 1006 10061261A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T15:52:002021-02-02 AB3C4591001SEC4591001 1006 10061261A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-06-30 B3BC4591001SEC4591001 1006 10061262ASCRN Screening ASCREENING 2020-12-14 2020-12-14T17:40:00AAC4591001SEC4591001 1006 10061262A VAXP Placebo A VACCINATION 2020-12-14T17:40:002021-02-09 AB:C4591001SEC4591001 1006 10061262A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-05-25 B:BC4591001SEC4591001 1006 10061262A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T17:42:00BBC4591001SEC4591001 1006 10061262APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T17:42:002021-08-11 BBC4591001SEC4591001 1006 10061262A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-11 2021-09-01 BC`C4591001SEC4591001 1006 10061263ASCRN Screening ASCREENING 2020-12-14 2020-12-14T17:30:00AAC4591001SEC4591001 1006 10061263A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T17:30:002021-02-05 AB6C4591001SEC4591001 1006 10061263A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-07 B6BC4591001SEC4591001 1006 10061264ASCRN Screening ASCREENING 2020-12-14 2020-12-14T18:00:00AAC4591001SEC4591001 1006 10061264A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T18:00:002021-02-03 AB4C4591001SEC4591001 1006 10061264A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-06 B4BC4591001SEC4591001 1006 10061265ASCRN Screening ASCREENING 2020-12-15 2020-12-18T10:00:000AC4591001SEC4591001 1006 10061265A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T10:00:002021-02-04 AB1C4591001SEC4591001 1006 10061265A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-14 B1BC4591001SEC4591001 1006 10061266ASCRN Screening ASCREENING 2020-12-15 2020-12-15T11:15:00AAC4591001SEC4591001 1006 10061266A VAXP Placebo A VACCINATION 2020-12-15T11:15:002021-02-10 AB:C4591001SEC4591001 1006 10061266A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-02-24 B:BHC4591001SEC4591001 1006 10061266A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-24 2021-02-24T11:18:00BHBHC4591001SEC4591001 1006 10061266APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-24T11:18:002021-04-14 BHByC4591001SEC4591001 1006 10061266A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-14 2021-04-14 ByByC4591001SEC4591001 1006 10061267ASCRN Screening ASCREENING 2020-12-15 2020-12-15T13:25:00AAC4591001SEC4591001 1006 10061267A VAXP Placebo A VACCINATION 2020-12-15T13:25:002021-02-19 ABCC4591001SEC4591001 1006 10061267A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-07-21 BCBC4591001SEC4591001 1006 10061267A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-21 2021-07-21T17:40:00BBC4591001SEC4591001 1006 10061267APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-21T17:40:002021-08-13 BBC4591001SEC4591001 1006 10061269ASCRN Screening ASCREENING 2020-12-15 2020-12-15T17:36:00AAC4591001SEC4591001 1006 10061269A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T17:36:002021-02-10 AB:C4591001SEC4591001 1006 10061269A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-06-29 B:BC4591001SEC4591001 1006 10061270ASCRN Screening ASCREENING 2020-12-16 2020-12-16T10:56:00AAC4591001SEC4591001 1006 10061270A VAXP Placebo A VACCINATION 2020-12-16T10:56:002021-02-03 AB2C4591001SEC4591001 1006 10061270A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-02-18 B2BAC4591001SEC4591001 1006 10061270A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-18 2021-02-18T09:46:00BABAC4591001SEC4591001 1006 10061270APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-18T09:46:002021-04-09 BABsC4591001SEC4591001 1006 10061270A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-09 2021-04-09 BsBsC4591001SEC4591001 1006 10061271ASCRN Screening ASCREENING 2020-12-16 2020-12-16T11:47:00AAC4591001SEC4591001 1006 10061271A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T11:47:002021-02-03 AB2C4591001SEC4591001 1006 10061271A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-07 B2BC4591001SEC4591001 1006 10061272ASCRN Screening ASCREENING 2020-12-16 2020-12-16T12:07:00AAC4591001SEC4591001 1006 10061272A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T12:07:002021-02-08 AB7C4591001SEC4591001 1006 10061272A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-08-12 B7BC4591001SEC4591001 1006 10061273ASCRN Screening ASCREENING 2020-12-16 2020-12-16T16:05:00AAC4591001SEC4591001 1006 10061273A VAXP Placebo A VACCINATION 2020-12-16T16:05:002021-02-05 AB4C4591001SEC4591001 1006 10061273A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-18 B4BC4591001SEC4591001 1006 10061273A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T15:16:00BBC4591001SEC4591001 1006 10061273APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T15:16:002021-07-08 BBC4591001SEC4591001 1006 10061273A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1006 10061274ASCRN Screening ASCREENING 2020-12-16 2020-12-16T17:48:00AAC4591001SEC4591001 1006 10061274A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T17:48:002021-02-05 AB4C4591001SEC4591001 1006 10061274A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-07 B4BC4591001SEC4591001 1006 10061276ASCRN Screening ASCREENING 2020-12-17 2020-12-17T12:52:00AAC4591001SEC4591001 1006 10061276A VAXP Placebo A VACCINATION 2020-12-17T12:52:002021-02-05 AB3C4591001SEC4591001 1006 10061276A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-19 B3BC4591001SEC4591001 1006 10061276A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T09:22:00BBC4591001SEC4591001 1006 10061276APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T09:22:002021-07-20 BBC4591001SEC4591001 1006 10061276A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-20 2021-07-20 BBC4591001SEC4591001 1006 10061277ASCRN Screening ASCREENING 2020-12-17 2020-12-17T15:30:00AAC4591001SEC4591001 1006 10061277A VAXP Placebo A VACCINATION 2020-12-17T15:30:002021-02-08 AB6C4591001SEC4591001 1006 10061277A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-18 B6BC4591001SEC4591001 1006 10061277A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T11:44:00BBC4591001SEC4591001 1006 10061277APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T11:44:002021-07-08 BBC4591001SEC4591001 1006 10061277A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-08-23 BBC4591001SEC4591001 1006 10061278ASCRN Screening ASCREENING 2020-12-17 2020-12-17T17:11:00AAC4591001SEC4591001 1006 10061278A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T17:11:002021-02-02 AB0C4591001SEC4591001 1006 10061278A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-07-02 B0BC4591001SEC4591001 1006 10061279ASCRN Screening ASCREENING 2020-12-17 2020-12-17T17:31:00AAC4591001SEC4591001 1006 10061279A VAXP Placebo A VACCINATION 2020-12-17T17:31:002021-02-02 AB0C4591001SEC4591001 1006 10061279A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-17 B0BC4591001SEC4591001 1006 10061279A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T10:54:00BBC4591001SEC4591001 1006 10061279APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T10:54:002021-07-08 BBC4591001SEC4591001 1006 10061279A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-08-11 BBC4591001SEC4591001 1006 10061280ASCRN Screening ASCREENING 2020-12-17 2020-12-17T17:41:00AAC4591001SEC4591001 1006 10061280A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T17:41:002021-02-10 AB8C4591001SEC4591001 1006 10061280A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-08-02 B8BC4591001SEC4591001 1006 10061282ASCRN Screening ASCREENING 2020-12-18 2020-12-18T11:37:00AAC4591001SEC4591001 1006 10061282A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T11:37:002021-02-12 AB9C4591001SEC4591001 1006 10061282A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-02 B9BC4591001SEC4591001 1006 10061283ASCRN Screening ASCREENING 2020-12-18 2020-12-18T12:28:00AAC4591001SEC4591001 1006 10061283A VAXP Placebo A VACCINATION 2020-12-18T12:28:002021-02-05 AB2C4591001SEC4591001 1006 10061283A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-20 B2BC4591001SEC4591001 1006 10061283A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T17:06:00BBC4591001SEC4591001 1006 10061283APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T17:06:002021-07-08 BBC4591001SEC4591001 1006 10061283A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1006 10061284ASCRN Screening ASCREENING 2020-12-18 2020-12-18T17:36:00AAC4591001SEC4591001 1006 10061284A VAXP Placebo A VACCINATION 2020-12-18T17:36:002021-02-05 AB2C4591001SEC4591001 1006 10061284A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-25 B2BC4591001SEC4591001 1006 10061284A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T09:11:00BBC4591001SEC4591001 1006 10061284APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T09:11:002021-07-15 BBC4591001SEC4591001 1006 10061284A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-15 2021-08-31 BCC4591001SEC4591001 1006 10061285ASCRN Screening ASCREENING 2020-12-21 2020-12-21T11:59:00AAC4591001SEC4591001 1006 10061285A VAXP Placebo A VACCINATION 2020-12-21T11:59:002021-02-16 AB:C4591001SEC4591001 1006 10061285A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-06-03 B:BC4591001SEC4591001 1006 10061285A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-03 2021-06-03T10:12:00BBC4591001SEC4591001 1006 10061285APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-03T10:12:002021-07-27 BBC4591001SEC4591001 1006 10061285A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-27 2021-07-27 BBC4591001SEC4591001 1006 10061286ASCRN Screening ASCREENING 2020-12-21 2020-12-21T14:26:00AAC4591001SEC4591001 1006 10061286A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T14:26:002021-02-09 AB3C4591001SEC4591001 1006 10061286A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-07-12 B3BC4591001SEC4591001 1006 10061287ASCRN Screening ASCREENING 2020-12-21 2020-12-21T16:08:00AAC4591001SEC4591001 1006 10061287A VAXP Placebo A VACCINATION 2020-12-21T16:08:002021-02-08 AB2C4591001SEC4591001 1006 10061287A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-25 B2BC4591001SEC4591001 1006 10061288ASCRN Screening ASCREENING 2020-12-21 2020-12-21T16:09:00AAC4591001SEC4591001 1006 10061288A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T16:09:002021-02-08 AB2C4591001SEC4591001 1006 10061288A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-08-02 B2BC4591001SEC4591001 1006 10061289ASCRN Screening ASCREENING 2020-12-22 2020-12-22T09:18:00AAC4591001SEC4591001 1006 10061289A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T09:18:002021-02-15 AB8C4591001SEC4591001 1006 10061289A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-08-19 B8BC4591001SEC4591001 1006 10061290ASCRN Screening ASCREENING 2020-12-22 2020-12-22T09:19:00AAC4591001SEC4591001 1006 10061290A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T09:19:002021-02-15 AB8C4591001SEC4591001 1006 10061290A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-08-24 B8BC4591001SEC4591001 1006 10061291ASCRN Screening ASCREENING 2020-12-22 2020-12-22T09:20:00AAC4591001SEC4591001 1006 10061291A VAXP Placebo A VACCINATION 2020-12-22T09:20:002021-02-15 AB8C4591001SEC4591001 1006 10061291A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-24 B8BC4591001SEC4591001 1006 10061291A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T17:24:00BBC4591001SEC4591001 1006 10061291APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T17:24:002021-07-13 BBC4591001SEC4591001 1006 10061291A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1006 10061292ASCRN Screening ASCREENING 2020-12-22 2020-12-22T13:53:00AAC4591001SEC4591001 1006 10061292A VAXP Placebo A VACCINATION 2020-12-22T13:53:002021-02-10 AB3C4591001SEC4591001 1006 10061292A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-14 B3BC4591001SEC4591001 1006 10061292A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T09:21:00BBC4591001SEC4591001 1006 10061292APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T09:21:002021-06-30 BBC4591001SEC4591001 1006 10061292A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-30 2021-06-30 BBC4591001SEC4591001 1006 10061293ASCRN Screening ASCREENING 2020-12-22 2020-12-22T13:52:00AAC4591001SEC4591001 1006 10061293A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T13:52:002021-02-10 AB3C4591001SEC4591001 1006 10061293A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-14 B3BC4591001SEC4591001 1006 10061294ASCRN Screening ASCREENING 2020-12-22 2020-12-22T16:43:00AAC4591001SEC4591001 1006 10061294A VAXP Placebo A VACCINATION 2020-12-22T16:43:002021-02-09 AB2C4591001SEC4591001 1006 10061294A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-05-20 B2BC4591001SEC4591001 1006 10061294A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T14:18:00BBC4591001SEC4591001 1006 10061294APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T14:18:002021-07-08 BBC4591001SEC4591001 1006 10061294A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1006 10061295ASCRN Screening ASCREENING 2020-12-24 2020-12-24T10:21:00AAC4591001SEC4591001 1006 10061295A VAXP Placebo A VACCINATION 2020-12-24T10:21:002021-02-10 AB1C4591001SEC4591001 1006 10061295A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-14 B1BC4591001SEC4591001 1006 10061295A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T09:22:00BBC4591001SEC4591001 1006 10061295APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T09:22:002021-06-30 BBC4591001SEC4591001 1006 10061295A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-30 2021-06-30 BBC4591001SEC4591001 1006 10061296ASCRN Screening ASCREENING 2020-12-29 2020-12-29T09:54:00AAC4591001SEC4591001 1006 10061296A VAXP Placebo A VACCINATION 2020-12-29T09:54:002021-02-16 AB2C4591001SEC4591001 1006 10061296A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-05-27 B2BC4591001SEC4591001 1006 10061297ASCRN Screening ASCREENING 2020-12-29 2020-12-29T09:55:00AAC4591001SEC4591001 1006 10061297A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T09:55:002021-02-16 AB2C4591001SEC4591001 1006 10061297A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-05-27 B2BC4591001SEC4591001 1006 10061298ASCRN Screening ASCREENING 2020-12-29 2020-12-29T14:51:00AAC4591001SEC4591001 1006 10061298A VAXP Placebo A VACCINATION 2020-12-29T14:51:002021-02-17 AB3C4591001SEC4591001 1006 10061298A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-19 B3BC4591001SEC4591001 1006 10061298A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T10:24:00BBC4591001SEC4591001 1006 10061298APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T10:24:002021-07-09 BBC4591001SEC4591001 1006 10061298A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1006 10061299ASCRN Screening ASCREENING 2020-12-31 2020-12-31T11:41:00AAC4591001SEC4591001 1006 10061299A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-31T11:41:002021-02-24 AB8C4591001SEC4591001 1006 10061299A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-26 B8BC4591001SEC4591001 1006 10061300ASCRN Screening ASCREENING 2021-01-07 2021-01-07T16:41:00AAC4591001SEC4591001 1006 10061300A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T16:41:002021-02-26 AB3C4591001SEC4591001 1006 10061300A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-22 B3BC4591001SEC4591001 1007 10071409ASCRN Screening ASCREENING 2020-10-22 2020-10-22T11:29:00AAC4591001SEC4591001 1007 10071409A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-22T11:29:002020-12-15 AB7C4591001SEC4591001 1007 10071409A0FUP Follow-up A0FOLLOW-UP 2020-12-15 2021-07-01 B7BC4591001SEC4591001 1007 10071414ASCRN Screening ASCREENING 2020-10-22 2020-10-22T12:17:00AAC4591001SEC4591001 1007 10071414A VAXP Placebo A VACCINATION 2020-10-22T12:17:002020-12-10 AB2C4591001SEC4591001 1007 10071414A0FUP Follow-up A0FOLLOW-UP 2020-12-10 2021-05-19 B2BC4591001SEC4591001 1007 10071414A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T13:05:00BBC4591001SEC4591001 1007 10071414APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T13:05:002021-07-12 BCC4591001SEC4591001 1007 10071414A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 CCC4591001SEC4591001 1007 10071415ASCRN Screening ASCREENING 2020-10-22 2020-10-22T12:57:00AAC4591001SEC4591001 1007 10071415A VAXP Placebo A VACCINATION 2020-10-22T12:57:002021-01-07 ABNC4591001SEC4591001 1007 10071415A0FUP Follow-up A0FOLLOW-UP 2021-01-07 2021-06-07 BNBC4591001SEC4591001 1007 10071417ASCRN Screening ASCREENING 2020-10-22 2020-10-22T13:32:00AAC4591001SEC4591001 1007 10071417A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-22T13:32:002020-12-10 AB2C4591001SEC4591001 1007 10071417A0FUP Follow-up A0FOLLOW-UP 2020-12-10 2021-05-06 B2BC4591001SEC4591001 1007 10071428ASCRN Screening ASCREENING 2020-10-22 2020-10-22T16:20:00AAC4591001SEC4591001 1007 10071428A VAXP Placebo A VACCINATION 2020-10-22T16:20:002020-12-14 AB6C4591001SEC4591001 1007 10071428A0FUP Follow-up A0FOLLOW-UP 2020-12-14 2021-05-13 B6BC4591001SEC4591001 1007 10071429ASCRN Screening ASCREENING 2020-10-22 2020-10-22T16:34:00AAC4591001SEC4591001 1007 10071429A VAXP Placebo A VACCINATION 2020-10-22T16:34:002020-12-10 AB2C4591001SEC4591001 1007 10071429A0FUP Follow-up A0FOLLOW-UP 2020-12-10 2021-07-24 B2C@C4591001SEC4591001 1007 10071467ASCRN Screening ASCREENING 2020-11-30 2020-11-30T10:26:00AAC4591001SEC4591001 1007 10071467A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-11-30T10:26:002021-01-19 AB3C4591001SEC4591001 1007 10071467A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-06-14 B3BC4591001SEC4591001 1007 10071469ASCRN Screening ASCREENING 2020-11-30 2020-11-30T11:22:00AAC4591001SEC4591001 1007 10071469A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-11-30T11:22:002021-01-20 AB4C4591001SEC4591001 1007 10071469A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-21 B4BC4591001SEC4591001 1007 10071471ASCRN Screening ASCREENING 2020-11-30 2020-11-30T12:25:00AAC4591001SEC4591001 1007 10071471A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-11-30T12:25:002021-01-19 AB3C4591001SEC4591001 1007 10071471A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-06-14 B3BC4591001SEC4591001 1007 10071472ASCRN Screening ASCREENING 2020-11-30 2020-11-30T13:57:00AAC4591001SEC4591001 1007 10071472A VAXP Placebo A VACCINATION 2020-11-30T13:57:002021-01-19 AB3C4591001SEC4591001 1007 10071472A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-05-17 B3BC4591001SEC4591001 1007 10071472A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T12:56:00BBC4591001SEC4591001 1007 10071472APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T12:56:002021-07-12 BBC4591001SEC4591001 1007 10071472A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1007 10071475ASCRN Screening ASCREENING 2020-11-30 2020-11-30T15:02:00AAC4591001SEC4591001 1007 10071475A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-11-30T15:02:002021-01-19 AB3C4591001SEC4591001 1007 10071475A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-06-14 B3BC4591001SEC4591001 1007 10071476ASCRN Screening ASCREENING 2020-11-30 2020-11-30T17:18:00AAC4591001SEC4591001 1007 10071476A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-11-30T17:18:002021-01-20 AB4C4591001SEC4591001 1007 10071476A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-14 B4BC4591001SEC4591001 1007 10071478ASCRN Screening ASCREENING 2020-11-30 2020-11-30T17:02:00AAC4591001SEC4591001 1007 10071478A VAXP Placebo A VACCINATION 2020-11-30T17:02:002021-01-19 AB3C4591001SEC4591001 1007 10071478A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-05-20 B3BC4591001SEC4591001 1007 10071478A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T13:49:00BBC4591001SEC4591001 1007 10071478APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T13:49:002021-07-13 BBC4591001SEC4591001 1007 10071478A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1007 10071480ASCRN Screening ASCREENING 2020-11-30 2020-11-30T17:21:00AAC4591001SEC4591001 1007 10071480A VAXP Placebo A VACCINATION 2020-11-30T17:21:002021-01-19 AB3C4591001SEC4591001 1007 10071480A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-05-17 B3BC4591001SEC4591001 1007 10071480A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T13:54:00BBC4591001SEC4591001 1007 10071480APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T13:54:002021-07-13 BBC4591001SEC4591001 1007 10071480A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1007 10071481ASCRN Screening ASCREENING 2020-12-01 2020-12-01T09:43:00AAC4591001SEC4591001 1007 10071481A VAXP Placebo A VACCINATION 2020-12-01T09:43:002021-01-20 AB3C4591001SEC4591001 1007 10071481A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-07 B3BC4591001SEC4591001 1007 10071481A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-07 2021-06-07T11:31:00BBC4591001SEC4591001 1007 10071481APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-07T11:31:002021-08-01 BBC4591001SEC4591001 1007 10071481A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-01 2021-08-01 BBC4591001SEC4591001 1007 10071482ASCRN Screening ASCREENING 2020-12-01 2020-12-01T10:05:00AAC4591001SEC4591001 1007 10071482A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-01T10:05:002021-01-21 AB4C4591001SEC4591001 1007 10071482A0FUP Follow-up A0FOLLOW-UP 2021-01-21 2021-07-15 B4BC4591001SEC4591001 1007 10071483ASCRN Screening ASCREENING 2020-12-01 2020-12-01T11:20:00AAC4591001SEC4591001 1007 10071483A VAXP Placebo A VACCINATION 2020-12-01T11:20:002021-01-26 AB9C4591001SEC4591001 1007 10071483A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-03-30 B9BxC4591001SEC4591001 1007 10071483A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-30 2021-03-30T16:29:00BxBxC4591001SEC4591001 1007 10071483APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-30T16:29:002021-05-18 BxBC4591001SEC4591001 1007 10071483A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-18 2021-05-18 BBC4591001SEC4591001 1007 10071484ASCRN Screening ASCREENING 2020-12-01 2020-12-01T11:16:00AAC4591001SEC4591001 1007 10071484A VAXP Placebo A VACCINATION 2020-12-01T11:16:002021-01-26 AB9C4591001SEC4591001 1007 10071484A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-05-19 B9BC4591001SEC4591001 1007 10071484A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T14:13:00BBC4591001SEC4591001 1007 10071484APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T14:13:002021-07-07 BBC4591001SEC4591001 1007 10071484A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1007 10071485ASCRN Screening ASCREENING 2020-12-01 2020-12-01T14:04:00AAC4591001SEC4591001 1007 10071485A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-01T14:04:002021-01-20 AB3C4591001SEC4591001 1007 10071485A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-15 B3BC4591001SEC4591001 1007 10071488ASCRN Screening ASCREENING 2020-12-01 2020-12-01T15:56:00AAC4591001SEC4591001 1007 10071488A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-01T15:56:002021-01-20 AB3C4591001SEC4591001 1007 10071488A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-15 B3BC4591001SEC4591001 1007 10071490ASCRN Screening ASCREENING 2020-12-01 2020-12-01T16:54:00AAC4591001SEC4591001 1007 10071490A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-01T16:54:002021-01-21 AB4C4591001SEC4591001 1007 10071490A0FUP Follow-up A0FOLLOW-UP 2021-01-21 2021-06-16 B4BC4591001SEC4591001 1007 10071492ASCRN Screening ASCREENING 2020-12-01 2020-12-01T17:22:00AAC4591001SEC4591001 1007 10071492A VAXP Placebo A VACCINATION 2020-12-01T17:22:002021-01-19 AB2C4591001SEC4591001 1007 10071492A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-06-24 B2BC4591001SEC4591001 1007 10071494ASCRN Screening ASCREENING 2020-12-02 2020-12-02T11:29:00AAC4591001SEC4591001 1007 10071494A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T11:29:002021-01-20 AB2C4591001SEC4591001 1007 10071494A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-21 B2BC4591001SEC4591001 1007 10071495ASCRN Screening ASCREENING 2020-12-02 2020-12-02T15:13:00AAC4591001SEC4591001 1007 10071495A VAXP Placebo A VACCINATION 2020-12-02T15:13:002021-01-20 AB2C4591001SEC4591001 1007 10071495A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-05-25 B2BC4591001SEC4591001 1007 10071495A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T15:46:00BBC4591001SEC4591001 1007 10071495APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T15:46:002021-07-13 BBC4591001SEC4591001 1007 10071495A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1007 10071496ASCRN Screening ASCREENING 2020-12-02 2020-12-02T17:12:00AAC4591001SEC4591001 1007 10071496A VAXP Placebo A VACCINATION 2020-12-02T17:12:002021-01-20 AB2C4591001SEC4591001 1007 10071496A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-05-24 B2BC4591001SEC4591001 1007 10071496A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T14:56:00BBC4591001SEC4591001 1007 10071496APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T14:56:002021-07-12 BBC4591001SEC4591001 1007 10071496A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1007 10071497ASCRN Screening ASCREENING 2020-12-02 2020-12-02T17:22:00AAC4591001SEC4591001 1007 10071497A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T17:22:002021-01-20 AB2C4591001SEC4591001 1007 10071497A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-16 B2BC4591001SEC4591001 1007 10071499ASCRN Screening ASCREENING 2020-12-03 2020-12-03T16:21:00AAC4591001SEC4591001 1007 10071499A VAXP Placebo A VACCINATION 2020-12-03T16:21:002021-01-20 AB1C4591001SEC4591001 1007 10071499A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-28 B1BC4591001SEC4591001 1007 10071500ASCRN Screening ASCREENING 2020-12-03 2020-12-03T16:54:00AAC4591001SEC4591001 1007 10071500A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-03T16:54:002021-01-21 AB2C4591001SEC4591001 1007 10071500A0FUP Follow-up A0FOLLOW-UP 2021-01-21 2021-06-22 B2BC4591001SEC4591001 1007 10071504ASCRN Screening ASCREENING 2020-12-07 2020-12-07T09:41:00AAC4591001SEC4591001 1007 10071504A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T09:41:002021-01-27 AB4C4591001SEC4591001 1007 10071504A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-23 B4BC4591001SEC4591001 1007 10071505ASCRN Screening ASCREENING 2020-12-07 2020-12-07T10:16:00AAC4591001SEC4591001 1007 10071505A VAXP Placebo A VACCINATION 2020-12-07T10:16:002021-02-01 AB9C4591001SEC4591001 1007 10071505A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-06-02 B9BC4591001SEC4591001 1007 10071505A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-02 2021-06-02T11:13:00BBC4591001SEC4591001 1007 10071505APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-02T11:13:002021-07-22 BBC4591001SEC4591001 1007 10071505A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-22 2021-07-22 BBC4591001SEC4591001 1007 10071506ASCRN Screening ASCREENING 2020-12-07 2020-12-07T10:42:00AAC4591001SEC4591001 1007 10071506A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T10:42:002021-01-25 AB2C4591001SEC4591001 1007 10071506A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-06-21 B2BC4591001SEC4591001 1007 10071507ASCRN Screening ASCREENING 2020-12-07 2020-12-07T12:07:00AAC4591001SEC4591001 1007 10071507A VAXP Placebo A VACCINATION 2020-12-07T12:07:002021-01-25 AB2C4591001SEC4591001 1007 10071507A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-05-19 B2BC4591001SEC4591001 1007 10071507A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T13:42:00BBC4591001SEC4591001 1007 10071507APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T13:42:002021-07-09 BBC4591001SEC4591001 1007 10071507A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1007 10071508ASCRN Screening ASCREENING 2020-12-07 2020-12-07T13:47:00AAC4591001SEC4591001 1007 10071508A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T13:47:002021-01-28 AB5C4591001SEC4591001 1007 10071508A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-06-21 B5BC4591001SEC4591001 1007 10071509ASCRN Screening ASCREENING 2020-12-07 2020-12-07T14:42:00AAC4591001SEC4591001 1007 10071509A VAXP Placebo A VACCINATION 2020-12-07T14:42:002021-01-27 AB4C4591001SEC4591001 1007 10071509A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-20 B4BC4591001SEC4591001 1007 10071509A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T09:43:00BBC4591001SEC4591001 1007 10071509APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T09:43:002021-07-07 BBC4591001SEC4591001 1007 10071509A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1007 10071511ASCRN Screening ASCREENING 2020-12-07 2020-12-07T16:50:00AAC4591001SEC4591001 1007 10071511A VAXP Placebo A VACCINATION 2020-12-07T16:50:002021-01-25 AB2C4591001SEC4591001 1007 10071511A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-05-18 B2BC4591001SEC4591001 1007 10071511A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T09:28:00BBC4591001SEC4591001 1007 10071511APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T09:28:002021-07-13 BBC4591001SEC4591001 1007 10071511A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1007 10071512ASCRN Screening ASCREENING 2020-12-07 2020-12-07T17:14:00AAC4591001SEC4591001 1007 10071512A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T17:14:002021-01-25 AB2C4591001SEC4591001 1007 10071512A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-08-10 B2BC4591001SEC4591001 1007 10071514ASCRN Screening ASCREENING 2020-12-07 2020-12-07T17:11:00AAC4591001SEC4591001 1007 10071514A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T17:11:002021-01-28 AB5C4591001SEC4591001 1007 10071514A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-06-21 B5BC4591001SEC4591001 1007 10071515ASCRN Screening ASCREENING 2020-12-08 2020-12-08T09:50:00AAC4591001SEC4591001 1007 10071515A VAXP Placebo A VACCINATION 2020-12-08T09:50:002021-01-26 AB2C4591001SEC4591001 1007 10071515A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-06-24 B2BC4591001SEC4591001 1007 10071516ASCRN Screening ASCREENING 2020-12-08 2020-12-08T09:43:00AAC4591001SEC4591001 1007 10071516A VAXP Placebo A VACCINATION 2020-12-08T09:43:002021-01-26 AB2C4591001SEC4591001 1007 10071516A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-05-18 B2BC4591001SEC4591001 1007 10071516A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T15:07:00BBC4591001SEC4591001 1007 10071516APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T15:07:002021-07-13 BBC4591001SEC4591001 1007 10071516A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1007 10071517ASCRN Screening ASCREENING 2020-12-08 2020-12-08T10:45:00AAC4591001SEC4591001 1007 10071517A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T10:45:002021-01-26 AB2C4591001SEC4591001 1007 10071517A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-06-22 B2BC4591001SEC4591001 1007 10071518ASCRN Screening ASCREENING 2020-12-08 2020-12-08T11:20:00AAC4591001SEC4591001 1007 10071518A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T11:20:002021-01-26 AB2C4591001SEC4591001 1007 10071518A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-07-01 B2BC4591001SEC4591001 1007 10071519ASCRN Screening ASCREENING 2020-12-08 2020-12-08T11:58:00AAC4591001SEC4591001 1007 10071519A VAXP Placebo A VACCINATION 2020-12-08T11:58:002021-01-27 AB3C4591001SEC4591001 1007 10071519A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-03-31 B3BrC4591001SEC4591001 1007 10071519A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-31 2021-03-31T10:54:00BrBrC4591001SEC4591001 1007 10071519APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-31T10:54:002021-05-19 BrBC4591001SEC4591001 1007 10071519A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-19 2021-06-09 BBC4591001SEC4591001 1007 10071520ASCRN Screening ASCREENING 2020-12-08 2020-12-08T12:03:00AAC4591001SEC4591001 1007 10071520A VAXP Placebo A VACCINATION 2020-12-08T12:03:002021-01-27 AB3C4591001SEC4591001 1007 10071520A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-09 B3BC4591001SEC4591001 1007 10071520A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-09 2021-06-09T13:36:00BBC4591001SEC4591001 1007 10071520APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-09T13:36:002021-08-01 BBC4591001SEC4591001 1007 10071520A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-01 2021-08-01 BBC4591001SEC4591001 1007 10071521ASCRN Screening ASCREENING 2020-12-08 2020-12-08T13:50:00AAC4591001SEC4591001 1007 10071521A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T13:50:002021-01-28 AB4C4591001SEC4591001 1007 10071521A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-07-19 B4BC4591001SEC4591001 1007 10071522ASCRN Screening ASCREENING 2020-12-08 2020-12-08T15:38:00AAC4591001SEC4591001 1007 10071522A VAXP Placebo A VACCINATION 2020-12-08T15:38:002021-01-28 AB4C4591001SEC4591001 1007 10071522A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-05-26 B4BC4591001SEC4591001 1007 10071522A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T11:32:00BBC4591001SEC4591001 1007 10071522APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T11:32:002021-07-16 BBC4591001SEC4591001 1007 10071522A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-16 2021-07-16 BBC4591001SEC4591001 1007 10071523ASCRN Screening ASCREENING 2020-12-08 2020-12-08T15:30:00AAC4591001SEC4591001 1007 10071523A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T15:30:002021-01-26 AB2C4591001SEC4591001 1007 10071523A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-08-25 B2CPC4591001SEC4591001 1007 10071524ASCRN Screening ASCREENING 2020-12-08 2020-12-08T16:55:00AAC4591001SEC4591001 1007 10071524A VAXP Placebo A VACCINATION 2020-12-08T16:55:002021-02-03 AB:C4591001SEC4591001 1007 10071524A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-02-25 B:BPC4591001SEC4591001 1007 10071524A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-25 2021-02-25T14:53:00BPBPC4591001SEC4591001 1007 10071524APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-25T14:53:002021-04-20 BPBC4591001SEC4591001 1007 10071524A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-20 2021-04-20 BBC4591001SEC4591001 1007 10071525ASCRN Screening ASCREENING 2020-12-08 2020-12-08T16:48:00AAC4591001SEC4591001 1007 10071525A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T16:48:002021-02-03 AB:C4591001SEC4591001 1007 10071525A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-24 B:BC4591001SEC4591001 1007 10071526ASCRN Screening ASCREENING 2020-12-08 2020-12-08T17:18:00AAC4591001SEC4591001 1007 10071526A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T17:18:002021-01-26 AB2C4591001SEC4591001 1007 10071526A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-07-26 B2BC4591001SEC4591001 1007 10071527ASCRN Screening ASCREENING 2020-12-08 2020-12-08T17:09:00AAC4591001SEC4591001 1007 10071527A VAXP Placebo A VACCINATION 2020-12-08T17:09:002021-01-26 AB2C4591001SEC4591001 1007 10071527A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-06-03 B2BC4591001SEC4591001 1007 10071527A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-03 2021-06-03T12:05:00BBC4591001SEC4591001 1007 10071527APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-03T12:05:002021-07-21 BBC4591001SEC4591001 1007 10071527A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-21 2021-07-21 BBC4591001SEC4591001 1007 10071528ASCRN Screening ASCREENING 2020-12-09 2020-12-09T09:40:00AAC4591001SEC4591001 1007 10071528A VAXP Placebo A VACCINATION 2020-12-09T09:40:002021-01-27 AB2C4591001SEC4591001 1007 10071528A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-23 B2BC4591001SEC4591001 1007 10071529ASCRN Screening ASCREENING 2020-12-09 2020-12-09T10:28:00AAC4591001SEC4591001 1007 10071529A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T10:28:002021-01-27 AB2C4591001SEC4591001 1007 10071529A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-29 B2BC4591001SEC4591001 1007 10071530ASCRN Screening ASCREENING 2020-12-09 2020-12-09T10:40:00AAC4591001SEC4591001 1007 10071530A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T10:40:002021-01-27 AB2C4591001SEC4591001 1007 10071530A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-07-13 B2BC4591001SEC4591001 1007 10071531ASCRN Screening ASCREENING 2020-12-09 2020-12-09T10:46:00AAC4591001SEC4591001 1007 10071531A VAXP Placebo A VACCINATION 2020-12-09T10:46:002021-01-27 AB2C4591001SEC4591001 1007 10071531A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-25 B2BC4591001SEC4591001 1007 10071531A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T12:07:00BBC4591001SEC4591001 1007 10071531APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T12:07:002021-07-28 BBC4591001SEC4591001 1007 10071531A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-28 2021-07-28 BBC4591001SEC4591001 1007 10071533ASCRN Screening ASCREENING 2020-12-09 2020-12-09T11:46:00AAC4591001SEC4591001 1007 10071533A VAXP Placebo A VACCINATION 2020-12-09T11:46:002021-01-27 AB2C4591001SEC4591001 1007 10071533A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-26 B2BC4591001SEC4591001 1007 10071533A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T11:12:00BBC4591001SEC4591001 1007 10071533APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T11:12:002021-07-19 BBC4591001SEC4591001 1007 10071533A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-19 BBC4591001SEC4591001 1007 10071535ASCRN Screening ASCREENING 2020-12-09 2020-12-09T11:57:00AAC4591001SEC4591001 1007 10071535A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T11:57:002021-01-27 AB2C4591001SEC4591001 1007 10071535A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-08-27 B2C`C4591001SEC4591001 1007 10071536ASCRN Screening ASCREENING 2020-12-09 2020-12-09T12:48:00AAC4591001SEC4591001 1007 10071536A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T12:48:002021-01-26 AB1C4591001SEC4591001 1007 10071536A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-06-17 B1BC4591001SEC4591001 1007 10071537ASCRN Screening ASCREENING 2020-12-09 2020-12-09T14:12:00AAC4591001SEC4591001 1007 10071537A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T14:12:002021-01-27 AB2C4591001SEC4591001 1007 10071537A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-23 B2BC4591001SEC4591001 1007 10071539ASCRN Screening ASCREENING 2020-12-09 2020-12-09T15:23:00AAC4591001SEC4591001 1007 10071539A VAXP Placebo A VACCINATION 2020-12-09T15:23:002021-01-27 AB2C4591001SEC4591001 1007 10071539A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-02 B2BC4591001SEC4591001 1007 10071539A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-02 2021-06-02T14:27:00BBC4591001SEC4591001 1007 10071539APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-02T14:27:002021-07-21 BBC4591001SEC4591001 1007 10071539A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-21 2021-08-30 BCC4591001SEC4591001 1007 10071540ASCRN Screening ASCREENING 2020-12-09 2020-12-09T15:30:00AAC4591001SEC4591001 1007 10071540A VAXP Placebo A VACCINATION 2020-12-09T15:30:002021-01-27 AB2C4591001SEC4591001 1007 10071540A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-02 B2BC4591001SEC4591001 1007 10071540A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-02 2021-06-02T14:31:00BBC4591001SEC4591001 1007 10071540APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-02T14:31:002021-07-22 BBC4591001SEC4591001 1007 10071540A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-22 2021-08-30 BCC4591001SEC4591001 1007 10071541ASCRN Screening ASCREENING 2020-12-09 2020-12-09T16:50:00AAC4591001SEC4591001 1007 10071541A VAXP Placebo A VACCINATION 2020-12-09T16:50:002021-01-28 AB3C4591001SEC4591001 1007 10071541A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-02-09 B3B?C4591001SEC4591001 1007 10071541A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-09 2021-02-09T15:37:00B?B?C4591001SEC4591001 1007 10071541APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-09T15:37:002021-03-30 B?BpC4591001SEC4591001 1007 10071541A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-03-30 2021-08-24 BpC0C4591001SEC4591001 1007 10071542ASCRN Screening ASCREENING 2020-12-09 2020-12-09T17:04:00AAC4591001SEC4591001 1007 10071542A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T17:04:002021-02-01 AB7C4591001SEC4591001 1007 10071542A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-06-23 B7BC4591001SEC4591001 1007 10071543ASCRN Screening ASCREENING 2020-12-09 2020-12-09T17:05:00AAC4591001SEC4591001 1007 10071543A VAXP Placebo A VACCINATION 2020-12-09T17:05:002021-01-27 AB2C4591001SEC4591001 1007 10071543A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-08-16 B2BC4591001SEC4591001 1007 10071544ASCRN Screening ASCREENING 2020-12-09 2020-12-09T17:09:00AAC4591001SEC4591001 1007 10071544A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T17:09:002021-01-27 AB2C4591001SEC4591001 1007 10071544A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-08-16 B2BC4591001SEC4591001 1007 10071546ASCRN Screening ASCREENING 2020-12-10 2020-12-10T09:54:00AAC4591001SEC4591001 1007 10071546A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T09:54:002021-01-27 AB1C4591001SEC4591001 1007 10071546A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-23 B1BC4591001SEC4591001 1007 10071547ASCRN Screening ASCREENING 2020-12-10 2020-12-10T10:59:00AAC4591001SEC4591001 1007 10071547A VAXP Placebo A VACCINATION 2020-12-10T10:59:002021-01-27 AB1C4591001SEC4591001 1007 10071547A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-20 B1BC4591001SEC4591001 1007 10071547A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T13:59:00BBC4591001SEC4591001 1007 10071547APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T13:59:002021-07-13 BBC4591001SEC4591001 1007 10071547A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1007 10071550ASCRN Screening ASCREENING 2020-12-10 2020-12-10T15:20:00AAC4591001SEC4591001 1007 10071550A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T15:20:002021-01-28 AB2C4591001SEC4591001 1007 10071550A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-06-24 B2BC4591001SEC4591001 1007 10071551ASCRN Screening ASCREENING 2020-12-10 2020-12-10T15:08:00AAC4591001SEC4591001 1007 10071551A VAXP Placebo A VACCINATION 2020-12-10T15:08:002021-01-28 AB2C4591001SEC4591001 1007 10071551A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-05-24 B2BC4591001SEC4591001 1007 10071551A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T13:51:00BBC4591001SEC4591001 1007 10071551APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T13:51:002021-07-12 BBC4591001SEC4591001 1007 10071551A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-08-30 BCC4591001SEC4591001 1007 10071552ASCRN Screening ASCREENING 2020-12-10 2020-12-10T16:40:00AAC4591001SEC4591001 1007 10071552A VAXP Placebo A VACCINATION 2020-12-10T16:40:002021-01-27 AB1C4591001SEC4591001 1007 10071552A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-26 B1BC4591001SEC4591001 1007 10071552A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T14:45:00BBC4591001SEC4591001 1007 10071552APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T14:45:002021-07-16 BBC4591001SEC4591001 1007 10071552A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-16 2021-07-16 BBC4591001SEC4591001 1007 10071554ASCRN Screening ASCREENING 2020-12-10 2020-12-10T16:55:00AAC4591001SEC4591001 1007 10071554A VAXP Placebo A VACCINATION 2020-12-10T16:55:002021-01-28 AB2C4591001SEC4591001 1007 10071554A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-08-04 B2BC4591001SEC4591001 1007 10071555ASCRN Screening ASCREENING 2020-12-10 2020-12-10T16:36:00AAC4591001SEC4591001 1007 10071555A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T16:36:002021-01-26 AB0C4591001SEC4591001 1007 10071555A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-06-22 B0BC4591001SEC4591001 1007 10071557ASCRN Screening ASCREENING 2020-12-14 2020-12-14T09:42:00AAC4591001SEC4591001 1007 10071557A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T09:42:002021-02-04 AB5C4591001SEC4591001 1007 10071557A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-08-10 B5BC4591001SEC4591001 1007 10071558ASCRN Screening ASCREENING 2020-12-14 2020-12-14T09:53:00AAC4591001SEC4591001 1007 10071558A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T09:53:002021-02-03 AB4C4591001SEC4591001 1007 10071558A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-28 B4BC4591001SEC4591001 1007 10071559ASCRN Screening ASCREENING 2020-12-14 2020-12-14T11:52:00AAC4591001SEC4591001 1007 10071559A VAXP Placebo A VACCINATION 2020-12-14T11:52:002021-02-08 AB9C4591001SEC4591001 1007 10071559A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-27 B9BC4591001SEC4591001 1007 10071559A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-27 2021-05-27T15:48:00BBC4591001SEC4591001 1007 10071559APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-27T15:48:002021-07-16 BBC4591001SEC4591001 1007 10071559A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-16 2021-08-30 BC@C4591001SEC4591001 1007 10071560ASCRN Screening ASCREENING 2020-12-14 2020-12-14T14:21:00AAC4591001SEC4591001 1007 10071560A VAXP Placebo A VACCINATION 2020-12-14T14:21:002021-02-02 AB3C4591001SEC4591001 1007 10071560A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-17 B3BC4591001SEC4591001 1007 10071560A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T12:49:00BBC4591001SEC4591001 1007 10071560APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T12:49:002021-07-06 BBC4591001SEC4591001 1007 10071560A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1007 10071561ASCRN Screening ASCREENING 2020-12-14 2020-12-14T15:08:00AAC4591001SEC4591001 1007 10071561A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T15:08:002021-02-02 AB3C4591001SEC4591001 1007 10071561A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-08-19 B3BC4591001SEC4591001 1007 10071562ASCRN Screening ASCREENING 2020-12-14 2020-12-14T16:30:00AAC4591001SEC4591001 1007 10071562A VAXP Placebo A VACCINATION 2020-12-14T16:30:002021-02-01 AB2C4591001SEC4591001 1007 10071562A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-17 B2BC4591001SEC4591001 1007 10071562A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T11:23:00BBC4591001SEC4591001 1007 10071562APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T11:23:002021-07-06 BBC4591001SEC4591001 1007 10071562A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1007 10071563ASCRN Screening ASCREENING 2020-12-14 2020-12-14T16:21:00AAC4591001SEC4591001 1007 10071563A VAXP Placebo A VACCINATION 2020-12-14T16:21:002021-02-01 AB2C4591001SEC4591001 1007 10071563A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-17 B2BC4591001SEC4591001 1007 10071563A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T11:27:00BBC4591001SEC4591001 1007 10071563APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T11:27:002021-07-06 BBC4591001SEC4591001 1007 10071563A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1007 10071564ASCRN Screening ASCREENING 2020-12-14 2020-12-14T17:10:00AAC4591001SEC4591001 1007 10071564A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T17:10:002021-02-08 AB9C4591001SEC4591001 1007 10071564A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-06-30 B9BC4591001SEC4591001 1007 10071565ASCRN Screening ASCREENING 2020-12-14 2020-12-14T17:22:00AAC4591001SEC4591001 1007 10071565A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T17:22:002021-02-08 AB9C4591001SEC4591001 1007 10071565A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-06-30 B9BC4591001SEC4591001 1007 10071566ASCRN Screening ASCREENING 2020-12-14 2020-12-14T17:14:00AAC4591001SEC4591001 1007 10071566A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T17:14:002021-02-01 AB2C4591001SEC4591001 1007 10071566A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-07-07 B2BC4591001SEC4591001 1007 10071567ASCRN Screening ASCREENING 2020-12-15 2020-12-15T10:06:00AAC4591001SEC4591001 1007 10071567A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T10:06:002021-02-02 AB2C4591001SEC4591001 1007 10071567A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-06-29 B2BC4591001SEC4591001 1007 10071568ASCRN Screening ASCREENING 2020-12-15 2020-12-15T10:16:00AAC4591001SEC4591001 1007 10071568A VAXP Placebo A VACCINATION 2020-12-15T10:16:002021-02-02 AB2C4591001SEC4591001 1007 10071568A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-06-01 B2BC4591001SEC4591001 1007 10071568A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T10:02:00BBC4591001SEC4591001 1007 10071568APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T10:02:002021-07-22 BBC4591001SEC4591001 1007 10071568A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-22 2021-07-22 BBC4591001SEC4591001 1007 10071569ASCRN Screening ASCREENING 2020-12-15 2020-12-15T11:10:00AAC4591001SEC4591001 1007 10071569A VAXP Placebo A VACCINATION 2020-12-15T11:10:002021-02-03 AB3C4591001SEC4591001 1007 10071569A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-03 B3BC4591001SEC4591001 1007 10071569A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-03 2021-06-03T11:54:00BBC4591001SEC4591001 1007 10071569APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-03T11:54:002021-07-22 BBC4591001SEC4591001 1007 10071569A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-22 2021-07-22 BBC4591001SEC4591001 1007 10071570ASCRN Screening ASCREENING 2020-12-15 2020-12-15T11:24:00AAC4591001SEC4591001 1007 10071570A VAXP Placebo A VACCINATION 2020-12-15T11:24:002021-02-03 AB3C4591001SEC4591001 1007 10071570A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-03 B3BC4591001SEC4591001 1007 10071570A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-03 2021-06-03T11:59:00BBC4591001SEC4591001 1007 10071570APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-03T11:59:002021-07-22 BBC4591001SEC4591001 1007 10071570A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-22 2021-07-22 BBC4591001SEC4591001 1007 10071571ASCRN Screening ASCREENING 2020-12-15 2020-12-15T13:46:00AAC4591001SEC4591001 1007 10071571A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T13:46:002021-02-03 AB3C4591001SEC4591001 1007 10071571A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-30 B3BC4591001SEC4591001 1007 10071572ASCRN Screening ASCREENING 2020-12-15 2020-12-15T17:05:00AAC4591001SEC4591001 1007 10071572A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T17:05:002021-02-02 AB2C4591001SEC4591001 1007 10071572A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-07-06 B2BC4591001SEC4591001 1007 10071573ASCRN Screening ASCREENING 2020-12-15 2020-12-15T17:14:00AAC4591001SEC4591001 1007 10071573A VAXP Placebo A VACCINATION 2020-12-15T17:14:002021-02-03 AB3C4591001SEC4591001 1007 10071573A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-30 B3BC4591001SEC4591001 1007 10071574ASCRN Screening ASCREENING 2020-12-16 2020-12-16T10:00:00AAC4591001SEC4591001 1007 10071574A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T10:00:002021-02-04 AB3C4591001SEC4591001 1007 10071574A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-08-24 B3BC4591001SEC4591001 1007 10071575ASCRN Screening ASCREENING 2020-12-16 2020-12-16T15:11:00AAC4591001SEC4591001 1007 10071575A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T15:11:002021-02-03 AB2C4591001SEC4591001 1007 10071575A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-30 B2BC4591001SEC4591001 1007 10071576ASCRN Screening ASCREENING 2020-12-16 2020-12-16T15:31:00AAC4591001SEC4591001 1007 10071576A VAXP Placebo A VACCINATION 2020-12-16T15:31:002021-02-03 AB2C4591001SEC4591001 1007 10071576A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-05-12 B2BC4591001SEC4591001 1007 10071576A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-12 2021-05-12T17:02:00BBC4591001SEC4591001 1007 10071576APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-12T17:02:002021-07-01 BBC4591001SEC4591001 1007 10071576A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1007 10071577ASCRN Screening ASCREENING 2020-12-16 2020-12-16T17:32:00AAC4591001SEC4591001 1007 10071577A VAXP Placebo A VACCINATION 2020-12-16T17:32:002021-02-04 AB3C4591001SEC4591001 1007 10071577A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-04-19 B3B}C4591001SEC4591001 1007 10071577A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-19 2021-04-19T10:19:00B}B}C4591001SEC4591001 1007 10071577APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-19T10:19:002021-06-08 B}BC4591001SEC4591001 1007 10071577A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-08 2021-06-08 BBC4591001SEC4591001 1007 10071578ASCRN Screening ASCREENING 2020-12-16 2020-12-16T17:26:00AAC4591001SEC4591001 1007 10071578A VAXP Placebo A VACCINATION 2020-12-16T17:26:002021-02-04 AB3C4591001SEC4591001 1007 10071578A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-24 B3BC4591001SEC4591001 1007 10071578A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T13:38:00BBC4591001SEC4591001 1007 10071578APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T13:38:002021-07-12 BBC4591001SEC4591001 1007 10071578A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1007 10071579ASCRN Screening ASCREENING 2020-12-16 2020-12-16T17:36:00AAC4591001SEC4591001 1007 10071579A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T17:36:002021-02-08 AB7C4591001SEC4591001 1007 10071579A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-07 B7BC4591001SEC4591001 1007 10071580ASCRN Screening ASCREENING 2020-12-16 2020-12-16T17:44:00AAC4591001SEC4591001 1007 10071580A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T17:44:002021-02-04 AB3C4591001SEC4591001 1007 10071580A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-06-30 B3BC4591001SEC4591001 1007 10071581ASCRN Screening ASCREENING 2020-12-17 2020-12-17T15:49:00AAC4591001SEC4591001 1007 10071581A VAXP Placebo A VACCINATION 2020-12-17T15:49:002021-02-04 AB2C4591001SEC4591001 1007 10071581A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-24 B2BC4591001SEC4591001 1007 10071581A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T12:07:00BBC4591001SEC4591001 1007 10071581APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T12:07:002021-07-13 BBC4591001SEC4591001 1007 10071581A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1007 10071582ASCRN Screening ASCREENING 2020-12-17 2020-12-17T15:59:00AAC4591001SEC4591001 1007 10071582A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T15:59:002021-02-04 AB2C4591001SEC4591001 1007 10071582A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-07-08 B2BC4591001SEC4591001 1007 10071583ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:41:00AAC4591001SEC4591001 1007 10071583A VAXP Placebo A VACCINATION 2020-12-17T16:41:002021-02-04 AB2C4591001SEC4591001 1007 10071583A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-18 B2BC4591001SEC4591001 1007 10071583A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T15:18:00BBC4591001SEC4591001 1007 10071583APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T15:18:002021-07-09 BBC4591001SEC4591001 1007 10071583A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1007 10071584ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:25:00AAC4591001SEC4591001 1007 10071584A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T16:25:002021-02-04 AB2C4591001SEC4591001 1007 10071584A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-08-27 B2BC4591001SEC4591001 1007 10071585ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:27:00AAC4591001SEC4591001 1007 10071585A VAXP Placebo A VACCINATION 2020-12-17T16:27:002021-02-04 AB2C4591001SEC4591001 1007 10071585A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-17 B2BC4591001SEC4591001 1007 10071585A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T15:12:00BBC4591001SEC4591001 1007 10071585APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T15:12:002021-07-06 BBC4591001SEC4591001 1007 10071585A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1007 10071586ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:34:00AAC4591001SEC4591001 1007 10071586A VAXP Placebo A VACCINATION 2020-12-17T16:34:002021-02-04 AB2C4591001SEC4591001 1007 10071586A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-06-01 B2BC4591001SEC4591001 1007 10071586A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T10:06:00BBC4591001SEC4591001 1007 10071586APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T10:06:002021-07-21 BBC4591001SEC4591001 1007 10071586A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-21 2021-07-21 BBC4591001SEC4591001 1007 10071587ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:47:00AAC4591001SEC4591001 1007 10071587A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T16:47:002021-02-04 AB2C4591001SEC4591001 1007 10071587A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-07-01 B2BC4591001SEC4591001 1007 10071588ASCRN Screening ASCREENING 2020-12-28 2020-12-28T10:19:00AAC4591001SEC4591001 1007 10071588A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T10:19:002021-02-17 AB4C4591001SEC4591001 1007 10071588A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-27 B4BC4591001SEC4591001 1007 10071589ASCRN Screening ASCREENING 2020-12-28 2020-12-28T11:25:00AAC4591001SEC4591001 1007 10071589A VAXP Placebo A VACCINATION 2020-12-28T11:25:002021-02-17 AB4C4591001SEC4591001 1007 10071589A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-18 B4BC4591001SEC4591001 1007 10071589A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T14:39:00BBC4591001SEC4591001 1007 10071589APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T14:39:002021-07-07 BBC4591001SEC4591001 1007 10071589A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1007 10071590ASCRN Screening ASCREENING 2020-12-28 2020-12-28T12:21:00AAC4591001SEC4591001 1007 10071590A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T12:21:002021-02-17 AB4C4591001SEC4591001 1007 10071590A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-14 B4BC4591001SEC4591001 1007 10071591ASCRN Screening ASCREENING 2020-12-28 2020-12-28T12:56:00AAC4591001SEC4591001 1007 10071591A VAXP Placebo A VACCINATION 2020-12-28T12:56:002021-02-23 AB:C4591001SEC4591001 1007 10071591A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-06-02 B:BC4591001SEC4591001 1007 10071591A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-02 2021-06-02T11:25:00BBC4591001SEC4591001 1007 10071591APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-02T11:25:002021-07-22 BBC4591001SEC4591001 1007 10071591A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-22 2021-07-22 BBC4591001SEC4591001 1007 10071592ASCRN Screening ASCREENING 2020-12-28 2020-12-28T12:50:00AAC4591001SEC4591001 1007 10071592A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T12:50:002021-02-24 AB;C4591001SEC4591001 1007 10071592A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-13 B;BC4591001SEC4591001 1007 10071593ASCRN Screening ASCREENING 2020-12-28 2020-12-28T12:57:00AAC4591001SEC4591001 1007 10071593A VAXP Placebo A VACCINATION 2020-12-28T12:57:002021-02-12 AB/C4591001SEC4591001 1007 10071594ASCRN Screening ASCREENING 2020-12-28 2020-12-28T14:21:00AAC4591001SEC4591001 1007 10071594A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T14:21:002021-02-22 AB9C4591001SEC4591001 1007 10071594A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-19 B9BC4591001SEC4591001 1007 10071595ASCRN Screening ASCREENING 2020-12-28 2020-12-28T14:50:00AAC4591001SEC4591001 1007 10071595A VAXP Placebo A VACCINATION 2020-12-28T14:50:002021-02-17 AB4C4591001SEC4591001 1007 10071595A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-18 B4BC4591001SEC4591001 1007 10071595A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T11:19:00BBC4591001SEC4591001 1007 10071595APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T11:19:002021-07-08 BBC4591001SEC4591001 1007 10071595A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-08-04 BBC4591001SEC4591001 1007 10071596ASCRN Screening ASCREENING 2020-12-28 2020-12-28T15:26:00AAC4591001SEC4591001 1007 10071596A VAXP Placebo A VACCINATION 2020-12-28T15:26:002021-02-17 AB4C4591001SEC4591001 1007 10071596A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-24 B4BC4591001SEC4591001 1007 10071596A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T14:51:00BBC4591001SEC4591001 1007 10071596APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T14:51:002021-07-12 BBC4591001SEC4591001 1007 10071596A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1007 10071597ASCRN Screening ASCREENING 2020-12-28 2020-12-28T15:35:00AAC4591001SEC4591001 1007 10071597A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T15:35:002021-02-23 AB:C4591001SEC4591001 1007 10071597A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-15 B:BC4591001SEC4591001 1007 10071599ASCRN Screening ASCREENING 2020-12-28 2020-12-28T16:40:00AAC4591001SEC4591001 1007 10071599A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T16:40:002021-02-17 AB4C4591001SEC4591001 1007 10071599A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-13 B4BC4591001SEC4591001 1007 10071600ASCRN Screening ASCREENING 2020-12-28 2020-12-28T16:44:00AAC4591001SEC4591001 1007 10071600A VAXP Placebo A VACCINATION 2020-12-28T16:44:002021-02-17 AB4C4591001SEC4591001 1007 10071600A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-06-01 B4BC4591001SEC4591001 1007 10071600A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T11:33:00BBC4591001SEC4591001 1007 10071600APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T11:33:002021-08-12 BBC4591001SEC4591001 1007 10071600A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-12 2021-08-12 BBC4591001SEC4591001 1007 10071601ASCRN Screening ASCREENING 2020-12-28 2020-12-28T16:54:00AAC4591001SEC4591001 1007 10071601A VAXP Placebo A VACCINATION 2020-12-28T16:54:002021-03-16 ABOC4591001SEC4591001 1007 10071601A0FUP Follow-up A0FOLLOW-UP 2021-03-16 2021-07-29 BOBC4591001SEC4591001 1007 10071602ASCRN Screening ASCREENING 2020-12-28 2020-12-28T17:02:00AAC4591001SEC4591001 1007 10071602A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T17:02:002021-02-17 AB4C4591001SEC4591001 1007 10071602A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-20 B4BC4591001SEC4591001 1007 10071603ASCRN Screening ASCREENING 2020-12-29 2020-12-29T10:08:00AAC4591001SEC4591001 1007 10071603A VAXP Placebo A VACCINATION 2020-12-29T10:08:002021-02-23 AB9C4591001SEC4591001 1007 10071603A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-20 B9BC4591001SEC4591001 1007 10071604ASCRN Screening ASCREENING 2020-12-29 2020-12-29T09:40:00AAC4591001SEC4591001 1007 10071604A VAXP Placebo A VACCINATION 2020-12-29T09:40:002021-02-17 AB3C4591001SEC4591001 1007 10071604A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-14 B3BC4591001SEC4591001 1007 10071605ASCRN Screening ASCREENING 2020-12-29 2020-12-29T10:33:00AAC4591001SEC4591001 1007 10071605A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T10:33:002021-02-23 AB9C4591001SEC4591001 1007 10071605A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-13 B9BC4591001SEC4591001 1007 10071606ASCRN Screening ASCREENING 2020-12-29 2020-12-29T12:15:00AAC4591001SEC4591001 1007 10071606A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T12:15:002021-03-04 ABBC4591001SEC4591001 1007 10071606A0FUP Follow-up A0FOLLOW-UP 2021-03-04 2021-07-19 BBBC4591001SEC4591001 1007 10071607ASCRN Screening ASCREENING 2020-12-29 2020-12-29T14:27:00AAC4591001SEC4591001 1007 10071607A VAXP Placebo A VACCINATION 2020-12-29T14:27:002021-02-24 AB:C4591001SEC4591001 1007 10071607A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-18 B:BC4591001SEC4591001 1007 10071607A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T12:26:00BBC4591001SEC4591001 1007 10071607APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T12:26:002021-07-13 BBC4591001SEC4591001 1007 10071607A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-08-31 BBC4591001SEC4591001 1007 10071608ASCRN Screening ASCREENING 2020-12-29 2020-12-29T14:21:00AAC4591001SEC4591001 1007 10071608A VAXP Placebo A VACCINATION 2020-12-29T14:21:002021-02-24 AB:C4591001SEC4591001 1007 10071608A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-18 B:BC4591001SEC4591001 1007 10071608A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T12:29:00BBC4591001SEC4591001 1007 10071608APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T12:29:002021-07-13 BBC4591001SEC4591001 1007 10071608A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1007 10071609ASCRN Screening ASCREENING 2020-12-29 2020-12-29T14:49:00AAC4591001SEC4591001 1007 10071609A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T14:49:002021-02-22 AB8C4591001SEC4591001 1007 10071609A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-19 B8BC4591001SEC4591001 1007 10071610ASCRN Screening ASCREENING 2020-12-29 2020-12-29T15:05:00AAC4591001SEC4591001 1007 10071610A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T15:05:002021-02-18 AB4C4591001SEC4591001 1007 10071610A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-07-22 B4BC4591001SEC4591001 1007 10071612ASCRN Screening ASCREENING 2020-12-29 2020-12-29T15:00:00AAC4591001SEC4591001 1007 10071612A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T15:00:002021-02-25 AB;C4591001SEC4591001 1007 10071612A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-07-13 B;BC4591001SEC4591001 1007 10071613ASCRN Screening ASCREENING 2020-12-29 2020-12-29T16:13:00AAC4591001SEC4591001 1007 10071613A VAXP Placebo A VACCINATION 2020-12-29T16:13:002021-02-17 AB3C4591001SEC4591001 1007 10071613A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-25 B3BC4591001SEC4591001 1007 10071613A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T11:47:00BBC4591001SEC4591001 1007 10071613APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T11:47:002021-07-13 BBC4591001SEC4591001 1007 10071613A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1007 10071614ASCRN Screening ASCREENING 2020-12-29 2020-12-29T16:40:00AAC4591001SEC4591001 1007 10071614A VAXP Placebo A VACCINATION 2020-12-29T16:40:002021-02-23 AB9C4591001SEC4591001 1007 10071614A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-05-20 B9BC4591001SEC4591001 1007 10071614A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T15:01:00BBC4591001SEC4591001 1007 10071614APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T15:01:002021-07-26 BBC4591001SEC4591001 1007 10071614A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-26 2021-08-26 BBC4591001SEC4591001 1007 10071615ASCRN Screening ASCREENING 2020-12-29 2020-12-29T16:12:00AAC4591001SEC4591001 1007 10071615A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T16:12:002021-02-23 AB9C4591001SEC4591001 1007 10071615A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-08-30 B9BC4591001SEC4591001 1007 10071616ASCRN Screening ASCREENING 2020-12-29 2020-12-29T16:31:00AAC4591001SEC4591001 1007 10071616A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T16:31:002021-02-23 AB9C4591001SEC4591001 1007 10071616A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-28 B9BC4591001SEC4591001 1007 10071617ASCRN Screening ASCREENING 2020-12-29 2020-12-29T17:14:00AAC4591001SEC4591001 1007 10071617A VAXP Placebo A VACCINATION 2020-12-29T17:14:002021-02-17 AB3C4591001SEC4591001 1007 10071617A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-04-19 B3BpC4591001SEC4591001 1007 10071617A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-19 2021-04-19T09:42:00BpBpC4591001SEC4591001 1007 10071617APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-19T09:42:002021-06-09 BpBC4591001SEC4591001 1007 10071617A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-09 2021-06-09 BBC4591001SEC4591001 1007 10071618ASCRN Screening ASCREENING 2020-12-29 2020-12-29T17:13:00AAC4591001SEC4591001 1007 10071618A VAXP Placebo A VACCINATION 2020-12-29T17:13:002021-02-24 AB:C4591001SEC4591001 1007 10071618A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-26 B:BC4591001SEC4591001 1007 10071619ASCRN Screening ASCREENING 2020-12-30 2020-12-30T09:45:00AAC4591001SEC4591001 1007 10071619A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T09:45:002021-02-24 AB9C4591001SEC4591001 1007 10071619A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-14 B9BC4591001SEC4591001 1007 10071620ASCRN Screening ASCREENING 2020-12-30 2020-12-30T10:26:00AAC4591001SEC4591001 1007 10071620A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T10:26:002021-02-18 AB3C4591001SEC4591001 1007 10071620A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-07-14 B3BC4591001SEC4591001 1007 10071621ASCRN Screening ASCREENING 2020-12-30 2020-12-30T10:45:00AAC4591001SEC4591001 1007 10071621A VAXP Placebo A VACCINATION 2020-12-30T10:45:002021-02-18 AB3C4591001SEC4591001 1007 10071621A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-07-14 B3BC4591001SEC4591001 1007 10071622ASCRN Screening ASCREENING 2020-12-30 2020-12-30T10:39:00AAC4591001SEC4591001 1007 10071622A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T10:39:002021-02-18 AB3C4591001SEC4591001 1007 10071622A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-07-14 B3BC4591001SEC4591001 1007 10071623ASCRN Screening ASCREENING 2020-12-30 2020-12-30T10:59:00AAC4591001SEC4591001 1007 10071623A VAXP Placebo A VACCINATION 2020-12-30T10:59:002021-02-24 AB9C4591001SEC4591001 1007 10071623A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-06-01 B9BC4591001SEC4591001 1007 10071623A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T15:42:00BBC4591001SEC4591001 1007 10071623APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T15:42:002021-07-20 BBC4591001SEC4591001 1007 10071623A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-20 2021-07-20 BBC4591001SEC4591001 1007 10071624ASCRN Screening ASCREENING 2020-12-30 2020-12-30T12:08:00AAC4591001SEC4591001 1007 10071624A VAXP Placebo A VACCINATION 2020-12-30T12:08:002021-02-23 AB8C4591001SEC4591001 1007 10071624A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-05-19 B8BC4591001SEC4591001 1007 10071624A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T14:34:00BBC4591001SEC4591001 1007 10071624APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T14:34:002021-07-07 BBC4591001SEC4591001 1007 10071624A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1007 10071625ASCRN Screening ASCREENING 2020-12-30 2020-12-30T12:17:00AAC4591001SEC4591001 1007 10071625A VAXP Placebo A VACCINATION 2020-12-30T12:17:002021-02-23 AB8C4591001SEC4591001 1007 10071625A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-05-19 B8BC4591001SEC4591001 1007 10071625A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T14:31:00BBC4591001SEC4591001 1007 10071625APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T14:31:002021-07-07 BBC4591001SEC4591001 1007 10071625A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1007 10071626ASCRN Screening ASCREENING 2020-12-30 2020-12-30T14:05:00AAC4591001SEC4591001 1007 10071626A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T14:05:002021-02-17 AB2C4591001SEC4591001 1007 10071626A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-14 B2BC4591001SEC4591001 1007 10071627ASCRN Screening ASCREENING 2020-12-30 2020-12-30T14:33:00AAC4591001SEC4591001 1007 10071627A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T14:33:002021-02-17 AB2C4591001SEC4591001 1007 10071627A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-21 B2BC4591001SEC4591001 1007 10071628ASCRN Screening ASCREENING 2020-12-30 2020-12-30T16:10:00AAC4591001SEC4591001 1007 10071628A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T16:10:002021-02-22 AB7C4591001SEC4591001 1007 10071628A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-08-02 B7BC4591001SEC4591001 1007 10071629ASCRN Screening ASCREENING 2020-12-30 2020-12-30T15:45:00AAC4591001SEC4591001 1007 10071629A VAXP Placebo A VACCINATION 2020-12-30T15:45:002021-02-24 AB9C4591001SEC4591001 1007 10071629A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-06-01 B9BC4591001SEC4591001 1007 10071629A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T14:33:00BBC4591001SEC4591001 1007 10071629APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T14:33:002021-07-20 BBC4591001SEC4591001 1007 10071629A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-20 2021-07-20 BBC4591001SEC4591001 1007 10071630ASCRN Screening ASCREENING 2020-12-30 2020-12-30T15:39:00AAC4591001SEC4591001 1007 10071630A VAXP Placebo A VACCINATION 2020-12-30T15:39:002021-02-24 AB9C4591001SEC4591001 1007 10071630A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-06-01 B9BC4591001SEC4591001 1007 10071630A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T14:43:00BBC4591001SEC4591001 1007 10071630APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T14:43:002021-07-20 BBC4591001SEC4591001 1007 10071630A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-20 2021-07-20 BBC4591001SEC4591001 1007 10071631ASCRN Screening ASCREENING 2020-12-30 2020-12-30T16:26:00AAC4591001SEC4591001 1007 10071631A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T16:26:002021-02-25 AB:C4591001SEC4591001 1007 10071631A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-07-15 B:BC4591001SEC4591001 1007 10071632ASCRN Screening ASCREENING 2020-12-30 2020-12-30T16:45:00AAC4591001SEC4591001 1007 10071632A VAXP Placebo A VACCINATION 2020-12-30T16:45:002021-02-24 AB9C4591001SEC4591001 1007 10071632A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-18 B9BC4591001SEC4591001 1007 10071632A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T10:20:00BBC4591001SEC4591001 1007 10071632APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T10:20:002021-07-07 BBC4591001SEC4591001 1007 10071632A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1007 10071633ASCRN Screening ASCREENING 2020-12-30 2020-12-30T16:41:00AAC4591001SEC4591001 1007 10071633A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T16:41:002021-02-23 AB8C4591001SEC4591001 1007 10071633A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-15 B8BC4591001SEC4591001 1007 10071634ASCRN Screening ASCREENING 2021-01-04 2021-01-04T10:34:00AAC4591001SEC4591001 1007 10071634A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T10:34:002021-02-22 AB2C4591001SEC4591001 1007 10071634A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-19 B2BC4591001SEC4591001 1007 10071635ASCRN Screening ASCREENING 2021-01-04 2021-01-04T10:09:00AAC4591001SEC4591001 1007 10071635A VAXP Placebo A VACCINATION 2021-01-04T10:09:002021-02-22 AB2C4591001SEC4591001 1007 10071635A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-12 B2BC4591001SEC4591001 1007 10071636ASCRN Screening ASCREENING 2021-01-04 2021-01-04T11:21:00AAC4591001SEC4591001 1007 10071636A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T11:21:002021-02-22 AB2C4591001SEC4591001 1007 10071636A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-19 B2BC4591001SEC4591001 1007 10071638ASCRN Screening ASCREENING 2021-01-04 2021-01-04T11:45:00AAC4591001SEC4591001 1007 10071638A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T11:45:002021-02-24 AB4C4591001SEC4591001 1007 10071638A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-08-02 B4BC4591001SEC4591001 1007 10071639ASCRN Screening ASCREENING 2021-01-04 2021-01-04T12:10:00AAC4591001SEC4591001 1007 10071639A VAXP Placebo A VACCINATION 2021-01-04T12:10:002021-03-01 AB9C4591001SEC4591001 1007 10071639A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-06-01 B9BC4591001SEC4591001 1007 10071640ASCRN Screening ASCREENING 2021-01-04 2021-01-04T13:30:00AAC4591001SEC4591001 1007 10071640A VAXP Placebo A VACCINATION 2021-01-04T13:30:002021-03-02 AB:C4591001SEC4591001 1007 10071640A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-06-03 B:BC4591001SEC4591001 1007 10071640A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-03 2021-06-03T13:52:00BBC4591001SEC4591001 1007 10071640APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-03T13:52:002021-07-21 BBC4591001SEC4591001 1007 10071640A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-21 2021-07-21 BBC4591001SEC4591001 1007 10071641ASCRN Screening ASCREENING 2021-01-04 2021-01-04T14:14:00AAC4591001SEC4591001 1007 10071641A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T14:14:002021-02-24 AB4C4591001SEC4591001 1007 10071641A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-08-09 B4BC4591001SEC4591001 1007 10071642ASCRN Screening ASCREENING 2021-01-04 2021-01-04T15:01:00AAC4591001SEC4591001 1007 10071642A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T15:01:002021-02-22 AB2C4591001SEC4591001 1007 10071642A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-08-09 B2BC4591001SEC4591001 1007 10071643ASCRN Screening ASCREENING 2021-01-04 2021-01-04T14:55:00AAC4591001SEC4591001 1007 10071643A VAXP Placebo A VACCINATION 2021-01-04T14:55:002021-02-22 AB2C4591001SEC4591001 1007 10071643A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-27 B2BC4591001SEC4591001 1007 10071643A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-27 2021-05-27T14:50:00BBC4591001SEC4591001 1007 10071643APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-27T14:50:002021-07-22 BBC4591001SEC4591001 1007 10071643A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-22 2021-08-29 BBC4591001SEC4591001 1007 10071644ASCRN Screening ASCREENING 2021-01-04 2021-01-04T16:36:00AAC4591001SEC4591001 1007 10071644A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T16:36:002021-02-22 AB2C4591001SEC4591001 1007 10071644A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-19 B2BC4591001SEC4591001 1007 10071645ASCRN Screening ASCREENING 2021-01-04 2021-01-04T16:22:00AAC4591001SEC4591001 1007 10071645A VAXP Placebo A VACCINATION 2021-01-04T16:22:002021-02-22 AB2C4591001SEC4591001 1007 10071645A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-26 B2BC4591001SEC4591001 1007 10071645A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T11:53:00BBC4591001SEC4591001 1007 10071645APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T11:53:002021-07-14 BBC4591001SEC4591001 1007 10071645A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-07-14 BBC4591001SEC4591001 1007 10071646ASCRN Screening ASCREENING 2021-01-04 2021-01-04T17:09:00AAC4591001SEC4591001 1007 10071646A VAXP Placebo A VACCINATION 2021-01-04T17:09:002021-02-22 AB2C4591001SEC4591001 1007 10071646A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-06-03 B2BC4591001SEC4591001 1007 10071646A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-03 2021-06-03T14:36:00BBC4591001SEC4591001 1007 10071646APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-03T14:36:002021-07-20 BBC4591001SEC4591001 1007 10071646A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-20 2021-07-20 BBC4591001SEC4591001 1007 10071647ASCRN Screening ASCREENING 2021-01-04 2021-01-04T17:19:00AAC4591001SEC4591001 1007 10071647A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T17:19:002021-02-25 AB5C4591001SEC4591001 1007 10071647A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-07-19 B5BC4591001SEC4591001 1007 10071648ASCRN Screening ASCREENING 2021-01-05 2021-01-05T09:27:00AAC4591001SEC4591001 1007 10071648A VAXP Placebo A VACCINATION 2021-01-05T09:27:002021-02-23 AB2C4591001SEC4591001 1007 10071648A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-04-20 B2BjC4591001SEC4591001 1007 10071648A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-20 2021-04-20T12:38:00BjBjC4591001SEC4591001 1007 10071648APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-20T12:38:002021-06-08 BjBC4591001SEC4591001 1007 10071648A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-08 2021-06-08 BBC4591001SEC4591001 1007 10071649ASCRN Screening ASCREENING 2021-01-05 2021-01-05T09:55:00AAC4591001SEC4591001 1007 10071649A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T09:55:002021-02-23 AB2C4591001SEC4591001 1007 10071649A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-20 B2BC4591001SEC4591001 1007 10071650ASCRN Screening ASCREENING 2021-01-05 2021-01-05T11:09:00AAC4591001SEC4591001 1007 10071650A VAXP Placebo A VACCINATION 2021-01-05T11:09:002021-02-25 AB4C4591001SEC4591001 1007 10071650A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-25 B4BC4591001SEC4591001 1007 10071650A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T14:28:00BBC4591001SEC4591001 1007 10071650APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T14:28:002021-07-13 BBC4591001SEC4591001 1007 10071650A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1007 10071651ASCRN Screening ASCREENING 2021-01-05 2021-01-05T10:55:00AAC4591001SEC4591001 1007 10071651A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T10:55:002021-02-23 AB2C4591001SEC4591001 1007 10071651A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-22 B2BC4591001SEC4591001 1007 10071652ASCRN Screening ASCREENING 2021-01-05 2021-01-05T11:17:00AAC4591001SEC4591001 1007 10071652A VAXP Placebo A VACCINATION 2021-01-05T11:17:002021-02-23 AB2C4591001SEC4591001 1007 10071652A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-05-25 B2BC4591001SEC4591001 1007 10071652A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T10:22:00BBC4591001SEC4591001 1007 10071652APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T10:22:002021-07-19 BBC4591001SEC4591001 1007 10071652A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-19 BBC4591001SEC4591001 1007 10071653ASCRN Screening ASCREENING 2021-01-05 2021-01-05T14:25:00AAC4591001SEC4591001 1007 10071653A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T14:25:002021-02-23 AB2C4591001SEC4591001 1007 10071653A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-20 B2BC4591001SEC4591001 1007 10071654ASCRN Screening ASCREENING 2021-01-05 2021-01-05T14:14:00AAC4591001SEC4591001 1007 10071654A VAXP Placebo A VACCINATION 2021-01-05T14:14:002021-02-23 AB2C4591001SEC4591001 1007 10071654A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-22 B2BC4591001SEC4591001 1007 10071655ASCRN Screening ASCREENING 2021-01-06 2021-01-06T09:35:00AAC4591001SEC4591001 1007 10071655A VAXP Placebo A VACCINATION 2021-01-06T09:35:002021-02-24 AB2C4591001SEC4591001 1007 10071655A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-17 B2BC4591001SEC4591001 1007 10071655A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T15:29:00BBC4591001SEC4591001 1007 10071655APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T15:29:002021-07-06 BBC4591001SEC4591001 1007 10071655A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1007 10071656ASCRN Screening ASCREENING 2021-01-06 2021-01-06T10:14:00AAC4591001SEC4591001 1007 10071656A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T10:14:002021-03-02 AB8C4591001SEC4591001 1007 10071656A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-07-27 B8BC4591001SEC4591001 1007 10071658ASCRN Screening ASCREENING 2021-01-06 2021-01-06T17:12:00AAC4591001SEC4591001 1007 10071658A VAXP Placebo A VACCINATION 2021-01-06T17:12:002021-02-24 AB2C4591001SEC4591001 1007 10071658A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-17 B2BC4591001SEC4591001 1007 10071658A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T15:17:00BBC4591001SEC4591001 1007 10071658APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T15:17:002021-07-12 BBC4591001SEC4591001 1007 10071658A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1007 10071659ASCRN Screening ASCREENING 2021-01-06 2021-01-06T16:57:00AAC4591001SEC4591001 1007 10071659A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T16:57:002021-02-24 AB2C4591001SEC4591001 1007 10071659A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-21 B2BC4591001SEC4591001 1007 10071660ASCRN Screening ASCREENING 2021-01-06 2021-01-06T16:53:00AAC4591001SEC4591001 1007 10071660A VAXP Placebo A VACCINATION 2021-01-06T16:53:002021-02-24 AB2C4591001SEC4591001 1007 10071660A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-06-02 B2BC4591001SEC4591001 1007 10071660A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-02 2021-06-02T12:29:00BBC4591001SEC4591001 1007 10071660APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-02T12:29:002021-07-22 BBC4591001SEC4591001 1007 10071660A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-22 2021-07-22 BBC4591001SEC4591001 1007 10071661ASCRN Screening ASCREENING 2021-01-07 2021-01-07T15:30:00AAC4591001SEC4591001 1007 10071661A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T15:30:002021-02-25 AB2C4591001SEC4591001 1007 10071661A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-08-17 B2BC4591001SEC4591001 1007 10071662ASCRN Screening ASCREENING 2021-01-07 2021-01-07T16:07:00AAC4591001SEC4591001 1007 10071662A VAXP Placebo A VACCINATION 2021-01-07T16:07:002021-02-25 AB2C4591001SEC4591001 1007 10071662A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-08-12 B2BC4591001SEC4591001 1008 10081751ASCRN Screening ASCREENING 2020-12-01 2020-12-01T11:04:00AAC4591001SEC4591001 1008 10081751A VAXP Placebo A VACCINATION 2020-12-01T11:04:002021-01-25 AB8C4591001SEC4591001 1008 10081751A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-05-14 B8BC4591001SEC4591001 1008 10081751A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T14:12:00BBC4591001SEC4591001 1008 10081751APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T14:12:002021-07-02 BBC4591001SEC4591001 1008 10081751A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1008 10081752ASCRN Screening ASCREENING 2020-12-01 2020-12-01T15:26:00AAC4591001SEC4591001 1008 10081752A VAXP Placebo A VACCINATION 2020-12-01T15:26:002021-01-21 AB4C4591001SEC4591001 1008 10081752A0FUP Follow-up A0FOLLOW-UP 2021-01-21 2021-05-13 B4BC4591001SEC4591001 1008 10081752A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T09:36:00BBC4591001SEC4591001 1008 10081752APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T09:36:002021-07-02 BBC4591001SEC4591001 1008 10081752A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1008 10081753ASCRN Screening ASCREENING 2020-12-01 2020-12-01T15:27:00AAC4591001SEC4591001 1008 10081753A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-01T15:27:002021-01-21 AB4C4591001SEC4591001 1008 10081753A0FUP Follow-up A0FOLLOW-UP 2021-01-21 2021-06-17 B4BC4591001SEC4591001 1008 10081754ASCRN Screening ASCREENING 2020-12-02 2020-12-02T13:50:00AAC4591001SEC4591001 1008 10081754A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T13:50:002021-01-22 AB4C4591001SEC4591001 1008 10081754A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-06-16 B4BC4591001SEC4591001 1008 10081755ASCRN Screening ASCREENING 2020-12-02 2020-12-02T13:57:00AAC4591001SEC4591001 1008 10081755A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T13:57:002021-01-21 AB3C4591001SEC4591001 1008 10081755A0FUP Follow-up A0FOLLOW-UP 2021-01-21 2021-06-17 B3BC4591001SEC4591001 1008 10081756ASCRN Screening ASCREENING 2020-12-02 2020-12-02T14:25:00AAC4591001SEC4591001 1008 10081756A VAXP Placebo A VACCINATION 2020-12-02T14:25:002021-01-20 AB2C4591001SEC4591001 1008 10081756A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-04-22 B2BC4591001SEC4591001 1008 10081756A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-22 2021-04-22T15:14:00BBC4591001SEC4591001 1008 10081756APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-22T15:14:002021-06-14 BBC4591001SEC4591001 1008 10081756A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-14 2021-06-14 BBC4591001SEC4591001 1008 10081757ASCRN Screening ASCREENING 2020-12-02 2020-12-02T14:22:00AAC4591001SEC4591001 1008 10081757A VAXP Placebo A VACCINATION 2020-12-02T14:22:002021-01-20 AB2C4591001SEC4591001 1008 10081757A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-05-17 B2BC4591001SEC4591001 1008 10081757A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T13:55:00BBC4591001SEC4591001 1008 10081757APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T13:55:002021-07-07 BBC4591001SEC4591001 1008 10081757A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1008 10081758ASCRN Screening ASCREENING 2020-12-02 2020-12-02T15:05:00AAC4591001SEC4591001 1008 10081758A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T15:05:002021-01-25 AB7C4591001SEC4591001 1008 10081758A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-08-02 B7BC4591001SEC4591001 1008 10081760ASCRN Screening ASCREENING 2020-12-07 2020-12-07T15:53:00AAC4591001SEC4591001 1008 10081760A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T15:53:002021-01-26 AB3C4591001SEC4591001 1008 10081760A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-07-06 B3BC4591001SEC4591001 1008 10081761ASCRN Screening ASCREENING 2020-12-07 2020-12-07T15:00:00AAC4591001SEC4591001 1008 10081761A VAXP Placebo A VACCINATION 2020-12-07T15:00:002021-01-29 AB6C4591001SEC4591001 1008 10081761A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-04-05 B6BxC4591001SEC4591001 1008 10081761A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-05 2021-04-05T15:22:00BxBxC4591001SEC4591001 1008 10081761APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-05T15:22:002021-05-25 BxBC4591001SEC4591001 1008 10081761A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-25 2021-05-25 BBC4591001SEC4591001 1008 10081763ASCRN Screening ASCREENING 2020-12-07 2020-12-07T16:28:00AAC4591001SEC4591001 1008 10081763A VAXP Placebo A VACCINATION 2020-12-07T16:28:002021-01-25 AB2C4591001SEC4591001 1008 10081763A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-05-19 B2BC4591001SEC4591001 1008 10081763A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T13:59:00BBC4591001SEC4591001 1008 10081763APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T13:59:002021-07-08 BBC4591001SEC4591001 1008 10081763A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1008 10081764ASCRN Screening ASCREENING 2020-12-07 2020-12-07T16:23:00AAC4591001SEC4591001 1008 10081764A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T16:23:002021-01-25 AB2C4591001SEC4591001 1008 10081764A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-06-25 B2BC4591001SEC4591001 1008 10081767ASCRN Screening ASCREENING 2020-12-08 2020-12-08T14:35:00AAC4591001SEC4591001 1008 10081767A VAXP Placebo A VACCINATION 2020-12-08T14:35:002021-01-26 AB2C4591001SEC4591001 1008 10081767A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-05-13 B2BC4591001SEC4591001 1008 10081767A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T16:45:00BBC4591001SEC4591001 1008 10081767APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T16:45:002021-07-01 BBC4591001SEC4591001 1008 10081767A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1008 10081768ASCRN Screening ASCREENING 2020-12-08 2020-12-08T14:52:00AAC4591001SEC4591001 1008 10081768A VAXP Placebo A VACCINATION 2020-12-08T14:52:002021-01-29 AB5C4591001SEC4591001 1008 10081768A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-06-29 B5BC4591001SEC4591001 1008 10081769ASCRN Screening ASCREENING 2020-12-08 2020-12-08T15:08:00AAC4591001SEC4591001 1008 10081769A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T15:08:002021-02-23 ABNC4591001SEC4591001 1008 10081769A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-08-09 BNBC4591001SEC4591001 1008 10081770ASCRN Screening ASCREENING 2020-12-09 2020-12-09T10:57:00AAC4591001SEC4591001 1008 10081770A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T10:57:002021-01-27 AB2C4591001SEC4591001 1008 10081770A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-23 B2BC4591001SEC4591001 1008 10081771ASCRN Screening ASCREENING 2020-12-09 2020-12-09T10:50:00AAC4591001SEC4591001 1008 10081771A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T10:50:002021-01-27 AB2C4591001SEC4591001 1008 10081771A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-23 B2BC4591001SEC4591001 1008 10081773ASCRN Screening ASCREENING 2020-12-09 2020-12-09T14:14:00AAC4591001SEC4591001 1008 10081773A VAXP Placebo A VACCINATION 2020-12-09T14:14:002021-01-27 AB2C4591001SEC4591001 1008 10081773A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-14 B2BC4591001SEC4591001 1008 10081773A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T12:12:00BBC4591001SEC4591001 1008 10081773APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T12:12:002021-07-02 BBC4591001SEC4591001 1008 10081773A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1008 10081774ASCRN Screening ASCREENING 2020-12-09 2020-12-09T15:00:00AAC4591001SEC4591001 1008 10081774A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T15:00:002021-01-28 AB3C4591001SEC4591001 1008 10081774A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-06-30 B3BC4591001SEC4591001 1008 10081775ASCRN Screening ASCREENING 2020-12-09 2020-12-09T14:57:00AAC4591001SEC4591001 1008 10081775A VAXP Placebo A VACCINATION 2020-12-09T14:57:002021-01-28 AB3C4591001SEC4591001 1008 10081775A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-05-21 B3BC4591001SEC4591001 1008 10081775A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T14:16:00BBC4591001SEC4591001 1008 10081775APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T14:16:002021-07-16 BBC4591001SEC4591001 1008 10081775A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-16 2021-07-16 BBC4591001SEC4591001 1008 10081777ASCRN Screening ASCREENING 2020-12-10 2020-12-10T11:22:00AAC4591001SEC4591001 1008 10081777A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T11:22:002021-01-28 AB2C4591001SEC4591001 1008 10081777A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-06-28 B2BC4591001SEC4591001 1008 10081780ASCRN Screening ASCREENING 2020-12-10 2020-12-10T14:55:00AAC4591001SEC4591001 1008 10081780A VAXP Placebo A VACCINATION 2020-12-10T14:55:002021-01-27 AB1C4591001SEC4591001 1008 10081780A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-17 B1BC4591001SEC4591001 1008 10081780A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T09:53:00BBC4591001SEC4591001 1008 10081780APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T09:53:002021-07-07 BBC4591001SEC4591001 1008 10081780A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1008 10081781ASCRN Screening ASCREENING 2020-12-10 2020-12-10T15:02:00AAC4591001SEC4591001 1008 10081781A VAXP Placebo A VACCINATION 2020-12-10T15:02:002021-02-02 AB7C4591001SEC4591001 1008 10081781A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-20 B7BC4591001SEC4591001 1008 10081781A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T10:22:00BBC4591001SEC4591001 1008 10081781APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T10:22:002021-07-07 BBC4591001SEC4591001 1008 10081781A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1008 10081785ASCRN Screening ASCREENING 2020-12-11 2020-12-11T14:37:00AAC4591001SEC4591001 1008 10081785A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-11T14:37:002021-01-29 AB2C4591001SEC4591001 1008 10081785A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-06-25 B2BC4591001SEC4591001 1008 10081788ASCRN Screening ASCREENING 2020-12-14 2020-12-14T10:17:00AAC4591001SEC4591001 1008 10081788A VAXP Placebo A VACCINATION 2020-12-14T10:17:002021-02-01 AB2C4591001SEC4591001 1008 10081788A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-13 B2BC4591001SEC4591001 1008 10081788A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T11:07:00BBC4591001SEC4591001 1008 10081788APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T11:07:002021-07-01 BBC4591001SEC4591001 1008 10081788A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1008 10081789ASCRN Screening ASCREENING 2020-12-14 2020-12-14T10:23:00AAC4591001SEC4591001 1008 10081789A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T10:23:002021-02-04 AB5C4591001SEC4591001 1008 10081789A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-07-08 B5BC4591001SEC4591001 1008 10081790ASCRN Screening ASCREENING 2020-12-14 2020-12-14T14:22:00AAC4591001SEC4591001 1008 10081790A VAXP Placebo A VACCINATION 2020-12-14T14:22:002021-02-02 AB3C4591001SEC4591001 1008 10081790A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-13 B3BC4591001SEC4591001 1008 10081790A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T09:12:00BBC4591001SEC4591001 1008 10081790APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T09:12:002021-07-01 BBC4591001SEC4591001 1008 10081790A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-08-10 BBC4591001SEC4591001 1008 10081791ASCRN Screening ASCREENING 2020-12-14 2020-12-14T15:11:00AAC4591001SEC4591001 1008 10081791A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T15:11:002021-02-01 AB2C4591001SEC4591001 1008 10081791A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-07-02 B2BC4591001SEC4591001 1008 10081792ASCRN Screening ASCREENING 2020-12-14 2020-12-14T15:15:00AAC4591001SEC4591001 1008 10081792A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T15:15:002021-02-01 AB2C4591001SEC4591001 1008 10081792A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-07-02 B2BC4591001SEC4591001 1008 10081793ASCRN Screening ASCREENING 2020-12-14 2020-12-14T15:21:00AAC4591001SEC4591001 1008 10081793A VAXP Placebo A VACCINATION 2020-12-14T15:21:002021-02-01 AB2C4591001SEC4591001 1008 10081793A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-13 B2BC4591001SEC4591001 1008 10081793A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T14:07:00BBC4591001SEC4591001 1008 10081793APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T14:07:002021-07-01 BBC4591001SEC4591001 1008 10081793A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1008 10081794ASCRN Screening ASCREENING 2020-12-14 2020-12-14T15:26:00AAC4591001SEC4591001 1008 10081794A VAXP Placebo A VACCINATION 2020-12-14T15:26:002021-02-01 AB2C4591001SEC4591001 1008 10081794A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-13 B2BC4591001SEC4591001 1008 10081794A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T14:37:00BBC4591001SEC4591001 1008 10081794APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T14:37:002021-07-01 BBC4591001SEC4591001 1008 10081794A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1008 10081795ASCRN Screening ASCREENING 2020-12-15 2020-12-15T11:41:00AAC4591001SEC4591001 1008 10081795A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T11:41:002021-02-04 AB4C4591001SEC4591001 1008 10081795A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-07-06 B4BC4591001SEC4591001 1008 10081796ASCRN Screening ASCREENING 2020-12-15 2020-12-15T14:07:00AAC4591001SEC4591001 1008 10081796A VAXP Placebo A VACCINATION 2020-12-15T14:07:002021-02-02 AB2C4591001SEC4591001 1008 10081796A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-14 B2BC4591001SEC4591001 1008 10081796A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T10:07:00BBC4591001SEC4591001 1008 10081796APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T10:07:002021-07-06 BBC4591001SEC4591001 1008 10081796A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081797ASCRN Screening ASCREENING 2020-12-15 2020-12-15T15:08:00AAC4591001SEC4591001 1008 10081797A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T15:08:002021-02-03 AB3C4591001SEC4591001 1008 10081797A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-06 B3BC4591001SEC4591001 1008 10081798ASCRN Screening ASCREENING 2020-12-15 2020-12-15T15:16:00AAC4591001SEC4591001 1008 10081798A VAXP Placebo A VACCINATION 2020-12-15T15:16:002021-02-02 AB2C4591001SEC4591001 1008 10081798A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-14 B2BC4591001SEC4591001 1008 10081798A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T12:19:00BBC4591001SEC4591001 1008 10081798APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T12:19:002021-07-02 BBC4591001SEC4591001 1008 10081798A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-12 BBC4591001SEC4591001 1008 10081799ASCRN Screening ASCREENING 2020-12-15 2020-12-15T15:21:00AAC4591001SEC4591001 1008 10081799A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T15:21:002021-02-02 AB2C4591001SEC4591001 1008 10081799A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-07-12 B2BC4591001SEC4591001 1008 10081800ASCRN Screening ASCREENING 2020-12-16 2020-12-16T11:20:00AAC4591001SEC4591001 1008 10081800A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T11:20:002021-02-03 AB2C4591001SEC4591001 1008 10081800A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-07 B2BC4591001SEC4591001 1008 10081801ASCRN Screening ASCREENING 2020-12-17 2020-12-17T11:02:00AAC4591001SEC4591001 1008 10081801A VAXP Placebo A VACCINATION 2020-12-17T11:02:002021-02-05 AB3C4591001SEC4591001 1008 10081801A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-17 B3BC4591001SEC4591001 1008 10081801A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T14:00:00BBC4591001SEC4591001 1008 10081801APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T14:00:002021-07-06 BBC4591001SEC4591001 1008 10081801A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081802ASCRN Screening ASCREENING 2020-12-17 2020-12-17T14:04:00AAC4591001SEC4591001 1008 10081802A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T14:04:002021-02-04 AB2C4591001SEC4591001 1008 10081802A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-08-13 B2BC4591001SEC4591001 1008 10081803ASCRN Screening ASCREENING 2020-12-17 2020-12-17T14:13:00AAC4591001SEC4591001 1008 10081803A VAXP Placebo A VACCINATION 2020-12-17T14:13:002021-02-04 AB2C4591001SEC4591001 1008 10081803A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-03-19 B2B]C4591001SEC4591001 1008 10081803A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-19 2021-03-19T14:03:00B]B]C4591001SEC4591001 1008 10081803APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-19T14:03:002021-05-11 B]BC4591001SEC4591001 1008 10081803A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-11 2021-05-11 BBC4591001SEC4591001 1008 10081804ASCRN Screening ASCREENING 2020-12-17 2020-12-17T14:42:00AAC4591001SEC4591001 1008 10081804A VAXP Placebo A VACCINATION 2020-12-17T14:42:002021-02-11 AB9C4591001SEC4591001 1008 10081804A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-05-13 B9BC4591001SEC4591001 1008 10081804A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T14:40:00BBC4591001SEC4591001 1008 10081804APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T14:40:002021-07-01 BBC4591001SEC4591001 1008 10081804A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1008 10081805ASCRN Screening ASCREENING 2020-12-17 2020-12-17T15:33:00AAC4591001SEC4591001 1008 10081805A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T15:33:002021-02-05 AB3C4591001SEC4591001 1008 10081805A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-02 B3BC4591001SEC4591001 1008 10081806ASCRN Screening ASCREENING 2020-12-17 2020-12-17T15:45:00AAC4591001SEC4591001 1008 10081806A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T15:45:002021-02-04 AB2C4591001SEC4591001 1008 10081806A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-07-09 B2BC4591001SEC4591001 1008 10081807ASCRN Screening ASCREENING 2020-12-18 2020-12-18T10:25:00AAC4591001SEC4591001 1008 10081807A VAXP Placebo A VACCINATION 2020-12-18T10:25:002021-02-05 AB2C4591001SEC4591001 1008 10081807A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-14 B2BC4591001SEC4591001 1008 10081807A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T10:10:00BBC4591001SEC4591001 1008 10081807APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T10:10:002021-07-06 BBC4591001SEC4591001 1008 10081807A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081808ASCRN Screening ASCREENING 2020-12-18 2020-12-18T10:40:00AAC4591001SEC4591001 1008 10081808A VAXP Placebo A VACCINATION 2020-12-18T10:40:002021-02-12 AB9C4591001SEC4591001 1008 10081808A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-05-17 B9BC4591001SEC4591001 1008 10081808A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T09:47:00BBC4591001SEC4591001 1008 10081808APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T09:47:002021-07-06 BBC4591001SEC4591001 1008 10081808A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081809ASCRN Screening ASCREENING 2020-12-18 2020-12-18T11:36:00AAC4591001SEC4591001 1008 10081809A VAXP Placebo A VACCINATION 2020-12-18T11:36:002021-02-09 AB6C4591001SEC4591001 1008 10081809A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-05-13 B6BC4591001SEC4591001 1008 10081809A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T16:48:00BBC4591001SEC4591001 1008 10081809APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T16:48:002021-07-14 BBC4591001SEC4591001 1008 10081809A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-07-14 BBC4591001SEC4591001 1008 10081810ASCRN Screening ASCREENING 2020-12-18 2020-12-18T11:56:00AAC4591001SEC4591001 1008 10081810A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T11:56:002021-02-05 AB2C4591001SEC4591001 1008 10081810A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-02 B2BC4591001SEC4591001 1008 10081811ASCRN Screening ASCREENING 2020-12-18 2020-12-18T11:49:00AAC4591001SEC4591001 1008 10081811A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T11:49:002021-02-05 AB2C4591001SEC4591001 1008 10081811A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-02 B2BC4591001SEC4591001 1008 10081812ASCRN Screening ASCREENING 2020-12-18 2020-12-18T14:20:00AAC4591001SEC4591001 1008 10081812A VAXP Placebo A VACCINATION 2020-12-18T14:20:002021-02-10 AB7C4591001SEC4591001 1008 10081812A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-13 B7BC4591001SEC4591001 1008 10081812A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T16:19:00BBC4591001SEC4591001 1008 10081812APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T16:19:002021-07-02 BBC4591001SEC4591001 1008 10081812A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1008 10081813ASCRN Screening ASCREENING 2020-12-18 2020-12-18T14:42:00AAC4591001SEC4591001 1008 10081813A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T14:42:002021-02-08 AB5C4591001SEC4591001 1008 10081813A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-12 B5BC4591001SEC4591001 1008 10081814ASCRN Screening ASCREENING 2020-12-18 2020-12-18T15:12:00AAC4591001SEC4591001 1008 10081814A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T15:12:002021-02-05 AB2C4591001SEC4591001 1008 10081814A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-02 B2BC4591001SEC4591001 1008 10081815ASCRN Screening ASCREENING 2020-12-18 2020-12-18T15:22:00AAC4591001SEC4591001 1008 10081815A VAXP Placebo A VACCINATION 2020-12-18T15:22:002021-02-05 AB2C4591001SEC4591001 1008 10081815A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-20 B2BC4591001SEC4591001 1008 10081815A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T13:38:00BBC4591001SEC4591001 1008 10081815APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T13:38:002021-07-08 BBC4591001SEC4591001 1008 10081815A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1008 10081816ASCRN Screening ASCREENING 2020-12-18 2020-12-18T15:19:00AAC4591001SEC4591001 1008 10081816A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T15:19:002021-02-05 AB2C4591001SEC4591001 1008 10081816A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-02 B2BC4591001SEC4591001 1008 10081817ASCRN Screening ASCREENING 2020-12-18 2020-12-18T15:42:00AAC4591001SEC4591001 1008 10081817A VAXP Placebo A VACCINATION 2020-12-18T15:42:002021-02-12 AB9C4591001SEC4591001 1008 10081817A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-05-14 B9BC4591001SEC4591001 1008 10081817A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T12:39:00BBC4591001SEC4591001 1008 10081817APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T12:39:002021-07-02 BBC4591001SEC4591001 1008 10081817A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1008 10081818ASCRN Screening ASCREENING 2020-12-18 2020-12-18T15:50:00AAC4591001SEC4591001 1008 10081818A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T15:50:002021-02-05 AB2C4591001SEC4591001 1008 10081818A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-08 B2BC4591001SEC4591001 1008 10081819ASCRN Screening ASCREENING 2020-12-21 2020-12-21T10:12:00AAC4591001SEC4591001 1008 10081819A VAXP Placebo A VACCINATION 2020-12-21T10:12:002021-02-08 AB2C4591001SEC4591001 1008 10081819A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-18 B2BC4591001SEC4591001 1008 10081819A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T09:10:00BBC4591001SEC4591001 1008 10081819APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T09:10:002021-07-06 BBC4591001SEC4591001 1008 10081819A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081820ASCRN Screening ASCREENING 2020-12-21 2020-12-21T10:18:00AAC4591001SEC4591001 1008 10081820A VAXP Placebo A VACCINATION 2020-12-21T10:18:002021-02-10 AB4C4591001SEC4591001 1008 10081820A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-25 B4BC4591001SEC4591001 1008 10081820A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T13:40:00BBC4591001SEC4591001 1008 10081820APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T13:40:002021-07-13 BBC4591001SEC4591001 1008 10081820A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1008 10081821ASCRN Screening ASCREENING 2020-12-21 2020-12-21T10:49:00AAC4591001SEC4591001 1008 10081821A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T10:49:002021-02-08 AB2C4591001SEC4591001 1008 10081821A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-09 B2BC4591001SEC4591001 1008 10081822ASCRN Screening ASCREENING 2020-12-21 2020-12-21T11:05:00AAC4591001SEC4591001 1008 10081822A VAXP Placebo A VACCINATION 2020-12-21T11:05:002021-02-10 AB4C4591001SEC4591001 1008 10081822A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-14 B4BC4591001SEC4591001 1008 10081822A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T12:26:00BBC4591001SEC4591001 1008 10081822APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T12:26:002021-07-06 BBC4591001SEC4591001 1008 10081822A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081823ASCRN Screening ASCREENING 2020-12-21 2020-12-21T11:10:00AAC4591001SEC4591001 1008 10081823A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T11:10:002021-02-15 AB9C4591001SEC4591001 1008 10081823A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-08-24 B9BC4591001SEC4591001 1008 10081824ASCRN Screening ASCREENING 2020-12-21 2020-12-21T11:45:00AAC4591001SEC4591001 1008 10081824A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T11:45:002021-02-12 AB6C4591001SEC4591001 1008 10081824A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-16 B6BC4591001SEC4591001 1008 10081825ASCRN Screening ASCREENING 2020-12-21 2020-12-21T14:07:00AAC4591001SEC4591001 1008 10081825A VAXP Placebo A VACCINATION 2020-12-21T14:07:002021-02-11 AB5C4591001SEC4591001 1008 10081825A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-05-13 B5BC4591001SEC4591001 1008 10081825A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T13:54:00BBC4591001SEC4591001 1008 10081825APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T13:54:002021-07-01 BBC4591001SEC4591001 1008 10081825A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1008 10081826ASCRN Screening ASCREENING 2020-12-21 2020-12-21T14:13:00AAC4591001SEC4591001 1008 10081826A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T14:13:002021-02-15 AB9C4591001SEC4591001 1008 10081826A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-28 B9BC4591001SEC4591001 1008 10081827ASCRN Screening ASCREENING 2020-12-21 2020-12-21T15:07:00AAC4591001SEC4591001 1008 10081827A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T15:07:002021-02-12 AB6C4591001SEC4591001 1008 10081827A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-07 B6BC4591001SEC4591001 1008 10081828ASCRN Screening ASCREENING 2020-12-21 2020-12-21T14:56:00AAC4591001SEC4591001 1008 10081828A VAXP Placebo A VACCINATION 2020-12-21T14:56:002021-02-25 ABCC4591001SEC4591001 1008 10081828A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-14 BCBC4591001SEC4591001 1008 10081828A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T11:37:00BBC4591001SEC4591001 1008 10081828APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T11:37:002021-07-07 BBC4591001SEC4591001 1008 10081828A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1008 10081829ASCRN Screening ASCREENING 2020-12-22 2020-12-22T09:56:00AAC4591001SEC4591001 1008 10081829A VAXP Placebo A VACCINATION 2020-12-22T09:56:002021-02-09 AB2C4591001SEC4591001 1008 10081829A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-05-13 B2BC4591001SEC4591001 1008 10081830ASCRN Screening ASCREENING 2020-12-22 2020-12-22T10:02:00AAC4591001SEC4591001 1008 10081830A VAXP Placebo A VACCINATION 2020-12-22T10:02:002021-02-10 AB3C4591001SEC4591001 1008 10081830A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-19 B3BC4591001SEC4591001 1008 10081830A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T13:56:00BBC4591001SEC4591001 1008 10081830APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T13:56:002021-07-07 BBC4591001SEC4591001 1008 10081830A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1008 10081831ASCRN Screening ASCREENING 2020-12-22 2020-12-22T10:46:00AAC4591001SEC4591001 1008 10081831A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T10:46:002021-02-15 AB8C4591001SEC4591001 1008 10081831A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-06 B8BC4591001SEC4591001 1008 10081832ASCRN Screening ASCREENING 2020-12-22 2020-12-22T11:06:00AAC4591001SEC4591001 1008 10081832A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T11:06:002021-02-09 AB2C4591001SEC4591001 1008 10081832A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-08-20 B2BC4591001SEC4591001 1008 10081833ASCRN Screening ASCREENING 2020-12-22 2020-12-22T11:01:00AAC4591001SEC4591001 1008 10081833A VAXP Placebo A VACCINATION 2020-12-22T11:01:002021-02-09 AB2C4591001SEC4591001 1008 10081833A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-05-14 B2BC4591001SEC4591001 1008 10081833A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T13:17:00BBC4591001SEC4591001 1008 10081833APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T13:17:002021-07-02 BBC4591001SEC4591001 1008 10081833A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1008 10081834ASCRN Screening ASCREENING 2020-12-22 2020-12-22T12:50:00AAC4591001SEC4591001 1008 10081834A VAXP Placebo A VACCINATION 2020-12-22T12:50:002021-02-10 AB3C4591001SEC4591001 1008 10081834A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-13 B3BC4591001SEC4591001 1008 10081835ASCRN Screening ASCREENING 2020-12-22 2020-12-22T14:18:00AAC4591001SEC4591001 1008 10081835A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T14:18:002021-02-09 AB2C4591001SEC4591001 1008 10081835A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-07-06 B2BC4591001SEC4591001 1008 10081836ASCRN Screening ASCREENING 2020-12-22 2020-12-22T14:59:00AAC4591001SEC4591001 1008 10081836A VAXP Placebo A VACCINATION 2020-12-22T14:59:002021-02-11 AB4C4591001SEC4591001 1008 10081836A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-05-14 B4BC4591001SEC4591001 1008 10081836A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T10:44:00BBC4591001SEC4591001 1008 10081836APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T10:44:002021-07-02 BBC4591001SEC4591001 1008 10081836A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1008 10081837ASCRN Screening ASCREENING 2020-12-22 2020-12-22T15:40:00AAC4591001SEC4591001 1008 10081837A VAXP Placebo A VACCINATION 2020-12-22T15:40:002021-02-12 AB5C4591001SEC4591001 1008 10081837A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-05-19 B5BC4591001SEC4591001 1008 10081837A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T14:04:00BBC4591001SEC4591001 1008 10081837APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T14:04:002021-07-07 BBC4591001SEC4591001 1008 10081837A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-09-01 BBC4591001SEC4591001 1008 10081838ASCRN Screening ASCREENING 2020-12-22 2020-12-22T15:44:00AAC4591001SEC4591001 1008 10081838A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T15:44:002021-02-12 AB5C4591001SEC4591001 1008 10081838A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-08 B5BC4591001SEC4591001 1008 10081839ASCRN Screening ASCREENING 2020-12-22 2020-12-22T15:50:00AAC4591001SEC4591001 1008 10081839A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T15:50:002021-02-15 AB8C4591001SEC4591001 1008 10081839A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-19 B8BC4591001SEC4591001 1008 10081840ASCRN Screening ASCREENING 2020-12-23 2020-12-23T09:40:00AAC4591001SEC4591001 1008 10081840A VAXP Placebo A VACCINATION 2020-12-23T09:40:002021-02-10 AB2C4591001SEC4591001 1008 10081840A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-14 B2BC4591001SEC4591001 1008 10081840A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T15:03:00BBC4591001SEC4591001 1008 10081840APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T15:03:002021-07-02 BBC4591001SEC4591001 1008 10081840A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1008 10081841ASCRN Screening ASCREENING 2020-12-23 2020-12-23T09:44:00AAC4591001SEC4591001 1008 10081841A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T09:44:002021-02-12 AB4C4591001SEC4591001 1008 10081841A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-13 B4BC4591001SEC4591001 1008 10081842ASCRN Screening ASCREENING 2020-12-23 2020-12-23T09:48:00AAC4591001SEC4591001 1008 10081842A VAXP Placebo A VACCINATION 2020-12-23T09:48:002021-02-19 AB;C4591001SEC4591001 1008 10081842A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-05-19 B;BC4591001SEC4591001 1008 10081842A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T13:12:00BBC4591001SEC4591001 1008 10081842APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T13:12:002021-07-08 BBC4591001SEC4591001 1008 10081842A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1008 10081843ASCRN Screening ASCREENING 2020-12-23 2020-12-23T10:09:00AAC4591001SEC4591001 1008 10081843A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T10:09:002021-02-10 AB2C4591001SEC4591001 1008 10081843A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-07 B2BC4591001SEC4591001 1008 10081844ASCRN Screening ASCREENING 2020-12-23 2020-12-23T10:13:00AAC4591001SEC4591001 1008 10081844A VAXP Placebo A VACCINATION 2020-12-23T10:13:002021-02-10 AB2C4591001SEC4591001 1008 10081844A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-19 B2BC4591001SEC4591001 1008 10081844A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T10:07:00BBC4591001SEC4591001 1008 10081844APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T10:07:002021-07-08 BBC4591001SEC4591001 1008 10081844A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1008 10081845ASCRN Screening ASCREENING 2020-12-23 2020-12-23T11:15:00AAC4591001SEC4591001 1008 10081845A VAXP Placebo A VACCINATION 2020-12-23T11:15:002021-02-12 AB4C4591001SEC4591001 1008 10081845A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-05-17 B4BC4591001SEC4591001 1008 10081845A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T14:02:00BBC4591001SEC4591001 1008 10081845APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T14:02:002021-07-08 BBC4591001SEC4591001 1008 10081845A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-08-11 BBC4591001SEC4591001 1008 10081846ASCRN Screening ASCREENING 2020-12-23 2020-12-23T11:24:00AAC4591001SEC4591001 1008 10081846A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T11:24:002021-02-12 AB4C4591001SEC4591001 1008 10081846A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-08 B4BC4591001SEC4591001 1008 10081847ASCRN Screening ASCREENING 2020-12-23 2020-12-23T11:09:00AAC4591001SEC4591001 1008 10081847A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T11:09:002021-02-12 AB4C4591001SEC4591001 1008 10081847A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-08 B4BC4591001SEC4591001 1008 10081848ASCRN Screening ASCREENING 2020-12-23 2020-12-23T11:31:00AAC4591001SEC4591001 1008 10081848A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T11:31:002021-02-12 AB4C4591001SEC4591001 1008 10081848A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-09-01 B4BC4591001SEC4591001 1008 10081849ASCRN Screening ASCREENING 2020-12-23 2020-12-23T11:37:00AAC4591001SEC4591001 1008 10081849A VAXP Placebo A VACCINATION 2020-12-23T11:37:002021-02-18 AB:C4591001SEC4591001 1008 10081849A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-05-14 B:BC4591001SEC4591001 1008 10081849A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T14:03:00BBC4591001SEC4591001 1008 10081849APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T14:03:002021-07-02 BBC4591001SEC4591001 1008 10081849A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1008 10081850ASCRN Screening ASCREENING 2020-12-23 2020-12-23T11:58:00AAC4591001SEC4591001 1008 10081850A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T11:58:002021-02-16 AB8C4591001SEC4591001 1008 10081850A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-07-12 B8BC4591001SEC4591001 1008 10081851ASCRN Screening ASCREENING 2020-12-23 2020-12-23T12:43:00AAC4591001SEC4591001 1008 10081851A VAXP Placebo A VACCINATION 2020-12-23T12:43:002021-02-18 AB:C4591001SEC4591001 1008 10081851A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-05-18 B:BC4591001SEC4591001 1008 10081851A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T09:07:00BBC4591001SEC4591001 1008 10081851APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T09:07:002021-07-06 BBC4591001SEC4591001 1008 10081851A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081852ASCRN Screening ASCREENING 2020-12-23 2020-12-23T12:47:00AAC4591001SEC4591001 1008 10081852A VAXP Placebo A VACCINATION 2020-12-23T12:47:002021-02-18 AB:C4591001SEC4591001 1008 10081852A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-05-18 B:BC4591001SEC4591001 1008 10081852A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T09:09:00BBC4591001SEC4591001 1008 10081852APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T09:09:002021-07-06 BBC4591001SEC4591001 1008 10081852A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081853ASCRN Screening ASCREENING 2020-12-28 2020-12-28T10:18:00AAC4591001SEC4591001 1008 10081853A VAXP Placebo A VACCINATION 2020-12-28T10:18:002021-02-15 AB2C4591001SEC4591001 1008 10081853A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-17 B2BC4591001SEC4591001 1008 10081853A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T13:58:00BBC4591001SEC4591001 1008 10081853APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T13:58:002021-07-06 BBC4591001SEC4591001 1008 10081853A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081854ASCRN Screening ASCREENING 2020-12-28 2020-12-28T11:05:00AAC4591001SEC4591001 1008 10081854A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T11:05:002021-02-15 AB2C4591001SEC4591001 1008 10081854A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-09 B2BC4591001SEC4591001 1008 10081855ASCRN Screening ASCREENING 2020-12-28 2020-12-28T11:26:00AAC4591001SEC4591001 1008 10081855A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T11:26:002021-02-19 AB6C4591001SEC4591001 1008 10081855A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-07-26 B6BC4591001SEC4591001 1008 10081856ASCRN Screening ASCREENING 2020-12-28 2020-12-28T11:39:00AAC4591001SEC4591001 1008 10081856A VAXP Placebo A VACCINATION 2020-12-28T11:39:002021-02-19 AB6C4591001SEC4591001 1008 10081856A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-05-19 B6BC4591001SEC4591001 1008 10081856A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T14:24:00BBC4591001SEC4591001 1008 10081856APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T14:24:002021-07-08 BBC4591001SEC4591001 1008 10081856A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-08-03 BBC4591001SEC4591001 1008 10081857ASCRN Screening ASCREENING 2020-12-28 2020-12-28T15:03:00AAC4591001SEC4591001 1008 10081857A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T15:03:002021-02-16 AB3C4591001SEC4591001 1008 10081857A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-07-13 B3BC4591001SEC4591001 1008 10081858ASCRN Screening ASCREENING 2020-12-28 2020-12-28T15:00:00AAC4591001SEC4591001 1008 10081858A VAXP Placebo A VACCINATION 2020-12-28T15:00:002021-02-16 AB3C4591001SEC4591001 1008 10081858A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-02-17 B3B4C4591001SEC4591001 1008 10081858A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-17 2021-02-17T12:37:00B4B4C4591001SEC4591001 1008 10081858APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-17T12:37:002021-04-07 B4BeC4591001SEC4591001 1008 10081858A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-07 2021-09-01 BeBC4591001SEC4591001 1008 10081859ASCRN Screening ASCREENING 2020-12-28 2020-12-28T15:10:00AAC4591001SEC4591001 1008 10081859A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T15:10:002021-02-19 AB6C4591001SEC4591001 1008 10081859A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-07-12 B6BC4591001SEC4591001 1008 10081860ASCRN Screening ASCREENING 2020-12-28 2020-12-28T15:16:00AAC4591001SEC4591001 1008 10081860A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T15:16:002021-02-15 AB2C4591001SEC4591001 1008 10081860A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-19 B2BC4591001SEC4591001 1008 10081861ASCRN Screening ASCREENING 2020-12-29 2020-12-29T10:25:00AAC4591001SEC4591001 1008 10081861A VAXP Placebo A VACCINATION 2020-12-29T10:25:002021-02-17 AB3C4591001SEC4591001 1008 10081861A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-14 B3BC4591001SEC4591001 1008 10081861A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T14:35:00BBC4591001SEC4591001 1008 10081861APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T14:35:002021-06-30 BBC4591001SEC4591001 1008 10081861A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-30 2021-06-30 BBC4591001SEC4591001 1008 10081862ASCRN Screening ASCREENING 2020-12-29 2020-12-29T11:15:00AAC4591001SEC4591001 1008 10081862A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T11:15:002021-02-17 AB3C4591001SEC4591001 1008 10081862A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-08-06 B3BC4591001SEC4591001 1008 10081863ASCRN Screening ASCREENING 2020-12-29 2020-12-29T11:24:00AAC4591001SEC4591001 1008 10081863A VAXP Placebo A VACCINATION 2020-12-29T11:24:002021-02-16 AB2C4591001SEC4591001 1008 10081863A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-05-17 B2BC4591001SEC4591001 1008 10081863A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T09:48:00BBC4591001SEC4591001 1008 10081863APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T09:48:002021-07-06 BBC4591001SEC4591001 1008 10081863A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081864ASCRN Screening ASCREENING 2020-12-29 2020-12-29T11:29:00AAC4591001SEC4591001 1008 10081864A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T11:29:002021-02-16 AB2C4591001SEC4591001 1008 10081864A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-07-26 B2BC4591001SEC4591001 1008 10081865ASCRN Screening ASCREENING 2020-12-29 2020-12-29T11:35:00AAC4591001SEC4591001 1008 10081865A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T11:35:002021-02-16 AB2C4591001SEC4591001 1008 10081865A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-08-09 B2BC4591001SEC4591001 1008 10081866ASCRN Screening ASCREENING 2020-12-29 2020-12-29T14:47:00AAC4591001SEC4591001 1008 10081866A VAXP Placebo A VACCINATION 2020-12-29T14:47:002021-02-17 AB3C4591001SEC4591001 1008 10081866A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-14 B3BC4591001SEC4591001 1008 10081866A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T10:18:00BBC4591001SEC4591001 1008 10081866APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T10:18:002021-07-02 BBC4591001SEC4591001 1008 10081866A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1008 10081867ASCRN Screening ASCREENING 2020-12-29 2020-12-29T14:51:00AAC4591001SEC4591001 1008 10081867A VAXP Placebo A VACCINATION 2020-12-29T14:51:002021-02-17 AB3C4591001SEC4591001 1008 10081867A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-14 B3BC4591001SEC4591001 1008 10081867A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T10:22:00BBC4591001SEC4591001 1008 10081867APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T10:22:002021-07-02 BBC4591001SEC4591001 1008 10081867A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-22 BBC4591001SEC4591001 1008 10081868ASCRN Screening ASCREENING 2020-12-29 2020-12-29T14:56:00AAC4591001SEC4591001 1008 10081868A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T14:56:002021-02-17 AB3C4591001SEC4591001 1008 10081868A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-14 B3BC4591001SEC4591001 1008 10081869ASCRN Screening ASCREENING 2020-12-29 2020-12-29T15:13:00AAC4591001SEC4591001 1008 10081869A VAXP Placebo A VACCINATION 2020-12-29T15:13:002021-02-18 AB4C4591001SEC4591001 1008 10081869A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-05-14 B4BC4591001SEC4591001 1008 10081869A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T10:35:00BBC4591001SEC4591001 1008 10081869APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T10:35:002021-06-30 BBC4591001SEC4591001 1008 10081869A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-30 2021-06-30 BBC4591001SEC4591001 1008 10081870ASCRN Screening ASCREENING 2020-12-29 2020-12-29T15:33:00AAC4591001SEC4591001 1008 10081870A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T15:33:002021-02-18 AB4C4591001SEC4591001 1008 10081870A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-07-09 B4BC4591001SEC4591001 1008 10081871ASCRN Screening ASCREENING 2020-12-30 2020-12-30T10:40:00AAC4591001SEC4591001 1008 10081871A VAXP Placebo A VACCINATION 2020-12-30T10:40:002021-03-17 ABNC4591001SEC4591001 1008 10081871A0FUP Follow-up A0FOLLOW-UP 2021-03-17 2021-05-13 BNBC4591001SEC4591001 1008 10081871A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T14:44:00BBC4591001SEC4591001 1008 10081871APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T14:44:002021-07-02 BBC4591001SEC4591001 1008 10081871A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1008 10081872ASCRN Screening ASCREENING 2020-12-30 2020-12-30T11:12:00AAC4591001SEC4591001 1008 10081872A VAXP Placebo A VACCINATION 2020-12-30T11:12:002021-02-19 AB4C4591001SEC4591001 1008 10081872A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-04-09 B4BeC4591001SEC4591001 1008 10081872A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-09 2021-04-09T14:55:00BeBeC4591001SEC4591001 1008 10081872APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-09T14:55:002021-06-01 BeBC4591001SEC4591001 1008 10081872A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-01 2021-06-01 BBC4591001SEC4591001 1008 10081873ASCRN Screening ASCREENING 2020-12-30 2020-12-30T11:16:00AAC4591001SEC4591001 1008 10081873A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T11:16:002021-02-18 AB3C4591001SEC4591001 1008 10081873A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-07-30 B3BC4591001SEC4591001 1008 10081874ASCRN Screening ASCREENING 2020-12-30 2020-12-30T11:45:00AAC4591001SEC4591001 1008 10081874A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T11:45:002021-02-17 AB2C4591001SEC4591001 1008 10081874A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-14 B2BC4591001SEC4591001 1008 10081875ASCRN Screening ASCREENING 2020-12-30 2020-12-30T11:49:00AAC4591001SEC4591001 1008 10081875A VAXP Placebo A VACCINATION 2020-12-30T11:49:002021-02-17 AB2C4591001SEC4591001 1008 10081875A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-13 B2BC4591001SEC4591001 1008 10081875A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T09:22:00BBC4591001SEC4591001 1008 10081875APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T09:22:002021-07-01 BBC4591001SEC4591001 1008 10081875A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1008 10081876ASCRN Screening ASCREENING 2020-12-30 2020-12-30T14:22:00AAC4591001SEC4591001 1008 10081876A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T14:22:002021-02-24 AB9C4591001SEC4591001 1008 10081876A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-21 B9BC4591001SEC4591001 1008 10081877ASCRN Screening ASCREENING 2020-12-30 2020-12-30T14:36:00AAC4591001SEC4591001 1008 10081877A VAXP Placebo A VACCINATION 2020-12-30T14:36:002021-02-24 AB9C4591001SEC4591001 1008 10081877A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-17 B9BC4591001SEC4591001 1008 10081877A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T13:55:00BBC4591001SEC4591001 1008 10081877APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T13:55:002021-07-07 BBC4591001SEC4591001 1008 10081877A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1008 10081878ASCRN Screening ASCREENING 2020-12-30 2020-12-30T14:42:00AAC4591001SEC4591001 1008 10081878A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T14:42:002021-02-17 AB2C4591001SEC4591001 1008 10081878A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-16 B2BC4591001SEC4591001 1008 10081879ASCRN Screening ASCREENING 2020-12-30 2020-12-30T14:47:00AAC4591001SEC4591001 1008 10081879A VAXP Placebo A VACCINATION 2020-12-30T14:47:002021-02-17 AB2C4591001SEC4591001 1008 10081879A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-16 B2BC4591001SEC4591001 1008 10081880ASCRN Screening ASCREENING 2020-12-30 2020-12-30T15:08:00AAC4591001SEC4591001 1008 10081880A VAXP Placebo A VACCINATION 2020-12-30T15:08:002021-02-18 AB3C4591001SEC4591001 1008 10081880A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-05-18 B3BC4591001SEC4591001 1008 10081880A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T15:04:00BBC4591001SEC4591001 1008 10081880APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T15:04:002021-07-06 BBC4591001SEC4591001 1008 10081880A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081881ASCRN Screening ASCREENING 2020-12-30 2020-12-30T15:12:00AAC4591001SEC4591001 1008 10081881A VAXP Placebo A VACCINATION 2020-12-30T15:12:002021-02-18 AB3C4591001SEC4591001 1008 10081881A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-05-18 B3BC4591001SEC4591001 1008 10081881A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T15:06:00BBC4591001SEC4591001 1008 10081881APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T15:06:002021-07-06 BBC4591001SEC4591001 1008 10081881A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081882ASCRN Screening ASCREENING 2020-12-31 2020-12-31T10:50:00AAC4591001SEC4591001 1008 10081882A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-31T10:50:002021-02-18 AB2C4591001SEC4591001 1008 10081882A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-08-16 B2BC4591001SEC4591001 1008 10081883ASCRN Screening ASCREENING 2020-12-31 2020-12-31T10:55:00AAC4591001SEC4591001 1008 10081883A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-31T10:55:002021-02-25 AB9C4591001SEC4591001 1008 10081883A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-07-16 B9BC4591001SEC4591001 1008 10081884ASCRN Screening ASCREENING 2020-12-31 2020-12-31T11:30:00AAC4591001SEC4591001 1008 10081884A VAXP Placebo A VACCINATION 2020-12-31T11:30:002021-03-19 ABOC4591001SEC4591001 1008 10081884A0FUP Follow-up A0FOLLOW-UP 2021-03-19 2021-05-13 BOBC4591001SEC4591001 1008 10081884A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T16:22:00BBC4591001SEC4591001 1008 10081884APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T16:22:002021-07-09 BBC4591001SEC4591001 1008 10081884A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1008 10081885ASCRN Screening ASCREENING 2020-12-31 2020-12-31T11:51:00AAC4591001SEC4591001 1008 10081885A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-31T11:51:002021-02-18 AB2C4591001SEC4591001 1008 10081885A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-07-29 B2BC4591001SEC4591001 1008 10081886ASCRN Screening ASCREENING 2020-12-31 2020-12-31T11:54:00AAC4591001SEC4591001 1008 10081886A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-31T11:54:002021-02-18 AB2C4591001SEC4591001 1008 10081886A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-07-21 B2BC4591001SEC4591001 1008 10081887ASCRN Screening ASCREENING 2021-01-04 2021-01-04T10:31:00AAC4591001SEC4591001 1008 10081887A VAXP Placebo A VACCINATION 2021-01-04T10:31:002021-02-22 AB2C4591001SEC4591001 1008 10081887A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-13 B2BC4591001SEC4591001 1008 10081887A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T16:30:00BBC4591001SEC4591001 1008 10081887APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T16:30:002021-07-01 BBC4591001SEC4591001 1008 10081887A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1008 10081888ASCRN Screening ASCREENING 2021-01-04 2021-01-04T10:40:00AAC4591001SEC4591001 1008 10081888A VAXP Placebo A VACCINATION 2021-01-04T10:40:002021-02-22 AB2C4591001SEC4591001 1008 10081888A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-13 B2BC4591001SEC4591001 1008 10081888A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T16:27:00BBC4591001SEC4591001 1008 10081888APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T16:27:002021-07-01 BBC4591001SEC4591001 1008 10081888A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1008 10081889ASCRN Screening ASCREENING 2021-01-04 2021-01-04T11:24:00AAC4591001SEC4591001 1008 10081889A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T11:24:002021-02-22 AB2C4591001SEC4591001 1008 10081889A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-26 B2BC4591001SEC4591001 1008 10081890ASCRN Screening ASCREENING 2021-01-04 2021-01-04T11:21:00AAC4591001SEC4591001 1008 10081890A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T11:21:002021-02-22 AB2C4591001SEC4591001 1008 10081890A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-26 B2BC4591001SEC4591001 1008 10081891ASCRN Screening ASCREENING 2021-01-04 2021-01-04T11:31:00AAC4591001SEC4591001 1008 10081891A VAXP Placebo A VACCINATION 2021-01-04T11:31:002021-02-22 AB2C4591001SEC4591001 1008 10081891A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-18 B2BC4591001SEC4591001 1008 10081891A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T09:07:00BBC4591001SEC4591001 1008 10081891APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T09:07:002021-07-06 BBC4591001SEC4591001 1008 10081891A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081892ASCRN Screening ASCREENING 2021-01-04 2021-01-04T14:32:00AAC4591001SEC4591001 1008 10081892A VAXP Placebo A VACCINATION 2021-01-04T14:32:002021-02-22 AB2C4591001SEC4591001 1008 10081892A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-25 B2BC4591001SEC4591001 1008 10081892A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T09:00:00BBC4591001SEC4591001 1008 10081892APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T09:00:002021-07-13 BBC4591001SEC4591001 1008 10081892A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1008 10081893ASCRN Screening ASCREENING 2021-01-04 2021-01-04T14:37:00AAC4591001SEC4591001 1008 10081893A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T14:37:002021-02-22 AB2C4591001SEC4591001 1008 10081893A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-26 B2BC4591001SEC4591001 1008 10081894ASCRN Screening ASCREENING 2021-01-04 2021-01-04T15:21:00AAC4591001SEC4591001 1008 10081894A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T15:21:002021-03-02 AB:C4591001SEC4591001 1008 10081894A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-07-21 B:BC4591001SEC4591001 1008 10081895ASCRN Screening ASCREENING 2021-01-04 2021-01-04T15:28:00AAC4591001SEC4591001 1008 10081895A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T15:28:002021-02-22 AB2C4591001SEC4591001 1008 10081895A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-19 B2BC4591001SEC4591001 1008 10081896ASCRN Screening ASCREENING 2021-01-04 2021-01-04T15:26:00AAC4591001SEC4591001 1008 10081896A VAXP Placebo A VACCINATION 2021-01-04T15:26:002021-02-22 AB2C4591001SEC4591001 1008 10081896A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-14 B2BC4591001SEC4591001 1008 10081896A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T14:17:00BBC4591001SEC4591001 1008 10081896APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T14:17:002021-07-06 BBC4591001SEC4591001 1008 10081896A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081897ASCRN Screening ASCREENING 2021-01-05 2021-01-05T10:54:00AAC4591001SEC4591001 1008 10081897A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T10:54:002021-03-01 AB8C4591001SEC4591001 1008 10081897A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-08-30 B8BC4591001SEC4591001 1008 10081898ASCRN Screening ASCREENING 2021-01-05 2021-01-05T11:05:00AAC4591001SEC4591001 1008 10081898A VAXP Placebo A VACCINATION 2021-01-05T11:05:002021-02-24 AB3C4591001SEC4591001 1008 10081898A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-13 B3BC4591001SEC4591001 1008 10081898A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T09:11:00BBC4591001SEC4591001 1008 10081898APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T09:11:002021-07-01 BBC4591001SEC4591001 1008 10081898A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1008 10081899ASCRN Screening ASCREENING 2021-01-05 2021-01-05T11:07:00AAC4591001SEC4591001 1008 10081899A VAXP Placebo A VACCINATION 2021-01-05T11:07:002021-02-24 AB3C4591001SEC4591001 1008 10081899A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-13 B3BC4591001SEC4591001 1008 10081899A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T09:14:00BBC4591001SEC4591001 1008 10081899APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T09:14:002021-07-01 BBC4591001SEC4591001 1008 10081899A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1008 10081900ASCRN Screening ASCREENING 2021-01-05 2021-01-05T14:44:00AAC4591001SEC4591001 1008 10081900A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T14:44:002021-02-23 AB2C4591001SEC4591001 1008 10081900A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-08-11 B2BC4591001SEC4591001 1008 10081901ASCRN Screening ASCREENING 2021-01-05 2021-01-05T14:50:00AAC4591001SEC4591001 1008 10081901A VAXP Placebo A VACCINATION 2021-01-05T14:50:002021-02-15 AB*C4591001SEC4591001 1008 10081901A0SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-15 2021-02-15T10:58:00B*B*C4591001SEC4591001 1008 10081901A@VAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-15T10:58:002021-04-05 B*B[C4591001SEC4591001 1008 10081901APFUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-05 2021-08-31 B[BC4591001SEC4591001 1008 10081902ASCRN Screening ASCREENING 2021-01-05 2021-01-05T15:02:00AAC4591001SEC4591001 1008 10081902A VAXP Placebo A VACCINATION 2021-01-05T15:02:002021-02-23 AB2C4591001SEC4591001 1008 10081902A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-05-13 B2BC4591001SEC4591001 1008 10081902A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T16:15:00BBC4591001SEC4591001 1008 10081902APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T16:15:002021-07-01 BBC4591001SEC4591001 1008 10081902A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1008 10081903ASCRN Screening ASCREENING 2021-01-05 2021-01-05T15:07:00AAC4591001SEC4591001 1008 10081903A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T15:07:002021-02-23 AB2C4591001SEC4591001 1008 10081903A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-16 B2BC4591001SEC4591001 1008 10081904ASCRN Screening ASCREENING 2021-01-05 2021-01-05T15:25:00AAC4591001SEC4591001 1008 10081904A VAXP Placebo A VACCINATION 2021-01-05T15:25:002021-02-25 AB4C4591001SEC4591001 1008 10081904A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-13 B4BC4591001SEC4591001 1008 10081904A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T15:35:00BBC4591001SEC4591001 1008 10081904APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T15:35:002021-07-01 BBC4591001SEC4591001 1008 10081904A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1008 10081905ASCRN Screening ASCREENING 2021-01-06 2021-01-06T10:28:00AAC4591001SEC4591001 1008 10081905A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T10:28:002021-03-03 AB9C4591001SEC4591001 1008 10081905A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-07-29 B9BC4591001SEC4591001 1008 10081906ASCRN Screening ASCREENING 2021-01-06 2021-01-06T10:58:00AAC4591001SEC4591001 1008 10081906A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T10:58:002021-03-03 AB9C4591001SEC4591001 1008 10081906A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-07-21 B9BC4591001SEC4591001 1008 10081907ASCRN Screening ASCREENING 2021-01-06 2021-01-06T11:22:00AAC4591001SEC4591001 1008 10081907A VAXP Placebo A VACCINATION 2021-01-06T11:22:002021-02-24 AB2C4591001SEC4591001 1008 10081907A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-14 B2BC4591001SEC4591001 1008 10081907A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T14:31:00BBC4591001SEC4591001 1008 10081907APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T14:31:002021-07-02 BBC4591001SEC4591001 1008 10081907A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1008 10081908ASCRN Screening ASCREENING 2021-01-06 2021-01-06T11:18:00AAC4591001SEC4591001 1008 10081908A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T11:18:002021-02-24 AB2C4591001SEC4591001 1008 10081908A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-21 B2BC4591001SEC4591001 1008 10081909ASCRN Screening ASCREENING 2021-01-06 2021-01-06T11:28:00AAC4591001SEC4591001 1008 10081909A VAXP Placebo A VACCINATION 2021-01-06T11:28:002021-02-26 AB4C4591001SEC4591001 1008 10081909A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-19 B4BC4591001SEC4591001 1008 10081909A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T14:08:00BBC4591001SEC4591001 1008 10081909APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T14:08:002021-07-07 BBC4591001SEC4591001 1008 10081909A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1008 10081910ASCRN Screening ASCREENING 2021-01-06 2021-01-06T14:46:00AAC4591001SEC4591001 1008 10081910A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T14:46:002021-02-24 AB2C4591001SEC4591001 1008 10081910A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-28 B2BC4591001SEC4591001 1008 10081911ASCRN Screening ASCREENING 2021-01-06 2021-01-06T14:52:00AAC4591001SEC4591001 1008 10081911A VAXP Placebo A VACCINATION 2021-01-06T14:52:002021-02-26 AB4C4591001SEC4591001 1008 10081911A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-14 B4BC4591001SEC4591001 1008 10081911A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T10:14:00BBC4591001SEC4591001 1008 10081911APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T10:14:002021-07-02 BBC4591001SEC4591001 1008 10081911A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1008 10081912ASCRN Screening ASCREENING 2021-01-06 2021-01-06T15:31:00AAC4591001SEC4591001 1008 10081912A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T15:31:002021-02-26 AB4C4591001SEC4591001 1008 10081912A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-02 B4BC4591001SEC4591001 1008 10081913ASCRN Screening ASCREENING 2021-01-06 2021-01-06T15:20:00AAC4591001SEC4591001 1008 10081913A VAXP Placebo A VACCINATION 2021-01-06T15:20:002021-02-26 AB4C4591001SEC4591001 1008 10081913A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-17 B4BC4591001SEC4591001 1008 10081913A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T09:51:00BBC4591001SEC4591001 1008 10081913APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T09:51:002021-07-06 BBC4591001SEC4591001 1008 10081913A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081914ASCRN Screening ASCREENING 2021-01-06 2021-01-06T15:15:00AAC4591001SEC4591001 1008 10081914A VAXP Placebo A VACCINATION 2021-01-06T15:15:002021-03-12 ABBC4591001SEC4591001 1008 10081914A0FUP Follow-up A0FOLLOW-UP 2021-03-12 2021-05-13 BBBC4591001SEC4591001 1008 10081914A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T15:39:00BBC4591001SEC4591001 1008 10081914APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T15:39:002021-06-30 BBC4591001SEC4591001 1008 10081914A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-30 2021-06-30 BBC4591001SEC4591001 1008 10081915ASCRN Screening ASCREENING 2021-01-07 2021-01-07T10:57:00AAC4591001SEC4591001 1008 10081915A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T10:57:002021-02-25 AB2C4591001SEC4591001 1008 10081915A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-07-22 B2BC4591001SEC4591001 1008 10081916ASCRN Screening ASCREENING 2021-01-07 2021-01-07T11:13:00AAC4591001SEC4591001 1008 10081916A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T11:13:002021-02-25 AB2C4591001SEC4591001 1008 10081916A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-07-22 B2BC4591001SEC4591001 1008 10081917ASCRN Screening ASCREENING 2021-01-07 2021-01-07T11:06:00AAC4591001SEC4591001 1008 10081917A VAXP Placebo A VACCINATION 2021-01-07T11:06:002021-02-25 AB2C4591001SEC4591001 1008 10081917A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-19 B2BC4591001SEC4591001 1008 10081917A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T10:11:00BBC4591001SEC4591001 1008 10081917APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T10:11:002021-07-09 BBC4591001SEC4591001 1008 10081917A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1008 10081918ASCRN Screening ASCREENING 2021-01-07 2021-01-07T14:45:00AAC4591001SEC4591001 1008 10081918A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T14:45:002021-02-25 AB2C4591001SEC4591001 1008 10081918A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-07-22 B2BC4591001SEC4591001 1008 10081919ASCRN Screening ASCREENING 2021-01-07 2021-01-07T14:57:00AAC4591001SEC4591001 1008 10081919A VAXP Placebo A VACCINATION 2021-01-07T14:57:002021-02-26 AB3C4591001SEC4591001 1008 10081919A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-19 B3BC4591001SEC4591001 1008 10081919A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T13:53:00BBC4591001SEC4591001 1008 10081919APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T13:53:002021-07-08 BBC4591001SEC4591001 1008 10081919A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1008 10081920ASCRN Screening ASCREENING 2021-01-07 2021-01-07T15:17:00AAC4591001SEC4591001 1008 10081920A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T15:17:002021-03-01 AB6C4591001SEC4591001 1008 10081920A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-26 B6BC4591001SEC4591001 1008 10081921ASCRN Screening ASCREENING 2021-01-07 2021-01-07T15:42:00AAC4591001SEC4591001 1008 10081921A VAXP Placebo A VACCINATION 2021-01-07T15:42:002021-03-02 AB7C4591001SEC4591001 1008 10081921A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-04-26 B7BnC4591001SEC4591001 1008 10081921A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-26 2021-04-26T13:41:00BnBnC4591001SEC4591001 1008 10081921APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-26T13:41:002021-06-14 BnBC4591001SEC4591001 1008 10081921A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-14 2021-07-12 BBC4591001SEC4591001 1008 10081922ASCRN Screening ASCREENING 2021-01-08 2021-01-08T10:28:00AAC4591001SEC4591001 1008 10081922A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T10:28:002021-02-26 AB2C4591001SEC4591001 1008 10081922A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-23 B2BC4591001SEC4591001 1008 10081923ASCRN Screening ASCREENING 2021-01-08 2021-01-08T10:36:00AAC4591001SEC4591001 1008 10081923A VAXP Placebo A VACCINATION 2021-01-08T10:36:002021-02-26 AB2C4591001SEC4591001 1008 10081923A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-13 B2B~C4591001SEC4591001 1008 10081923A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T13:59:00B~B~C4591001SEC4591001 1008 10081923APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T13:59:002021-07-01 B~BC4591001SEC4591001 1008 10081923A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1008 10081924ASCRN Screening ASCREENING 2021-01-08 2021-01-08T10:49:00AAC4591001SEC4591001 1008 10081924A VAXP Placebo A VACCINATION 2021-01-08T10:49:002021-02-26 AB2C4591001SEC4591001 1008 10081924A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-14 B2BC4591001SEC4591001 1008 10081924A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T10:30:00BBC4591001SEC4591001 1008 10081924APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T10:30:002021-07-06 BBC4591001SEC4591001 1008 10081924A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081925ASCRN Screening ASCREENING 2021-01-08 2021-01-08T11:27:00AAC4591001SEC4591001 1008 10081925A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T11:27:002021-02-26 AB2C4591001SEC4591001 1008 10081925A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-28 B2BC4591001SEC4591001 1008 10081926ASCRN Screening ASCREENING 2021-01-08 2021-01-08T15:13:00AAC4591001SEC4591001 1008 10081926A VAXP Placebo A VACCINATION 2021-01-08T15:13:002021-02-26 AB2C4591001SEC4591001 1008 10081926A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-14 B2BC4591001SEC4591001 1008 10081926A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T14:39:00BBC4591001SEC4591001 1008 10081926APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T14:39:002021-07-07 BBC4591001SEC4591001 1008 10081926A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1008 10081927ASCRN Screening ASCREENING 2021-01-08 2021-01-08T14:44:00AAC4591001SEC4591001 1008 10081927A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T14:44:002021-02-26 AB2C4591001SEC4591001 1008 10081927A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-02 B2BC4591001SEC4591001 1008 10081928ASCRN Screening ASCREENING 2021-01-08 2021-01-08T15:23:00AAC4591001SEC4591001 1008 10081928A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T15:23:002021-02-26 AB2C4591001SEC4591001 1008 10081928A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-30 B2BC4591001SEC4591001 1008 10081929ASCRN Screening ASCREENING 2021-01-08 2021-01-08T15:37:00AAC4591001SEC4591001 1008 10081929A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T15:37:002021-03-02 AB6C4591001SEC4591001 1008 10081929A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-07-27 B6BC4591001SEC4591001 1008 10081930ASCRN Screening ASCREENING 2021-01-11 2021-01-11T10:41:00AAC4591001SEC4591001 1008 10081930A VAXP Placebo A VACCINATION 2021-01-11T10:41:002021-03-01 AB2C4591001SEC4591001 1008 10081930A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-05-13 B2B{C4591001SEC4591001 1008 10081930A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T14:02:00B{B{C4591001SEC4591001 1008 10081930APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T14:02:002021-07-06 B{BC4591001SEC4591001 1008 10081930A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081931ASCRN Screening ASCREENING 2021-01-11 2021-01-11T10:48:00AAC4591001SEC4591001 1008 10081931A VAXP Placebo A VACCINATION 2021-01-11T10:48:002021-03-01 AB2C4591001SEC4591001 1008 10081931A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-05-19 B2BC4591001SEC4591001 1008 10081931A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T10:08:00BBC4591001SEC4591001 1008 10081931APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T10:08:002021-07-12 BBC4591001SEC4591001 1008 10081931A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1008 10081932ASCRN Screening ASCREENING 2021-01-11 2021-01-11T10:52:00AAC4591001SEC4591001 1008 10081932A VAXP Placebo A VACCINATION 2021-01-11T10:52:002021-03-01 AB2C4591001SEC4591001 1008 10081932A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-05-19 B2BC4591001SEC4591001 1008 10081932A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T10:06:00BBC4591001SEC4591001 1008 10081932APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T10:06:002021-07-07 BBC4591001SEC4591001 1008 10081932A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1008 10081933ASCRN Screening ASCREENING 2021-01-11 2021-01-11T13:49:00AAC4591001SEC4591001 1008 10081933A VAXP Placebo A VACCINATION 2021-01-11T13:49:002021-03-02 AB3C4591001SEC4591001 1008 10081933A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-17 B3BC4591001SEC4591001 1008 10081933A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T14:32:00BBC4591001SEC4591001 1008 10081933APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T14:32:002021-07-06 BBC4591001SEC4591001 1008 10081933A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081934ASCRN Screening ASCREENING 2021-01-11 2021-01-11T14:27:00AAC4591001SEC4591001 1008 10081934A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T14:27:002021-03-01 AB2C4591001SEC4591001 1008 10081934A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-27 B2BC4591001SEC4591001 1008 10081935ASCRN Screening ASCREENING 2021-01-11 2021-01-11T14:57:00AAC4591001SEC4591001 1008 10081935A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T14:57:002021-03-03 AB4C4591001SEC4591001 1008 10081935A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-08-13 B4BC4591001SEC4591001 1008 10081936ASCRN Screening ASCREENING 2021-01-11 2021-01-11T15:06:00AAC4591001SEC4591001 1008 10081936A VAXP Placebo A VACCINATION 2021-01-11T15:06:002021-03-01 AB2C4591001SEC4591001 1008 10081936A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-05-14 B2B|C4591001SEC4591001 1008 10081936A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T10:40:00B|B|C4591001SEC4591001 1008 10081936APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T10:40:002021-06-30 B|BC4591001SEC4591001 1008 10081936A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-30 2021-06-30 BBC4591001SEC4591001 1008 10081937ASCRN Screening ASCREENING 2021-01-11 2021-01-11T15:27:00AAC4591001SEC4591001 1008 10081937A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T15:27:002021-03-01 AB2C4591001SEC4591001 1008 10081937A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-26 B2BC4591001SEC4591001 1008 10081938ASCRN Screening ASCREENING 2021-01-11 2021-01-11T15:36:00AAC4591001SEC4591001 1008 10081938A VAXP Placebo A VACCINATION 2021-01-11T15:36:002021-03-02 AB3C4591001SEC4591001 1008 10081938A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-17 B3BC4591001SEC4591001 1008 10081938A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T09:53:00BBC4591001SEC4591001 1008 10081938APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T09:53:002021-07-06 BBC4591001SEC4591001 1008 10081938A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1008 10081940ASCRN Screening ASCREENING 2021-01-12 2021-01-12T11:49:00AAC4591001SEC4591001 1008 10081940A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T11:49:002021-03-02 AB2C4591001SEC4591001 1008 10081940A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-07-27 B2BC4591001SEC4591001 1008 10081941ASCRN Screening ASCREENING 2021-01-12 2021-01-12T14:34:00AAC4591001SEC4591001 1008 10081941A VAXP Placebo A VACCINATION 2021-01-12T14:34:002021-03-02 AB2C4591001SEC4591001 1008 10081941A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-14 B2B{C4591001SEC4591001 1008 10081941A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T14:07:00B{B{C4591001SEC4591001 1008 10081941APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T14:07:002021-07-02 B{BC4591001SEC4591001 1008 10081941A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1008 10081942ASCRN Screening ASCREENING 2021-01-12 2021-01-12T14:35:00AAC4591001SEC4591001 1008 10081942A VAXP Placebo A VACCINATION 2021-01-12T14:35:002021-03-02 AB2C4591001SEC4591001 1008 10081942A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-14 B2B{C4591001SEC4591001 1008 10081942A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T14:09:00B{B{C4591001SEC4591001 1008 10081942APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T14:09:002021-07-02 B{BC4591001SEC4591001 1008 10081942A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1008 10081943ASCRN Screening ASCREENING 2021-01-12 2021-01-12T14:40:00AAC4591001SEC4591001 1008 10081943A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T14:40:002021-03-03 AB3C4591001SEC4591001 1008 10081943A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-08-04 B3BC4591001SEC4591001 1009 10091204ASCRN Screening ASCREENING 2020-10-15 2020-10-15T10:10:00AAC4591001SEC4591001 1009 10091204A VAXP Placebo A VACCINATION 2020-10-15T10:10:002020-12-03 AB2C4591001SEC4591001 1009 10091204A0FUP Follow-up A0FOLLOW-UP 2020-12-03 2021-08-02 B2C@C4591001SEC4591001 1009 10091204A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-08-02 2021-08-02T16:04:00C@C@C4591001SEC4591001 1009 10091204APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-08-02T16:04:002021-08-23 C@CC4591001SEC4591001 1009 10091205ASCRN Screening ASCREENING 2020-10-15 2020-10-15T12:58:00AAC4591001SEC4591001 1009 10091205A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-15T12:58:002020-12-04 AB3C4591001SEC4591001 1009 10091205A0FUP Follow-up A0FOLLOW-UP 2020-12-04 2021-06-10 B3BC4591001SEC4591001 1009 10091208ASCRN Screening ASCREENING 2020-10-15 2020-10-15T13:24:00AAC4591001SEC4591001 1009 10091208A VAXP Placebo A VACCINATION 2020-10-15T13:24:002020-12-04 AB3C4591001SEC4591001 1009 10091208A0FUP Follow-up A0FOLLOW-UP 2020-12-04 2021-03-05 B3BC4591001SEC4591001 1009 10091208A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-05 2021-03-05T12:15:00BBC4591001SEC4591001 1009 10091208APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-05T12:15:002021-04-23 BBC4591001SEC4591001 1009 10091208A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-23 2021-04-23 BBC4591001SEC4591001 1009 10091209ASCRN Screening ASCREENING 2020-10-15 2020-10-15T16:52:00AAC4591001SEC4591001 1009 10091209A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-15T16:52:002020-12-02 AB1C4591001SEC4591001 1009 10091209A0FUP Follow-up A0FOLLOW-UP 2020-12-02 2021-05-21 B1BC4591001SEC4591001 1009 10091212ASCRN Screening ASCREENING 2020-10-16 2020-10-16T09:45:00AAC4591001SEC4591001 1009 10091212A VAXP Placebo A VACCINATION 2020-10-16T09:45:002020-12-18 AB@C4591001SEC4591001 1009 10091212A0FUP Follow-up A0FOLLOW-UP 2020-12-18 2021-05-21 B@BC4591001SEC4591001 1009 10091212A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T12:05:00BBC4591001SEC4591001 1009 10091212APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T12:05:002021-07-08 BCC4591001SEC4591001 1009 10091212A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 CCC4591001SEC4591001 1009 10091213ASCRN Screening ASCREENING 2020-10-16 2020-10-16T10:21:00AAC4591001SEC4591001 1009 10091213A VAXP Placebo A VACCINATION 2020-10-16T10:21:002020-12-16 AB>C4591001SEC4591001 1009 10091213A0FUP Follow-up A0FOLLOW-UP 2020-12-16 2021-02-22 B>BC4591001SEC4591001 1009 10091213A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-22 2021-02-22T15:46:00BBC4591001SEC4591001 1009 10091213APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-22T15:46:002021-04-16 BBC4591001SEC4591001 1009 10091213A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-16 2021-04-16 BBC4591001SEC4591001 1009 10091216ASCRN Screening ASCREENING 2020-10-16 2020-10-16T11:58:00AAC4591001SEC4591001 1009 10091216A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-16T11:58:002020-12-04 AB2C4591001SEC4591001 1009 10091216A0FUP Follow-up A0FOLLOW-UP 2020-12-04 2021-05-14 B2BC4591001SEC4591001 1009 10091218ASCRN Screening ASCREENING 2020-10-16 2020-10-16T12:03:00AAC4591001SEC4591001 1009 10091218A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-16T12:03:002020-12-04 AB2C4591001SEC4591001 1009 10091218A0FUP Follow-up A0FOLLOW-UP 2020-12-04 2021-05-14 B2BC4591001SEC4591001 1009 10091220ASCRN Screening ASCREENING 2020-10-19 2020-10-19T13:53:00AAC4591001SEC4591001 1009 10091220A VAXP Placebo A VACCINATION 2020-10-19T13:53:002020-12-10 AB5C4591001SEC4591001 1009 10091220A0FUP Follow-up A0FOLLOW-UP 2020-12-10 2021-08-18 B5CC4591001SEC4591001 1009 10091221ASCRN Screening ASCREENING 2020-10-19 2020-10-19T13:58:00AAC4591001SEC4591001 1009 10091221A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-19T13:58:002020-12-10 AB5C4591001SEC4591001 1009 10091221A0FUP Follow-up A0FOLLOW-UP 2020-12-10 2021-05-14 B5BC4591001SEC4591001 1009 10091223ASCRN Screening ASCREENING 2020-10-19 2020-10-19T14:11:00AAC4591001SEC4591001 1009 10091223A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-19T14:11:002020-12-08 AB3C4591001SEC4591001 1009 10091223A0FUP Follow-up A0FOLLOW-UP 2020-12-08 2021-05-14 B3BC4591001SEC4591001 1009 10091226ASCRN Screening ASCREENING 2020-10-20 2020-10-20T13:13:00AAC4591001SEC4591001 1009 10091226A VAXP Placebo A VACCINATION 2020-10-20T13:13:002020-12-07 AB1C4591001SEC4591001 1009 10091226A0FUP Follow-up A0FOLLOW-UP 2020-12-07 2021-05-20 B1BC4591001SEC4591001 1009 10091226A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T12:28:00BBC4591001SEC4591001 1009 10091226APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T12:28:002021-07-14 BCC4591001SEC4591001 1009 10091226A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-07-14 CCC4591001SEC4591001 1009 10091227ASCRN Screening ASCREENING 2020-10-20 2020-10-20T16:49:00AAC4591001SEC4591001 1009 10091227A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-20T16:49:002020-12-09 AB3C4591001SEC4591001 1009 10091227A0FUP Follow-up A0FOLLOW-UP 2020-12-09 2021-07-26 B3CC4591001SEC4591001 1009 10091229ASCRN Screening ASCREENING 2020-10-20 2020-10-20T17:21:00AAC4591001SEC4591001 1009 10091229A VAXP Placebo A VACCINATION 2020-10-20T17:21:002020-12-21 AB?C4591001SEC4591001 1009 10091229A0FUP Follow-up A0FOLLOW-UP 2020-12-21 2021-05-21 B?BC4591001SEC4591001 1009 10091229A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T16:10:00BBC4591001SEC4591001 1009 10091229APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T16:10:002021-07-13 BCC4591001SEC4591001 1009 10091229A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 CCC4591001SEC4591001 1009 10091231ASCRN Screening ASCREENING 2020-10-20 2020-10-20T18:16:00AAC4591001SEC4591001 1009 10091231A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-20T18:16:002020-12-10 AB4C4591001SEC4591001 1009 10091231A0FUP Follow-up A0FOLLOW-UP 2020-12-10 2021-05-19 B4BC4591001SEC4591001 1009 10091233ASCRN Screening ASCREENING 2020-10-21 2020-10-21T10:46:00AAC4591001SEC4591001 1009 10091233A VAXP Placebo A VACCINATION 2020-10-21T10:46:002020-12-14 AB7C4591001SEC4591001 1009 10091233A0FUP Follow-up A0FOLLOW-UP 2020-12-14 2021-06-02 B7BC4591001SEC4591001 1009 10091233A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-02 2021-06-02T17:06:00BBC4591001SEC4591001 1009 10091233APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-02T17:06:002021-07-22 BC0C4591001SEC4591001 1009 10091233A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-22 2021-07-22 C0C0C4591001SEC4591001 1009 10091234ASCRN Screening ASCREENING 2020-10-21 2020-10-21T14:40:00AAC4591001SEC4591001 1009 10091234A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-21T14:40:002020-12-16 AB9C4591001SEC4591001 1009 10091234A0FUP Follow-up A0FOLLOW-UP 2020-12-16 2021-09-01 B9CC4591001SEC4591001 1009 10091237ASCRN Screening ASCREENING 2020-10-21 2020-10-21T15:47:00AAC4591001SEC4591001 1009 10091237A VAXP Placebo A VACCINATION 2020-10-21T15:47:002020-12-14 AB7C4591001SEC4591001 1009 10091237A0FUP Follow-up A0FOLLOW-UP 2020-12-14 2021-08-30 B7CC4591001SEC4591001 1009 10091238ASCRN Screening ASCREENING 2020-10-21 2020-10-21T17:23:00AAC4591001SEC4591001 1009 10091238A VAXP Placebo A VACCINATION 2020-10-21T17:23:002020-12-08 AB1C4591001SEC4591001 1009 10091238A0FUP Follow-up A0FOLLOW-UP 2020-12-08 2021-04-26 B1BC4591001SEC4591001 1009 10091238A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-26 2021-04-26T17:17:00BBC4591001SEC4591001 1009 10091238APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-26T17:17:002021-06-21 BBC4591001SEC4591001 1009 10091238A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-21 2021-06-21 BBC4591001SEC4591001 1009 10091240ASCRN Screening ASCREENING 2020-10-21 2020-10-21T17:42:00AAC4591001SEC4591001 1009 10091240A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-21T17:42:002020-12-07 AB0C4591001SEC4591001 1009 10091240A0FUP Follow-up A0FOLLOW-UP 2020-12-07 2021-05-17 B0BC4591001SEC4591001 1009 10091246ASCRN Screening ASCREENING 2020-10-22 2020-10-22T16:02:00AAC4591001SEC4591001 1009 10091246A VAXP Placebo A VACCINATION 2020-10-22T16:02:002020-12-14 AB6C4591001SEC4591001 1009 10091246A0FUP Follow-up A0FOLLOW-UP 2020-12-14 2021-05-18 B6BC4591001SEC4591001 1009 10091246A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T15:55:00BBC4591001SEC4591001 1009 10091246APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T15:55:002021-07-08 BC@C4591001SEC4591001 1009 10091246A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 C@C@C4591001SEC4591001 1009 10091247ASCRN Screening ASCREENING 2020-10-22 2020-10-22T16:31:00AAC4591001SEC4591001 1009 10091247A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-22T16:31:002020-12-09 AB1C4591001SEC4591001 1009 10091247A0FUP Follow-up A0FOLLOW-UP 2020-12-09 2021-05-19 B1BC4591001SEC4591001 1009 10091249ASCRN Screening ASCREENING 2020-10-22 2020-10-22T19:44:00AAC4591001SEC4591001 1009 10091249A VAXP Placebo A VACCINATION 2020-10-22T19:44:002020-12-11 AB3C4591001SEC4591001 1009 10091249A0FUP Follow-up A0FOLLOW-UP 2020-12-11 2021-05-18 B3BC4591001SEC4591001 1009 10091249A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T14:21:00BBC4591001SEC4591001 1009 10091249APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T14:21:002021-07-13 BCC4591001SEC4591001 1009 10091249A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 CCC4591001SEC4591001 1009 10091250ASCRN Screening ASCREENING 2020-10-22 2020-10-22T19:46:00AAC4591001SEC4591001 1009 10091250A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-22T19:46:002020-12-11 AB3C4591001SEC4591001 1009 10091250A0FUP Follow-up A0FOLLOW-UP 2020-12-11 2021-05-18 B3BC4591001SEC4591001 1009 10091265ASCRN Screening ASCREENING 2020-12-01 2020-12-01T14:57:00AAC4591001SEC4591001 1009 10091265A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-01T14:57:002021-01-19 AB2C4591001SEC4591001 1009 10091265A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-06-29 B2BC4591001SEC4591001 1009 10091266ASCRN Screening ASCREENING 2020-12-01 2020-12-01T11:28:00AAC4591001SEC4591001 1009 10091266A VAXP Placebo A VACCINATION 2020-12-01T11:28:002021-01-20 AB3C4591001SEC4591001 1009 10091266A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-03-04 B3B^C4591001SEC4591001 1009 10091266A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-04 2021-03-04T12:36:00B^B^C4591001SEC4591001 1009 10091266APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-04T12:36:002021-04-20 B^BC4591001SEC4591001 1009 10091266A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-20 2021-04-20 BBC4591001SEC4591001 1009 10091267ASCRN Screening ASCREENING 2020-12-01 2020-12-01T13:17:00AAC4591001SEC4591001 1009 10091267A VAXP Placebo A VACCINATION 2020-12-01T13:17:002021-01-21 AB4C4591001SEC4591001 1009 10091267A0FUP Follow-up A0FOLLOW-UP 2021-01-21 2021-05-17 B4BC4591001SEC4591001 1009 10091267A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T15:18:00BBC4591001SEC4591001 1009 10091267APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T15:18:002021-07-12 BBC4591001SEC4591001 1009 10091267A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1009 10091269ASCRN Screening ASCREENING 2020-12-01 2020-12-01T18:04:00AAC4591001SEC4591001 1009 10091269A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-01T18:04:002021-01-20 AB3C4591001SEC4591001 1009 10091269A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-17 B3BC4591001SEC4591001 1009 10091270ASCRN Screening ASCREENING 2020-12-01 2020-12-01T18:06:00AAC4591001SEC4591001 1009 10091270A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-01T18:06:002021-01-20 AB3C4591001SEC4591001 1009 10091270A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-17 B3BC4591001SEC4591001 1009 10091272ASCRN Screening ASCREENING 2020-12-02 2020-12-02T13:33:00AAC4591001SEC4591001 1009 10091272A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T13:33:002021-01-19 AB1C4591001SEC4591001 1009 10091272A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-08-10 B1BC4591001SEC4591001 1009 10091273ASCRN Screening ASCREENING 2020-12-02 2020-12-02T13:35:00AAC4591001SEC4591001 1009 10091273A VAXP Placebo A VACCINATION 2020-12-02T13:35:002021-01-19 AB1C4591001SEC4591001 1009 10091273A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-05-21 B1BC4591001SEC4591001 1009 10091273A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T16:18:00BBC4591001SEC4591001 1009 10091273APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T16:18:002021-07-15 BBC4591001SEC4591001 1009 10091273A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-15 2021-07-15 BBC4591001SEC4591001 1009 10091274ASCRN Screening ASCREENING 2020-12-02 2020-12-02T17:52:00AAC4591001SEC4591001 1009 10091274A VAXP Placebo A VACCINATION 2020-12-02T17:52:002021-01-27 AB9C4591001SEC4591001 1009 10091274A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-07-02 B9BC4591001SEC4591001 1009 10091274A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-02 2021-07-02T14:30:00BBC4591001SEC4591001 1009 10091274APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-02T14:30:002021-08-23 BCC4591001SEC4591001 1009 10091274A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-23 2021-08-23 CCC4591001SEC4591001 1009 10091275ASCRN Screening ASCREENING 2020-12-02 2020-12-02T17:50:00AAC4591001SEC4591001 1009 10091275A VAXP Placebo A VACCINATION 2020-12-02T17:50:002021-01-27 AB9C4591001SEC4591001 1009 10091275A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-07-02 B9BC4591001SEC4591001 1009 10091275A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-02 2021-07-02T14:31:00BBC4591001SEC4591001 1009 10091275APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-02T14:31:002021-08-23 BCC4591001SEC4591001 1009 10091275A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-23 2021-08-23 CCC4591001SEC4591001 1009 10091277ASCRN Screening ASCREENING 2020-12-03 2020-12-03T15:24:00AAC4591001SEC4591001 1009 10091277A VAXP Placebo A VACCINATION 2020-12-03T15:24:002021-01-28 AB9C4591001SEC4591001 1009 10091277A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-06-09 B9BC4591001SEC4591001 1009 10091277A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-09 2021-06-09T14:29:00BBC4591001SEC4591001 1009 10091277APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-09T14:29:002021-07-30 BBC4591001SEC4591001 1009 10091277A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-30 2021-07-30 BBC4591001SEC4591001 1009 10091280ASCRN Screening ASCREENING 2020-12-03 2020-12-03T19:31:00AAC4591001SEC4591001 1009 10091280A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-03T19:31:002021-01-22 AB3C4591001SEC4591001 1009 10091280A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-06-23 B3BC4591001SEC4591001 1009 10091281ASCRN Screening ASCREENING 2020-12-03 2020-12-03T17:20:00AAC4591001SEC4591001 1009 10091281A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-03T17:20:002021-01-22 AB3C4591001SEC4591001 1009 10091281A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-06-18 B3BC4591001SEC4591001 1009 10091282ASCRN Screening ASCREENING 2020-12-03 2020-12-03T17:13:00AAC4591001SEC4591001 1009 10091282A VAXP Placebo A VACCINATION 2020-12-03T17:13:002021-01-22 AB3C4591001SEC4591001 1009 10091282A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-06-21 B3BC4591001SEC4591001 1009 10091282A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-21 2021-06-21T15:21:00BBC4591001SEC4591001 1009 10091282APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-21T15:21:002021-08-09 BBC4591001SEC4591001 1009 10091282A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-09 2021-08-09 BBC4591001SEC4591001 1009 10091283ASCRN Screening ASCREENING 2020-12-03 2020-12-03T17:40:00AAC4591001SEC4591001 1009 10091283A VAXP Placebo A VACCINATION 2020-12-03T17:40:002021-01-27 AB8C4591001SEC4591001 1009 10091283A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-23 B8BC4591001SEC4591001 1009 10091283A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-23 2021-06-23T10:25:00BBC4591001SEC4591001 1009 10091283APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-23T10:25:002021-08-13 BBC4591001SEC4591001 1009 10091283A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-13 2021-08-13 BBC4591001SEC4591001 1009 10091284ASCRN Screening ASCREENING 2020-12-03 2020-12-03T17:43:00AAC4591001SEC4591001 1009 10091284A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-03T17:43:002021-01-27 AB8C4591001SEC4591001 1009 10091284A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-21 B8BC4591001SEC4591001 1009 10091287ASCRN Screening ASCREENING 2020-12-04 2020-12-04T13:29:00AAC4591001SEC4591001 1009 10091287A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-04T13:29:002021-01-22 AB2C4591001SEC4591001 1009 10091287A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-08-04 B2BC4591001SEC4591001 1009 10091288ASCRN Screening ASCREENING 2020-12-04 2020-12-04T13:31:00AAC4591001SEC4591001 1009 10091288A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-04T13:31:002021-01-22 AB2C4591001SEC4591001 1009 10091288A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-06-21 B2BC4591001SEC4591001 1009 10091289ASCRN Screening ASCREENING 2020-12-04 2020-12-04T14:55:00AAC4591001SEC4591001 1009 10091289A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-04T14:55:002021-01-22 AB2C4591001SEC4591001 1009 10091289A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-06-22 B2BC4591001SEC4591001 1009 10091292ASCRN Screening ASCREENING 2020-12-04 2020-12-04T15:36:00AAC4591001SEC4591001 1009 10091292A VAXP Placebo A VACCINATION 2020-12-04T15:36:002021-01-22 AB2C4591001SEC4591001 1009 10091292A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-04-02 B2BxC4591001SEC4591001 1009 10091292A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-02 2021-04-02T16:34:00BxBxC4591001SEC4591001 1009 10091292APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-02T16:34:002021-05-28 BxBC4591001SEC4591001 1009 10091292A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-28 2021-05-28 BBC4591001SEC4591001 1009 10091293ASCRN Screening ASCREENING 2020-12-04 2020-12-04T17:49:00AAC4591001SEC4591001 1009 10091293A VAXP Placebo A VACCINATION 2020-12-04T17:49:002021-01-25 AB5C4591001SEC4591001 1009 10091293A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-05-19 B5BC4591001SEC4591001 1009 10091293A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T16:20:00BBC4591001SEC4591001 1009 10091293APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T16:20:002021-07-14 BBC4591001SEC4591001 1009 10091293A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-08-06 BBC4591001SEC4591001 1009 10091294ASCRN Screening ASCREENING 2020-12-07 2020-12-07T11:38:00AAC4591001SEC4591001 1009 10091294A VAXP Placebo A VACCINATION 2020-12-07T11:38:002021-01-25 AB2C4591001SEC4591001 1009 10091294A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-04-06 B2ByC4591001SEC4591001 1009 10091294A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-06 2021-04-06T09:22:00ByByC4591001SEC4591001 1009 10091294APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-06T09:22:002021-06-01 ByBC4591001SEC4591001 1009 10091294A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-01 2021-07-27 BBC4591001SEC4591001 1009 10091295ASCRN Screening ASCREENING 2020-12-07 2020-12-07T14:43:00AAC4591001SEC4591001 1009 10091295A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T14:43:002021-01-26 AB3C4591001SEC4591001 1009 10091295A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-06-23 B3BC4591001SEC4591001 1009 10091296ASCRN Screening ASCREENING 2020-12-07 2020-12-07T14:41:00AAC4591001SEC4591001 1009 10091296A VAXP Placebo A VACCINATION 2020-12-07T14:41:002021-01-26 AB3C4591001SEC4591001 1009 10091296A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-06-24 B3BC4591001SEC4591001 1009 10091296A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-24 2021-06-24T15:02:00BBC4591001SEC4591001 1009 10091296APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-24T15:02:002021-08-19 BCC4591001SEC4591001 1009 10091296A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-19 2021-08-19 CCC4591001SEC4591001 1009 10091297ASCRN Screening ASCREENING 2020-12-07 2020-12-07T15:30:00AAC4591001SEC4591001 1009 10091297A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T15:30:002021-01-26 AB3C4591001SEC4591001 1009 10091297A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-08-11 B3BC4591001SEC4591001 1009 10091298ASCRN Screening ASCREENING 2020-12-07 2020-12-07T16:33:00AAC4591001SEC4591001 1009 10091298A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T16:33:002021-01-25 AB2C4591001SEC4591001 1009 10091298A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-08-10 B2BC4591001SEC4591001 1009 10091300ASCRN Screening ASCREENING 2020-12-07 2020-12-07T18:07:00AAC4591001SEC4591001 1009 10091300A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T18:07:002021-01-28 AB5C4591001SEC4591001 1009 10091300A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-06-21 B5BC4591001SEC4591001 1009 10091301ASCRN Screening ASCREENING 2020-12-07 2020-12-07T18:05:00AAC4591001SEC4591001 1009 10091301A VAXP Placebo A VACCINATION 2020-12-07T18:05:002021-01-28 AB5C4591001SEC4591001 1009 10091301A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-06-01 B5BC4591001SEC4591001 1009 10091301A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T17:54:00BBC4591001SEC4591001 1009 10091301APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T17:54:002021-07-26 BBC4591001SEC4591001 1009 10091301A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-26 2021-08-26 BCpC4591001SEC4591001 1009 10091303ASCRN Screening ASCREENING 2020-12-08 2020-12-08T12:52:00AAC4591001SEC4591001 1009 10091303A VAXP Placebo A VACCINATION 2020-12-08T12:52:002021-01-29 AB5C4591001SEC4591001 1009 10091303A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-06-21 B5BC4591001SEC4591001 1009 10091303A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-21 2021-06-21T13:36:00BBC4591001SEC4591001 1009 10091303APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-21T13:36:002021-08-13 BBC4591001SEC4591001 1009 10091303A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-13 2021-08-13 BBC4591001SEC4591001 1009 10091304ASCRN Screening ASCREENING 2020-12-08 2020-12-08T16:51:00AAC4591001SEC4591001 1009 10091304A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T16:51:002021-01-28 AB4C4591001SEC4591001 1009 10091304A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-06-28 B4BC4591001SEC4591001 1009 10091305ASCRN Screening ASCREENING 2020-12-08 2020-12-08T18:00:00AAC4591001SEC4591001 1009 10091305A VAXP Placebo A VACCINATION 2020-12-08T18:00:002021-01-27 AB3C4591001SEC4591001 1009 10091305A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-03-19 B3BfC4591001SEC4591001 1009 10091305A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-19 2021-03-19T12:11:00BfBfC4591001SEC4591001 1009 10091305APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-19T12:11:002021-05-07 BfBC4591001SEC4591001 1009 10091305A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-07 2021-09-02 BCC4591001SEC4591001 1009 10091306ASCRN Screening ASCREENING 2020-12-08 2020-12-08T17:58:00AAC4591001SEC4591001 1009 10091306A VAXP Placebo A VACCINATION 2020-12-08T17:58:002021-01-27 AB3C4591001SEC4591001 1009 10091306A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-14 B3BC4591001SEC4591001 1009 10091306A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T14:35:00BBC4591001SEC4591001 1009 10091306APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T14:35:002021-07-07 BBC4591001SEC4591001 1009 10091306A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-09-02 BCC4591001SEC4591001 1009 10091307ASCRN Screening ASCREENING 2020-12-09 2020-12-09T09:38:00AAC4591001SEC4591001 1009 10091307A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T09:38:002021-01-27 AB2C4591001SEC4591001 1009 10091307A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-08-31 B2CC4591001SEC4591001 1009 10091308ASCRN Screening ASCREENING 2020-12-09 2020-12-09T09:40:00AAC4591001SEC4591001 1009 10091308A VAXP Placebo A VACCINATION 2020-12-09T09:40:002021-01-27 AB2C4591001SEC4591001 1009 10091308A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-08-31 B2CC4591001SEC4591001 1009 10091309ASCRN Screening ASCREENING 2020-12-09 2020-12-09T11:42:00AAC4591001SEC4591001 1009 10091309A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T11:42:002021-01-26 AB1C4591001SEC4591001 1009 10091309A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-06-22 B1BC4591001SEC4591001 1009 10091310ASCRN Screening ASCREENING 2020-12-09 2020-12-09T11:50:00AAC4591001SEC4591001 1009 10091310A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T11:50:002021-02-01 AB7C4591001SEC4591001 1009 10091310A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-06-24 B7BC4591001SEC4591001 1009 10091311ASCRN Screening ASCREENING 2020-12-09 2020-12-09T13:52:00AAC4591001SEC4591001 1009 10091311A VAXP Placebo A VACCINATION 2020-12-09T13:52:002021-01-25 AB0C4591001SEC4591001 1009 10091311A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-05-17 B0BC4591001SEC4591001 1009 10091311A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T16:50:00BBC4591001SEC4591001 1009 10091311APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T16:50:002021-07-13 BBC4591001SEC4591001 1009 10091311A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1009 10091312ASCRN Screening ASCREENING 2020-12-09 2020-12-09T15:37:00AAC4591001SEC4591001 1009 10091312A VAXP Placebo A VACCINATION 2020-12-09T15:37:002021-02-02 AB8C4591001SEC4591001 1009 10091312A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-06-01 B8BC4591001SEC4591001 1009 10091312A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T13:52:00BBC4591001SEC4591001 1009 10091312APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T13:52:002021-07-28 BBC4591001SEC4591001 1009 10091312A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-28 2021-07-28 BBC4591001SEC4591001 1009 10091313ASCRN Screening ASCREENING 2020-12-09 2020-12-09T15:34:00AAC4591001SEC4591001 1009 10091313A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T15:34:002021-02-02 AB8C4591001SEC4591001 1009 10091313A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-06-30 B8BC4591001SEC4591001 1009 10091314ASCRN Screening ASCREENING 2020-12-09 2020-12-09T16:33:00AAC4591001SEC4591001 1009 10091314A VAXP Placebo A VACCINATION 2020-12-09T16:33:002021-02-01 AB7C4591001SEC4591001 1009 10091314A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-07-06 B7BC4591001SEC4591001 1009 10091314A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-06 2021-07-06T12:56:00BBC4591001SEC4591001 1009 10091314APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-06T12:56:002021-08-02 BBC4591001SEC4591001 1009 10091315ASCRN Screening ASCREENING 2020-12-09 2020-12-09T18:30:00AAC4591001SEC4591001 1009 10091315A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T18:30:002021-01-29 AB4C4591001SEC4591001 1009 10091315A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-06-21 B4BC4591001SEC4591001 1009 10091316ASCRN Screening ASCREENING 2020-12-09 2020-12-09T18:27:00AAC4591001SEC4591001 1009 10091316A VAXP Placebo A VACCINATION 2020-12-09T18:27:002021-01-29 AB4C4591001SEC4591001 1009 10091316A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-03-17 B4BcC4591001SEC4591001 1009 10091316A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-17 2021-03-17T15:05:00BcBcC4591001SEC4591001 1009 10091316APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-17T15:05:002021-05-07 BcBC4591001SEC4591001 1009 10091316A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-07 2021-05-07 BBC4591001SEC4591001 1009 10091317ASCRN Screening ASCREENING 2020-12-10 2020-12-10T11:23:00AAC4591001SEC4591001 1009 10091317A VAXP Placebo A VACCINATION 2020-12-10T11:23:002021-01-27 AB1C4591001SEC4591001 1009 10091317A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-25 B1BC4591001SEC4591001 1009 10091317A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-25 2021-06-25T12:31:00BBC4591001SEC4591001 1009 10091317APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-25T12:31:002021-08-13 BBC4591001SEC4591001 1009 10091317A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-13 2021-08-13 BBC4591001SEC4591001 1009 10091318ASCRN Screening ASCREENING 2020-12-10 2020-12-10T13:07:00AAC4591001SEC4591001 1009 10091318A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T13:07:002021-01-27 AB1C4591001SEC4591001 1009 10091318A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-23 B1BC4591001SEC4591001 1009 10091319ASCRN Screening ASCREENING 2020-12-10 2020-12-10T14:27:00AAC4591001SEC4591001 1009 10091319A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T14:27:002021-02-02 AB7C4591001SEC4591001 1009 10091319A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-06-22 B7BC4591001SEC4591001 1009 10091320ASCRN Screening ASCREENING 2020-12-10 2020-12-10T14:35:00AAC4591001SEC4591001 1009 10091320A VAXP Placebo A VACCINATION 2020-12-10T14:35:002021-01-29 AB3C4591001SEC4591001 1009 10091320A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-06-01 B3BC4591001SEC4591001 1009 10091320A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T16:48:00BBC4591001SEC4591001 1009 10091320APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T16:48:002021-07-30 BBC4591001SEC4591001 1009 10091320A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-30 2021-08-25 BC0C4591001SEC4591001 1009 10091321ASCRN Screening ASCREENING 2020-12-10 2020-12-10T15:32:00AAC4591001SEC4591001 1009 10091321A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T15:32:002021-01-29 AB3C4591001SEC4591001 1009 10091321A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-06-24 B3BC4591001SEC4591001 1009 10091322ASCRN Screening ASCREENING 2020-12-10 2020-12-10T16:25:00AAC4591001SEC4591001 1009 10091322A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T16:25:002021-01-28 AB2C4591001SEC4591001 1009 10091322A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-08-31 B2CC4591001SEC4591001 1009 10091323ASCRN Screening ASCREENING 2020-12-10 2020-12-10T16:28:00AAC4591001SEC4591001 1009 10091323A VAXP Placebo A VACCINATION 2020-12-10T16:28:002021-01-28 AB2C4591001SEC4591001 1009 10091323A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-07-06 B2BC4591001SEC4591001 1009 10091323A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-06 2021-07-06T09:36:00BBC4591001SEC4591001 1009 10091323APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-06T09:36:002021-08-23 BCC4591001SEC4591001 1009 10091323A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-23 2021-08-23 CCC4591001SEC4591001 1009 10091324ASCRN Screening ASCREENING 2020-12-11 2020-12-11T10:44:00AAC4591001SEC4591001 1009 10091324A VAXP Placebo A VACCINATION 2020-12-11T10:44:002021-02-01 AB5C4591001SEC4591001 1009 10091324A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-07-29 B5BC4591001SEC4591001 1009 10091324A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-29 2021-07-29T12:47:00BBC4591001SEC4591001 1009 10091324APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-29T12:47:002021-08-18 BBC4591001SEC4591001 1009 10091325ASCRN Screening ASCREENING 2020-12-11 2020-12-11T10:47:00AAC4591001SEC4591001 1009 10091325A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-11T10:47:002021-02-01 AB5C4591001SEC4591001 1009 10091325A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-06-30 B5BC4591001SEC4591001 1009 10091326ASCRN Screening ASCREENING 2020-12-11 2020-12-11T10:58:00AAC4591001SEC4591001 1009 10091326A VAXP Placebo A VACCINATION 2020-12-11T10:58:002021-01-29 AB2C4591001SEC4591001 1009 10091326A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-05-27 B2BC4591001SEC4591001 1009 10091326A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-27 2021-05-27T11:37:00BBC4591001SEC4591001 1009 10091326APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-27T11:37:002021-07-28 BBC4591001SEC4591001 1009 10091326A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-28 2021-07-28 BBC4591001SEC4591001 1009 10091328ASCRN Screening ASCREENING 2020-12-11 2020-12-11T13:47:00AAC4591001SEC4591001 1009 10091328A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-11T13:47:002021-02-02 AB6C4591001SEC4591001 1009 10091328A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-07-02 B6BC4591001SEC4591001 1009 10091329ASCRN Screening ASCREENING 2020-12-11 2020-12-11T13:45:00AAC4591001SEC4591001 1009 10091329A VAXP Placebo A VACCINATION 2020-12-11T13:45:002021-02-02 AB6C4591001SEC4591001 1009 10091329A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-28 B6BC4591001SEC4591001 1009 10091329A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-28 2021-05-28T14:22:00BBC4591001SEC4591001 1009 10091329APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-28T14:22:002021-07-20 BBC4591001SEC4591001 1009 10091329A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-20 2021-07-20 BBC4591001SEC4591001 1009 10091330ASCRN Screening ASCREENING 2020-12-11 2020-12-11T13:43:00AAC4591001SEC4591001 1009 10091330A VAXP Placebo A VACCINATION 2020-12-11T13:43:002021-02-02 AB6C4591001SEC4591001 1009 10091330A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-07-07 B6BC4591001SEC4591001 1009 10091330A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-07 2021-07-07T10:26:00BBC4591001SEC4591001 1009 10091330APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-07T10:26:002021-08-30 BCpC4591001SEC4591001 1009 10091330A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-30 2021-08-30 CpCpC4591001SEC4591001 1009 10091331ASCRN Screening ASCREENING 2020-12-11 2020-12-11T15:00:00AAC4591001SEC4591001 1009 10091331A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-11T15:00:002021-01-29 AB2C4591001SEC4591001 1009 10091331A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-07-09 B2BC4591001SEC4591001 1009 10091332ASCRN Screening ASCREENING 2020-12-11 2020-12-11T15:04:00AAC4591001SEC4591001 1009 10091332A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-11T15:04:002021-01-29 AB2C4591001SEC4591001 1009 10091332A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-08-02 B2BC4591001SEC4591001 1009 10091333ASCRN Screening ASCREENING 2020-12-11 2020-12-11T15:30:00AAC4591001SEC4591001 1009 10091333A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-11T15:30:002021-01-29 AB2C4591001SEC4591001 1009 10091333A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-06-24 B2BC4591001SEC4591001 1009 10091334ASCRN Screening ASCREENING 2020-12-11 2020-12-11T19:06:00AAC4591001SEC4591001 1009 10091334A VAXP Placebo A VACCINATION 2020-12-11T19:06:002021-01-29 AB2C4591001SEC4591001 1009 10091334A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-05-19 B2BC4591001SEC4591001 1009 10091334A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T17:09:00BBC4591001SEC4591001 1009 10091334APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T17:09:002021-07-12 BBC4591001SEC4591001 1009 10091334A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1009 10091335ASCRN Screening ASCREENING 2020-12-11 2020-12-11T18:08:00AAC4591001SEC4591001 1009 10091335A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-11T18:08:002021-01-29 AB2C4591001SEC4591001 1009 10091335A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-06-29 B2BC4591001SEC4591001 1009 10091336ASCRN Screening ASCREENING 2020-12-11 2020-12-11T18:10:00AAC4591001SEC4591001 1009 10091336A VAXP Placebo A VACCINATION 2020-12-11T18:10:002021-01-29 AB2C4591001SEC4591001 1009 10091336A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-07-16 B2BC4591001SEC4591001 1009 10091336A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-16 2021-07-16T08:31:00BBC4591001SEC4591001 1009 10091336APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-16T08:31:002021-08-05 BBC4591001SEC4591001 1009 10091337ASCRN Screening ASCREENING 2020-12-14 2020-12-14T11:11:00AAC4591001SEC4591001 1009 10091337A VAXP Placebo A VACCINATION 2020-12-14T11:11:002021-02-02 AB3C4591001SEC4591001 1009 10091337A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-18 B3BC4591001SEC4591001 1009 10091337A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T10:14:00BBC4591001SEC4591001 1009 10091337APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T10:14:002021-07-13 BBC4591001SEC4591001 1009 10091337A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-09-01 BC`C4591001SEC4591001 1009 10091338ASCRN Screening ASCREENING 2020-12-14 2020-12-14T13:57:00AAC4591001SEC4591001 1009 10091338A VAXP Placebo A VACCINATION 2020-12-14T13:57:002021-02-15 AB@C4591001SEC4591001 1009 10091338A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-20 B@BC4591001SEC4591001 1009 10091338A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-20 2021-07-20T11:10:00BBC4591001SEC4591001 1009 10091338APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-20T11:10:002021-08-10 BBC4591001SEC4591001 1009 10091339ASCRN Screening ASCREENING 2020-12-14 2020-12-14T13:59:00AAC4591001SEC4591001 1009 10091339A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T13:59:002021-02-15 AB@C4591001SEC4591001 1009 10091339A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-20 B@BC4591001SEC4591001 1009 10091340ASCRN Screening ASCREENING 2020-12-14 2020-12-14T16:37:00AAC4591001SEC4591001 1009 10091340A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T16:37:002021-02-08 AB9C4591001SEC4591001 1009 10091340A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-01 B9BC4591001SEC4591001 1009 10091341ASCRN Screening ASCREENING 2020-12-14 2020-12-14T18:27:00AAC4591001SEC4591001 1009 10091341A VAXP Placebo A VACCINATION 2020-12-14T18:27:002021-02-05 AB6C4591001SEC4591001 1009 10091341A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-02 B6BC4591001SEC4591001 1009 10091341A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-02 2021-07-02T13:18:00BBC4591001SEC4591001 1009 10091341APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-02T13:18:002021-08-23 BBC4591001SEC4591001 1009 10091341A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-23 2021-08-23 BBC4591001SEC4591001 1009 10091342ASCRN Screening ASCREENING 2020-12-14 2020-12-14T18:25:00AAC4591001SEC4591001 1009 10091342A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T18:25:002021-02-05 AB6C4591001SEC4591001 1009 10091342A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-06-30 B6BC4591001SEC4591001 1009 10091343ASCRN Screening ASCREENING 2020-12-15 2020-12-15T12:50:00AAC4591001SEC4591001 1009 10091343A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T12:50:002021-02-05 AB5C4591001SEC4591001 1009 10091343A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-06 B5BC4591001SEC4591001 1009 10091344ASCRN Screening ASCREENING 2020-12-15 2020-12-15T12:47:00AAC4591001SEC4591001 1009 10091344A VAXP Placebo A VACCINATION 2020-12-15T12:47:002021-02-02 AB2C4591001SEC4591001 1009 10091344A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-03-01 B2BMC4591001SEC4591001 1009 10091344A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-01 2021-03-01T16:19:00BMBMC4591001SEC4591001 1009 10091344APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-01T16:19:002021-04-20 BMBC4591001SEC4591001 1009 10091344A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-20 2021-04-20 BBC4591001SEC4591001 1009 10091345ASCRN Screening ASCREENING 2020-12-15 2020-12-15T15:16:00AAC4591001SEC4591001 1009 10091345A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T15:16:002021-02-05 AB5C4591001SEC4591001 1009 10091345A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-08-30 B5C0C4591001SEC4591001 1009 10091346ASCRN Screening ASCREENING 2020-12-15 2020-12-15T15:14:00AAC4591001SEC4591001 1009 10091346A VAXP Placebo A VACCINATION 2020-12-15T15:14:002021-02-05 AB5C4591001SEC4591001 1009 10091346A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-03-18 B5B^C4591001SEC4591001 1009 10091346A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-18 2021-03-18T16:16:00B^B^C4591001SEC4591001 1009 10091346APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-18T16:16:002021-05-04 B^BC4591001SEC4591001 1009 10091346A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-04 2021-05-04 BBC4591001SEC4591001 1009 10091347ASCRN Screening ASCREENING 2020-12-15 2020-12-15T15:31:00AAC4591001SEC4591001 1009 10091347A VAXP Placebo A VACCINATION 2020-12-15T15:31:002021-02-05 AB5C4591001SEC4591001 1009 10091347A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-09 B5BC4591001SEC4591001 1009 10091347A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-09 2021-07-09T11:43:00BBC4591001SEC4591001 1009 10091347APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-09T11:43:002021-08-05 BBC4591001SEC4591001 1009 10091348ASCRN Screening ASCREENING 2020-12-15 2020-12-15T15:33:00AAC4591001SEC4591001 1009 10091348A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T15:33:002021-02-05 AB5C4591001SEC4591001 1009 10091348A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-02 B5BC4591001SEC4591001 1009 10091349ASCRN Screening ASCREENING 2020-12-15 2020-12-15T17:50:00AAC4591001SEC4591001 1009 10091349A VAXP Placebo A VACCINATION 2020-12-15T17:50:002021-02-04 AB4C4591001SEC4591001 1009 10091349A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-18 B4BC4591001SEC4591001 1009 10091349A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T16:55:00BBC4591001SEC4591001 1009 10091349APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T16:55:002021-07-08 BBC4591001SEC4591001 1009 10091349A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-08-19 BBC4591001SEC4591001 1009 10091350ASCRN Screening ASCREENING 2020-12-16 2020-12-16T10:57:00AAC4591001SEC4591001 1009 10091350A VAXP Placebo A VACCINATION 2020-12-16T10:57:002021-02-04 AB3C4591001SEC4591001 1009 10091350A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-07-14 B3BC4591001SEC4591001 1009 10091350A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-14 2021-07-14T15:55:00BBC4591001SEC4591001 1009 10091350APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-14T15:55:002021-08-04 BBC4591001SEC4591001 1009 10091351ASCRN Screening ASCREENING 2020-12-16 2020-12-16T12:58:00AAC4591001SEC4591001 1009 10091351A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T12:58:002021-02-03 AB2C4591001SEC4591001 1009 10091351A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-01 B2BC4591001SEC4591001 1009 10091353ASCRN Screening ASCREENING 2020-12-16 2020-12-16T13:19:00AAC4591001SEC4591001 1009 10091353A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T13:19:002021-02-03 AB2C4591001SEC4591001 1009 10091353A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-13 B2BC4591001SEC4591001 1009 10091354ASCRN Screening ASCREENING 2020-12-16 2020-12-16T14:45:00AAC4591001SEC4591001 1009 10091354A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T14:45:002021-02-04 AB3C4591001SEC4591001 1009 10091354A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-07-08 B3BC4591001SEC4591001 1009 10091355ASCRN Screening ASCREENING 2020-12-16 2020-12-16T16:41:00AAC4591001SEC4591001 1009 10091355A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T16:41:002021-02-11 AB:C4591001SEC4591001 1009 10091355A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-08-24 B:BC4591001SEC4591001 1009 10091356ASCRN Screening ASCREENING 2020-12-16 2020-12-16T17:29:00AAC4591001SEC4591001 1009 10091356A VAXP Placebo A VACCINATION 2020-12-16T17:29:002021-02-10 AB9C4591001SEC4591001 1009 10091356A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-17 B9BC4591001SEC4591001 1009 10091356A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T16:05:00BBC4591001SEC4591001 1009 10091356APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T16:05:002021-07-09 BBC4591001SEC4591001 1009 10091356A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1009 10091357ASCRN Screening ASCREENING 2020-12-17 2020-12-17T10:40:00AAC4591001SEC4591001 1009 10091357A VAXP Placebo A VACCINATION 2020-12-17T10:40:002021-02-02 AB0C4591001SEC4591001 1009 10091357A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-03-16 B0BZC4591001SEC4591001 1009 10091357A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-16 2021-03-16T14:15:00BZBZC4591001SEC4591001 1009 10091357APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-16T14:15:002021-05-04 BZBC4591001SEC4591001 1009 10091357A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-04 2021-05-04 BBC4591001SEC4591001 1009 10091358ASCRN Screening ASCREENING 2020-12-17 2020-12-17T10:37:00AAC4591001SEC4591001 1009 10091358A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T10:37:002021-02-05 AB3C4591001SEC4591001 1009 10091358A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-08-25 B3BC4591001SEC4591001 1009 10091359ASCRN Screening ASCREENING 2020-12-17 2020-12-17T13:02:00AAC4591001SEC4591001 1009 10091359A VAXP Placebo A VACCINATION 2020-12-17T13:02:002021-02-03 AB1C4591001SEC4591001 1009 10091359A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-05-17 B1BC4591001SEC4591001 1009 10091359A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T13:30:00BBC4591001SEC4591001 1009 10091359APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T13:30:002021-07-08 BBC4591001SEC4591001 1009 10091359A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-08-02 BBC4591001SEC4591001 1009 10091360ASCRN Screening ASCREENING 2020-12-17 2020-12-17T13:05:00AAC4591001SEC4591001 1009 10091360A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T13:05:002021-02-03 AB1C4591001SEC4591001 1009 10091360A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-12 B1BC4591001SEC4591001 1009 10091361ASCRN Screening ASCREENING 2020-12-17 2020-12-17T14:13:00AAC4591001SEC4591001 1009 10091361A VAXP Placebo A VACCINATION 2020-12-17T14:13:002021-02-02 AB0C4591001SEC4591001 1009 10091361A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-17 B0BC4591001SEC4591001 1009 10091361A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T17:17:00BBC4591001SEC4591001 1009 10091361APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T17:17:002021-07-19 BBC4591001SEC4591001 1009 10091361A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-19 BBC4591001SEC4591001 1009 10091362ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:21:00AAC4591001SEC4591001 1009 10091362A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T16:21:002021-02-08 AB6C4591001SEC4591001 1009 10091362A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-19 B6BC4591001SEC4591001 1009 10091363ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:19:00AAC4591001SEC4591001 1009 10091363A VAXP Placebo A VACCINATION 2020-12-17T16:19:002021-02-09 AB7C4591001SEC4591001 1009 10091363A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-07-30 B7BC4591001SEC4591001 1009 10091363A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-30 2021-07-30T11:08:00BBC4591001SEC4591001 1009 10091363APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-30T11:08:002021-08-27 BBC4591001SEC4591001 1009 10091364ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:47:00AAC4591001SEC4591001 1009 10091364A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T16:47:002021-02-16 AB>C4591001SEC4591001 1009 10091364A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-07-22 B>BC4591001SEC4591001 1009 10091365ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:50:00AAC4591001SEC4591001 1009 10091365A VAXP Placebo A VACCINATION 2020-12-17T16:50:002021-02-16 AB>C4591001SEC4591001 1009 10091365A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-07-20 B>BC4591001SEC4591001 1009 10091365A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-20 2021-07-20T13:59:00BBC4591001SEC4591001 1009 10091365APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-20T13:59:002021-08-19 BBC4591001SEC4591001 1009 10091366ASCRN Screening ASCREENING 2020-12-17 2020-12-17T17:05:00AAC4591001SEC4591001 1009 10091366A VAXP Placebo A VACCINATION 2020-12-17T17:05:002021-02-05 AB3C4591001SEC4591001 1009 10091366A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-08-10 B3BC4591001SEC4591001 1009 10091366A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-08-10 2021-08-10T09:09:00BBC4591001SEC4591001 1009 10091366APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-08-10T09:09:002021-08-30 BCC4591001SEC4591001 1009 10091369ASCRN Screening ASCREENING 2020-12-18 2020-12-18T11:00:00AAC4591001SEC4591001 1009 10091369A VAXP Placebo A VACCINATION 2020-12-18T11:00:002021-02-12 AB9C4591001SEC4591001 1009 10091369A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-05-21 B9BC4591001SEC4591001 1009 10091369A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T09:56:00BBC4591001SEC4591001 1009 10091369APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T09:56:002021-07-14 BBC4591001SEC4591001 1009 10091369A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-07-14 BBC4591001SEC4591001 1009 10091370ASCRN Screening ASCREENING 2020-12-18 2020-12-18T11:25:00AAC4591001SEC4591001 1009 10091370A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T11:25:002021-02-05 AB2C4591001SEC4591001 1009 10091370A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-08-24 B2BC4591001SEC4591001 1009 10091371ASCRN Screening ASCREENING 2020-12-18 2020-12-18T13:39:00AAC4591001SEC4591001 1009 10091371A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T13:39:002021-02-05 AB2C4591001SEC4591001 1009 10091371A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-21 B2BC4591001SEC4591001 1009 10091372ASCRN Screening ASCREENING 2020-12-18 2020-12-18T15:10:00AAC4591001SEC4591001 1009 10091372A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T15:10:002021-02-11 AB8C4591001SEC4591001 1009 10091372A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-07-02 B8BC4591001SEC4591001 1009 10091373ASCRN Screening ASCREENING 2020-12-18 2020-12-18T15:57:00AAC4591001SEC4591001 1009 10091373A VAXP Placebo A VACCINATION 2020-12-18T15:57:002021-02-05 AB2C4591001SEC4591001 1009 10091373A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-16 B2BC4591001SEC4591001 1009 10091373A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-16 2021-07-16T16:06:00BBC4591001SEC4591001 1009 10091373APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-16T16:06:002021-08-06 BBC4591001SEC4591001 1009 10091374ASCRN Screening ASCREENING 2020-12-21 2020-12-21T11:58:00AAC4591001SEC4591001 1009 10091374A VAXP Placebo A VACCINATION 2020-12-21T11:58:002021-02-08 AB2C4591001SEC4591001 1009 10091374A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-24 B2BC4591001SEC4591001 1009 10091374A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T15:05:00BBC4591001SEC4591001 1009 10091374APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T15:05:002021-07-16 BBC4591001SEC4591001 1009 10091374A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-16 2021-07-16 BBC4591001SEC4591001 1009 10091375ASCRN Screening ASCREENING 2020-12-21 2020-12-21T12:00:00AAC4591001SEC4591001 1009 10091375A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T12:00:002021-02-08 AB2C4591001SEC4591001 1009 10091375A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-12 B2BC4591001SEC4591001 1009 10091376ASCRN Screening ASCREENING 2020-12-21 2020-12-21T14:00:00AAC4591001SEC4591001 1009 10091376A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T14:00:002021-02-12 AB6C4591001SEC4591001 1009 10091376A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-08 B6BC4591001SEC4591001 1009 10091377ASCRN Screening ASCREENING 2020-12-21 2020-12-21T15:50:00AAC4591001SEC4591001 1009 10091377A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T15:50:002021-02-15 AB9C4591001SEC4591001 1009 10091377A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-12 B9BC4591001SEC4591001 1009 10091378ASCRN Screening ASCREENING 2020-12-21 2020-12-21T15:52:00AAC4591001SEC4591001 1009 10091378A VAXP Placebo A VACCINATION 2020-12-21T15:52:002021-02-15 AB9C4591001SEC4591001 1009 10091378A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-26 B9BC4591001SEC4591001 1009 10091378A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-26 2021-07-26T13:37:00BBC4591001SEC4591001 1009 10091378APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-26T13:37:002021-08-18 BBC4591001SEC4591001 1009 10091379ASCRN Screening ASCREENING 2020-12-22 2020-12-22T14:19:00AAC4591001SEC4591001 1009 10091379A VAXP Placebo A VACCINATION 2020-12-22T14:19:002021-02-15 AB8C4591001SEC4591001 1009 10091379A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-19 B8BC4591001SEC4591001 1009 10091379A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T10:13:00BBC4591001SEC4591001 1009 10091379APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T10:13:002021-07-13 BBC4591001SEC4591001 1009 10091379A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1009 10091380ASCRN Screening ASCREENING 2020-12-29 2020-12-29T16:31:00AAC4591001SEC4591001 1009 10091380A VAXP Placebo A VACCINATION 2020-12-29T16:31:002021-02-22 AB8C4591001SEC4591001 1009 10091380A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-06-23 B8BC4591001SEC4591001 1009 10091380A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-23 2021-06-23T13:15:00BBC4591001SEC4591001 1009 10091380APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-23T13:15:002021-08-18 BBC4591001SEC4591001 1009 10091380A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-18 2021-08-18 BBC4591001SEC4591001 1009 10091381ASCRN Screening ASCREENING 2020-12-31 2020-12-31T11:28:00AAC4591001SEC4591001 1009 10091381A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-31T11:28:002021-02-16 AB0C4591001SEC4591001 1009 10091381A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-07-13 B0BC4591001SEC4591001 1009 10091382ASCRN Screening ASCREENING 2021-01-04 2021-01-04T16:30:00AAC4591001SEC4591001 1009 10091382A VAXP Placebo A VACCINATION 2021-01-04T16:30:002021-02-25 AB5C4591001SEC4591001 1009 10091382A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-14 B5BC4591001SEC4591001 1009 10091382A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T09:08:00BBC4591001SEC4591001 1009 10091382APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T09:08:002021-07-02 BBC4591001SEC4591001 1009 10091382A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1009 10091383ASCRN Screening ASCREENING 2021-01-05 2021-01-05T13:39:00AAC4591001SEC4591001 1009 10091383A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T13:39:002021-03-01 AB8C4591001SEC4591001 1009 10091383A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-08-05 B8BC4591001SEC4591001 1009 10091384ASCRN Screening ASCREENING 2021-01-05 2021-01-05T13:37:00AAC4591001SEC4591001 1009 10091384A VAXP Placebo A VACCINATION 2021-01-05T13:37:002021-02-23 AB2C4591001SEC4591001 1009 10091384A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-02-23 B2B2C4591001SEC4591001 1009 10091384A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-23 2021-02-23T10:45:00B2B2C4591001SEC4591001 1009 10091384APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-23T10:45:002021-04-20 B2BjC4591001SEC4591001 1009 10091384A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-20 2021-04-20 BjBjC4591001SEC4591001 1009 10091385ASCRN Screening ASCREENING 2021-01-05 2021-01-05T14:05:00AAC4591001SEC4591001 1009 10091385A VAXP Placebo A VACCINATION 2021-01-05T14:05:002021-02-24 AB3C4591001SEC4591001 1009 10091385A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-24 B3BC4591001SEC4591001 1009 10091385A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T11:20:00BBC4591001SEC4591001 1009 10091385APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T11:20:002021-07-13 BBC4591001SEC4591001 1009 10091385A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1009 10091386ASCRN Screening ASCREENING 2021-01-06 2021-01-06T12:40:00AAC4591001SEC4591001 1009 10091386A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T12:40:002021-02-26 AB4C4591001SEC4591001 1009 10091386A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-21 B4BC4591001SEC4591001 1009 10091387ASCRN Screening ASCREENING 2021-01-06 2021-01-06T14:12:00AAC4591001SEC4591001 1009 10091387A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T14:12:002021-03-05 AB;C4591001SEC4591001 1009 10091387A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-07-30 B;BC4591001SEC4591001 1009 10091388ASCRN Screening ASCREENING 2021-01-06 2021-01-06T16:25:00AAC4591001SEC4591001 1009 10091388A VAXP Placebo A VACCINATION 2021-01-06T16:25:002021-02-25 AB3C4591001SEC4591001 1009 10091388A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-19 B3BC4591001SEC4591001 1009 10091388A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T13:05:00BBC4591001SEC4591001 1009 10091388APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T13:05:002021-07-12 BBC4591001SEC4591001 1009 10091388A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1009 10091389ASCRN Screening ASCREENING 2021-01-06 2021-01-06T16:53:00AAC4591001SEC4591001 1009 10091389A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T16:53:002021-02-25 AB3C4591001SEC4591001 1009 10091389A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-07-28 B3BC4591001SEC4591001 1009 10091390ASCRN Screening ASCREENING 2021-01-07 2021-01-07T13:02:00AAC4591001SEC4591001 1009 10091390A VAXP Placebo A VACCINATION 2021-01-07T13:02:002021-02-26 AB3C4591001SEC4591001 1009 10091390A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-02 B3BC4591001SEC4591001 1009 10091390A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-08-02 2021-08-02T12:06:00BBC4591001SEC4591001 1009 10091390APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-08-02T12:06:002021-08-23 BBC4591001SEC4591001 1009 10091391ASCRN Screening ASCREENING 2021-01-07 2021-01-07T14:34:00AAC4591001SEC4591001 1009 10091391A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T14:34:002021-03-01 AB6C4591001SEC4591001 1009 10091391A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-08-02 B6BC4591001SEC4591001 1009 10091392ASCRN Screening ASCREENING 2021-01-07 2021-01-07T14:36:00AAC4591001SEC4591001 1009 10091392A VAXP Placebo A VACCINATION 2021-01-07T14:36:002021-03-01 AB6C4591001SEC4591001 1009 10091392A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-01 B6BC4591001SEC4591001 1009 10091392A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-01 2021-07-01T09:40:00BBC4591001SEC4591001 1009 10091392APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-01T09:40:002021-08-19 BBC4591001SEC4591001 1009 10091392A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-19 2021-08-19 BBC4591001SEC4591001 1009 10091393ASCRN Screening ASCREENING 2021-01-07 2021-01-07T14:30:00AAC4591001SEC4591001 1009 10091393A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T14:30:002021-03-01 AB6C4591001SEC4591001 1009 10091393A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-27 B6BC4591001SEC4591001 1009 10091394ASCRN Screening ASCREENING 2021-01-07 2021-01-07T15:46:00AAC4591001SEC4591001 1009 10091394A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T15:46:002021-03-01 AB6C4591001SEC4591001 1009 10091394A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-08-04 B6BC4591001SEC4591001 1009 10091395ASCRN Screening ASCREENING 2021-01-07 2021-01-07T15:43:00AAC4591001SEC4591001 1009 10091395A VAXP Placebo A VACCINATION 2021-01-07T15:43:002021-03-01 AB6C4591001SEC4591001 1009 10091395A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-05-26 B6BC4591001SEC4591001 1009 10091395A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T14:31:00BBC4591001SEC4591001 1009 10091395APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T14:31:002021-07-16 BBC4591001SEC4591001 1009 10091395A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-16 2021-07-16 BBC4591001SEC4591001 1009 10091396ASCRN Screening ASCREENING 2021-01-07 2021-01-07T16:30:00AAC4591001SEC4591001 1009 10091396A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T16:30:002021-02-25 AB2C4591001SEC4591001 1009 10091396A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-08-11 B2BC4591001SEC4591001 1009 10091398ASCRN Screening ASCREENING 2021-01-07 2021-01-07T17:42:00AAC4591001SEC4591001 1009 10091398A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T17:42:002021-02-26 AB3C4591001SEC4591001 1009 10091398A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-26 B3BC4591001SEC4591001 1009 10091399ASCRN Screening ASCREENING 2021-01-08 2021-01-08T12:00:00AAC4591001SEC4591001 1009 10091399A VAXP Placebo A VACCINATION 2021-01-08T12:00:002021-02-26 AB2C4591001SEC4591001 1009 10091399A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-30 B2BC4591001SEC4591001 1009 10091399A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-30 2021-07-30T12:28:00BBC4591001SEC4591001 1009 10091399APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-30T12:28:002021-08-20 BBC4591001SEC4591001 1009 10091400ASCRN Screening ASCREENING 2021-01-08 2021-01-08T13:28:00AAC4591001SEC4591001 1009 10091400A VAXP Placebo A VACCINATION 2021-01-08T13:28:002021-03-12 AB@C4591001SEC4591001 1009 10091400A0FUP Follow-up A0FOLLOW-UP 2021-03-12 2021-08-30 B@BC4591001SEC4591001 1009 10091400A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-08-30 2021-08-30T16:38:00BBC4591001SEC4591001 1009 10091400APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-08-30T16:38:002021-08-30 BBC4591001SEC4591001 1009 10091401ASCRN Screening ASCREENING 2021-01-08 2021-01-08T14:50:00AAC4591001SEC4591001 1009 10091401A VAXP Placebo A VACCINATION 2021-01-08T14:50:002021-02-26 AB2C4591001SEC4591001 1009 10091401A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-02 B2BC4591001SEC4591001 1009 10091401A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-08-02 2021-08-02T13:06:00BBC4591001SEC4591001 1009 10091401APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-08-02T13:06:002021-08-23 BBC4591001SEC4591001 1009 10091402ASCRN Screening ASCREENING 2021-01-08 2021-01-08T14:48:00AAC4591001SEC4591001 1009 10091402A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T14:48:002021-02-26 AB2C4591001SEC4591001 1009 10091402A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-27 B2BC4591001SEC4591001 1009 10091403ASCRN Screening ASCREENING 2021-01-08 2021-01-08T15:41:00AAC4591001SEC4591001 1009 10091403A VAXP Placebo A VACCINATION 2021-01-08T15:41:002021-02-24 AB0C4591001SEC4591001 1009 10091403A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-02-24 B0B0C4591001SEC4591001 1009 10091403A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-24 2021-02-24T16:07:00B0B0C4591001SEC4591001 1009 10091403APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-24T16:07:002021-04-19 B0BfC4591001SEC4591001 1009 10091403A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-19 2021-04-19 BfBfC4591001SEC4591001 1009 10091404ASCRN Screening ASCREENING 2021-01-08 2021-01-08T16:49:00AAC4591001SEC4591001 1009 10091404A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T16:49:002021-02-26 AB2C4591001SEC4591001 1009 10091404A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-27 B2BC4591001SEC4591001 1009 10091405ASCRN Screening ASCREENING 2021-01-08 2021-01-08T18:16:00AAC4591001SEC4591001 1009 10091405A VAXP Placebo A VACCINATION 2021-01-08T18:16:002021-02-26 AB2C4591001SEC4591001 1009 10091405A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-28 B2BC4591001SEC4591001 1009 10091405A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-28 2021-07-28T12:21:00BBC4591001SEC4591001 1009 10091405APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-28T12:21:002021-08-19 BBC4591001SEC4591001 1009 10091406ASCRN Screening ASCREENING 2021-01-08 2021-01-08T18:14:00AAC4591001SEC4591001 1009 10091406A VAXP Placebo A VACCINATION 2021-01-08T18:14:002021-02-26 AB2C4591001SEC4591001 1009 10091406A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-27 B2BC4591001SEC4591001 1009 10091406A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-27 2021-07-27T13:11:00BBC4591001SEC4591001 1009 10091406APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-27T13:11:002021-08-19 BBC4591001SEC4591001 1009 10091407ASCRN Screening ASCREENING 2021-01-11 2021-01-11T12:55:00AAC4591001SEC4591001 1009 10091407A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T12:55:002021-03-01 AB2C4591001SEC4591001 1009 10091407A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-08-04 B2BC4591001SEC4591001 1009 10091408ASCRN Screening ASCREENING 2021-01-11 2021-01-11T17:38:00AAC4591001SEC4591001 1009 10091408A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T17:38:002021-03-05 AB6C4591001SEC4591001 1009 10091408A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-08-11 B6BC4591001SEC4591001 1009 10091409ASCRN Screening ASCREENING 2021-01-11 2021-01-11T17:36:00AAC4591001SEC4591001 1009 10091409A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T17:36:002021-03-05 AB6C4591001SEC4591001 1009 10091409A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-08-11 B6BC4591001SEC4591001 1009 10091410ASCRN Screening ASCREENING 2021-01-12 2021-01-12T09:48:00AAC4591001SEC4591001 1009 10091410A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T09:48:002021-03-01 AB1C4591001SEC4591001 1009 10091410A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-26 B1BC4591001SEC4591001 1009 10091411ASCRN Screening ASCREENING 2021-01-12 2021-01-12T10:37:00AAC4591001SEC4591001 1009 10091411A VAXP Placebo A VACCINATION 2021-01-12T10:37:002021-03-05 AB5C4591001SEC4591001 1009 10091411A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-05-20 B5BC4591001SEC4591001 1009 10091411A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T11:35:00BBC4591001SEC4591001 1009 10091411APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T11:35:002021-07-13 BBC4591001SEC4591001 1009 10091411A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1009 10091412ASCRN Screening ASCREENING 2021-01-12 2021-01-12T15:29:00AAC4591001SEC4591001 1009 10091412A VAXP Placebo A VACCINATION 2021-01-12T15:29:002021-03-15 AB?C4591001SEC4591001 1009 10091412A0FUP Follow-up A0FOLLOW-UP 2021-03-15 2021-07-30 B?BC4591001SEC4591001 1009 10091412A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-30 2021-07-30T15:18:00BBC4591001SEC4591001 1009 10091412APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-30T15:18:002021-08-20 BBC4591001SEC4591001 1009 10091413ASCRN Screening ASCREENING 2021-01-12 2021-01-12T15:50:00AAC4591001SEC4591001 1009 10091413A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T15:50:002021-03-05 AB5C4591001SEC4591001 1009 10091413A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-08-09 B5BC4591001SEC4591001 1009 10091414ASCRN Screening ASCREENING 2021-01-12 2021-01-12T16:59:00AAC4591001SEC4591001 1009 10091414A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T16:59:002021-03-05 AB5C4591001SEC4591001 1009 10091414A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-08-02 B5BC4591001SEC4591001 1013 10131821ASCRN Screening ASCREENING 2020-11-30 2020-11-30T13:28:00AAC4591001SEC4591001 1013 10131821A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-11-30T13:28:002021-01-18 AB2C4591001SEC4591001 1013 10131821A0FUP Follow-up A0FOLLOW-UP 2021-01-18 2021-06-21 B2BC4591001SEC4591001 1013 10131822ASCRN Screening ASCREENING 2020-11-30 2020-11-30T13:25:00AAC4591001SEC4591001 1013 10131822A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-11-30T13:25:002021-01-18 AB2C4591001SEC4591001 1013 10131822A0FUP Follow-up A0FOLLOW-UP 2021-01-18 2021-08-26 B2CC4591001SEC4591001 1013 10131823ASCRN Screening ASCREENING 2020-12-01 2020-12-01T13:05:00AAC4591001SEC4591001 1013 10131823A VAXP Placebo A VACCINATION 2020-12-01T13:05:002021-01-19 AB2C4591001SEC4591001 1013 10131823A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-06-23 B2BC4591001SEC4591001 1013 10131823A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-23 2021-06-23T09:51:00BBC4591001SEC4591001 1013 10131823APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-23T09:51:002021-08-10 BBC4591001SEC4591001 1013 10131823A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-10 2021-08-10 BBC4591001SEC4591001 1013 10131824ASCRN Screening ASCREENING 2020-12-01 2020-12-01T13:08:00AAC4591001SEC4591001 1013 10131824A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-01T13:08:002021-01-19 AB2C4591001SEC4591001 1013 10131824A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-08-03 B2BC4591001SEC4591001 1013 10131826ASCRN Screening ASCREENING 2020-12-01 2020-12-01T16:29:00AAC4591001SEC4591001 1013 10131826A VAXP Placebo A VACCINATION 2020-12-01T16:29:002021-01-20 AB3C4591001SEC4591001 1013 10131826A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-02 B3BC4591001SEC4591001 1013 10131826A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-02 2021-06-02T09:40:00BBC4591001SEC4591001 1013 10131826APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-02T09:40:002021-07-19 BBC4591001SEC4591001 1013 10131826A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-19 BBC4591001SEC4591001 1013 10131828ASCRN Screening ASCREENING 2020-12-02 2020-12-02T10:32:00AAC4591001SEC4591001 1013 10131828A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T10:32:002021-01-28 AB:C4591001SEC4591001 1013 10131828A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-06-09 B:BC4591001SEC4591001 1013 10131830ASCRN Screening ASCREENING 2020-12-02 2020-12-02T10:42:00AAC4591001SEC4591001 1013 10131830A VAXP Placebo A VACCINATION 2020-12-02T10:42:002021-01-18 AB0C4591001SEC4591001 1013 10131830A0FUP Follow-up A0FOLLOW-UP 2021-01-18 2021-05-12 B0BC4591001SEC4591001 1013 10131835ASCRN Screening ASCREENING 2020-12-02 2020-12-02T12:40:00AAC4591001SEC4591001 1013 10131835A VAXP Placebo A VACCINATION 2020-12-02T12:40:002021-01-19 AB1C4591001SEC4591001 1013 10131835A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-05-26 B1BC4591001SEC4591001 1013 10131835A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T16:45:00BBC4591001SEC4591001 1013 10131835APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T16:45:002021-07-19 BBC4591001SEC4591001 1013 10131835A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-19 BBC4591001SEC4591001 1013 10131836ASCRN Screening ASCREENING 2020-12-02 2020-12-02T12:42:00AAC4591001SEC4591001 1013 10131836A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T12:42:002021-01-19 AB1C4591001SEC4591001 1013 10131836A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-06-15 B1BC4591001SEC4591001 1013 10131839ASCRN Screening ASCREENING 2020-12-02 2020-12-02T13:15:00AAC4591001SEC4591001 1013 10131839A VAXP Placebo A VACCINATION 2020-12-02T13:15:002021-01-19 AB1C4591001SEC4591001 1013 10131839A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-07-14 B1BC4591001SEC4591001 1013 10131841ASCRN Screening ASCREENING 2020-12-02 2020-12-02T16:50:00AAC4591001SEC4591001 1013 10131841A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T16:50:002021-01-20 AB2C4591001SEC4591001 1013 10131841A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-17 B2BC4591001SEC4591001 1013 10131842ASCRN Screening ASCREENING 2020-12-02 2020-12-02T16:52:00AAC4591001SEC4591001 1013 10131842A VAXP Placebo A VACCINATION 2020-12-02T16:52:002021-01-20 AB2C4591001SEC4591001 1013 10131842A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-17 B2BC4591001SEC4591001 1013 10131842A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-17 2021-06-17T15:54:00BBC4591001SEC4591001 1013 10131842APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-17T15:54:002021-07-20 BBC4591001SEC4591001 1013 10131843ASCRN Screening ASCREENING 2020-12-02 2020-12-02T17:02:00AAC4591001SEC4591001 1013 10131843A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T17:02:002021-01-27 AB9C4591001SEC4591001 1013 10131843A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-08-03 B9BC4591001SEC4591001 1013 10131844ASCRN Screening ASCREENING 2020-12-02 2020-12-02T17:00:00AAC4591001SEC4591001 1013 10131844A VAXP Placebo A VACCINATION 2020-12-02T17:00:002021-01-27 AB9C4591001SEC4591001 1013 10131844A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-24 B9BC4591001SEC4591001 1013 10131844A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-24 2021-06-24T16:47:00BBC4591001SEC4591001 1013 10131844APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-24T16:47:002021-08-16 BC C4591001SEC4591001 1013 10131844A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-16 2021-08-16 C C C4591001SEC4591001 1013 10131845ASCRN Screening ASCREENING 2020-12-03 2020-12-03T10:00:00AAC4591001SEC4591001 1013 10131845A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-03T10:00:002021-01-21 AB2C4591001SEC4591001 1013 10131845A0FUP Follow-up A0FOLLOW-UP 2021-01-21 2021-06-21 B2BC4591001SEC4591001 1013 10131846ASCRN Screening ASCREENING 2020-12-03 2020-12-03T11:48:00AAC4591001SEC4591001 1013 10131846A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-03T11:48:002021-01-20 AB1C4591001SEC4591001 1013 10131846A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-05-14 B1BC4591001SEC4591001 1013 10131848ASCRN Screening ASCREENING 2020-12-03 2020-12-03T11:50:00AAC4591001SEC4591001 1013 10131848A VAXP Placebo A VACCINATION 2020-12-03T11:50:002021-01-20 AB1C4591001SEC4591001 1013 10131848A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-05-14 B1BC4591001SEC4591001 1013 10131850ASCRN Screening ASCREENING 2020-12-03 2020-12-03T13:05:00AAC4591001SEC4591001 1013 10131850A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-03T13:05:002021-01-25 AB6C4591001SEC4591001 1013 10131850A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-06-21 B6BC4591001SEC4591001 1013 10131851ASCRN Screening ASCREENING 2020-12-07 2020-12-07T11:15:00AAC4591001SEC4591001 1013 10131851A VAXP Placebo A VACCINATION 2020-12-07T11:15:002021-01-25 AB2C4591001SEC4591001 1013 10131851A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-06-21 B2BC4591001SEC4591001 1013 10131851A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-21 2021-06-21T14:21:00BBC4591001SEC4591001 1013 10131851APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-21T14:21:002021-08-31 BCC4591001SEC4591001 1013 10131851A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-31 2021-08-31 CCC4591001SEC4591001 1013 10131852ASCRN Screening ASCREENING 2020-12-07 2020-12-07T11:50:00AAC4591001SEC4591001 1013 10131852A VAXP Placebo A VACCINATION 2020-12-07T11:50:002021-01-25 AB2C4591001SEC4591001 1013 10131852A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-06-01 B2BC4591001SEC4591001 1013 10131852A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T15:20:00BBC4591001SEC4591001 1013 10131852APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T15:20:002021-07-21 BBC4591001SEC4591001 1013 10131852A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-21 2021-07-21 BBC4591001SEC4591001 1013 10131855ASCRN Screening ASCREENING 2020-12-08 2020-12-08T11:25:00AAC4591001SEC4591001 1013 10131855A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T11:25:002021-01-27 AB3C4591001SEC4591001 1013 10131855A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-23 B3BC4591001SEC4591001 1013 10131856ASCRN Screening ASCREENING 2020-12-09 2020-12-09T12:48:00AAC4591001SEC4591001 1013 10131856A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T12:48:002021-02-08 AB>C4591001SEC4591001 1013 10131856A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-11 B>BC4591001SEC4591001 1013 10131858ASCRN Screening ASCREENING 2020-12-09 2020-12-09T12:42:00AAC4591001SEC4591001 1013 10131858A VAXP Placebo A VACCINATION 2020-12-09T12:42:002021-01-26 AB1C4591001SEC4591001 1013 10131858A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-05-18 B1BC4591001SEC4591001 1013 10131858A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T15:50:00BBC4591001SEC4591001 1013 10131858APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T15:50:002021-08-31 BCC4591001SEC4591001 1013 10131859ASCRN Screening ASCREENING 2020-12-09 2020-12-09T12:36:00AAC4591001SEC4591001 1013 10131859A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T12:36:002021-02-02 AB8C4591001SEC4591001 1013 10131859A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-06-30 B8BC4591001SEC4591001 1013 10131860ASCRN Screening ASCREENING 2020-12-09 2020-12-09T14:58:00AAC4591001SEC4591001 1013 10131860A VAXP Placebo A VACCINATION 2020-12-09T14:58:002021-01-27 AB2C4591001SEC4591001 1013 10131860A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-26 B2BC4591001SEC4591001 1013 10131860A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T15:10:00BBC4591001SEC4591001 1013 10131860APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T15:10:002021-07-15 BBC4591001SEC4591001 1013 10131860A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-15 2021-07-15 BBC4591001SEC4591001 1013 10131861ASCRN Screening ASCREENING 2020-12-10 2020-12-10T10:42:00AAC4591001SEC4591001 1013 10131861A VAXP Placebo A VACCINATION 2020-12-10T10:42:002021-02-11 AB@C4591001SEC4591001 1013 10131861A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-08-25 B@C0C4591001SEC4591001 1013 10131862ASCRN Screening ASCREENING 2020-12-10 2020-12-10T12:27:00AAC4591001SEC4591001 1013 10131862A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T12:27:002021-01-27 AB1C4591001SEC4591001 1013 10131862A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-08-17 B1BC4591001SEC4591001 1013 10131863ASCRN Screening ASCREENING 2020-12-10 2020-12-10T16:30:00AAC4591001SEC4591001 1013 10131863A VAXP Placebo A VACCINATION 2020-12-10T16:30:002021-01-27 AB1C4591001SEC4591001 1013 10131863A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-24 B1BC4591001SEC4591001 1013 10131863A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T15:55:00BBC4591001SEC4591001 1013 10131863APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T15:55:002021-07-13 BBC4591001SEC4591001 1013 10131863A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1013 10131865ASCRN Screening ASCREENING 2020-12-14 2020-12-14T11:03:00AAC4591001SEC4591001 1013 10131865A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T11:03:002021-02-03 AB4C4591001SEC4591001 1013 10131865A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-08 B4BC4591001SEC4591001 1013 10131866ASCRN Screening ASCREENING 2020-12-14 2020-12-14T11:00:00AAC4591001SEC4591001 1013 10131866A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T11:00:002021-02-03 AB4C4591001SEC4591001 1013 10131866A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-08 B4BC4591001SEC4591001 1013 10131867ASCRN Screening ASCREENING 2020-12-17 2020-12-17T12:32:00AAC4591001SEC4591001 1013 10131867A VAXP Placebo A VACCINATION 2020-12-17T12:32:002021-02-03 AB1C4591001SEC4591001 1013 10131867A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-01 B1BC4591001SEC4591001 1013 10131867A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T14:30:00BBC4591001SEC4591001 1013 10131867APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T14:30:002021-08-02 BBC4591001SEC4591001 1013 10131867A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-02 2021-08-02 BBC4591001SEC4591001 1013 10131868ASCRN Screening ASCREENING 2020-12-21 2020-12-21T11:04:00AAC4591001SEC4591001 1013 10131868A VAXP Placebo A VACCINATION 2020-12-21T11:04:002021-02-11 AB5C4591001SEC4591001 1013 10131868A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-05-18 B5BC4591001SEC4591001 1013 10131869ASCRN Screening ASCREENING 2020-12-21 2020-12-21T12:05:00AAC4591001SEC4591001 1013 10131869A VAXP Placebo A VACCINATION 2020-12-21T12:05:002021-02-15 AB9C4591001SEC4591001 1013 10131869A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-06-02 B9BC4591001SEC4591001 1013 10131870ASCRN Screening ASCREENING 2020-12-21 2020-12-21T12:08:00AAC4591001SEC4591001 1013 10131870A VAXP Placebo A VACCINATION 2020-12-21T12:08:002021-02-15 AB9C4591001SEC4591001 1013 10131870A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-04-22 B9B{C4591001SEC4591001 1013 10131871ASCRN Screening ASCREENING 2020-12-21 2020-12-21T13:28:00AAC4591001SEC4591001 1013 10131871A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T13:28:002021-02-08 AB2C4591001SEC4591001 1013 10131871A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-06 B2BC4591001SEC4591001 1013 10131872ASCRN Screening ASCREENING 2020-12-21 2020-12-21T13:25:00AAC4591001SEC4591001 1013 10131872A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T13:25:002021-02-08 AB2C4591001SEC4591001 1013 10131872A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-08-11 B2BC4591001SEC4591001 1013 10131873ASCRN Screening ASCREENING 2020-12-22 2020-12-22T13:02:00AAC4591001SEC4591001 1013 10131873A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T13:02:002021-02-03 AB,C4591001SEC4591001 1013 10131873A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-20 B,BC4591001SEC4591001 1013 10131874ASCRN Screening ASCREENING 2020-12-22 2020-12-22T12:14:00AAC4591001SEC4591001 1013 10131874A VAXP Placebo A VACCINATION 2020-12-22T12:14:002021-02-03 AB,C4591001SEC4591001 1013 10131874A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-20 B,BC4591001SEC4591001 1013 10131874A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-20 2021-07-20T15:40:00BBC4591001SEC4591001 1013 10131874APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-20T15:40:002021-08-11 BBC4591001SEC4591001 1013 10131875ASCRN Screening ASCREENING 2020-12-22 2020-12-22T12:17:00AAC4591001SEC4591001 1013 10131875A VAXP Placebo A VACCINATION 2020-12-22T12:17:002021-02-10 AB3C4591001SEC4591001 1013 10131875A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-24 B3BC4591001SEC4591001 1013 10131875A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T14:55:00BBC4591001SEC4591001 1013 10131875APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T14:55:002021-07-19 BBC4591001SEC4591001 1013 10131875A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-19 BBC4591001SEC4591001 1013 10131876ASCRN Screening ASCREENING 2020-12-22 2020-12-22T13:06:00AAC4591001SEC4591001 1013 10131876A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T13:06:002021-02-16 AB9C4591001SEC4591001 1013 10131876A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-07-12 B9BC4591001SEC4591001 1013 10131877ASCRN Screening ASCREENING 2020-12-23 2020-12-23T09:50:00AAC4591001SEC4591001 1013 10131877A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T09:50:002021-03-01 ABEC4591001SEC4591001 1013 10131877A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-13 BEBC4591001SEC4591001 1013 10131878ASCRN Screening ASCREENING 2020-12-23 2020-12-23T10:20:00AAC4591001SEC4591001 1013 10131878A VAXP Placebo A VACCINATION 2020-12-23T10:20:002021-02-16 AB8C4591001SEC4591001 1013 10131878A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-05-25 B8BC4591001SEC4591001 1013 10131879ASCRN Screening ASCREENING 2020-12-23 2020-12-23T10:14:00AAC4591001SEC4591001 1013 10131879A VAXP Placebo A VACCINATION 2020-12-23T10:14:002021-02-08 AB0C4591001SEC4591001 1013 10131879A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-04-28 B0BC4591001SEC4591001 1013 10131879A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-28 2021-04-28T15:43:00BBC4591001SEC4591001 1013 10131879APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-28T15:43:002021-06-16 BBC4591001SEC4591001 1013 10131879A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-16 2021-06-16 BBC4591001SEC4591001 1013 10131880ASCRN Screening ASCREENING 2020-12-23 2020-12-23T10:07:00AAC4591001SEC4591001 1013 10131880A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T10:07:002021-02-08 AB0C4591001SEC4591001 1013 10131880A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-06 B0BC4591001SEC4591001 1013 10131881ASCRN Screening ASCREENING 2020-12-28 2020-12-28T11:45:00AAC4591001SEC4591001 1013 10131881A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T11:45:002021-02-17 AB4C4591001SEC4591001 1013 10131881A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-15 B4BC4591001SEC4591001 1013 10131882ASCRN Screening ASCREENING 2020-12-30 2020-12-30T10:55:00AAC4591001SEC4591001 1013 10131882A VAXP Placebo A VACCINATION 2020-12-30T10:55:002021-02-18 AB3C4591001SEC4591001 1013 10131882A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-05-17 B3BC4591001SEC4591001 1013 10131882A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T15:00:00BBC4591001SEC4591001 1013 10131882APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T15:00:002021-07-09 BBC4591001SEC4591001 1013 10131882A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1013 10131883ASCRN Screening ASCREENING 2020-12-31 2020-12-31T11:00:00AAC4591001SEC4591001 1013 10131883A VAXP Placebo A VACCINATION 2020-12-31T11:00:002021-02-24 AB8C4591001SEC4591001 1013 10131883A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-20 B8BC4591001SEC4591001 1013 10131883A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T16:42:00BBC4591001SEC4591001 1013 10131883APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T16:42:002021-07-08 BBC4591001SEC4591001 1013 10131883A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1013 10131884ASCRN Screening ASCREENING 2021-01-07 2021-01-07T10:05:00AAC4591001SEC4591001 1013 10131884A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T10:05:002021-02-25 AB2C4591001SEC4591001 1013 10131884A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-08-18 B2BC4591001SEC4591001 1013 10131885ASCRN Screening ASCREENING 2021-01-07 2021-01-07T10:10:00AAC4591001SEC4591001 1013 10131885A VAXP Placebo A VACCINATION 2021-01-07T10:10:002021-02-24 AB1C4591001SEC4591001 1013 10131885A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-27 B1BC4591001SEC4591001 1013 10131885A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-27 2021-05-27T14:20:00BBC4591001SEC4591001 1013 10131885APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-27T14:20:002021-07-13 BBC4591001SEC4591001 1013 10131885A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1013 10131886ASCRN Screening ASCREENING 2021-01-07 2021-01-07T12:20:00AAC4591001SEC4591001 1013 10131886A VAXP Placebo A VACCINATION 2021-01-07T12:20:002021-02-24 AB1C4591001SEC4591001 1013 10131886A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-19 B1BC4591001SEC4591001 1013 10131886A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T09:42:00BBC4591001SEC4591001 1013 10131886APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T09:42:002021-07-09 BBC4591001SEC4591001 1013 10131886A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1016 10161307ASCRN Screening ASCREENING 2020-10-15 2020-10-15T12:18:00AAC4591001SEC4591001 1016 10161307A VAXP Placebo A VACCINATION 2020-10-15T12:18:002020-12-03 AB2C4591001SEC4591001 1016 10161307A0FUP Follow-up A0FOLLOW-UP 2020-12-03 2021-05-19 B2BC4591001SEC4591001 1016 10161307A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T10:55:00BBC4591001SEC4591001 1016 10161307APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T10:55:002021-07-09 BCC4591001SEC4591001 1016 10161307A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-08-30 CCC4591001SEC4591001 1016 10161308ASCRN Screening ASCREENING 2020-10-15 2020-10-15T12:24:00AAC4591001SEC4591001 1016 10161308A VAXP Placebo A VACCINATION 2020-10-15T12:24:002020-12-07 AB6C4591001SEC4591001 1016 10161308A0FUP Follow-up A0FOLLOW-UP 2020-12-07 2021-05-26 B6BC4591001SEC4591001 1016 10161308A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T09:52:00BBC4591001SEC4591001 1016 10161308APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T09:52:002021-07-12 BCC4591001SEC4591001 1016 10161308A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 CCC4591001SEC4591001 1016 10161309ASCRN Screening ASCREENING 2020-10-15 2020-10-15T14:54:00AAC4591001SEC4591001 1016 10161309A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-15T14:54:002020-12-16 AB?C4591001SEC4591001 1016 10161309A0FUP Follow-up A0FOLLOW-UP 2020-12-16 2021-08-26 B?CC4591001SEC4591001 1016 10161310ASCRN Screening ASCREENING 2020-10-15 2020-10-15T15:07:00AAC4591001SEC4591001 1016 10161310A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-15T15:07:002020-12-02 AB1C4591001SEC4591001 1016 10161310A0FUP Follow-up A0FOLLOW-UP 2020-12-02 2021-05-25 B1BC4591001SEC4591001 1016 10161311ASCRN Screening ASCREENING 2020-10-15 2020-10-15T15:32:00AAC4591001SEC4591001 1016 10161311A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-15T15:32:002020-12-02 AB1C4591001SEC4591001 1016 10161311A0FUP Follow-up A0FOLLOW-UP 2020-12-02 2021-05-28 B1BC4591001SEC4591001 1016 10161314ASCRN Screening ASCREENING 2020-10-16 2020-10-16T11:13:00AAC4591001SEC4591001 1016 10161314A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-16T11:13:002020-12-04 AB2C4591001SEC4591001 1016 10161314A0FUP Follow-up A0FOLLOW-UP 2020-12-04 2021-05-26 B2BC4591001SEC4591001 1016 10161315ASCRN Screening ASCREENING 2020-10-16 2020-10-16T15:01:00AAC4591001SEC4591001 1016 10161315A VAXP Placebo A VACCINATION 2020-10-16T15:01:002020-12-04 AB2C4591001SEC4591001 1016 10161315A0FUP Follow-up A0FOLLOW-UP 2020-12-04 2021-05-20 B2BC4591001SEC4591001 1016 10161315A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T14:40:00BBC4591001SEC4591001 1016 10161315APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T14:40:002021-07-07 BCC4591001SEC4591001 1016 10161315A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 CCC4591001SEC4591001 1016 10161316ASCRN Screening ASCREENING 2020-10-16 2020-10-16T15:10:00AAC4591001SEC4591001 1016 10161316A VAXP Placebo A VACCINATION 2020-10-16T15:10:002020-12-14 AB<C4591001SEC4591001 1016 10161316A0FUP Follow-up A0FOLLOW-UP 2020-12-14 2021-02-25 B<BC4591001SEC4591001 1016 10161316A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-25 2021-02-25T14:45:00BBC4591001SEC4591001 1016 10161316APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-25T14:45:002021-04-13 BBC4591001SEC4591001 1016 10161316A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-13 2021-04-13 BBC4591001SEC4591001 1016 10161318ASCRN Screening ASCREENING 2020-10-16 2020-10-16T15:39:00AAC4591001SEC4591001 1016 10161318A VAXP Placebo A VACCINATION 2020-10-16T15:39:002020-12-04 AB2C4591001SEC4591001 1016 10161318A0FUP Follow-up A0FOLLOW-UP 2020-12-04 2021-06-10 B2BC4591001SEC4591001 1016 10161318A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-10 2021-06-10T15:14:00BBC4591001SEC4591001 1016 10161318APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-10T15:14:002021-07-27 BCC4591001SEC4591001 1016 10161318A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-27 2021-07-27 CCC4591001SEC4591001 1016 10161319ASCRN Screening ASCREENING 2020-10-16 2020-10-16T15:53:00AAC4591001SEC4591001 1016 10161319A VAXP Placebo A VACCINATION 2020-10-16T15:53:002020-12-02 AB0C4591001SEC4591001 1016 10161319A0FUP Follow-up A0FOLLOW-UP 2020-12-02 2021-05-25 B0BC4591001SEC4591001 1016 10161319A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T16:07:00BBC4591001SEC4591001 1016 10161319APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T16:07:002021-07-12 BCC4591001SEC4591001 1016 10161319A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 CCC4591001SEC4591001 1016 10161320ASCRN Screening ASCREENING 2020-10-19 2020-10-21T11:07:00 AC4591001SEC4591001 1016 10161320A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-21T11:07:002020-12-08 AB1C4591001SEC4591001 1016 10161320A0FUP Follow-up A0FOLLOW-UP 2020-12-08 2021-05-17 B1BC4591001SEC4591001 1016 10161322ASCRN Screening ASCREENING 2020-10-19 2020-10-19T11:52:00AAC4591001SEC4591001 1016 10161322A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-19T11:52:002020-12-07 AB2C4591001SEC4591001 1016 10161322A0FUP Follow-up A0FOLLOW-UP 2020-12-07 2021-05-13 B2BC4591001SEC4591001 1016 10161323ASCRN Screening ASCREENING 2020-10-19 2020-10-19T14:04:00AAC4591001SEC4591001 1016 10161323A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-19T14:04:002020-12-07 AB2C4591001SEC4591001 1016 10161323A0FUP Follow-up A0FOLLOW-UP 2020-12-07 2021-05-13 B2BC4591001SEC4591001 1016 10161324ASCRN Screening ASCREENING 2020-10-19 2020-10-19T14:02:00AAC4591001SEC4591001 1016 10161324A VAXP Placebo A VACCINATION 2020-10-19T14:02:002020-12-07 AB2C4591001SEC4591001 1016 10161324A0FUP Follow-up A0FOLLOW-UP 2020-12-07 2021-05-27 B2BC4591001SEC4591001 1016 10161324A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-27 2021-05-27T15:00:00BBC4591001SEC4591001 1016 10161324APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-27T15:00:002021-07-15 BCC4591001SEC4591001 1016 10161324A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-15 2021-07-15 CCC4591001SEC4591001 1016 10161325ASCRN Screening ASCREENING 2020-10-19 2020-10-19T14:58:00AAC4591001SEC4591001 1016 10161325A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-19T14:58:002020-12-08 AB3C4591001SEC4591001 1016 10161325A0FUP Follow-up A0FOLLOW-UP 2020-12-08 2021-08-30 B3CC4591001SEC4591001 1016 10161326ASCRN Screening ASCREENING 2020-10-20 2020-10-20T09:46:00AAC4591001SEC4591001 1016 10161326A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-20T09:46:002020-12-08 AB2C4591001SEC4591001 1016 10161326A0FUP Follow-up A0FOLLOW-UP 2020-12-08 2021-05-13 B2BC4591001SEC4591001 1016 10161327ASCRN Screening ASCREENING 2020-10-20 2020-10-20T09:46:00AAC4591001SEC4591001 1016 10161327A VAXP Placebo A VACCINATION 2020-10-20T09:46:002020-12-08 AB2C4591001SEC4591001 1016 10161327A0FUP Follow-up A0FOLLOW-UP 2020-12-08 2021-06-01 B2BC4591001SEC4591001 1016 10161327A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T15:15:00BBC4591001SEC4591001 1016 10161327APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T15:15:002021-07-20 BC C4591001SEC4591001 1016 10161327A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-20 2021-07-20 C C C4591001SEC4591001 1016 10161329ASCRN Screening ASCREENING 2020-10-20 2020-10-20T09:53:00AAC4591001SEC4591001 1016 10161329A VAXP Placebo A VACCINATION 2020-10-20T09:53:002020-12-14 AB8C4591001SEC4591001 1016 10161329A0FUP Follow-up A0FOLLOW-UP 2020-12-14 2021-05-19 B8BC4591001SEC4591001 1016 10161329A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T15:07:00BBC4591001SEC4591001 1016 10161329APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T15:07:002021-07-07 BCPC4591001SEC4591001 1016 10161329A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 CPCPC4591001SEC4591001 1016 10161330ASCRN Screening ASCREENING 2020-10-20 2020-10-20T14:59:00AAC4591001SEC4591001 1016 10161330A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-20T14:59:002020-12-11 AB5C4591001SEC4591001 1016 10161330A0FUP Follow-up A0FOLLOW-UP 2020-12-11 2021-05-13 B5BC4591001SEC4591001 1016 10161331ASCRN Screening ASCREENING 2020-10-20 2020-10-20T14:54:00AAC4591001SEC4591001 1016 10161331A VAXP Placebo A VACCINATION 2020-10-20T14:54:002020-12-09 AB3C4591001SEC4591001 1016 10161331A0FUP Follow-up A0FOLLOW-UP 2020-12-09 2021-05-26 B3BC4591001SEC4591001 1016 10161331A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T16:10:00BBC4591001SEC4591001 1016 10161331APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T16:10:002021-07-12 BCC4591001SEC4591001 1016 10161331A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-08-09 CC`C4591001SEC4591001 1016 10161332ASCRN Screening ASCREENING 2020-10-21 2020-10-21T14:35:00AAC4591001SEC4591001 1016 10161332A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-21T14:35:002020-12-07 AB0C4591001SEC4591001 1016 10161332A0FUP Follow-up A0FOLLOW-UP 2020-12-07 2021-05-13 B0BC4591001SEC4591001 1016 10161334ASCRN Screening ASCREENING 2020-10-21 2020-10-21T14:59:00AAC4591001SEC4591001 1016 10161334A VAXP Placebo A VACCINATION 2020-10-21T14:59:002020-12-10 AB3C4591001SEC4591001 1016 10161334A0FUP Follow-up A0FOLLOW-UP 2020-12-10 2021-05-27 B3BC4591001SEC4591001 1016 10161334A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-27 2021-05-27T16:25:00BBC4591001SEC4591001 1016 10161334APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-27T16:25:002021-07-14 BCC4591001SEC4591001 1016 10161334A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-07-14 CCC4591001SEC4591001 1016 10161335ASCRN Screening ASCREENING 2020-10-21 2020-10-21T16:51:00AAC4591001SEC4591001 1016 10161335A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-21T16:51:002020-12-09 AB2C4591001SEC4591001 1016 10161335A0FUP Follow-up A0FOLLOW-UP 2020-12-09 2021-08-20 B2CC4591001SEC4591001 1016 10161336ASCRN Screening ASCREENING 2020-10-21 2020-10-21T16:53:00AAC4591001SEC4591001 1016 10161336A VAXP Placebo A VACCINATION 2020-10-21T16:53:002020-12-09 AB2C4591001SEC4591001 1016 10161336A0FUP Follow-up A0FOLLOW-UP 2020-12-09 2021-07-06 B2C0C4591001SEC4591001 1016 10161336A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-06 2021-07-06T11:09:00C0C0C4591001SEC4591001 1016 10161336APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-06T11:09:002021-08-23 C0C0C4591001SEC4591001 1016 10161336A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-23 2021-08-23 C0C0C4591001SEC4591001 1016 10161337ASCRN Screening ASCREENING 2020-10-21 2020-10-21T16:31:00AAC4591001SEC4591001 1016 10161337A VAXP Placebo A VACCINATION 2020-10-21T16:31:002020-12-09 AB2C4591001SEC4591001 1016 10161337A0FUP Follow-up A0FOLLOW-UP 2020-12-09 2021-04-19 B2BC4591001SEC4591001 1016 10161337A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-19 2021-04-19T16:15:00BBC4591001SEC4591001 1016 10161337APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-19T16:15:002021-06-08 BBC4591001SEC4591001 1016 10161337A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-08 2021-06-08 BBC4591001SEC4591001 1016 10161338ASCRN Screening ASCREENING 2020-10-22 2020-10-22T10:10:00AAC4591001SEC4591001 1016 10161338A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-22T10:10:002020-12-28 ABDC4591001SEC4591001 1016 10161338A0FUP Follow-up A0FOLLOW-UP 2020-12-28 2021-05-14 BDBC4591001SEC4591001 1016 10161339ASCRN Screening ASCREENING 2020-10-22 2020-10-22T11:02:00AAC4591001SEC4591001 1016 10161339A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-22T11:02:002020-12-09 AB1C4591001SEC4591001 1016 10161339A0FUP Follow-up A0FOLLOW-UP 2020-12-09 2021-05-18 B1BC4591001SEC4591001 1016 10161340ASCRN Screening ASCREENING 2020-10-22 2020-10-22T11:03:00AAC4591001SEC4591001 1016 10161340A VAXP Placebo A VACCINATION 2020-10-22T11:03:002020-12-09 AB1C4591001SEC4591001 1016 10161340A0FUP Follow-up A0FOLLOW-UP 2020-12-09 2021-05-26 B1BC4591001SEC4591001 1016 10161340A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T09:53:00BBC4591001SEC4591001 1016 10161340APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T09:53:002021-07-19 BCC4591001SEC4591001 1016 10161340A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-19 CCC4591001SEC4591001 1016 10161343ASCRN Screening ASCREENING 2020-10-22 2020-10-22T16:39:00AAC4591001SEC4591001 1016 10161343A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-10-22T16:39:002020-12-11 AB3C4591001SEC4591001 1016 10161343A0FUP Follow-up A0FOLLOW-UP 2020-12-11 2021-05-14 B3BC4591001SEC4591001 1016 10161344ASCRN Screening ASCREENING 2020-10-22 2020-10-22T16:44:00AAC4591001SEC4591001 1016 10161344A VAXP Placebo A VACCINATION 2020-10-22T16:44:002020-12-10 AB2C4591001SEC4591001 1016 10161344A0FUP Follow-up A0FOLLOW-UP 2020-12-10 2021-05-19 B2BC4591001SEC4591001 1016 10161344A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T09:56:00BBC4591001SEC4591001 1016 10161344APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T09:56:002021-07-05 BCC4591001SEC4591001 1016 10161344A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-05 2021-07-05 CCC4591001SEC4591001 1016 10161350ASCRN Screening ASCREENING 2020-11-30 2020-11-30T10:30:00AAC4591001SEC4591001 1016 10161350A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-11-30T10:30:002021-01-18 AB2C4591001SEC4591001 1016 10161350A0FUP Follow-up A0FOLLOW-UP 2021-01-18 2021-08-09 B2BC4591001SEC4591001 1016 10161351ASCRN Screening ASCREENING 2020-11-30 2020-11-30T10:23:00AAC4591001SEC4591001 1016 10161351A VAXP Placebo A VACCINATION 2020-11-30T10:23:002021-01-18 AB2C4591001SEC4591001 1016 10161351A0FUP Follow-up A0FOLLOW-UP 2021-01-18 2021-06-14 B2BC4591001SEC4591001 1016 10161351A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-14 2021-06-14T10:08:00BBC4591001SEC4591001 1016 10161351APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-14T10:08:002021-08-09 BBC4591001SEC4591001 1016 10161351A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-09 2021-08-09 BBC4591001SEC4591001 1016 10161352ASCRN Screening ASCREENING 2020-11-30 2020-11-30T15:49:00AAC4591001SEC4591001 1016 10161352A VAXP Placebo A VACCINATION 2020-11-30T15:49:002021-01-20 AB4C4591001SEC4591001 1016 10161352A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-01 B4BC4591001SEC4591001 1016 10161352A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T09:54:00BBC4591001SEC4591001 1016 10161352APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T09:54:002021-07-19 BBC4591001SEC4591001 1016 10161352A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-19 BBC4591001SEC4591001 1016 10161353ASCRN Screening ASCREENING 2020-11-30 2020-11-30T16:33:00AAC4591001SEC4591001 1016 10161353A VAXP Placebo A VACCINATION 2020-11-30T16:33:002021-01-20 AB4C4591001SEC4591001 1016 10161353A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-05-24 B4BC4591001SEC4591001 1016 10161353A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T16:30:00BBC4591001SEC4591001 1016 10161353APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T16:30:002021-07-12 BBC4591001SEC4591001 1016 10161353A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1016 10161354ASCRN Screening ASCREENING 2020-12-02 2020-12-02T10:08:00AAC4591001SEC4591001 1016 10161354A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T10:08:002021-01-21 AB3C4591001SEC4591001 1016 10161354A0FUP Follow-up A0FOLLOW-UP 2021-01-21 2021-06-24 B3BC4591001SEC4591001 1016 10161356ASCRN Screening ASCREENING 2020-12-02 2020-12-02T11:02:00AAC4591001SEC4591001 1016 10161356A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T11:02:002021-01-21 AB3C4591001SEC4591001 1016 10161356A0FUP Follow-up A0FOLLOW-UP 2021-01-21 2021-06-17 B3BC4591001SEC4591001 1016 10161357ASCRN Screening ASCREENING 2020-12-02 2020-12-02T11:32:00AAC4591001SEC4591001 1016 10161357A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T11:32:002021-01-21 AB3C4591001SEC4591001 1016 10161357A0FUP Follow-up A0FOLLOW-UP 2021-01-21 2021-06-15 B3BC4591001SEC4591001 1016 10161358ASCRN Screening ASCREENING 2020-12-03 2020-12-03T09:45:00AAC4591001SEC4591001 1016 10161358A VAXP Placebo A VACCINATION 2020-12-03T09:45:002021-01-21 AB2C4591001SEC4591001 1016 10161358A0FUP Follow-up A0FOLLOW-UP 2021-01-21 2021-06-22 B2BC4591001SEC4591001 1016 10161361ASCRN Screening ASCREENING 2020-12-04 2020-12-04T10:29:00AAC4591001SEC4591001 1016 10161361A VAXP Placebo A VACCINATION 2020-12-04T10:29:002021-01-22 AB2C4591001SEC4591001 1016 10161361A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-05-17 B2BC4591001SEC4591001 1016 10161361A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T13:45:00BBC4591001SEC4591001 1016 10161361APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T13:45:002021-07-05 BBC4591001SEC4591001 1016 10161361A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-05 2021-07-05 BBC4591001SEC4591001 1016 10161362ASCRN Screening ASCREENING 2020-12-04 2020-12-04T15:38:00AAC4591001SEC4591001 1016 10161362A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-04T15:38:002021-01-26 AB6C4591001SEC4591001 1016 10161362A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-06-23 B6BC4591001SEC4591001 1016 10161363ASCRN Screening ASCREENING 2020-12-08 2020-12-08T16:07:00AAC4591001SEC4591001 1016 10161363A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T16:07:002021-01-26 AB2C4591001SEC4591001 1016 10161363A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-06-23 B2BC4591001SEC4591001 1016 10161364ASCRN Screening ASCREENING 2020-12-09 2020-12-09T15:34:00AAC4591001SEC4591001 1016 10161364A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T15:34:002021-02-04 AB:C4591001SEC4591001 1016 10161364A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-06-28 B:BC4591001SEC4591001 1016 10161365ASCRN Screening ASCREENING 2020-12-10 2020-12-10T11:42:00AAC4591001SEC4591001 1016 10161365A VAXP Placebo A VACCINATION 2020-12-10T11:42:002021-01-27 AB1C4591001SEC4591001 1016 10161365A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-17 B1BC4591001SEC4591001 1016 10161365A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T15:07:00BBC4591001SEC4591001 1016 10161365APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T15:07:002021-07-08 BBC4591001SEC4591001 1016 10161365A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1016 10161366ASCRN Screening ASCREENING 2020-12-15 2020-12-15T15:38:00AAC4591001SEC4591001 1016 10161366A VAXP Placebo A VACCINATION 2020-12-15T15:38:002021-02-17 ABAC4591001SEC4591001 1016 10161366A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-19 BABC4591001SEC4591001 1016 10161366A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T16:26:00BBC4591001SEC4591001 1016 10161366APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T16:26:002021-08-10 BBC4591001SEC4591001 1016 10161366A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-10 2021-08-10 BBC4591001SEC4591001 1016 10161367ASCRN Screening ASCREENING 2020-12-29 2020-12-29T10:57:00AAC4591001SEC4591001 1016 10161367A VAXP Placebo A VACCINATION 2020-12-29T10:57:002021-02-22 AB8C4591001SEC4591001 1016 10161367A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-24 B8BC4591001SEC4591001 1016 10161367A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T14:32:00BBC4591001SEC4591001 1016 10161367APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T14:32:002021-07-12 BBC4591001SEC4591001 1016 10161367A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1016 10161368ASCRN Screening ASCREENING 2020-12-30 2020-12-30T16:02:00AAC4591001SEC4591001 1016 10161368A VAXP Placebo A VACCINATION 2020-12-30T16:02:002021-02-19 AB4C4591001SEC4591001 1016 10161368A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-05-19 B4BC4591001SEC4591001 1016 10161368A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T15:36:00BBC4591001SEC4591001 1016 10161368APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T15:36:002021-07-07 BBC4591001SEC4591001 1016 10161368A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1016 10161369ASCRN Screening ASCREENING 2020-12-30 2020-12-30T16:18:00AAC4591001SEC4591001 1016 10161369A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T16:18:002021-03-03 AB@C4591001SEC4591001 1016 10161369A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-08-23 B@BC4591001SEC4591001 1016 10161370ASCRN Screening ASCREENING 2021-01-04 2021-01-04T11:37:00AAC4591001SEC4591001 1016 10161370A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T11:37:002021-02-26 AB6C4591001SEC4591001 1016 10161370A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-28 B6BC4591001SEC4591001 1016 10161371ASCRN Screening ASCREENING 2021-01-04 2021-01-04T15:34:00AAC4591001SEC4591001 1016 10161371A VAXP Placebo A VACCINATION 2021-01-04T15:34:002021-02-23 AB3C4591001SEC4591001 1016 10161371A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-05-25 B3BC4591001SEC4591001 1016 10161371A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T15:41:00BBC4591001SEC4591001 1016 10161371APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T15:41:002021-07-12 BBC4591001SEC4591001 1016 10161371A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1016 10161372ASCRN Screening ASCREENING 2021-01-05 2021-01-05T15:51:00AAC4591001SEC4591001 1016 10161372A VAXP Placebo A VACCINATION 2021-01-05T15:51:002021-02-25 AB4C4591001SEC4591001 1016 10161372A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-13 B4BC4591001SEC4591001 1016 10161372A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T16:22:00BBC4591001SEC4591001 1016 10161372APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T16:22:002021-07-01 BBC4591001SEC4591001 1016 10161372A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1016 10161373ASCRN Screening ASCREENING 2021-01-05 2021-01-05T16:26:00AAC4591001SEC4591001 1016 10161373A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T16:26:002021-02-24 AB3C4591001SEC4591001 1016 10161373A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-21 B3BC4591001SEC4591001 1016 10161374ASCRN Screening ASCREENING 2021-01-06 2021-01-06T12:28:00AAC4591001SEC4591001 1016 10161374A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T12:28:002021-02-26 AB4C4591001SEC4591001 1016 10161374A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-04 B4BC4591001SEC4591001 1016 10161375ASCRN Screening ASCREENING 2021-01-06 2021-01-06T16:08:00AAC4591001SEC4591001 1016 10161375A VAXP Placebo A VACCINATION 2021-01-06T16:08:002021-02-24 AB2C4591001SEC4591001 1016 10161375A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-17 B2BC4591001SEC4591001 1016 10161375A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T16:44:00BBC4591001SEC4591001 1016 10161375APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T16:44:002021-07-06 BBC4591001SEC4591001 1016 10161375A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1016 10161376ASCRN Screening ASCREENING 2021-01-07 2021-01-07T12:04:00AAC4591001SEC4591001 1016 10161376A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T12:04:002021-02-23 AB0C4591001SEC4591001 1016 10161376A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-26 B0BC4591001SEC4591001 1016 10161377ASCRN Screening ASCREENING 2021-01-07 2021-01-07T12:05:00AAC4591001SEC4591001 1016 10161377A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T12:05:002021-02-23 AB0C4591001SEC4591001 1016 10161377A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-26 B0BC4591001SEC4591001 1016 10161378ASCRN Screening ASCREENING 2021-01-07 2021-01-07T16:06:00AAC4591001SEC4591001 1016 10161378A VAXP Placebo A VACCINATION 2021-01-07T16:06:002021-02-23 AB0C4591001SEC4591001 1016 10161378A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-08-04 B0BC4591001SEC4591001 1016 10161378A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-08-04 2021-08-04T16:31:00BBC4591001SEC4591001 1016 10161378APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-08-04T16:31:002021-08-25 BBC4591001SEC4591001 1016 10161379ASCRN Screening ASCREENING 2021-01-07 2021-01-07T16:49:00AAC4591001SEC4591001 1016 10161379A VAXP Placebo A VACCINATION 2021-01-07T16:49:002021-03-10 AB?C4591001SEC4591001 1016 10161379A0FUP Follow-up A0FOLLOW-UP 2021-03-10 2021-06-01 B?BC4591001SEC4591001 1016 10161379A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T12:17:00BBC4591001SEC4591001 1016 10161379APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T12:17:002021-07-28 BBC4591001SEC4591001 1016 10161379A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-28 2021-07-28 BBC4591001SEC4591001 1016 10161381ASCRN Screening ASCREENING 2021-01-08 2021-01-08T10:40:00AAC4591001SEC4591001 1016 10161381A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T10:40:002021-02-25 AB1C4591001SEC4591001 1016 10161381A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-09-01 B1BC4591001SEC4591001 1016 10161382ASCRN Screening ASCREENING 2021-01-08 2021-01-08T10:59:00AAC4591001SEC4591001 1016 10161382A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T10:59:002021-02-26 AB2C4591001SEC4591001 1016 10161382A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-26 B2BC4591001SEC4591001 1016 10161383ASCRN Screening ASCREENING 2021-01-08 2021-01-08T10:56:00AAC4591001SEC4591001 1016 10161383A VAXP Placebo A VACCINATION 2021-01-08T10:56:002021-02-26 AB2C4591001SEC4591001 1016 10161383A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-13 B2B~C4591001SEC4591001 1016 10161383A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T15:28:00B~B~C4591001SEC4591001 1016 10161383APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T15:28:002021-06-30 B~BC4591001SEC4591001 1016 10161383A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-30 2021-06-30 BBC4591001SEC4591001 1016 10161384ASCRN Screening ASCREENING 2021-01-08 2021-01-08T11:23:00AAC4591001SEC4591001 1016 10161384A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T11:23:002021-02-24 AB0C4591001SEC4591001 1016 10161384A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-26 B0BC4591001SEC4591001 1016 10161385ASCRN Screening ASCREENING 2021-01-08 2021-01-08T15:00:00AAC4591001SEC4591001 1016 10161385A VAXP Placebo A VACCINATION 2021-01-08T15:00:002021-02-26 AB2C4591001SEC4591001 1016 10161385A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-02 B2BC4591001SEC4591001 1016 10161386ASCRN Screening ASCREENING 2021-01-08 2021-01-08T15:25:00AAC4591001SEC4591001 1016 10161386A VAXP Placebo A VACCINATION 2021-01-08T15:25:002021-02-25 AB1C4591001SEC4591001 1016 10161386A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-13 B1B~C4591001SEC4591001 1016 10161386A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T17:14:00B~B~C4591001SEC4591001 1016 10161386APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T17:14:002021-06-29 B~BC4591001SEC4591001 1016 10161386A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-29 2021-07-23 BBC4591001SEC4591001 1016 10161387ASCRN Screening ASCREENING 2021-01-08 2021-01-08T16:06:00AAC4591001SEC4591001 1016 10161387A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T16:06:002021-02-24 AB0C4591001SEC4591001 1016 10161387A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-21 B0BC4591001SEC4591001 1016 10161388ASCRN Screening ASCREENING 2021-01-11 2021-01-11T16:14:00AAC4591001SEC4591001 1016 10161388A VAXP Placebo A VACCINATION 2021-01-11T16:14:002021-03-02 AB3C4591001SEC4591001 1016 10161388A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-05 B3BsC4591001SEC4591001 1016 10161388A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-05 2021-05-05T10:29:00BsBsC4591001SEC4591001 1016 10161388APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-05T10:29:002021-06-21 BsBC4591001SEC4591001 1016 10161388A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-21 2021-06-21 BBC4591001SEC4591001 1039 10391246ASCRN Screening ASCREENING 2020-12-01 2020-12-01T08:59:00AAC4591001SEC4591001 1039 10391246A VAXP Placebo A VACCINATION 2020-12-01T08:59:002021-01-19 AB2C4591001SEC4591001 1039 10391246A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-02-26 B2BXC4591001SEC4591001 1039 10391246A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-26 2021-02-26T07:48:00BXBXC4591001SEC4591001 1039 10391246APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-26T07:48:002021-04-15 BXBC4591001SEC4591001 1039 10391246A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-15 2021-04-15 BBC4591001SEC4591001 1039 10391247ASCRN Screening ASCREENING 2020-12-01 2020-12-01T09:09:00AAC4591001SEC4591001 1039 10391247A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-01T09:09:002021-01-19 AB2C4591001SEC4591001 1039 10391247A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-06-14 B2BC4591001SEC4591001 1039 10391250ASCRN Screening ASCREENING 2020-12-04 2020-12-04T09:34:00AAC4591001SEC4591001 1039 10391250A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-04T09:34:002021-01-27 AB7C4591001SEC4591001 1039 10391250A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-07-06 B7BC4591001SEC4591001 1039 10391251ASCRN Screening ASCREENING 2020-12-07 2020-12-07T08:11:00AAC4591001SEC4591001 1039 10391251A VAXP Placebo A VACCINATION 2020-12-07T08:11:002021-02-02 AB:C4591001SEC4591001 1039 10391251A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-02-02 B:B:C4591001SEC4591001 1039 10391251A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-02 2021-02-02T08:28:00B:B:C4591001SEC4591001 1039 10391251APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-02T08:28:002021-03-25 B:BmC4591001SEC4591001 1039 10391251A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-03-25 2021-08-20 BmCC4591001SEC4591001 1039 10391252ASCRN Screening ASCREENING 2020-12-07 2020-12-07T08:32:00AAC4591001SEC4591001 1039 10391252A VAXP Placebo A VACCINATION 2020-12-07T08:32:002021-01-27 AB4C4591001SEC4591001 1039 10391252A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-03-25 B4BmC4591001SEC4591001 1039 10391252A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-25 2021-03-25T14:00:00BmBmC4591001SEC4591001 1039 10391252APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-25T14:00:002021-05-14 BmBC4591001SEC4591001 1039 10391252A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-14 2021-05-14 BBC4591001SEC4591001 1039 10391253ASCRN Screening ASCREENING 2020-12-07 2020-12-07T09:11:00AAC4591001SEC4591001 1039 10391253A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T09:11:002021-01-27 AB4C4591001SEC4591001 1039 10391253A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-08-09 B4BC4591001SEC4591001 1039 10391255ASCRN Screening ASCREENING 2020-12-07 2020-12-07T12:04:00AAC4591001SEC4591001 1039 10391255A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T12:04:002021-01-27 AB4C4591001SEC4591001 1039 10391255A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-07-21 B4BC4591001SEC4591001 1039 10391256ASCRN Screening ASCREENING 2020-12-07 2020-12-07T12:49:00AAC4591001SEC4591001 1039 10391256A VAXP Placebo A VACCINATION 2020-12-07T12:49:002021-01-27 AB4C4591001SEC4591001 1039 10391256A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-13 B4BC4591001SEC4591001 1039 10391256A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T13:05:00BBC4591001SEC4591001 1039 10391256APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T13:05:002021-07-01 BBC4591001SEC4591001 1039 10391256A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-21 BBC4591001SEC4591001 1039 10391258ASCRN Screening ASCREENING 2020-12-07 2020-12-07T12:40:00AAC4591001SEC4591001 1039 10391258A VAXP Placebo A VACCINATION 2020-12-07T12:40:002021-01-28 AB5C4591001SEC4591001 1039 10391258A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-05-13 B5BC4591001SEC4591001 1039 10391258A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T12:55:00BBC4591001SEC4591001 1039 10391258APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T12:55:002021-07-06 BBC4591001SEC4591001 1039 10391258A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1039 10391259ASCRN Screening ASCREENING 2020-12-07 2020-12-07T13:39:00AAC4591001SEC4591001 1039 10391259A VAXP Placebo A VACCINATION 2020-12-07T13:39:002021-01-25 AB2C4591001SEC4591001 1039 10391259A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-05-14 B2BC4591001SEC4591001 1039 10391259A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T13:53:00BBC4591001SEC4591001 1039 10391259APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T13:53:002021-07-02 BBC4591001SEC4591001 1039 10391259A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1039 10391260ASCRN Screening ASCREENING 2020-12-07 2020-12-07T14:21:00AAC4591001SEC4591001 1039 10391260A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T14:21:002021-01-25 AB2C4591001SEC4591001 1039 10391260A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-07-28 B2BC4591001SEC4591001 1039 10391262ASCRN Screening ASCREENING 2020-12-08 2020-12-08T08:19:00AAC4591001SEC4591001 1039 10391262A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T08:19:002021-01-28 AB4C4591001SEC4591001 1039 10391262A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-06-22 B4BC4591001SEC4591001 1039 10391263ASCRN Screening ASCREENING 2020-12-08 2020-12-08T08:36:00AAC4591001SEC4591001 1039 10391263A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T08:36:002021-01-28 AB4C4591001SEC4591001 1039 10391263A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-08-04 B4BC4591001SEC4591001 1039 10391264ASCRN Screening ASCREENING 2020-12-08 2020-12-08T11:55:00AAC4591001SEC4591001 1039 10391264A VAXP Placebo A VACCINATION 2020-12-08T11:55:002021-03-01 ABTC4591001SEC4591001 1039 10391264A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-05-24 BTBC4591001SEC4591001 1039 10391264A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T13:58:00BBC4591001SEC4591001 1039 10391264APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T13:58:002021-06-08 BBC4591001SEC4591001 1039 10391265ASCRN Screening ASCREENING 2020-12-08 2020-12-08T12:10:00AAC4591001SEC4591001 1039 10391265A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T12:10:002021-03-01 ABTC4591001SEC4591001 1039 10391265A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-06-29 BTBC4591001SEC4591001 1039 10391266ASCRN Screening ASCREENING 2020-12-08 2020-12-08T13:16:00AAC4591001SEC4591001 1039 10391266A VAXP Placebo A VACCINATION 2020-12-08T13:16:002021-01-26 AB2C4591001SEC4591001 1039 10391266A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-05-14 B2BC4591001SEC4591001 1039 10391266A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T14:12:00BBC4591001SEC4591001 1039 10391266APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T14:12:002021-07-08 BBC4591001SEC4591001 1039 10391266A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1039 10391267ASCRN Screening ASCREENING 2020-12-08 2020-12-08T13:54:00AAC4591001SEC4591001 1039 10391267A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T13:54:002021-01-25 AB1C4591001SEC4591001 1039 10391267A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-07-02 B1BC4591001SEC4591001 1039 10391268ASCRN Screening ASCREENING 2020-12-08 2020-12-08T13:30:00AAC4591001SEC4591001 1039 10391268A VAXP Placebo A VACCINATION 2020-12-08T13:30:002021-01-25 AB1C4591001SEC4591001 1039 10391268A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-05-13 B1BC4591001SEC4591001 1039 10391268A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T10:10:00BBC4591001SEC4591001 1039 10391268APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T10:10:002021-07-02 BBC4591001SEC4591001 1039 10391268A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1039 10391269ASCRN Screening ASCREENING 2020-12-08 2020-12-08T13:42:00AAC4591001SEC4591001 1039 10391269A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T13:42:002021-01-25 AB1C4591001SEC4591001 1039 10391269A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-07-02 B1BC4591001SEC4591001 1039 10391270ASCRN Screening ASCREENING 2020-12-09 2020-12-09T11:31:00AAC4591001SEC4591001 1039 10391270A VAXP Placebo A VACCINATION 2020-12-09T11:31:002021-01-25 AB0C4591001SEC4591001 1039 10391270A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-05-13 B0BC4591001SEC4591001 1039 10391270A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T08:45:00BBC4591001SEC4591001 1039 10391270APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T08:45:002021-07-01 BBC4591001SEC4591001 1039 10391270A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1039 10391271ASCRN Screening ASCREENING 2020-12-09 2020-12-09T13:56:00AAC4591001SEC4591001 1039 10391271A VAXP Placebo A VACCINATION 2020-12-09T13:56:002021-01-25 AB0C4591001SEC4591001 1039 10391271A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-05-13 B0BC4591001SEC4591001 1039 10391271A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T11:07:00BBC4591001SEC4591001 1039 10391271APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T11:07:002021-07-01 BBC4591001SEC4591001 1039 10391271A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1039 10391272ASCRN Screening ASCREENING 2020-12-09 2020-12-09T12:57:00AAC4591001SEC4591001 1039 10391272A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T12:57:002021-01-25 AB0C4591001SEC4591001 1039 10391272A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-06-30 B0BC4591001SEC4591001 1039 10391273ASCRN Screening ASCREENING 2020-12-09 2020-12-09T13:58:00AAC4591001SEC4591001 1039 10391273A VAXP Placebo A VACCINATION 2020-12-09T13:58:002021-01-25 AB0C4591001SEC4591001 1039 10391273A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-05-13 B0BC4591001SEC4591001 1039 10391273A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T11:06:00BBC4591001SEC4591001 1039 10391273APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T11:06:002021-07-01 BBC4591001SEC4591001 1039 10391273A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1039 10391274ASCRN Screening ASCREENING 2020-12-16 2020-12-16T08:47:00AAC4591001SEC4591001 1039 10391274A VAXP Placebo A VACCINATION 2020-12-16T08:47:002021-02-01 AB0C4591001SEC4591001 1039 10391274A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-14 B0BC4591001SEC4591001 1039 10391274A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T10:59:00BBC4591001SEC4591001 1039 10391274APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T10:59:002021-07-06 BBC4591001SEC4591001 1039 10391274A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1039 10391275ASCRN Screening ASCREENING 2020-12-16 2020-12-16T08:35:00AAC4591001SEC4591001 1039 10391275A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T08:35:002021-02-01 AB0C4591001SEC4591001 1039 10391275A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-06-28 B0BC4591001SEC4591001 1039 10391276ASCRN Screening ASCREENING 2020-12-16 2020-12-16T10:35:00AAC4591001SEC4591001 1039 10391276A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T10:35:002021-02-03 AB2C4591001SEC4591001 1039 10391276A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-29 B2BC4591001SEC4591001 1039 10391277ASCRN Screening ASCREENING 2020-12-16 2020-12-16T10:49:00AAC4591001SEC4591001 1039 10391277A VAXP Placebo A VACCINATION 2020-12-16T10:49:002021-02-03 AB2C4591001SEC4591001 1039 10391277A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-05-13 B2BC4591001SEC4591001 1039 10391277A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T09:05:00BBC4591001SEC4591001 1039 10391277APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T09:05:002021-07-06 BBC4591001SEC4591001 1039 10391277A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1039 10391278ASCRN Screening ASCREENING 2020-12-16 2020-12-16T11:58:00AAC4591001SEC4591001 1039 10391278A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T11:58:002021-02-09 AB8C4591001SEC4591001 1039 10391278A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-07-02 B8BC4591001SEC4591001 1039 10391279ASCRN Screening ASCREENING 2020-12-16 2020-12-16T12:28:00AAC4591001SEC4591001 1039 10391279A VAXP Placebo A VACCINATION 2020-12-16T12:28:002021-02-08 AB7C4591001SEC4591001 1039 10391279A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-17 B7BC4591001SEC4591001 1039 10391279A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T11:16:00BBC4591001SEC4591001 1039 10391279APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T11:16:002021-07-06 BBC4591001SEC4591001 1039 10391279A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1039 10391280ASCRN Screening ASCREENING 2020-12-17 2020-12-17T09:27:00AAC4591001SEC4591001 1039 10391280A VAXP Placebo A VACCINATION 2020-12-17T09:27:002021-02-04 AB2C4591001SEC4591001 1039 10391280A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-14 B2BC4591001SEC4591001 1039 10391280A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T08:48:00BBC4591001SEC4591001 1039 10391280APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T08:48:002021-07-06 BBC4591001SEC4591001 1039 10391280A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-08-13 BBC4591001SEC4591001 1039 10391281ASCRN Screening ASCREENING 2020-12-17 2020-12-17T13:54:00AAC4591001SEC4591001 1039 10391281A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T13:54:002021-02-02 AB0C4591001SEC4591001 1039 10391281A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-07-23 B0BC4591001SEC4591001 1039 10391282ASCRN Screening ASCREENING 2020-12-18 2020-12-18T08:44:00AAC4591001SEC4591001 1039 10391282A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T08:44:002021-02-05 AB2C4591001SEC4591001 1039 10391282A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-14 B2BC4591001SEC4591001 1039 10391283ASCRN Screening ASCREENING 2020-12-18 2020-12-18T09:17:00AAC4591001SEC4591001 1039 10391283A VAXP Placebo A VACCINATION 2020-12-18T09:17:002021-02-04 AB1C4591001SEC4591001 1039 10391283A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-13 B1BC4591001SEC4591001 1039 10391283A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T08:11:00BBC4591001SEC4591001 1039 10391283APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T08:11:002021-07-01 BBC4591001SEC4591001 1039 10391283A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1039 10391284ASCRN Screening ASCREENING 2020-12-18 2020-12-18T09:27:00AAC4591001SEC4591001 1039 10391284A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T09:27:002021-02-04 AB1C4591001SEC4591001 1039 10391284A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-09-02 B1C0C4591001SEC4591001 1039 10391285ASCRN Screening ASCREENING 2020-12-18 2020-12-18T09:59:00AAC4591001SEC4591001 1039 10391285A VAXP Placebo A VACCINATION 2020-12-18T09:59:002021-02-05 AB2C4591001SEC4591001 1039 10391285A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-14 B2BC4591001SEC4591001 1039 10391285A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T08:35:00BBC4591001SEC4591001 1039 10391285APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T08:35:002021-07-12 BBC4591001SEC4591001 1039 10391285A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-26 BBC4591001SEC4591001 1039 10391286ASCRN Screening ASCREENING 2020-12-18 2020-12-18T10:11:00AAC4591001SEC4591001 1039 10391286A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T10:11:002021-02-05 AB2C4591001SEC4591001 1039 10391286A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-16 B2BC4591001SEC4591001 1039 10391287ASCRN Screening ASCREENING 2020-12-18 2020-12-18T10:54:00AAC4591001SEC4591001 1039 10391287A VAXP Placebo A VACCINATION 2020-12-18T10:54:002021-02-08 AB5C4591001SEC4591001 1039 10391287A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-13 B5BC4591001SEC4591001 1039 10391287A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T13:14:00BBC4591001SEC4591001 1039 10391287APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T13:14:002021-07-06 BBC4591001SEC4591001 1039 10391287A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1039 10391289ASCRN Screening ASCREENING 2020-12-18 2020-12-18T11:42:00AAC4591001SEC4591001 1039 10391289A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T11:42:002021-02-05 AB2C4591001SEC4591001 1039 10391289A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-08-29 B2BC4591001SEC4591001 1039 10391290ASCRN Screening ASCREENING 2020-12-18 2020-12-18T12:58:00AAC4591001SEC4591001 1039 10391290A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T12:58:002021-02-05 AB2C4591001SEC4591001 1039 10391290A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-13 B2BC4591001SEC4591001 1039 10391291ASCRN Screening ASCREENING 2020-12-18 2020-12-18T14:04:00AAC4591001SEC4591001 1039 10391291A VAXP Placebo A VACCINATION 2020-12-18T14:04:002021-02-05 AB2C4591001SEC4591001 1039 10391291A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-03-26 B2BcC4591001SEC4591001 1039 10391291A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-26 2021-03-26T12:00:00BcBcC4591001SEC4591001 1039 10391291APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-26T12:00:002021-05-14 BcBC4591001SEC4591001 1039 10391291A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-14 2021-05-14 BBC4591001SEC4591001 1039 10391292ASCRN Screening ASCREENING 2020-12-18 2020-12-18T13:42:00AAC4591001SEC4591001 1039 10391292A VAXP Placebo A VACCINATION 2020-12-18T13:42:002021-02-05 AB2C4591001SEC4591001 1039 10391292A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-14 B2BC4591001SEC4591001 1039 10391292A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T08:45:00BBC4591001SEC4591001 1039 10391292APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T08:45:002021-07-06 BBC4591001SEC4591001 1039 10391292A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1039 10391293ASCRN Screening ASCREENING 2020-12-21 2020-12-21T12:33:00AAC4591001SEC4591001 1039 10391293A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T12:33:002021-02-08 AB2C4591001SEC4591001 1039 10391293A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-15 B2BC4591001SEC4591001 1039 10391294ASCRN Screening ASCREENING 2020-12-21 2020-12-21T12:43:00AAC4591001SEC4591001 1039 10391294A VAXP Placebo A VACCINATION 2020-12-21T12:43:002021-02-10 AB4C4591001SEC4591001 1039 10391294A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-14 B4BC4591001SEC4591001 1039 10391294A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T08:26:00BBC4591001SEC4591001 1039 10391294APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T08:26:002021-07-07 BBC4591001SEC4591001 1039 10391294A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1039 10391295ASCRN Screening ASCREENING 2020-12-29 2020-12-29T08:32:00AAC4591001SEC4591001 1039 10391295A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T08:32:002021-02-23 AB9C4591001SEC4591001 1039 10391295A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-09-01 B9BC4591001SEC4591001 1039 10391296ASCRN Screening ASCREENING 2020-12-29 2020-12-29T09:16:00AAC4591001SEC4591001 1039 10391296A VAXP Placebo A VACCINATION 2020-12-29T09:16:002021-02-23 AB9C4591001SEC4591001 1039 10391296A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-05-14 B9BC4591001SEC4591001 1039 10391296A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T10:01:00BBC4591001SEC4591001 1039 10391296APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T10:01:002021-07-02 BBC4591001SEC4591001 1039 10391296A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1039 10391297ASCRN Screening ASCREENING 2020-12-29 2020-12-29T09:38:00AAC4591001SEC4591001 1039 10391297A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T09:38:002021-02-22 AB8C4591001SEC4591001 1039 10391297A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-20 B8BC4591001SEC4591001 1039 10391298ASCRN Screening ASCREENING 2020-12-29 2020-12-29T09:50:00AAC4591001SEC4591001 1039 10391298A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T09:50:002021-02-23 AB9C4591001SEC4591001 1039 10391298A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-13 B9BC4591001SEC4591001 1039 10391299ASCRN Screening ASCREENING 2020-12-29 2020-12-29T10:05:00AAC4591001SEC4591001 1039 10391299A VAXP Placebo A VACCINATION 2020-12-29T10:05:002021-02-22 AB8C4591001SEC4591001 1039 10391299A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-14 B8BC4591001SEC4591001 1039 10391299A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T09:57:00BBC4591001SEC4591001 1039 10391299APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T09:57:002021-07-02 BBC4591001SEC4591001 1039 10391299A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1039 10391300ASCRN Screening ASCREENING 2020-12-29 2020-12-29T12:06:00AAC4591001SEC4591001 1039 10391300A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T12:06:002021-02-22 AB8C4591001SEC4591001 1039 10391300A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-22 B8BC4591001SEC4591001 1039 10391301ASCRN Screening ASCREENING 2020-12-29 2020-12-29T12:03:00AAC4591001SEC4591001 1039 10391301A VAXP Placebo A VACCINATION 2020-12-29T12:03:002021-02-22 AB8C4591001SEC4591001 1039 10391301A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-13 B8BC4591001SEC4591001 1039 10391301A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T12:03:00BBC4591001SEC4591001 1039 10391301APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T12:03:002021-07-13 BBC4591001SEC4591001 1039 10391301A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-14 BBC4591001SEC4591001 1039 10391302ASCRN Screening ASCREENING 2020-12-29 2020-12-29T12:36:00AAC4591001SEC4591001 1039 10391302A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T12:36:002021-02-22 AB8C4591001SEC4591001 1039 10391302A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-08-19 B8BC4591001SEC4591001 1039 10391303ASCRN Screening ASCREENING 2020-12-29 2020-12-29T13:39:00AAC4591001SEC4591001 1039 10391303A VAXP Placebo A VACCINATION 2020-12-29T13:39:002021-02-23 AB9C4591001SEC4591001 1039 10391303A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-05-13 B9BC4591001SEC4591001 1039 10391303A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T12:37:00BBC4591001SEC4591001 1039 10391303APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T12:37:002021-07-06 BBC4591001SEC4591001 1039 10391303A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1039 10391304ASCRN Screening ASCREENING 2020-12-29 2020-12-29T13:51:00AAC4591001SEC4591001 1039 10391304A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T13:51:002021-02-24 AB:C4591001SEC4591001 1039 10391304A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-13 B:BC4591001SEC4591001 1039 10391305ASCRN Screening ASCREENING 2021-01-06 2021-01-06T13:27:00AAC4591001SEC4591001 1039 10391305A VAXP Placebo A VACCINATION 2021-01-06T13:27:002021-02-22 AB0C4591001SEC4591001 1039 10391305A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-14 B0BC4591001SEC4591001 1039 10391305A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T16:00:00BBC4591001SEC4591001 1039 10391305APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T16:00:002021-07-12 BBC4591001SEC4591001 1039 10391305A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1039 10391306ASCRN Screening ASCREENING 2021-01-06 2021-01-06T13:29:00AAC4591001SEC4591001 1039 10391306A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T13:29:002021-02-22 AB0C4591001SEC4591001 1039 10391306A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-28 B0BC4591001SEC4591001 1039 10391307ASCRN Screening ASCREENING 2021-01-06 2021-01-06T14:08:00AAC4591001SEC4591001 1039 10391307A VAXP Placebo A VACCINATION 2021-01-06T14:08:002021-02-24 AB2C4591001SEC4591001 1039 10391307A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-14 B2BC4591001SEC4591001 1039 10391307A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T13:40:00BBC4591001SEC4591001 1039 10391307APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T13:40:002021-07-02 BBC4591001SEC4591001 1039 10391307A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1039 10391308ASCRN Screening ASCREENING 2021-01-06 2021-01-06T14:09:00AAC4591001SEC4591001 1039 10391308A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T14:09:002021-02-24 AB2C4591001SEC4591001 1039 10391308A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-22 B2BC4591001SEC4591001 1039 10391309ASCRN Screening ASCREENING 2021-01-07 2021-01-07T08:10:00AAC4591001SEC4591001 1039 10391309A VAXP Placebo A VACCINATION 2021-01-07T08:10:002021-02-24 AB1C4591001SEC4591001 1039 10391309A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-17 B1BC4591001SEC4591001 1039 10391309A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T09:27:00BBC4591001SEC4591001 1039 10391309APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T09:27:002021-07-20 BBC4591001SEC4591001 1039 10391309A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-20 2021-07-20 BBC4591001SEC4591001 1039 10391310ASCRN Screening ASCREENING 2021-01-07 2021-01-07T08:45:00AAC4591001SEC4591001 1039 10391310A VAXP Placebo A VACCINATION 2021-01-07T08:45:002021-02-23 AB0C4591001SEC4591001 1039 10391310A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-05-14 B0BC4591001SEC4591001 1039 10391310A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T13:59:00BBC4591001SEC4591001 1039 10391310APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T13:59:002021-07-06 BBC4591001SEC4591001 1039 10391310A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1039 10391311ASCRN Screening ASCREENING 2021-01-07 2021-01-07T10:22:00AAC4591001SEC4591001 1039 10391311A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T10:22:002021-03-01 AB6C4591001SEC4591001 1039 10391311A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-21 B6BC4591001SEC4591001 1039 10391312ASCRN Screening ASCREENING 2021-01-07 2021-01-07T10:10:00AAC4591001SEC4591001 1039 10391312A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T10:10:002021-03-01 AB6C4591001SEC4591001 1039 10391312A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-08-10 B6BC4591001SEC4591001 1039 10391313ASCRN Screening ASCREENING 2021-01-07 2021-01-07T11:29:00AAC4591001SEC4591001 1039 10391313A VAXP Placebo A VACCINATION 2021-01-07T11:29:002021-03-02 AB7C4591001SEC4591001 1039 10391313A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-14 B7BC4591001SEC4591001 1039 10391313A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T12:40:00BBC4591001SEC4591001 1039 10391313APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T12:40:002021-07-06 BBC4591001SEC4591001 1039 10391313A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1039 10391314ASCRN Screening ASCREENING 2021-01-07 2021-01-07T11:57:00AAC4591001SEC4591001 1039 10391314A VAXP Placebo A VACCINATION 2021-01-07T11:57:002021-02-25 AB2C4591001SEC4591001 1039 10391314A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-17 B2BC4591001SEC4591001 1039 10391314A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T07:58:00BBC4591001SEC4591001 1039 10391314APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T07:58:002021-07-06 BBC4591001SEC4591001 1039 10391314A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1039 10391315ASCRN Screening ASCREENING 2021-01-07 2021-01-07T13:55:00AAC4591001SEC4591001 1039 10391315A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T13:55:002021-02-24 AB1C4591001SEC4591001 1039 10391315A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-22 B1BC4591001SEC4591001 1039 10391316ASCRN Screening ASCREENING 2021-01-07 2021-01-07T13:57:00AAC4591001SEC4591001 1039 10391316A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T13:57:002021-02-24 AB1C4591001SEC4591001 1039 10391316A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-22 B1BC4591001SEC4591001 1039 10391317ASCRN Screening ASCREENING 2021-01-07 2021-01-07T13:59:00AAC4591001SEC4591001 1039 10391317A VAXP Placebo A VACCINATION 2021-01-07T13:59:002021-02-26 AB3C4591001SEC4591001 1039 10391317A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-14 B3BC4591001SEC4591001 1039 10391317A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T15:13:00BBC4591001SEC4591001 1039 10391317APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T15:13:002021-07-01 BBC4591001SEC4591001 1039 10391317A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1039 10391318ASCRN Screening ASCREENING 2021-01-07 2021-01-07T15:07:00AAC4591001SEC4591001 1039 10391318A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T15:07:002021-02-26 AB3C4591001SEC4591001 1039 10391318A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-23 B3BC4591001SEC4591001 1039 10391319ASCRN Screening ASCREENING 2021-01-08 2021-01-08T08:20:00AAC4591001SEC4591001 1039 10391319A VAXP Placebo A VACCINATION 2021-01-08T08:20:002021-03-02 AB6C4591001SEC4591001 1039 10391319A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-20 B6BC4591001SEC4591001 1039 10391319A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T14:01:00BBC4591001SEC4591001 1039 10391319APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T14:01:002021-07-09 BBC4591001SEC4591001 1039 10391319A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1039 10391320ASCRN Screening ASCREENING 2021-01-08 2021-01-08T10:19:00AAC4591001SEC4591001 1039 10391320A VAXP Placebo A VACCINATION 2021-01-08T10:19:002021-02-26 AB2C4591001SEC4591001 1039 10391320A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-23 B2BC4591001SEC4591001 1039 10391321ASCRN Screening ASCREENING 2021-01-08 2021-01-08T10:00:00AAC4591001SEC4591001 1039 10391321A VAXP Placebo A VACCINATION 2021-01-08T10:00:002021-03-01 AB5C4591001SEC4591001 1039 10391321A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-05-17 B5BC4591001SEC4591001 1039 10391321A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T08:00:00BBC4591001SEC4591001 1039 10391321APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T08:00:002021-07-13 BBC4591001SEC4591001 1039 10391321A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1039 10391322ASCRN Screening ASCREENING 2021-01-08 2021-01-08T12:59:00AAC4591001SEC4591001 1039 10391322A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T12:59:002021-02-26 AB2C4591001SEC4591001 1039 10391322A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-23 B2BC4591001SEC4591001 1039 10391323ASCRN Screening ASCREENING 2021-01-08 2021-01-08T13:17:00AAC4591001SEC4591001 1039 10391323A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T13:17:002021-02-26 AB2C4591001SEC4591001 1039 10391323A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-23 B2BC4591001SEC4591001 1039 10391324ASCRN Screening ASCREENING 2021-01-08 2021-01-08T15:42:00AAC4591001SEC4591001 1039 10391324A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T15:42:002021-02-26 AB2C4591001SEC4591001 1039 10391324A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-29 B2BC4591001SEC4591001 1039 10391325ASCRN Screening ASCREENING 2021-01-11 2021-01-11T12:51:00AAC4591001SEC4591001 1039 10391325A VAXP Placebo A VACCINATION 2021-01-11T12:51:002021-03-04 AB5C4591001SEC4591001 1039 10391325A0FUP Follow-up A0FOLLOW-UP 2021-03-04 2021-05-13 B5B{C4591001SEC4591001 1039 10391325A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T10:04:00B{B{C4591001SEC4591001 1039 10391325APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T10:04:002021-07-06 B{BC4591001SEC4591001 1039 10391325A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1039 10391326ASCRN Screening ASCREENING 2021-01-11 2021-01-11T12:50:00AAC4591001SEC4591001 1039 10391326A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T12:50:002021-03-04 AB5C4591001SEC4591001 1039 10391326A0FUP Follow-up A0FOLLOW-UP 2021-03-04 2021-08-09 B5BC4591001SEC4591001 1039 10391327ASCRN Screening ASCREENING 2021-01-11 2021-01-11T13:08:00AAC4591001SEC4591001 1039 10391327A VAXP Placebo A VACCINATION 2021-01-11T13:08:002021-03-02 AB3C4591001SEC4591001 1039 10391327A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-07-28 B3BC4591001SEC4591001 1039 10391328ASCRN Screening ASCREENING 2021-01-11 2021-01-11T13:15:00AAC4591001SEC4591001 1039 10391328A VAXP Placebo A VACCINATION 2021-01-11T13:15:002021-03-02 AB3C4591001SEC4591001 1039 10391328A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-14 B3B|C4591001SEC4591001 1039 10391328A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T12:28:00B|B|C4591001SEC4591001 1039 10391328APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T12:28:002021-07-08 B|BC4591001SEC4591001 1039 10391328A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1039 10391329ASCRN Screening ASCREENING 2021-01-11 2021-01-11T15:06:00AAC4591001SEC4591001 1039 10391329A VAXP Placebo A VACCINATION 2021-01-11T15:06:002021-03-02 AB3C4591001SEC4591001 1039 10391329A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-20 B3BC4591001SEC4591001 1039 10391329A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T14:02:00BBC4591001SEC4591001 1039 10391329APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T14:02:002021-07-09 BBC4591001SEC4591001 1039 10391329A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1039 10391330ASCRN Screening ASCREENING 2021-01-11 2021-01-11T14:59:00AAC4591001SEC4591001 1039 10391330A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T14:59:002021-03-05 AB6C4591001SEC4591001 1039 10391330A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-08-10 B6BC4591001SEC4591001 1039 10391331ASCRN Screening ASCREENING 2021-01-12 2021-01-12T08:08:00AAC4591001SEC4591001 1039 10391331A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T08:08:002021-03-02 AB2C4591001SEC4591001 1039 10391331A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-07-26 B2BC4591001SEC4591001 1039 10391332ASCRN Screening ASCREENING 2021-01-12 2021-01-12T08:52:00AAC4591001SEC4591001 1039 10391332A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T08:52:002021-03-09 AB9C4591001SEC4591001 1039 10391332A0FUP Follow-up A0FOLLOW-UP 2021-03-09 2021-06-10 B9BC4591001SEC4591001 1039 10391333ASCRN Screening ASCREENING 2021-01-12 2021-01-12T09:36:00AAC4591001SEC4591001 1039 10391333A VAXP Placebo A VACCINATION 2021-01-12T09:36:002021-03-02 AB2C4591001SEC4591001 1039 10391333A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-21 B2BC4591001SEC4591001 1039 10391333A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T14:06:00BBC4591001SEC4591001 1039 10391333APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T14:06:002021-07-09 BBC4591001SEC4591001 1039 10391333A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1039 10391334ASCRN Screening ASCREENING 2021-01-12 2021-01-12T09:40:00AAC4591001SEC4591001 1039 10391334A VAXP Placebo A VACCINATION 2021-01-12T09:40:002021-03-02 AB2C4591001SEC4591001 1039 10391334A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-21 B2BC4591001SEC4591001 1039 10391334A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T14:07:00BBC4591001SEC4591001 1039 10391334APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T14:07:002021-07-09 BBC4591001SEC4591001 1039 10391334A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1039 10391335ASCRN Screening ASCREENING 2021-01-12 2021-01-12T11:36:00AAC4591001SEC4591001 1039 10391335A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T11:36:002021-03-04 AB4C4591001SEC4591001 1039 10391335A0FUP Follow-up A0FOLLOW-UP 2021-03-04 2021-08-10 B4BC4591001SEC4591001 1039 10391336ASCRN Screening ASCREENING 2021-01-12 2021-01-12T11:34:00AAC4591001SEC4591001 1039 10391336A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T11:34:002021-03-04 AB4C4591001SEC4591001 1039 10391336A0FUP Follow-up A0FOLLOW-UP 2021-03-04 2021-08-10 B4BC4591001SEC4591001 1039 10391337ASCRN Screening ASCREENING 2021-01-12 2021-01-12T12:09:00AAC4591001SEC4591001 1039 10391337A VAXP Placebo A VACCINATION 2021-01-12T12:09:002021-03-09 AB9C4591001SEC4591001 1039 10391337A0FUP Follow-up A0FOLLOW-UP 2021-03-09 2021-05-14 B9B{C4591001SEC4591001 1039 10391337A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T11:26:00B{B{C4591001SEC4591001 1039 10391337APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T11:26:002021-07-02 B{BC4591001SEC4591001 1039 10391337A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1039 10391338ASCRN Screening ASCREENING 2021-01-12 2021-01-12T14:50:00AAC4591001SEC4591001 1039 10391338A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T14:50:002021-03-04 AB4C4591001SEC4591001 1039 10391338A0FUP Follow-up A0FOLLOW-UP 2021-03-04 2021-08-03 B4BC4591001SEC4591001 1039 10391339ASCRN Screening ASCREENING 2021-01-12 2021-01-12T14:52:00AAC4591001SEC4591001 1039 10391339A VAXP Placebo A VACCINATION 2021-01-12T14:52:002021-03-04 AB4C4591001SEC4591001 1039 10391339A0FUP Follow-up A0FOLLOW-UP 2021-03-04 2021-05-18 B4BC4591001SEC4591001 1039 10391339A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T08:58:00BBC4591001SEC4591001 1039 10391339APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T08:58:002021-07-08 BBC4591001SEC4591001 1039 10391339A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-08-02 BBC4591001SEC4591001 1044 10441251ASCRN Screening ASCREENING 2020-11-30 2020-11-30T14:59:00AAC4591001SEC4591001 1044 10441251A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-11-30T14:59:002021-01-19 AB3C4591001SEC4591001 1044 10441251A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-06-23 B3BC4591001SEC4591001 1044 10441252ASCRN Screening ASCREENING 2020-11-30 2020-11-30T16:14:00AAC4591001SEC4591001 1044 10441252A VAXP Placebo A VACCINATION 2020-11-30T16:14:002021-01-18 AB2C4591001SEC4591001 1044 10441252A0FUP Follow-up A0FOLLOW-UP 2021-01-18 2021-05-17 B2BC4591001SEC4591001 1044 10441252A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T10:46:00BBC4591001SEC4591001 1044 10441252APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T10:46:002021-07-06 BBC4591001SEC4591001 1044 10441252A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1044 10441253ASCRN Screening ASCREENING 2020-11-30 2020-11-30T17:42:00AAC4591001SEC4591001 1044 10441253A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-11-30T17:42:002021-01-18 AB2C4591001SEC4591001 1044 10441253A0FUP Follow-up A0FOLLOW-UP 2021-01-18 2021-06-29 B2BC4591001SEC4591001 1044 10441255ASCRN Screening ASCREENING 2020-12-01 2020-12-01T11:34:00AAC4591001SEC4591001 1044 10441255A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-01T11:34:002021-01-18 AB1C4591001SEC4591001 1044 10441255A0FUP Follow-up A0FOLLOW-UP 2021-01-18 2021-06-25 B1BC4591001SEC4591001 1044 10441256ASCRN Screening ASCREENING 2020-12-01 2020-12-01T11:35:00AAC4591001SEC4591001 1044 10441256A VAXP Placebo A VACCINATION 2020-12-01T11:35:002021-01-18 AB1C4591001SEC4591001 1044 10441256A0FUP Follow-up A0FOLLOW-UP 2021-01-18 2021-05-17 B1BC4591001SEC4591001 1044 10441256A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T13:23:00BBC4591001SEC4591001 1044 10441256APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T13:23:002021-07-07 BBC4591001SEC4591001 1044 10441256A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1044 10441257ASCRN Screening ASCREENING 2020-12-01 2020-12-01T15:23:00AAC4591001SEC4591001 1044 10441257A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-01T15:23:002021-01-19 AB2C4591001SEC4591001 1044 10441257A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-06-30 B2BC4591001SEC4591001 1044 10441259ASCRN Screening ASCREENING 2020-12-01 2020-12-01T16:49:00AAC4591001SEC4591001 1044 10441259A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-01T16:49:002021-01-21 AB4C4591001SEC4591001 1044 10441259A0FUP Follow-up A0FOLLOW-UP 2021-01-21 2021-06-17 B4BC4591001SEC4591001 1044 10441260ASCRN Screening ASCREENING 2020-12-01 2020-12-01T17:43:00AAC4591001SEC4591001 1044 10441260A VAXP Placebo A VACCINATION 2020-12-01T17:43:002021-01-20 AB3C4591001SEC4591001 1044 10441260A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-05-14 B3BC4591001SEC4591001 1044 10441260A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T15:51:00BBC4591001SEC4591001 1044 10441260APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T15:51:002021-07-01 BBC4591001SEC4591001 1044 10441260A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1044 10441261ASCRN Screening ASCREENING 2020-12-01 2020-12-01T17:46:00AAC4591001SEC4591001 1044 10441261A VAXP Placebo A VACCINATION 2020-12-01T17:46:002021-01-18 AB1C4591001SEC4591001 1044 10441261A0FUP Follow-up A0FOLLOW-UP 2021-01-18 2021-05-14 B1BC4591001SEC4591001 1044 10441261A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T13:48:00BBC4591001SEC4591001 1044 10441261APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T13:48:002021-07-02 BBC4591001SEC4591001 1044 10441261A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1044 10441263ASCRN Screening ASCREENING 2020-12-07 2020-12-07T15:04:00AAC4591001SEC4591001 1044 10441263A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T15:04:002021-01-25 AB2C4591001SEC4591001 1044 10441263A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-06-22 B2BC4591001SEC4591001 1044 10441264ASCRN Screening ASCREENING 2020-12-07 2020-12-07T16:55:00AAC4591001SEC4591001 1044 10441264A VAXP Placebo A VACCINATION 2020-12-07T16:55:002021-02-01 AB9C4591001SEC4591001 1044 10441264A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-07-26 B9BC4591001SEC4591001 1044 10441264A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-26 2021-07-26T15:19:00BBC4591001SEC4591001 1044 10441264APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-26T15:19:002021-08-23 BC@C4591001SEC4591001 1044 10441265ASCRN Screening ASCREENING 2020-12-07 2020-12-07T17:32:00AAC4591001SEC4591001 1044 10441265A VAXP Placebo A VACCINATION 2020-12-07T17:32:002021-01-26 AB3C4591001SEC4591001 1044 10441265A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-05-19 B3BC4591001SEC4591001 1044 10441265A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T13:54:00BBC4591001SEC4591001 1044 10441265APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T13:54:002021-07-08 BBC4591001SEC4591001 1044 10441265A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1044 10441266ASCRN Screening ASCREENING 2020-12-08 2020-12-08T11:34:00AAC4591001SEC4591001 1044 10441266A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T11:34:002021-01-29 AB5C4591001SEC4591001 1044 10441266A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-06-28 B5BC4591001SEC4591001 1044 10441267ASCRN Screening ASCREENING 2020-12-08 2020-12-08T12:04:00AAC4591001SEC4591001 1044 10441267A VAXP Placebo A VACCINATION 2020-12-08T12:04:002021-01-25 AB1C4591001SEC4591001 1044 10441267A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-05-19 B1BC4591001SEC4591001 1044 10441267A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T11:26:00BBC4591001SEC4591001 1044 10441267APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T11:26:002021-07-12 BBC4591001SEC4591001 1044 10441267A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1044 10441268ASCRN Screening ASCREENING 2020-12-08 2020-12-08T12:52:00AAC4591001SEC4591001 1044 10441268A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T12:52:002021-01-25 AB1C4591001SEC4591001 1044 10441268A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-07-02 B1BC4591001SEC4591001 1044 10441270ASCRN Screening ASCREENING 2020-12-08 2020-12-08T15:26:00AAC4591001SEC4591001 1044 10441270A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T15:26:002021-01-28 AB4C4591001SEC4591001 1044 10441270A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-07-01 B4BC4591001SEC4591001 1044 10441271ASCRN Screening ASCREENING 2020-12-08 2020-12-08T18:10:00AAC4591001SEC4591001 1044 10441271A VAXP Placebo A VACCINATION 2020-12-08T18:10:002021-01-29 AB5C4591001SEC4591001 1044 10441271A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-06-26 B5BC4591001SEC4591001 1044 10441273ASCRN Screening ASCREENING 2020-12-08 2020-12-08T19:15:00AAC4591001SEC4591001 1044 10441273A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T19:15:002021-01-28 AB4C4591001SEC4591001 1044 10441273A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-07-06 B4BC4591001SEC4591001 1044 10441274ASCRN Screening ASCREENING 2020-12-08 2020-12-08T19:14:00AAC4591001SEC4591001 1044 10441274A VAXP Placebo A VACCINATION 2020-12-08T19:14:002021-01-28 AB4C4591001SEC4591001 1044 10441274A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-02-17 B4BHC4591001SEC4591001 1044 10441274A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-17 2021-02-17T11:11:00BHBHC4591001SEC4591001 1044 10441274APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-17T11:11:002021-04-09 BHB{C4591001SEC4591001 1044 10441274A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-09 2021-04-09 B{B{C4591001SEC4591001 1044 10441275ASCRN Screening ASCREENING 2020-12-09 2020-12-09T10:43:00AAC4591001SEC4591001 1044 10441275A VAXP Placebo A VACCINATION 2020-12-09T10:43:002021-01-29 AB4C4591001SEC4591001 1044 10441275A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-05-17 B4BC4591001SEC4591001 1044 10441275A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T13:02:00BBC4591001SEC4591001 1044 10441275APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T13:02:002021-07-07 BBC4591001SEC4591001 1044 10441275A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1044 10441276ASCRN Screening ASCREENING 2020-12-09 2020-12-09T12:07:00AAC4591001SEC4591001 1044 10441276A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T12:07:002021-01-25 AB0C4591001SEC4591001 1044 10441276A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-06-28 B0BC4591001SEC4591001 1044 10441277ASCRN Screening ASCREENING 2020-12-09 2020-12-09T14:09:00AAC4591001SEC4591001 1044 10441277A VAXP Placebo A VACCINATION 2020-12-09T14:09:002021-01-27 AB2C4591001SEC4591001 1044 10441277A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-17 B2BC4591001SEC4591001 1044 10441277A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T16:49:00BBC4591001SEC4591001 1044 10441277APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T16:49:002021-07-06 BBC4591001SEC4591001 1044 10441277A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1044 10441278ASCRN Screening ASCREENING 2020-12-09 2020-12-09T14:06:00AAC4591001SEC4591001 1044 10441278A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T14:06:002021-01-27 AB2C4591001SEC4591001 1044 10441278A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-30 B2BC4591001SEC4591001 1044 10441279ASCRN Screening ASCREENING 2020-12-09 2020-12-09T17:59:00AAC4591001SEC4591001 1044 10441279A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T17:59:002021-01-28 AB3C4591001SEC4591001 1044 10441279A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-07-06 B3BC4591001SEC4591001 1044 10441280ASCRN Screening ASCREENING 2020-12-09 2020-12-09T17:58:00AAC4591001SEC4591001 1044 10441280A VAXP Placebo A VACCINATION 2020-12-09T17:58:002021-01-28 AB3C4591001SEC4591001 1044 10441280A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-01-28 B3B3C4591001SEC4591001 1044 10441280A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-01-28 2021-01-28T10:11:00B3B3C4591001SEC4591001 1044 10441280APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-01-28T10:11:002021-03-17 B3BcC4591001SEC4591001 1044 10441280A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-03-17 2021-08-11 BcBC4591001SEC4591001 1044 10441281ASCRN Screening ASCREENING 2020-12-09 2020-12-09T18:38:00AAC4591001SEC4591001 1044 10441281A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T18:38:002021-01-27 AB2C4591001SEC4591001 1044 10441281A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-07-01 B2BC4591001SEC4591001 1044 10441282ASCRN Screening ASCREENING 2020-12-09 2020-12-09T18:31:00AAC4591001SEC4591001 1044 10441282A VAXP Placebo A VACCINATION 2020-12-09T18:31:002021-01-27 AB2C4591001SEC4591001 1044 10441282A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-03-03 B2BUC4591001SEC4591001 1044 10441282A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-03 2021-03-03T11:13:00BUBUC4591001SEC4591001 1044 10441282APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-03T11:13:002021-04-21 BUBC4591001SEC4591001 1044 10441282A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-21 2021-04-21 BBC4591001SEC4591001 1044 10441283ASCRN Screening ASCREENING 2020-12-10 2020-12-10T10:49:00AAC4591001SEC4591001 1044 10441283A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T10:49:002021-01-29 AB3C4591001SEC4591001 1044 10441283A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-06-30 B3BC4591001SEC4591001 1044 10441284ASCRN Screening ASCREENING 2020-12-10 2020-12-10T15:17:00AAC4591001SEC4591001 1044 10441284A VAXP Placebo A VACCINATION 2020-12-10T15:17:002021-01-26 AB0C4591001SEC4591001 1044 10441284A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-05-13 B0BC4591001SEC4591001 1044 10441284A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T15:17:00BBC4591001SEC4591001 1044 10441284APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T15:17:002021-07-01 BBC4591001SEC4591001 1044 10441284A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1044 10441285ASCRN Screening ASCREENING 2020-12-10 2020-12-10T16:14:00AAC4591001SEC4591001 1044 10441285A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T16:14:002021-01-29 AB3C4591001SEC4591001 1044 10441285A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-07-02 B3BC4591001SEC4591001 1044 10441286ASCRN Screening ASCREENING 2020-12-11 2020-12-11T11:01:00AAC4591001SEC4591001 1044 10441286A VAXP Placebo A VACCINATION 2020-12-11T11:01:002021-01-27 AB0C4591001SEC4591001 1044 10441286A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-17 B0BC4591001SEC4591001 1044 10441286A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T11:49:00BBC4591001SEC4591001 1044 10441286APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T11:49:002021-07-07 BBC4591001SEC4591001 1044 10441286A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1044 10441288ASCRN Screening ASCREENING 2020-12-16 2020-12-16T11:29:00AAC4591001SEC4591001 1044 10441288A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T11:29:002021-02-08 AB7C4591001SEC4591001 1044 10441288A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-06-17 B7BC4591001SEC4591001 1044 10441289ASCRN Screening ASCREENING 2020-12-16 2020-12-16T15:34:00AAC4591001SEC4591001 1044 10441289A VAXP Placebo A VACCINATION 2020-12-16T15:34:002021-02-08 AB7C4591001SEC4591001 1044 10441289A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-08-18 B7BC4591001SEC4591001 1044 10441290ASCRN Screening ASCREENING 2020-12-16 2021-01-08T13:51:00AC4591001SEC4591001 1044 10441290A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T13:51:002021-02-26 AB2C4591001SEC4591001 1044 10441290A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-29 B2BC4591001SEC4591001 1044 10441291ASCRN Screening ASCREENING 2020-12-17 2020-12-17T14:00:00AAC4591001SEC4591001 1044 10441291A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T14:00:002021-02-03 AB1C4591001SEC4591001 1044 10441291A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-02 B1BC4591001SEC4591001 1044 10441292ASCRN Screening ASCREENING 2020-12-17 2020-12-17T14:39:00AAC4591001SEC4591001 1044 10441292A VAXP Placebo A VACCINATION 2020-12-17T14:39:002021-02-04 AB2C4591001SEC4591001 1044 10441292A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-03-10 B2BTC4591001SEC4591001 1044 10441292A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-10 2021-03-10T15:10:00BTBTC4591001SEC4591001 1044 10441292APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-10T15:10:002021-05-03 BTBC4591001SEC4591001 1044 10441292A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-03 2021-05-03 BBC4591001SEC4591001 1044 10441293ASCRN Screening ASCREENING 2020-12-17 2020-12-17T18:27:00AAC4591001SEC4591001 1044 10441293A VAXP Placebo A VACCINATION 2020-12-17T18:27:002021-02-04 AB2C4591001SEC4591001 1044 10441293A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-14 B2BC4591001SEC4591001 1044 10441293A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T16:28:00BBC4591001SEC4591001 1044 10441293APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T16:28:002021-06-21 BBC4591001SEC4591001 1044 10441294ASCRN Screening ASCREENING 2020-12-17 2020-12-17T18:28:00AAC4591001SEC4591001 1044 10441294A VAXP Placebo A VACCINATION 2020-12-17T18:28:002021-02-04 AB2C4591001SEC4591001 1044 10441294A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-14 B2BC4591001SEC4591001 1044 10441294A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T16:27:00BBC4591001SEC4591001 1044 10441294APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T16:27:002021-07-02 BBC4591001SEC4591001 1044 10441294A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1044 10441295ASCRN Screening ASCREENING 2020-12-18 2020-12-18T09:44:00AAC4591001SEC4591001 1044 10441295A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T09:44:002021-02-10 AB7C4591001SEC4591001 1044 10441295A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-26 B7BC4591001SEC4591001 1044 10441296ASCRN Screening ASCREENING 2020-12-22 2020-12-22T14:05:00AAC4591001SEC4591001 1044 10441296A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T14:05:002021-02-15 AB8C4591001SEC4591001 1044 10441296A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-12 B8BC4591001SEC4591001 1044 10441297ASCRN Screening ASCREENING 2020-12-23 2020-12-23T09:44:00AAC4591001SEC4591001 1044 10441297A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T09:44:002021-02-10 AB2C4591001SEC4591001 1044 10441297A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-15 B2BC4591001SEC4591001 1044 10441298ASCRN Screening ASCREENING 2020-12-23 2020-12-23T11:53:00AAC4591001SEC4591001 1044 10441298A VAXP Placebo A VACCINATION 2020-12-23T11:53:002021-02-10 AB2C4591001SEC4591001 1044 10441298A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-28 B2BC4591001SEC4591001 1044 10441298A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-28 2021-05-28T14:34:00BBC4591001SEC4591001 1044 10441298APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-28T14:34:002021-07-16 BBC4591001SEC4591001 1044 10441298A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-16 2021-07-30 BBC4591001SEC4591001 1044 10441299ASCRN Screening ASCREENING 2020-12-28 2020-12-28T16:24:00AAC4591001SEC4591001 1044 10441299A VAXP Placebo A VACCINATION 2020-12-28T16:24:002021-02-16 AB3C4591001SEC4591001 1044 10441299A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-05-13 B3BC4591001SEC4591001 1044 10441299A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T10:20:00BBC4591001SEC4591001 1044 10441299APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T10:20:002021-07-06 BBC4591001SEC4591001 1044 10441299A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1044 10441300ASCRN Screening ASCREENING 2020-12-28 2020-12-28T17:48:00AAC4591001SEC4591001 1044 10441300A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T17:48:002021-02-15 AB2C4591001SEC4591001 1044 10441300A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-09-01 B2BC4591001SEC4591001 1044 10441301ASCRN Screening ASCREENING 2020-12-29 2020-12-29T14:58:00AAC4591001SEC4591001 1044 10441301A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T14:58:002021-02-15 AB1C4591001SEC4591001 1044 10441301A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-12 B1BC4591001SEC4591001 1044 10441302ASCRN Screening ASCREENING 2020-12-29 2020-12-29T16:55:00AAC4591001SEC4591001 1044 10441302A VAXP Placebo A VACCINATION 2020-12-29T16:55:002021-02-22 AB8C4591001SEC4591001 1044 10441302A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-17 B8BC4591001SEC4591001 1044 10441302A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T16:06:00BBC4591001SEC4591001 1044 10441302APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T16:06:002021-07-06 BBC4591001SEC4591001 1044 10441302A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1044 10441303ASCRN Screening ASCREENING 2020-12-29 2020-12-29T16:57:00AAC4591001SEC4591001 1044 10441303A VAXP Placebo A VACCINATION 2020-12-29T16:57:002021-02-22 AB8C4591001SEC4591001 1044 10441303A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-04-20 B8BqC4591001SEC4591001 1044 10441303A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-20 2021-04-20T11:09:00BqBqC4591001SEC4591001 1044 10441303APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-20T11:09:002021-06-14 BqBC4591001SEC4591001 1044 10441303A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-14 2021-06-14 BBC4591001SEC4591001 1044 10441304ASCRN Screening ASCREENING 2020-12-29 2020-12-29T17:54:00AAC4591001SEC4591001 1044 10441304A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T17:54:002021-02-23 AB9C4591001SEC4591001 1044 10441304A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-14 B9BC4591001SEC4591001 1044 10441306ASCRN Screening ASCREENING 2020-12-30 2020-12-30T12:00:00AAC4591001SEC4591001 1044 10441306A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T12:00:002021-02-22 AB7C4591001SEC4591001 1044 10441306A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-12 B7BC4591001SEC4591001 1044 10441307ASCRN Screening ASCREENING 2020-12-30 2020-12-30T12:01:00AAC4591001SEC4591001 1044 10441307A VAXP Placebo A VACCINATION 2020-12-30T12:01:002021-02-22 AB7C4591001SEC4591001 1044 10441307A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-08-17 B7BC4591001SEC4591001 1044 10441307A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-08-17 2021-08-17T10:16:00BBC4591001SEC4591001 1044 10441307APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-08-17T10:16:002021-08-17 BBC4591001SEC4591001 1044 10441308ASCRN Screening ASCREENING 2020-12-30 2020-12-30T12:24:00AAC4591001SEC4591001 1044 10441308A VAXP Placebo A VACCINATION 2020-12-30T12:24:002021-02-22 AB7C4591001SEC4591001 1044 10441308A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-17 B7BC4591001SEC4591001 1044 10441308A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T14:09:00BBC4591001SEC4591001 1044 10441308APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T14:09:002021-07-07 BBC4591001SEC4591001 1044 10441308A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1044 10441309ASCRN Screening ASCREENING 2020-12-30 2020-12-30T13:13:00AAC4591001SEC4591001 1044 10441309A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T13:13:002021-02-15 AB0C4591001SEC4591001 1044 10441309A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-16 B0BC4591001SEC4591001 1044 10441310ASCRN Screening ASCREENING 2020-12-30 2020-12-30T14:40:00AAC4591001SEC4591001 1044 10441310A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T14:40:002021-02-17 AB2C4591001SEC4591001 1044 10441310A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-21 B2BC4591001SEC4591001 1044 10441311ASCRN Screening ASCREENING 2021-01-04 2021-01-04T10:45:00AAC4591001SEC4591001 1044 10441311A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T10:45:002021-02-22 AB2C4591001SEC4591001 1044 10441311A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-20 B2BC4591001SEC4591001 1044 10441312ASCRN Screening ASCREENING 2021-01-04 2021-01-04T10:51:00AAC4591001SEC4591001 1044 10441312A VAXP Placebo A VACCINATION 2021-01-04T10:51:002021-02-24 AB4C4591001SEC4591001 1044 10441312A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-14 B4BC4591001SEC4591001 1044 10441312A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T13:44:00BBC4591001SEC4591001 1044 10441312APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T13:44:002021-06-30 BBC4591001SEC4591001 1044 10441312A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-30 2021-06-30 BBC4591001SEC4591001 1044 10441313ASCRN Screening ASCREENING 2021-01-04 2021-01-04T11:53:00AAC4591001SEC4591001 1044 10441313A VAXP Placebo A VACCINATION 2021-01-04T11:53:002021-02-24 AB4C4591001SEC4591001 1044 10441313A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-26 B4BC4591001SEC4591001 1044 10441313A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-26 2021-07-26T12:46:00BBC4591001SEC4591001 1044 10441313APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-26T12:46:002021-08-17 BBC4591001SEC4591001 1044 10441314ASCRN Screening ASCREENING 2021-01-04 2021-01-04T14:15:00AAC4591001SEC4591001 1044 10441314A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T14:15:002021-02-25 AB5C4591001SEC4591001 1044 10441314A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-08-02 B5BC4591001SEC4591001 1044 10441315ASCRN Screening ASCREENING 2021-01-04 2021-01-04T14:14:00AAC4591001SEC4591001 1044 10441315A VAXP Placebo A VACCINATION 2021-01-04T14:14:002021-02-25 AB5C4591001SEC4591001 1044 10441315A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-17 B5BC4591001SEC4591001 1044 10441315A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T17:07:00BBC4591001SEC4591001 1044 10441315APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T17:07:002021-07-06 BBC4591001SEC4591001 1044 10441315A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1044 10441316ASCRN Screening ASCREENING 2021-01-04 2021-01-04T15:38:00AAC4591001SEC4591001 1044 10441316A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T15:38:002021-02-23 AB3C4591001SEC4591001 1044 10441316A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-20 B3BC4591001SEC4591001 1044 10441317ASCRN Screening ASCREENING 2021-01-04 2021-01-04T16:07:00AAC4591001SEC4591001 1044 10441317A VAXP Placebo A VACCINATION 2021-01-04T16:07:002021-02-24 AB4C4591001SEC4591001 1044 10441317A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-19 B4BC4591001SEC4591001 1044 10441317A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T13:23:00BBC4591001SEC4591001 1044 10441317APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T13:23:002021-07-09 BBC4591001SEC4591001 1044 10441317A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1044 10441318ASCRN Screening ASCREENING 2021-01-05 2021-01-05T10:48:00AAC4591001SEC4591001 1044 10441318A VAXP Placebo A VACCINATION 2021-01-05T10:48:002021-02-26 AB5C4591001SEC4591001 1044 10441318A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-14 B5BC4591001SEC4591001 1044 10441318A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T12:09:00BBC4591001SEC4591001 1044 10441318APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T12:09:002021-07-06 BBC4591001SEC4591001 1044 10441318A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1044 10441319ASCRN Screening ASCREENING 2021-01-05 2021-01-05T10:49:00AAC4591001SEC4591001 1044 10441319A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T10:49:002021-02-26 AB5C4591001SEC4591001 1044 10441319A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-02 B5BC4591001SEC4591001 1044 10441320ASCRN Screening ASCREENING 2021-01-05 2021-01-05T12:56:00AAC4591001SEC4591001 1044 10441320A VAXP Placebo A VACCINATION 2021-01-05T12:56:002021-03-02 AB9C4591001SEC4591001 1044 10441320A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-14 B9BC4591001SEC4591001 1044 10441320A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T14:15:00BBC4591001SEC4591001 1044 10441320APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T14:15:002021-07-02 BBC4591001SEC4591001 1044 10441320A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1044 10441321ASCRN Screening ASCREENING 2021-01-05 2021-01-05T13:37:00AAC4591001SEC4591001 1044 10441321A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T13:37:002021-02-23 AB2C4591001SEC4591001 1044 10441321A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-08-03 B2BC4591001SEC4591001 1044 10441322ASCRN Screening ASCREENING 2021-01-05 2021-01-05T15:31:00AAC4591001SEC4591001 1044 10441322A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T15:31:002021-03-02 AB9C4591001SEC4591001 1044 10441322A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-13 B9BC4591001SEC4591001 1044 10441323ASCRN Screening ASCREENING 2021-01-05 2021-01-05T17:17:00AAC4591001SEC4591001 1044 10441323A VAXP Placebo A VACCINATION 2021-01-05T17:17:002021-02-25 AB4C4591001SEC4591001 1044 10441323A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-17 B4BC4591001SEC4591001 1044 10441323A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T17:08:00BBC4591001SEC4591001 1044 10441323APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T17:08:002021-07-06 BBC4591001SEC4591001 1044 10441323A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1044 10441324ASCRN Screening ASCREENING 2021-01-05 2021-01-05T18:39:00AAC4591001SEC4591001 1044 10441324A VAXP Placebo A VACCINATION 2021-01-05T18:39:002021-02-22 AB1C4591001SEC4591001 1044 10441324A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-14 B1BC4591001SEC4591001 1044 10441324A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T15:10:00BBC4591001SEC4591001 1044 10441324APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T15:10:002021-07-06 BBC4591001SEC4591001 1044 10441324A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1044 10441325ASCRN Screening ASCREENING 2021-01-05 2021-01-05T18:43:00AAC4591001SEC4591001 1044 10441325A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T18:43:002021-02-23 AB2C4591001SEC4591001 1044 10441325A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-26 B2BC4591001SEC4591001 1044 10441326ASCRN Screening ASCREENING 2021-01-06 2021-01-06T10:31:00AAC4591001SEC4591001 1044 10441326A VAXP Placebo A VACCINATION 2021-01-06T10:31:002021-02-23 AB1C4591001SEC4591001 1044 10441326A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-05-19 B1BC4591001SEC4591001 1044 10441326A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T14:15:00BBC4591001SEC4591001 1044 10441326APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T14:15:002021-07-12 BBC4591001SEC4591001 1044 10441326A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1044 10441327ASCRN Screening ASCREENING 2021-01-06 2021-01-06T10:32:00AAC4591001SEC4591001 1044 10441327A VAXP Placebo A VACCINATION 2021-01-06T10:32:002021-02-23 AB1C4591001SEC4591001 1044 10441327A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-05-19 B1BC4591001SEC4591001 1044 10441327A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T14:14:00BBC4591001SEC4591001 1044 10441327APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T14:14:002021-07-12 BBC4591001SEC4591001 1044 10441327A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1044 10441328ASCRN Screening ASCREENING 2021-01-06 2021-01-06T11:52:00AAC4591001SEC4591001 1044 10441328A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T11:52:002021-02-23 AB1C4591001SEC4591001 1044 10441328A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-08-03 B1BC4591001SEC4591001 1044 10441329ASCRN Screening ASCREENING 2021-01-06 2021-01-06T13:54:00AAC4591001SEC4591001 1044 10441329A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T13:54:002021-02-26 AB4C4591001SEC4591001 1044 10441329A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-10 B4BC4591001SEC4591001 1044 10441330ASCRN Screening ASCREENING 2021-01-06 2021-01-06T15:27:00AAC4591001SEC4591001 1044 10441330A VAXP Placebo A VACCINATION 2021-01-06T15:27:002021-02-24 AB2C4591001SEC4591001 1044 10441330A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-19 B2BC4591001SEC4591001 1044 10441330A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T12:57:00BBC4591001SEC4591001 1044 10441330APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T12:57:002021-07-07 BBC4591001SEC4591001 1044 10441330A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1044 10441331ASCRN Screening ASCREENING 2021-01-06 2021-01-06T17:42:00AAC4591001SEC4591001 1044 10441331A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T17:42:002021-03-02 AB8C4591001SEC4591001 1044 10441331A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-07-26 B8BC4591001SEC4591001 1044 10441332ASCRN Screening ASCREENING 2021-01-06 2021-01-06T17:43:00AAC4591001SEC4591001 1044 10441332A VAXP Placebo A VACCINATION 2021-01-06T17:43:002021-03-02 AB8C4591001SEC4591001 1044 10441332A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-14 B8BC4591001SEC4591001 1044 10441332A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T14:20:00BBC4591001SEC4591001 1044 10441332APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T14:20:002021-07-06 BBC4591001SEC4591001 1044 10441332A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1044 10441333ASCRN Screening ASCREENING 2021-01-06 2021-01-06T18:48:00AAC4591001SEC4591001 1044 10441333A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T18:48:002021-02-26 AB4C4591001SEC4591001 1044 10441333A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-02 B4BC4591001SEC4591001 1044 10441334ASCRN Screening ASCREENING 2021-01-07 2021-01-07T10:24:00AAC4591001SEC4591001 1044 10441334A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T10:24:002021-03-05 AB:C4591001SEC4591001 1044 10441334A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-08-03 B:BC4591001SEC4591001 1044 10441335ASCRN Screening ASCREENING 2021-01-07 2021-01-07T15:29:00AAC4591001SEC4591001 1044 10441335A VAXP Placebo A VACCINATION 2021-01-07T15:29:002021-03-05 AB:C4591001SEC4591001 1044 10441335A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-05-18 B:BC4591001SEC4591001 1044 10441335A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T16:41:00BBC4591001SEC4591001 1044 10441335APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T16:41:002021-07-07 BBC4591001SEC4591001 1044 10441335A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-08 BBC4591001SEC4591001 1044 10441336ASCRN Screening ASCREENING 2021-01-07 2021-01-07T16:35:00AAC4591001SEC4591001 1044 10441336A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T16:35:002021-02-25 AB2C4591001SEC4591001 1044 10441336A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-07-27 B2BC4591001SEC4591001 1044 10441337ASCRN Screening ASCREENING 2021-01-08 2021-01-08T10:15:00AAC4591001SEC4591001 1044 10441337A VAXP Placebo A VACCINATION 2021-01-08T10:15:002021-02-26 AB2C4591001SEC4591001 1044 10441337A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-19 B2BC4591001SEC4591001 1044 10441337A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T10:41:00BBC4591001SEC4591001 1044 10441337APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T10:41:002021-07-06 BBC4591001SEC4591001 1044 10441337A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1044 10441338ASCRN Screening ASCREENING 2021-01-08 2021-01-08T10:15:00AAC4591001SEC4591001 1044 10441338A VAXP Placebo A VACCINATION 2021-01-08T10:15:002021-02-26 AB2C4591001SEC4591001 1044 10441338A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-28 B2BC4591001SEC4591001 1044 10441339ASCRN Screening ASCREENING 2021-01-08 2021-01-08T16:02:00AAC4591001SEC4591001 1044 10441339A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T16:02:002021-03-02 AB6C4591001SEC4591001 1044 10441339A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-08-03 B6BC4591001SEC4591001 1044 10441340ASCRN Screening ASCREENING 2021-01-08 2021-01-08T16:06:00AAC4591001SEC4591001 1044 10441340A VAXP Placebo A VACCINATION 2021-01-08T16:06:002021-03-02 AB6C4591001SEC4591001 1044 10441340A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-13 B6B~C4591001SEC4591001 1044 10441340A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T15:47:00B~B~C4591001SEC4591001 1044 10441340APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T15:47:002021-07-06 B~BC4591001SEC4591001 1044 10441340A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1044 10441341ASCRN Screening ASCREENING 2021-01-08 2021-01-08T16:07:00AAC4591001SEC4591001 1044 10441341A VAXP Placebo A VACCINATION 2021-01-08T16:07:002021-03-02 AB6C4591001SEC4591001 1044 10441341A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-13 B6B~C4591001SEC4591001 1044 10441341A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T15:47:00B~B~C4591001SEC4591001 1044 10441341APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T15:47:002021-07-06 B~BC4591001SEC4591001 1044 10441341A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1044 10441342ASCRN Screening ASCREENING 2021-01-09 2021-01-09T10:20:00AAC4591001SEC4591001 1044 10441342A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-09T10:20:002021-03-01 AB4C4591001SEC4591001 1044 10441342A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-22 B4BC4591001SEC4591001 1044 10441343ASCRN Screening ASCREENING 2021-01-09 2021-01-09T10:24:00AAC4591001SEC4591001 1044 10441343A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-09T10:24:002021-02-26 AB1C4591001SEC4591001 1044 10441343A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-29 B1BC4591001SEC4591001 1044 10441344ASCRN Screening ASCREENING 2021-01-09 2021-01-09T10:23:00AAC4591001SEC4591001 1044 10441344A VAXP Placebo A VACCINATION 2021-01-09T10:23:002021-02-19 AB*C4591001SEC4591001 1044 10441344A0SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-19 2021-02-19T12:45:00B*B*C4591001SEC4591001 1044 10441344A@VAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-19T12:45:002021-04-13 B*B_C4591001SEC4591001 1044 10441344APFUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-13 2021-04-13 B_B_C4591001SEC4591001 1044 10441345ASCRN Screening ASCREENING 2021-01-09 2021-01-09T11:35:00AAC4591001SEC4591001 1044 10441345A VAXP Placebo A VACCINATION 2021-01-09T11:35:002021-03-02 AB5C4591001SEC4591001 1044 10441345A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-17 B5BC4591001SEC4591001 1044 10441345A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T10:57:00BBC4591001SEC4591001 1044 10441345APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T10:57:002021-07-06 BBC4591001SEC4591001 1044 10441345A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1044 10441346ASCRN Screening ASCREENING 2021-01-09 2021-01-09T11:33:00AAC4591001SEC4591001 1044 10441346A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-09T11:33:002021-03-02 AB5C4591001SEC4591001 1044 10441346A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-07-26 B5BC4591001SEC4591001 1044 10441347ASCRN Screening ASCREENING 2021-01-09 2021-01-09T11:38:00AAC4591001SEC4591001 1044 10441347A VAXP Placebo A VACCINATION 2021-01-09T11:38:002021-03-03 AB6C4591001SEC4591001 1044 10441347A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-05-28 B6BC4591001SEC4591001 1044 10441348ASCRN Screening ASCREENING 2021-01-09 2021-01-09T12:16:00AAC4591001SEC4591001 1044 10441348A VAXP Placebo A VACCINATION 2021-01-09T12:16:002021-02-25 AB0C4591001SEC4591001 1044 10441348A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-17 B0BC4591001SEC4591001 1044 10441348A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T15:40:00BBC4591001SEC4591001 1044 10441348APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T15:40:002021-07-06 BBC4591001SEC4591001 1044 10441348A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1044 10441349ASCRN Screening ASCREENING 2021-01-09 2021-01-09T12:19:00AAC4591001SEC4591001 1044 10441349A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-09T12:19:002021-02-26 AB1C4591001SEC4591001 1044 10441349A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-02 B1BC4591001SEC4591001 1044 10441350ASCRN Screening ASCREENING 2021-01-09 2021-01-09T12:48:00AAC4591001SEC4591001 1044 10441350A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-09T12:48:002021-02-26 AB1C4591001SEC4591001 1044 10441350A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-27 B1BC4591001SEC4591001 1044 10441351ASCRN Screening ASCREENING 2021-01-10 2021-01-10T10:09:00AAC4591001SEC4591001 1044 10441351A VAXP Placebo A VACCINATION 2021-01-10T10:09:002021-03-04 AB6C4591001SEC4591001 1044 10441351A0FUP Follow-up A0FOLLOW-UP 2021-03-04 2021-08-03 B6BC4591001SEC4591001 1044 10441351A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-08-03 2021-08-03T16:19:00BBC4591001SEC4591001 1044 10441351APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-08-03T16:19:002021-08-23 BBC4591001SEC4591001 1044 10441352ASCRN Screening ASCREENING 2021-01-10 2021-01-10T10:16:00AAC4591001SEC4591001 1044 10441352A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-10T10:16:002021-03-02 AB4C4591001SEC4591001 1044 10441352A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-08-05 B4BC4591001SEC4591001 1044 10441353ASCRN Screening ASCREENING 2021-01-10 2021-01-10T10:19:00AAC4591001SEC4591001 1044 10441353A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-10T10:19:002021-03-01 AB3C4591001SEC4591001 1044 10441353A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-29 B3BC4591001SEC4591001 1044 10441354ASCRN Screening ASCREENING 2021-01-10 2021-01-10T11:33:00AAC4591001SEC4591001 1044 10441354A VAXP Placebo A VACCINATION 2021-01-10T11:33:002021-02-26 AB0C4591001SEC4591001 1044 10441354A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-19 B0BC4591001SEC4591001 1044 10441354A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T10:38:00BBC4591001SEC4591001 1044 10441354APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T10:38:002021-07-09 BBC4591001SEC4591001 1044 10441354A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1044 10441355ASCRN Screening ASCREENING 2021-01-10 2021-01-10T11:34:00AAC4591001SEC4591001 1044 10441355A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-10T11:34:002021-02-26 AB0C4591001SEC4591001 1044 10441355A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-28 B0BC4591001SEC4591001 1044 10441356ASCRN Screening ASCREENING 2021-01-10 2021-01-10T11:38:00AAC4591001SEC4591001 1044 10441356A VAXP Placebo A VACCINATION 2021-01-10T11:38:002021-03-08 AB:C4591001SEC4591001 1044 10441356A0FUP Follow-up A0FOLLOW-UP 2021-03-08 2021-07-29 B:BC4591001SEC4591001 1044 10441357ASCRN Screening ASCREENING 2021-01-10 2021-01-10T12:34:00AAC4591001SEC4591001 1044 10441357A VAXP Placebo A VACCINATION 2021-01-10T12:34:002021-03-05 AB7C4591001SEC4591001 1044 10441357A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-05-18 B7BC4591001SEC4591001 1044 10441357A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T16:42:00BBC4591001SEC4591001 1044 10441357APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T16:42:002021-07-07 BBC4591001SEC4591001 1044 10441357A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1044 10441358ASCRN Screening ASCREENING 2021-01-10 2021-01-10T12:31:00AAC4591001SEC4591001 1044 10441358A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-10T12:31:002021-03-05 AB7C4591001SEC4591001 1044 10441358A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-08-09 B7BC4591001SEC4591001 1044 10441359ASCRN Screening ASCREENING 2021-01-11 2021-01-11T10:05:00AAC4591001SEC4591001 1044 10441359A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T10:05:002021-03-25 ABJC4591001SEC4591001 1044 10441359A0FUP Follow-up A0FOLLOW-UP 2021-03-25 2021-08-23 BJBC4591001SEC4591001 1044 10441360ASCRN Screening ASCREENING 2021-01-11 2021-01-11T10:04:00AAC4591001SEC4591001 1044 10441360A VAXP Placebo A VACCINATION 2021-01-11T10:04:002021-03-25 ABJC4591001SEC4591001 1044 10441360A0FUP Follow-up A0FOLLOW-UP 2021-03-25 2021-05-17 BJBC4591001SEC4591001 1044 10441360A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T10:47:00BBC4591001SEC4591001 1044 10441360APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T10:47:002021-07-07 BBC4591001SEC4591001 1044 10441360A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1044 10441361ASCRN Screening ASCREENING 2021-01-11 2021-01-11T12:43:00AAC4591001SEC4591001 1044 10441361A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T12:43:002021-03-09 AB:C4591001SEC4591001 1044 10441361A0FUP Follow-up A0FOLLOW-UP 2021-03-09 2021-07-28 B:BC4591001SEC4591001 1044 10441362ASCRN Screening ASCREENING 2021-01-11 2021-01-11T13:51:00AAC4591001SEC4591001 1044 10441362A VAXP Placebo A VACCINATION 2021-01-11T13:51:002021-03-04 AB5C4591001SEC4591001 1044 10441362A0FUP Follow-up A0FOLLOW-UP 2021-03-04 2021-05-13 B5B{C4591001SEC4591001 1044 10441362A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T16:28:00B{B{C4591001SEC4591001 1044 10441362APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T16:28:002021-07-02 B{BC4591001SEC4591001 1044 10441362A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1044 10441363ASCRN Screening ASCREENING 2021-01-11 2021-01-11T14:43:00AAC4591001SEC4591001 1044 10441363A VAXP Placebo A VACCINATION 2021-01-11T14:43:002021-03-03 AB4C4591001SEC4591001 1044 10441363A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-05-14 B4B|C4591001SEC4591001 1044 10441363A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T15:32:00B|B|C4591001SEC4591001 1044 10441363APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T15:32:002021-07-06 B|BC4591001SEC4591001 1044 10441363A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1044 10441364ASCRN Screening ASCREENING 2021-01-11 2021-01-11T15:16:00AAC4591001SEC4591001 1044 10441364A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T15:16:002021-03-04 AB5C4591001SEC4591001 1044 10441364A0FUP Follow-up A0FOLLOW-UP 2021-03-04 2021-08-04 B5BC4591001SEC4591001 1044 10441365ASCRN Screening ASCREENING 2021-01-11 2021-01-11T15:42:00AAC4591001SEC4591001 1044 10441365A VAXP Placebo A VACCINATION 2021-01-11T15:42:002021-03-03 AB4C4591001SEC4591001 1044 10441365A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-05-13 B4B{C4591001SEC4591001 1044 10441365A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T13:54:00B{B{C4591001SEC4591001 1044 10441365APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T13:54:002021-07-06 B{BC4591001SEC4591001 1044 10441365A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1044 10441366ASCRN Screening ASCREENING 2021-01-11 2021-01-11T15:40:00AAC4591001SEC4591001 1044 10441366A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T15:40:002021-03-03 AB4C4591001SEC4591001 1044 10441366A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-08-02 B4BC4591001SEC4591001 1044 10441367ASCRN Screening ASCREENING 2021-01-11 2021-01-11T16:56:00AAC4591001SEC4591001 1044 10441367A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T16:56:002021-03-09 AB:C4591001SEC4591001 1044 10441367A0FUP Follow-up A0FOLLOW-UP 2021-03-09 2021-07-28 B:BC4591001SEC4591001 1044 10441368ASCRN Screening ASCREENING 2021-01-11 2021-01-11T17:28:00AAC4591001SEC4591001 1044 10441368A VAXP Placebo A VACCINATION 2021-01-11T17:28:002021-03-09 AB:C4591001SEC4591001 1044 10441368A0FUP Follow-up A0FOLLOW-UP 2021-03-09 2021-03-09 B:B:C4591001SEC4591001 1044 10441368A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-09 2021-03-09T15:36:00B:B:C4591001SEC4591001 1044 10441368APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-09T15:36:002021-04-27 B:BkC4591001SEC4591001 1044 10441368A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-27 2021-04-27 BkBkC4591001SEC4591001 1044 10441369ASCRN Screening ASCREENING 2021-01-11 2021-01-11T17:45:00AAC4591001SEC4591001 1044 10441369A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T17:45:002021-03-03 AB4C4591001SEC4591001 1044 10441369A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-08-03 B4BC4591001SEC4591001 1044 10441370ASCRN Screening ASCREENING 2021-01-11 2021-01-11T17:44:00AAC4591001SEC4591001 1044 10441370A VAXP Placebo A VACCINATION 2021-01-11T17:44:002021-03-03 AB4C4591001SEC4591001 1044 10441370A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-06-01 B4BC4591001SEC4591001 1044 10441370A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T14:49:00BBC4591001SEC4591001 1044 10441370APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T14:49:002021-07-20 BBC4591001SEC4591001 1044 10441370A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-20 2021-07-20 BBC4591001SEC4591001 1044 10441371ASCRN Screening ASCREENING 2021-01-11 2021-01-11T18:41:00AAC4591001SEC4591001 1044 10441371A VAXP Placebo A VACCINATION 2021-01-11T18:41:002021-03-05 AB6C4591001SEC4591001 1044 10441371A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-08-03 B6BC4591001SEC4591001 1044 10441372ASCRN Screening ASCREENING 2021-01-11 2021-01-11T18:40:00AAC4591001SEC4591001 1044 10441372A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T18:40:002021-03-05 AB6C4591001SEC4591001 1044 10441372A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-08-03 B6BC4591001SEC4591001 1044 10441373ASCRN Screening ASCREENING 2021-01-12 2021-01-12T10:33:00AAC4591001SEC4591001 1044 10441373A VAXP Placebo A VACCINATION 2021-01-12T10:33:002021-03-09 AB9C4591001SEC4591001 1044 10441373A0FUP Follow-up A0FOLLOW-UP 2021-03-09 2021-05-17 B9B~C4591001SEC4591001 1044 10441373A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T10:43:00B~B~C4591001SEC4591001 1044 10441373APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T10:43:002021-07-07 B~BC4591001SEC4591001 1044 10441373A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1044 10441374ASCRN Screening ASCREENING 2021-01-12 2021-01-12T11:36:00AAC4591001SEC4591001 1044 10441374A VAXP Placebo A VACCINATION 2021-01-12T11:36:002021-03-03 AB3C4591001SEC4591001 1044 10441374A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-08-20 B3BC4591001SEC4591001 1044 10441374A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-08-20 2021-08-20T11:24:00BBC4591001SEC4591001 1044 10441374APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-08-20T11:24:002021-08-20 BBC4591001SEC4591001 1044 10441375ASCRN Screening ASCREENING 2021-01-12 2021-01-12T12:42:00AAC4591001SEC4591001 1044 10441375A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T12:42:002021-03-02 AB2C4591001SEC4591001 1044 10441375A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-07-29 B2BC4591001SEC4591001 1044 10441376ASCRN Screening ASCREENING 2021-01-12 2021-01-12T12:43:00AAC4591001SEC4591001 1044 10441376A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T12:43:002021-03-02 AB2C4591001SEC4591001 1044 10441376A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-07-29 B2BC4591001SEC4591001 1044 10441377ASCRN Screening ASCREENING 2021-01-12 2021-02-01T13:29:00AC4591001SEC4591001 1044 10441377A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-02-01T13:29:002021-03-22 AB2C4591001SEC4591001 1044 10441377A0FUP Follow-up A0FOLLOW-UP 2021-03-22 2021-08-25 B2BC4591001SEC4591001 1044 10441378ASCRN Screening ASCREENING 2021-01-12 2021-01-12T14:31:00AAC4591001SEC4591001 1044 10441378A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T14:31:002021-03-08 AB8C4591001SEC4591001 1044 10441378A0FUP Follow-up A0FOLLOW-UP 2021-03-08 2021-08-02 B8BC4591001SEC4591001 1044 10441379ASCRN Screening ASCREENING 2021-01-12 2021-01-12T14:32:00AAC4591001SEC4591001 1044 10441379A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T14:32:002021-03-08 AB8C4591001SEC4591001 1044 10441379A0FUP Follow-up A0FOLLOW-UP 2021-03-08 2021-08-02 B8BC4591001SEC4591001 1044 10441380ASCRN Screening ASCREENING 2021-01-12 2021-01-12T16:15:00AAC4591001SEC4591001 1044 10441380A VAXP Placebo A VACCINATION 2021-01-12T16:15:002021-03-04 AB4C4591001SEC4591001 1044 10441380A0FUP Follow-up A0FOLLOW-UP 2021-03-04 2021-05-13 B4BzC4591001SEC4591001 1044 10441380A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T13:56:00BzBzC4591001SEC4591001 1044 10441380APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T13:56:002021-07-01 BzBC4591001SEC4591001 1044 10441380A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1044 10441381ASCRN Screening ASCREENING 2021-01-12 2021-01-12T16:20:00AAC4591001SEC4591001 1044 10441381A VAXP Placebo A VACCINATION 2021-01-12T16:20:002021-03-05 AB5C4591001SEC4591001 1044 10441381A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-05-17 B5B~C4591001SEC4591001 1044 10441381A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T16:37:00B~B~C4591001SEC4591001 1044 10441381APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T16:37:002021-07-09 B~BC4591001SEC4591001 1044 10441381A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1044 10441382ASCRN Screening ASCREENING 2021-01-12 2021-01-12T17:46:00AAC4591001SEC4591001 1044 10441382A VAXP Placebo A VACCINATION 2021-01-12T17:46:002021-03-08 AB8C4591001SEC4591001 1044 10441382A0FUP Follow-up A0FOLLOW-UP 2021-03-08 2021-05-13 B8BzC4591001SEC4591001 1044 10441382A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T16:38:00BzBzC4591001SEC4591001 1044 10441382APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T16:38:002021-06-30 BzBC4591001SEC4591001 1044 10441382A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-30 2021-06-30 BBC4591001SEC4591001 1044 10441383ASCRN Screening ASCREENING 2021-01-12 2021-01-12T17:45:00AAC4591001SEC4591001 1044 10441383A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T17:45:002021-03-08 AB8C4591001SEC4591001 1044 10441383A0FUP Follow-up A0FOLLOW-UP 2021-03-08 2021-07-29 B8BC4591001SEC4591001 1044 10441384ASCRN Screening ASCREENING 2021-01-12 2021-01-12T17:50:00AAC4591001SEC4591001 1044 10441384A VAXP Placebo A VACCINATION 2021-01-12T17:50:002021-03-04 AB4C4591001SEC4591001 1044 10441384A0FUP Follow-up A0FOLLOW-UP 2021-03-04 2021-05-20 B4BC4591001SEC4591001 1044 10441384A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T15:25:00BBC4591001SEC4591001 1044 10441384APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T15:25:002021-07-06 BBC4591001SEC4591001 1044 10441384A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1057 10571376ASCRN Screening ASCREENING 2020-12-07 2020-12-07T10:39:00AAC4591001SEC4591001 1057 10571376A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T10:39:002021-02-01 AB9C4591001SEC4591001 1057 10571376A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-06-28 B9BC4591001SEC4591001 1057 10571377ASCRN Screening ASCREENING 2020-12-07 2020-12-07T14:52:00AAC4591001SEC4591001 1057 10571377A VAXP Placebo A VACCINATION 2020-12-07T14:52:002021-01-25 AB2C4591001SEC4591001 1057 10571377A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-08-25 B2C`C4591001SEC4591001 1057 10571378ASCRN Screening ASCREENING 2020-12-07 2020-12-07T15:18:00AAC4591001SEC4591001 1057 10571378A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T15:18:002021-01-25 AB2C4591001SEC4591001 1057 10571378A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-08-25 B2C`C4591001SEC4591001 1057 10571379ASCRN Screening ASCREENING 2020-12-07 2020-12-07T16:33:00AAC4591001SEC4591001 1057 10571379A VAXP Placebo A VACCINATION 2020-12-07T16:33:002021-01-28 AB5C4591001SEC4591001 1057 10571379A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-05-13 B5BC4591001SEC4591001 1057 10571379A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T16:18:00BBC4591001SEC4591001 1057 10571379APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T16:18:002021-07-02 BBC4591001SEC4591001 1057 10571379A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-06 BBC4591001SEC4591001 1057 10571380ASCRN Screening ASCREENING 2020-12-08 2020-12-08T09:51:00AAC4591001SEC4591001 1057 10571380A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T09:51:002021-02-05 AB<C4591001SEC4591001 1057 10571380A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-23 B<BC4591001SEC4591001 1057 10571382ASCRN Screening ASCREENING 2020-12-08 2020-12-08T16:32:00AAC4591001SEC4591001 1057 10571382A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T16:32:002021-02-02 AB9C4591001SEC4591001 1057 10571382A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-09-02 B9CC4591001SEC4591001 1057 10571383ASCRN Screening ASCREENING 2020-12-08 2020-12-08T15:54:00AAC4591001SEC4591001 1057 10571383A VAXP Placebo A VACCINATION 2020-12-08T15:54:002021-01-28 AB4C4591001SEC4591001 1057 10571383A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-05-17 B4BC4591001SEC4591001 1057 10571383A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T16:11:00BBC4591001SEC4591001 1057 10571383APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T16:11:002021-07-16 BBC4591001SEC4591001 1057 10571383A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-16 2021-08-19 BBC4591001SEC4591001 1057 10571384ASCRN Screening ASCREENING 2020-12-08 2020-12-08T16:25:00AAC4591001SEC4591001 1057 10571384A VAXP Placebo A VACCINATION 2020-12-08T16:25:002021-01-26 AB2C4591001SEC4591001 1057 10571384A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-06-29 B2BC4591001SEC4591001 1057 10571384A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-29 2021-06-29T13:58:00BBC4591001SEC4591001 1057 10571384APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-29T13:58:002021-08-17 BBC4591001SEC4591001 1057 10571384A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-17 2021-08-17 BBC4591001SEC4591001 1057 10571385ASCRN Screening ASCREENING 2020-12-08 2020-12-08T16:45:00AAC4591001SEC4591001 1057 10571385A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T16:45:002021-01-25 AB1C4591001SEC4591001 1057 10571385A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-07-22 B1BC4591001SEC4591001 1057 10571386ASCRN Screening ASCREENING 2020-12-08 2020-12-08T16:44:00AAC4591001SEC4591001 1057 10571386A VAXP Placebo A VACCINATION 2020-12-08T16:44:002021-01-26 AB2C4591001SEC4591001 1057 10571386A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-06-22 B2BC4591001SEC4591001 1057 10571387ASCRN Screening ASCREENING 2020-12-09 2020-12-09T14:03:00AAC4591001SEC4591001 1057 10571387A VAXP Placebo A VACCINATION 2020-12-09T14:03:002021-01-27 AB2C4591001SEC4591001 1057 10571387A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-02 B2BC4591001SEC4591001 1057 10571387A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-02 2021-06-02T15:32:00BBC4591001SEC4591001 1057 10571387APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-02T15:32:002021-07-21 BBC4591001SEC4591001 1057 10571387A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-21 2021-08-05 BBC4591001SEC4591001 1057 10571388ASCRN Screening ASCREENING 2020-12-09 2020-12-09T14:22:00AAC4591001SEC4591001 1057 10571388A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T14:22:002021-02-03 AB9C4591001SEC4591001 1057 10571388A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-12 B9BC4591001SEC4591001 1057 10571389ASCRN Screening ASCREENING 2020-12-09 2020-12-09T14:27:00AAC4591001SEC4591001 1057 10571389A VAXP Placebo A VACCINATION 2020-12-09T14:27:002021-02-03 AB9C4591001SEC4591001 1057 10571389A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-12 B9BC4591001SEC4591001 1057 10571390ASCRN Screening ASCREENING 2020-12-09 2020-12-09T14:45:00AAC4591001SEC4591001 1057 10571390A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T14:45:002021-01-28 AB3C4591001SEC4591001 1057 10571390A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-07-30 B3BC4591001SEC4591001 1057 10571391ASCRN Screening ASCREENING 2020-12-09 2020-12-09T14:50:00AAC4591001SEC4591001 1057 10571391A VAXP Placebo A VACCINATION 2020-12-09T14:50:002021-01-28 AB3C4591001SEC4591001 1057 10571391A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-02-24 B3BNC4591001SEC4591001 1057 10571391A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-24 2021-02-24T15:26:00BNBNC4591001SEC4591001 1057 10571391APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-24T15:26:002021-04-14 BNBC4591001SEC4591001 1057 10571391A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-14 2021-04-14 BBC4591001SEC4591001 1057 10571392ASCRN Screening ASCREENING 2020-12-09 2020-12-09T16:00:00AAC4591001SEC4591001 1057 10571392A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T16:00:002021-01-27 AB2C4591001SEC4591001 1057 10571392A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-07-22 B2BC4591001SEC4591001 1057 10571393ASCRN Screening ASCREENING 2020-12-09 2020-12-09T16:14:00AAC4591001SEC4591001 1057 10571393A VAXP Placebo A VACCINATION 2020-12-09T16:14:002021-01-29 AB4C4591001SEC4591001 1057 10571393A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-05-27 B4BC4591001SEC4591001 1057 10571393A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-27 2021-05-27T15:33:00BBC4591001SEC4591001 1057 10571393APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-27T15:33:002021-07-13 BBC4591001SEC4591001 1057 10571393A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1057 10571394ASCRN Screening ASCREENING 2020-12-09 2020-12-09T16:31:00AAC4591001SEC4591001 1057 10571394A VAXP Placebo A VACCINATION 2020-12-09T16:31:002021-01-26 AB1C4591001SEC4591001 1057 10571394A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-05-17 B1BC4591001SEC4591001 1057 10571394A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T15:46:00BBC4591001SEC4591001 1057 10571394APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T15:46:002021-07-08 BBC4591001SEC4591001 1057 10571394A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1057 10571395ASCRN Screening ASCREENING 2020-12-09 2020-12-09T16:39:00AAC4591001SEC4591001 1057 10571395A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T16:39:002021-02-17 ABGC4591001SEC4591001 1057 10571395A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-06-16 BGBC4591001SEC4591001 1057 10571396ASCRN Screening ASCREENING 2020-12-10 2020-12-10T14:42:00AAC4591001SEC4591001 1057 10571396A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T14:42:002021-02-01 AB6C4591001SEC4591001 1057 10571396A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-08-25 B6C0C4591001SEC4591001 1057 10571397ASCRN Screening ASCREENING 2020-12-10 2020-12-10T16:10:00AAC4591001SEC4591001 1057 10571397A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T16:10:002021-01-27 AB1C4591001SEC4591001 1057 10571397A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-23 B1BC4591001SEC4591001 1057 10571398ASCRN Screening ASCREENING 2020-12-10 2020-12-10T16:17:00AAC4591001SEC4591001 1057 10571398A VAXP Placebo A VACCINATION 2020-12-10T16:17:002021-01-27 AB1C4591001SEC4591001 1057 10571398A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-17 B1BC4591001SEC4591001 1057 10571398A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T13:45:00BBC4591001SEC4591001 1057 10571398APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T13:45:002021-07-01 BBC4591001SEC4591001 1057 10571398A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1057 10571399ASCRN Screening ASCREENING 2020-12-10 2020-12-10T16:35:00AAC4591001SEC4591001 1057 10571399A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T16:35:002021-01-27 AB1C4591001SEC4591001 1057 10571399A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-23 B1BC4591001SEC4591001 1057 10571400ASCRN Screening ASCREENING 2020-12-11 2020-12-11T10:55:00AAC4591001SEC4591001 1057 10571400A VAXP Placebo A VACCINATION 2020-12-11T10:55:002021-02-01 AB5C4591001SEC4591001 1057 10571400A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-17 B5BC4591001SEC4591001 1057 10571400A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T14:00:00BBC4591001SEC4591001 1057 10571400APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T14:00:002021-08-04 BBC4591001SEC4591001 1057 10571400A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-04 2021-08-04 BBC4591001SEC4591001 1057 10571401ASCRN Screening ASCREENING 2020-12-11 2020-12-11T12:14:00AAC4591001SEC4591001 1057 10571401A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-11T12:14:002021-01-28 AB1C4591001SEC4591001 1057 10571401A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-06-14 B1BC4591001SEC4591001 1057 10571402ASCRN Screening ASCREENING 2020-12-14 2020-12-14T16:12:00AAC4591001SEC4591001 1057 10571402A VAXP Placebo A VACCINATION 2020-12-14T16:12:002021-02-03 AB4C4591001SEC4591001 1057 10571402A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-03-03 B4BPC4591001SEC4591001 1057 10571402A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-03 2021-03-03T16:23:00BPBPC4591001SEC4591001 1057 10571402APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-03T16:23:002021-04-21 BPBC4591001SEC4591001 1057 10571402A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-21 2021-04-21 BBC4591001SEC4591001 1057 10571403ASCRN Screening ASCREENING 2020-12-14 2020-12-14T16:37:00AAC4591001SEC4591001 1057 10571403A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T16:37:002021-02-02 AB3C4591001SEC4591001 1057 10571403A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-06-28 B3BC4591001SEC4591001 1057 10571404ASCRN Screening ASCREENING 2020-12-16 2020-12-16T11:22:00AAC4591001SEC4591001 1057 10571404A VAXP Placebo A VACCINATION 2020-12-16T11:22:002021-02-16 AB?C4591001SEC4591001 1057 10571404A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-06-28 B?BC4591001SEC4591001 1057 10571404A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-28 2021-06-28T15:07:00BBC4591001SEC4591001 1057 10571404APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-28T15:07:002021-08-19 BBC4591001SEC4591001 1057 10571404A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-19 2021-08-19 BBC4591001SEC4591001 1057 10571405ASCRN Screening ASCREENING 2020-12-16 2020-12-16T16:35:00AAC4591001SEC4591001 1057 10571405A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T16:35:002021-02-02 AB1C4591001SEC4591001 1057 10571405A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-08-17 B1BC4591001SEC4591001 1057 10571406ASCRN Screening ASCREENING 2020-12-16 2020-12-16T16:40:00AAC4591001SEC4591001 1057 10571406A VAXP Placebo A VACCINATION 2020-12-16T16:40:002021-02-02 AB1C4591001SEC4591001 1057 10571406A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-17 B1BC4591001SEC4591001 1057 10571406A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T16:05:00BBC4591001SEC4591001 1057 10571406APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T16:05:002021-07-05 BBC4591001SEC4591001 1057 10571406A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-05 2021-07-05 BBC4591001SEC4591001 1057 10571407ASCRN Screening ASCREENING 2020-12-17 2020-12-17T14:30:00AAC4591001SEC4591001 1057 10571407A VAXP Placebo A VACCINATION 2020-12-17T14:30:002021-02-02 AB0C4591001SEC4591001 1057 10571407A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-03-12 B0BVC4591001SEC4591001 1057 10571407A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-12 2021-03-12T11:59:00BVBVC4591001SEC4591001 1057 10571407APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-12T11:59:002021-04-30 BVBC4591001SEC4591001 1057 10571407A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-30 2021-04-30 BBC4591001SEC4591001 1057 10571408ASCRN Screening ASCREENING 2020-12-17 2020-12-17T14:38:00AAC4591001SEC4591001 1057 10571408A VAXP Placebo A VACCINATION 2020-12-17T14:38:002021-02-02 AB0C4591001SEC4591001 1057 10571408A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-25 B0BC4591001SEC4591001 1057 10571408A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T15:44:00BBC4591001SEC4591001 1057 10571408APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T15:44:002021-07-14 BBC4591001SEC4591001 1057 10571408A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-07-14 BBC4591001SEC4591001 1057 10571409ASCRN Screening ASCREENING 2020-12-17 2020-12-17T14:09:00AAC4591001SEC4591001 1057 10571409A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T14:09:002021-02-02 AB0C4591001SEC4591001 1057 10571409A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-06-29 B0BC4591001SEC4591001 1057 10571410ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:10:00AAC4591001SEC4591001 1057 10571410A VAXP Placebo A VACCINATION 2020-12-17T16:10:002021-02-02 AB0C4591001SEC4591001 1057 10571410A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-19 B0BC4591001SEC4591001 1057 10571410A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T13:44:00BBC4591001SEC4591001 1057 10571410APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T13:44:002021-07-07 BBC4591001SEC4591001 1057 10571410A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1057 10571411ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:42:00AAC4591001SEC4591001 1057 10571411A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T16:42:002021-02-03 AB1C4591001SEC4591001 1057 10571411A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-25 B1BC4591001SEC4591001 1057 10571412ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:43:00AAC4591001SEC4591001 1057 10571412A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T16:43:002021-02-03 AB1C4591001SEC4591001 1057 10571412A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-21 B1BC4591001SEC4591001 1057 10571413ASCRN Screening ASCREENING 2020-12-21 2020-12-21 AAC4591001SEC4591001 1057 10571414ASCRN Screening ASCREENING 2020-12-21 2020-12-21T15:20:00AAC4591001SEC4591001 1057 10571414A VAXP Placebo A VACCINATION 2020-12-21T15:20:002021-02-10 AB4C4591001SEC4591001 1057 10571414A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-06-08 B4BC4591001SEC4591001 1057 10571415ASCRN Screening ASCREENING 2020-12-21 2020-12-21T15:22:00AAC4591001SEC4591001 1057 10571415A VAXP Placebo A VACCINATION 2020-12-21T15:22:002021-03-12 ABRC4591001SEC4591001 1057 10571415A0FUP Follow-up A0FOLLOW-UP 2021-03-12 2021-06-03 BRBC4591001SEC4591001 1057 10571415A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-03 2021-06-03T14:02:00BBC4591001SEC4591001 1057 10571415APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-03T14:02:002021-08-06 BBC4591001SEC4591001 1057 10571415A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-06 2021-08-06 BBC4591001SEC4591001 1057 10571416ASCRN Screening ASCREENING 2020-12-21 2020-12-21T15:30:00AAC4591001SEC4591001 1057 10571416A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T15:30:002021-03-19 ABYC4591001SEC4591001 1057 10571416A0FUP Follow-up A0FOLLOW-UP 2021-03-19 2021-07-19 BYBC4591001SEC4591001 1057 10571417ASCRN Screening ASCREENING 2020-12-21 2020-12-21T15:38:00AAC4591001SEC4591001 1057 10571417A VAXP Placebo A VACCINATION 2020-12-21T15:38:002021-02-16 AB:C4591001SEC4591001 1057 10571417A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-05-17 B:BC4591001SEC4591001 1057 10571417A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T14:45:00BBC4591001SEC4591001 1057 10571417APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T14:45:002021-07-12 BBC4591001SEC4591001 1057 10571417A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1057 10571418ASCRN Screening ASCREENING 2020-12-22 2020-12-22T15:27:00AAC4591001SEC4591001 1057 10571418A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T15:27:002021-02-08 AB1C4591001SEC4591001 1057 10571418A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-08-27 B1BC4591001SEC4591001 1057 10571419ASCRN Screening ASCREENING 2020-12-22 2020-12-22T15:35:00AAC4591001SEC4591001 1057 10571419A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T15:35:002021-02-16 AB9C4591001SEC4591001 1057 10571419A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-05-14 B9BC4591001SEC4591001 1057 10571420ASCRN Screening ASCREENING 2020-12-23 2020-12-23T11:13:00AAC4591001SEC4591001 1057 10571420A VAXP Placebo A VACCINATION 2020-12-23T11:13:002021-02-24 AB@C4591001SEC4591001 1057 10571421ASCRN Screening ASCREENING 2020-12-23 2020-12-23T14:36:00AAC4591001SEC4591001 1057 10571421A VAXP Placebo A VACCINATION 2020-12-23T14:36:002021-02-08 AB0C4591001SEC4591001 1057 10571421A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-09 B0BC4591001SEC4591001 1057 10571422ASCRN Screening ASCREENING 2020-12-23 2020-12-23T15:50:00AAC4591001SEC4591001 1057 10571422A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T15:50:002021-02-10 AB2C4591001SEC4591001 1057 10571422A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-08 B2BC4591001SEC4591001 1057 10571423ASCRN Screening ASCREENING 2020-12-24 2020-12-24T09:47:00AAC4591001SEC4591001 1057 10571423A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-24T09:47:002021-02-12 AB3C4591001SEC4591001 1057 10571423A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-12 B3BC4591001SEC4591001 1057 10571424ASCRN Screening ASCREENING 2020-12-24 2020-12-24T09:42:00AAC4591001SEC4591001 1057 10571424A VAXP Placebo A VACCINATION 2020-12-24T09:42:002021-02-12 AB3C4591001SEC4591001 1057 10571424A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-05-17 B3BC4591001SEC4591001 1057 10571424A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T12:10:00BBC4591001SEC4591001 1057 10571424APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T12:10:002021-07-08 BBC4591001SEC4591001 1057 10571424A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1057 10571425ASCRN Screening ASCREENING 2020-12-24 2020-12-24T11:08:00AAC4591001SEC4591001 1057 10571425A VAXP Placebo A VACCINATION 2020-12-24T11:08:002021-02-16 AB7C4591001SEC4591001 1057 10571425A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-07-15 B7BC4591001SEC4591001 1057 10571426ASCRN Screening ASCREENING 2020-12-24 2020-12-24T11:18:00AAC4591001SEC4591001 1057 10571426A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-24T11:18:002021-02-24 AB?C4591001SEC4591001 1057 10571426A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-08-02 B?BC4591001SEC4591001 1057 10571427ASCRN Screening ASCREENING 2020-12-24 2020-12-24T11:24:00AAC4591001SEC4591001 1057 10571427A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-24T11:24:002021-02-24 AB?C4591001SEC4591001 1057 10571427A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-08-02 B?BC4591001SEC4591001 1057 10571428ASCRN Screening ASCREENING 2020-12-24 2020-12-24T11:40:00AAC4591001SEC4591001 1057 10571428A VAXP Placebo A VACCINATION 2020-12-24T11:40:002021-02-24 AB?C4591001SEC4591001 1057 10571428A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-08-02 B?BC4591001SEC4591001 1057 10571429ASCRN Screening ASCREENING 2020-12-24 2020-12-24T11:44:00AAC4591001SEC4591001 1057 10571429A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-24T11:44:002021-02-24 AB?C4591001SEC4591001 1057 10571429A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-08-02 B?BC4591001SEC4591001 1057 10571430ASCRN Screening ASCREENING 2020-12-29 2020-12-29T14:37:00AAC4591001SEC4591001 1057 10571430A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T14:37:002021-02-15 AB1C4591001SEC4591001 1057 10571430A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-14 B1BC4591001SEC4591001 1057 10571431ASCRN Screening ASCREENING 2020-12-30 2020-12-30T14:25:00AAC4591001SEC4591001 1057 10571431A VAXP Placebo A VACCINATION 2020-12-30T14:25:002021-02-15 AB0C4591001SEC4591001 1057 10571431A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-27 B0BC4591001SEC4591001 1057 10571431A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-27 2021-05-27T15:43:00BBC4591001SEC4591001 1057 10571431APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-27T15:43:002021-07-19 BBC4591001SEC4591001 1057 10571431A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-19 BBC4591001SEC4591001 1057 10571432ASCRN Screening ASCREENING 2020-12-30 2020-12-30T14:39:00AAC4591001SEC4591001 1057 10571432A VAXP Placebo A VACCINATION 2020-12-30T14:39:002021-02-22 AB7C4591001SEC4591001 1057 10571432A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-13 B7BC4591001SEC4591001 1057 10571432A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T15:05:00BBC4591001SEC4591001 1057 10571432APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T15:05:002021-06-29 BBC4591001SEC4591001 1057 10571432A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-29 2021-06-29 BBC4591001SEC4591001 1057 10571433ASCRN Screening ASCREENING 2020-12-30 2020-12-30T16:28:00AAC4591001SEC4591001 1057 10571433A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T16:28:002021-02-19 AB4C4591001SEC4591001 1057 10571433A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-07-16 B4BC4591001SEC4591001 1057 10571434ASCRN Screening ASCREENING 2020-12-31 2020-12-31T11:15:00AAC4591001SEC4591001 1057 10571434A VAXP Placebo A VACCINATION 2020-12-31T11:15:002021-02-18 AB2C4591001SEC4591001 1057 10571434A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-06-10 B2BC4591001SEC4591001 1057 10571434A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-10 2021-06-10T11:38:00BBC4591001SEC4591001 1057 10571434APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-10T11:38:002021-07-27 BBC4591001SEC4591001 1057 10571434A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-27 2021-07-27 BBC4591001SEC4591001 1057 10571435ASCRN Screening ASCREENING 2021-01-04 2021-01-04T14:34:00AAC4591001SEC4591001 1057 10571435A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T14:34:002021-02-23 AB3C4591001SEC4591001 1057 10571435A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-21 B3BC4591001SEC4591001 1057 10571436ASCRN Screening ASCREENING 2021-01-04 2021-01-04T14:38:00AAC4591001SEC4591001 1057 10571436A VAXP Placebo A VACCINATION 2021-01-04T14:38:002021-02-23 AB3C4591001SEC4591001 1057 10571436A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-22 B3BC4591001SEC4591001 1057 10571436A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-22 2021-07-22T10:24:00BBC4591001SEC4591001 1057 10571436APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-22T10:24:002021-08-17 BBC4591001SEC4591001 1057 10571437ASCRN Screening ASCREENING 2021-01-04 2021-01-04T16:15:00AAC4591001SEC4591001 1057 10571437A VAXP Placebo A VACCINATION 2021-01-04T16:15:002021-03-01 AB9C4591001SEC4591001 1057 10571437A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-20 B9BC4591001SEC4591001 1057 10571437A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-20 2021-07-20T15:03:00BBC4591001SEC4591001 1057 10571437APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-20T15:03:002021-08-10 BBC4591001SEC4591001 1057 10571438ASCRN Screening ASCREENING 2021-01-04 2021-01-04T16:26:00AAC4591001SEC4591001 1057 10571438A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T16:26:002021-03-01 AB9C4591001SEC4591001 1057 10571438A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-20 B9BC4591001SEC4591001 1057 10571439ASCRN Screening ASCREENING 2021-01-06 2021-01-06T14:15:00AAC4591001SEC4591001 1057 10571439A VAXP Placebo A VACCINATION 2021-01-06T14:15:002021-03-01 AB7C4591001SEC4591001 1057 10571439A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-05-19 B7BC4591001SEC4591001 1057 10571439A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T14:58:00BBC4591001SEC4591001 1057 10571439APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T14:58:002021-07-05 BBC4591001SEC4591001 1057 10571439A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-05 2021-07-05 BBC4591001SEC4591001 1057 10571440ASCRN Screening ASCREENING 2021-01-06 2021-01-06T16:06:00AAC4591001SEC4591001 1057 10571440A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T16:06:002021-02-24 AB2C4591001SEC4591001 1057 10571440A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-19 B2BC4591001SEC4591001 1057 10571441ASCRN Screening ASCREENING 2021-01-06 2021-01-06T16:21:00AAC4591001SEC4591001 1057 10571441A VAXP Placebo A VACCINATION 2021-01-06T16:21:002021-02-24 AB2C4591001SEC4591001 1057 10571441A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-19 B2BC4591001SEC4591001 1057 10571441A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T16:06:00BBC4591001SEC4591001 1057 10571441APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T16:06:002021-07-07 BBC4591001SEC4591001 1057 10571441A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1057 10571442ASCRN Screening ASCREENING 2021-01-07 2021-01-07T11:27:00AAC4591001SEC4591001 1057 10571442A VAXP Placebo A VACCINATION 2021-01-07T11:27:002021-03-02 AB7C4591001SEC4591001 1057 10571442A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-28 B7BC4591001SEC4591001 1057 10571442A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-28 2021-05-28T10:57:00BBC4591001SEC4591001 1057 10571442APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-28T10:57:002021-08-19 BBC4591001SEC4591001 1057 10571442A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-19 2021-08-19 BBC4591001SEC4591001 1057 10571443ASCRN Screening ASCREENING 2021-01-08 2021-01-08T11:21:00AAC4591001SEC4591001 1057 10571443A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T11:21:002021-02-25 AB1C4591001SEC4591001 1057 10571443A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-08-11 B1BC4591001SEC4591001 1057 10571444ASCRN Screening ASCREENING 2021-01-08 2021-01-08T11:28:00AAC4591001SEC4591001 1057 10571444A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T11:28:002021-02-25 AB1C4591001SEC4591001 1057 10571444A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-08-11 B1BC4591001SEC4591001 1057 10571445ASCRN Screening ASCREENING 2021-01-11 2021-01-11T11:07:00AAC4591001SEC4591001 1057 10571445A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T11:07:002021-03-05 AB6C4591001SEC4591001 1057 10571445A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-08-03 B6BC4591001SEC4591001 1057 10571446ASCRN Screening ASCREENING 2021-01-11 2021-01-11T14:22:00AAC4591001SEC4591001 1057 10571446A VAXP Placebo A VACCINATION 2021-01-11T14:22:002021-03-04 AB5C4591001SEC4591001 1057 10571446A0FUP Follow-up A0FOLLOW-UP 2021-03-04 2021-09-01 B5BC4591001SEC4591001 1057 10571447ASCRN Screening ASCREENING 2021-01-11 2021-01-11T16:34:00AAC4591001SEC4591001 1057 10571447A VAXP Placebo A VACCINATION 2021-01-11T16:34:002021-03-03 AB4C4591001SEC4591001 1057 10571447A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-05-18 B4BC4591001SEC4591001 1057 10571447A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T15:50:00BBC4591001SEC4591001 1057 10571447APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T15:50:002021-07-05 BBC4591001SEC4591001 1057 10571447A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-05 2021-07-05 BBC4591001SEC4591001 1057 10571448ASCRN Screening ASCREENING 2021-01-11 2021-01-11T16:43:00AAC4591001SEC4591001 1057 10571448A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T16:43:002021-03-03 AB4C4591001SEC4591001 1057 10571448A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-07-26 B4BC4591001SEC4591001 1057 10571449ASCRN Screening ASCREENING 2021-01-12 2021-01-12T11:14:00AAC4591001SEC4591001 1057 10571449A VAXP Placebo A VACCINATION 2021-01-12T11:14:002021-03-02 AB2C4591001SEC4591001 1057 10571449A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-20 B2BC4591001SEC4591001 1057 10571449A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T15:54:00BBC4591001SEC4591001 1057 10571449APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T15:54:002021-07-06 BBC4591001SEC4591001 1057 10571449A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1057 10571450ASCRN Screening ASCREENING 2021-01-12 2021-01-12T11:20:00AAC4591001SEC4591001 1057 10571450A VAXP Placebo A VACCINATION 2021-01-12T11:20:002021-03-02 AB2C4591001SEC4591001 1057 10571450A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-08-26 B2BC4591001SEC4591001 1057 10571451ASCRN Screening ASCREENING 2021-01-12 2021-01-12T14:27:00AAC4591001SEC4591001 1057 10571451A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T14:27:002021-03-02 AB2C4591001SEC4591001 1057 10571451A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-07-27 B2BC4591001SEC4591001 1057 10571452ASCRN Screening ASCREENING 2021-01-12 2021-01-12T14:32:00AAC4591001SEC4591001 1057 10571452A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T14:32:002021-03-05 AB5C4591001SEC4591001 1057 10571452A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-07-28 B5BC4591001SEC4591001 1057 10571453ASCRN Screening ASCREENING 2021-01-12 2021-01-12T16:00:00AAC4591001SEC4591001 1057 10571453A VAXP Placebo A VACCINATION 2021-01-12T16:00:002021-03-01 AB1C4591001SEC4591001 1057 10571453A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-05-17 B1B~C4591001SEC4591001 1057 10571453A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T15:56:00B~B~C4591001SEC4591001 1057 10571453APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T15:56:002021-07-05 B~BC4591001SEC4591001 1057 10571453A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-05 2021-07-05 BBC4591001SEC4591001 1057 10571454ASCRN Screening ASCREENING 2021-01-12 2021-01-12T15:58:00AAC4591001SEC4591001 1057 10571454A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T15:58:002021-03-03 AB3C4591001SEC4591001 1057 10571454A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-08-02 B3BC4591001SEC4591001 1066 10661394ASCRN Screening ASCREENING 2020-12-01 2020-12-09T11:15:00AC4591001SEC4591001 1066 10661394A VAXP Placebo A VACCINATION 2020-12-09T11:15:002021-01-27 AB2C4591001SEC4591001 1066 10661394A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-18 B2BC4591001SEC4591001 1066 10661394A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T08:25:00BBC4591001SEC4591001 1066 10661394APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T08:25:002021-07-15 BBC4591001SEC4591001 1066 10661394A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-15 2021-07-15 BBC4591001SEC4591001 1066 10661395ASCRN Screening ASCREENING 2020-12-01 2020-12-01T14:38:00AAC4591001SEC4591001 1066 10661395A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-01T14:38:002021-01-19 AB2C4591001SEC4591001 1066 10661395A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-06-15 B2BC4591001SEC4591001 1066 10661397ASCRN Screening ASCREENING 2020-12-01 2020-12-01T17:27:00AAC4591001SEC4591001 1066 10661397A VAXP Placebo A VACCINATION 2020-12-01T17:27:002021-01-18 AB1C4591001SEC4591001 1066 10661397A0FUP Follow-up A0FOLLOW-UP 2021-01-18 2021-05-19 B1BC4591001SEC4591001 1066 10661397A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T08:47:00BBC4591001SEC4591001 1066 10661397APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T08:47:002021-07-07 BBC4591001SEC4591001 1066 10661397A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1066 10661401ASCRN Screening ASCREENING 2020-12-02 2020-12-02T15:00:00AAC4591001SEC4591001 1066 10661401A VAXP Placebo A VACCINATION 2020-12-02T15:00:002021-01-18 AB0C4591001SEC4591001 1066 10661401A0FUP Follow-up A0FOLLOW-UP 2021-01-18 2021-05-19 B0BC4591001SEC4591001 1066 10661401A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T15:45:00BBC4591001SEC4591001 1066 10661401APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T15:45:002021-07-08 BBC4591001SEC4591001 1066 10661401A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1066 10661402ASCRN Screening ASCREENING 2020-12-02 2020-12-02T15:50:00AAC4591001SEC4591001 1066 10661402A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T15:50:002021-01-20 AB2C4591001SEC4591001 1066 10661402A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-17 B2BC4591001SEC4591001 1066 10661403ASCRN Screening ASCREENING 2020-12-03 2020-12-03T11:41:00AAC4591001SEC4591001 1066 10661403A VAXP Placebo A VACCINATION 2020-12-03T11:41:002021-01-28 AB9C4591001SEC4591001 1066 10661403A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-05-18 B9BC4591001SEC4591001 1066 10661403A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T12:24:00BBC4591001SEC4591001 1066 10661403APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T12:24:002021-07-07 BBC4591001SEC4591001 1066 10661403A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1066 10661404ASCRN Screening ASCREENING 2020-12-03 2020-12-03T11:40:00AAC4591001SEC4591001 1066 10661404A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-03T11:40:002021-01-28 AB9C4591001SEC4591001 1066 10661404A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-06-16 B9BC4591001SEC4591001 1066 10661405ASCRN Screening ASCREENING 2020-12-03 2020-12-03T16:18:00AAC4591001SEC4591001 1066 10661405A VAXP Placebo A VACCINATION 2020-12-03T16:18:002021-01-21 AB2C4591001SEC4591001 1066 10661405A0FUP Follow-up A0FOLLOW-UP 2021-01-21 2021-05-18 B2BC4591001SEC4591001 1066 10661405A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T14:14:00BBC4591001SEC4591001 1066 10661405APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T14:14:002021-07-05 BBC4591001SEC4591001 1066 10661405A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-05 2021-07-05 BBC4591001SEC4591001 1066 10661407ASCRN Screening ASCREENING 2020-12-04 2020-12-04T10:50:00AAC4591001SEC4591001 1066 10661407A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-04T10:50:002021-01-21 AB1C4591001SEC4591001 1066 10661407A0FUP Follow-up A0FOLLOW-UP 2021-01-21 2021-06-17 B1BC4591001SEC4591001 1066 10661408ASCRN Screening ASCREENING 2020-12-08 2020-12-08T16:33:00AAC4591001SEC4591001 1066 10661408A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T16:33:002021-01-26 AB2C4591001SEC4591001 1066 10661408A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-08-02 B2BC4591001SEC4591001 1066 10661409ASCRN Screening ASCREENING 2020-12-08 2020-12-08T16:35:00AAC4591001SEC4591001 1066 10661409A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T16:35:002021-01-26 AB2C4591001SEC4591001 1066 10661409A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-06-22 B2BC4591001SEC4591001 1066 10661410ASCRN Screening ASCREENING 2020-12-09 2020-12-09T13:50:00AAC4591001SEC4591001 1066 10661410A VAXP Placebo A VACCINATION 2020-12-09T13:50:002021-01-27 AB2C4591001SEC4591001 1066 10661410A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-18 B2BC4591001SEC4591001 1066 10661410A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T12:55:00BBC4591001SEC4591001 1066 10661410APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T12:55:002021-07-08 BBC4591001SEC4591001 1066 10661410A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1066 10661411ASCRN Screening ASCREENING 2020-12-09 2020-12-09T16:47:00AAC4591001SEC4591001 1066 10661411A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T16:47:002021-01-28 AB3C4591001SEC4591001 1066 10661411A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-06-23 B3BC4591001SEC4591001 1066 10661412ASCRN Screening ASCREENING 2020-12-09 2020-12-09T16:45:00AAC4591001SEC4591001 1066 10661412A VAXP Placebo A VACCINATION 2020-12-09T16:45:002021-01-28 AB3C4591001SEC4591001 1066 10661412A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-05-18 B3BC4591001SEC4591001 1066 10661412A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T07:50:00BBC4591001SEC4591001 1066 10661412APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T07:50:002021-07-20 BBC4591001SEC4591001 1066 10661412A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-20 2021-07-20 BBC4591001SEC4591001 1066 10661414ASCRN Screening ASCREENING 2020-12-14 2020-12-14T15:50:00AAC4591001SEC4591001 1066 10661414A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T15:50:002021-02-01 AB2C4591001SEC4591001 1066 10661414A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-06-28 B2BC4591001SEC4591001 1066 10661415ASCRN Screening ASCREENING 2020-12-14 2020-12-14T15:42:00AAC4591001SEC4591001 1066 10661415A VAXP Placebo A VACCINATION 2020-12-14T15:42:002021-02-01 AB2C4591001SEC4591001 1066 10661415A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-07-05 B2BC4591001SEC4591001 1066 10661415A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-05 2021-07-05T10:20:00BBC4591001SEC4591001 1066 10661415APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-05T10:20:002021-08-23 BBC4591001SEC4591001 1066 10661415A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-23 2021-08-23 BBC4591001SEC4591001 1066 10661416ASCRN Screening ASCREENING 2020-12-15 2020-12-15T16:25:00AAC4591001SEC4591001 1066 10661416A VAXP Placebo A VACCINATION 2020-12-15T16:25:002021-02-02 AB2C4591001SEC4591001 1066 10661416A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-25 B2BC4591001SEC4591001 1066 10661416A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T15:27:00BBC4591001SEC4591001 1066 10661416APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T15:27:002021-07-14 BBC4591001SEC4591001 1066 10661416A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-07-14 BBC4591001SEC4591001 1066 10661417ASCRN Screening ASCREENING 2020-12-16 2020-12-16T14:55:00AAC4591001SEC4591001 1066 10661417A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T14:55:002021-02-10 AB9C4591001SEC4591001 1066 10661417A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-08-18 B9BC4591001SEC4591001 1066 10661418ASCRN Screening ASCREENING 2020-12-16 2020-12-16T15:17:00AAC4591001SEC4591001 1066 10661418A VAXP Placebo A VACCINATION 2020-12-16T15:17:002021-02-02 AB1C4591001SEC4591001 1066 10661418A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-20 B1BC4591001SEC4591001 1066 10661418A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T14:20:00BBC4591001SEC4591001 1066 10661418APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T14:20:002021-07-20 BBC4591001SEC4591001 1066 10661418A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-20 2021-07-20 BBC4591001SEC4591001 1066 10661419ASCRN Screening ASCREENING 2020-12-16 2020-12-16T16:00:00AAC4591001SEC4591001 1066 10661419A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T16:00:002021-02-03 AB2C4591001SEC4591001 1066 10661419A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-19 B2BC4591001SEC4591001 1066 10661420ASCRN Screening ASCREENING 2020-12-17 2020-12-17T15:28:00AAC4591001SEC4591001 1066 10661420A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T15:28:002021-02-03 AB1C4591001SEC4591001 1066 10661420A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-03-08 B1BRC4591001SEC4591001 1066 10661421ASCRN Screening ASCREENING 2020-12-22 2020-12-22T10:35:00AAC4591001SEC4591001 1066 10661421A VAXP Placebo A VACCINATION 2020-12-22T10:35:002021-02-11 AB4C4591001SEC4591001 1066 10661421A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-05-19 B4BC4591001SEC4591001 1066 10661421A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T12:00:00BBC4591001SEC4591001 1066 10661421APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T12:00:002021-07-15 BBC4591001SEC4591001 1066 10661421A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-15 2021-07-15 BBC4591001SEC4591001 1066 10661422ASCRN Screening ASCREENING 2020-12-22 2020-12-22T10:37:00AAC4591001SEC4591001 1066 10661422A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T10:37:002021-02-11 AB4C4591001SEC4591001 1066 10661422A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-07-08 B4BC4591001SEC4591001 1066 10661423ASCRN Screening ASCREENING 2020-12-30 2020-12-30T08:20:00AAC4591001SEC4591001 1066 10661423A VAXP Placebo A VACCINATION 2020-12-30T08:20:002021-02-23 AB8C4591001SEC4591001 1066 10661423A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-05-19 B8BC4591001SEC4591001 1066 10661423A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T15:08:00BBC4591001SEC4591001 1066 10661423APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T15:08:002021-07-12 BBC4591001SEC4591001 1066 10661423A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1066 10661424ASCRN Screening ASCREENING 2020-12-30 2020-12-30T10:18:00AAC4591001SEC4591001 1066 10661424A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T10:18:002021-02-24 AB9C4591001SEC4591001 1066 10661424A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-28 B9BC4591001SEC4591001 1066 10661425ASCRN Screening ASCREENING 2021-01-05 2021-01-05T16:01:00AAC4591001SEC4591001 1066 10661425A VAXP Placebo A VACCINATION 2021-01-05T16:01:002021-03-02 AB9C4591001SEC4591001 1066 10661425A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-20 B9BC4591001SEC4591001 1066 10661425A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T08:35:00BBC4591001SEC4591001 1066 10661425APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T08:35:002021-07-08 BBC4591001SEC4591001 1066 10661425A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1066 10661426ASCRN Screening ASCREENING 2021-01-06 2021-01-06T11:05:00AAC4591001SEC4591001 1066 10661426A VAXP Placebo A VACCINATION 2021-01-06T11:05:002021-03-04 AB:C4591001SEC4591001 1066 10661426A0FUP Follow-up A0FOLLOW-UP 2021-03-04 2021-05-19 B:BC4591001SEC4591001 1066 10661426A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T10:50:00BBC4591001SEC4591001 1066 10661426APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T10:50:002021-07-05 BBC4591001SEC4591001 1066 10661426A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-05 2021-07-05 BBC4591001SEC4591001 1066 10661427ASCRN Screening ASCREENING 2021-01-06 2021-01-06T11:06:00AAC4591001SEC4591001 1066 10661427A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T11:06:002021-03-03 AB9C4591001SEC4591001 1066 10661427A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-07-21 B9BC4591001SEC4591001 1066 10661428ASCRN Screening ASCREENING 2021-01-06 2021-01-06T13:00:00AAC4591001SEC4591001 1066 10661428A VAXP Placebo A VACCINATION 2021-01-06T13:00:002021-03-15 ABEC4591001SEC4591001 1066 10661428A0SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-15 2021-03-15T15:35:00BEBEC4591001SEC4591001 1066 10661428A@VAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-15T15:35:002021-05-03 BEBvC4591001SEC4591001 1066 10661428APFUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-03 2021-05-03 BvBvC4591001SEC4591001 1066 10661429ASCRN Screening ASCREENING 2021-01-06 2021-01-06T15:50:00AAC4591001SEC4591001 1066 10661429A VAXP Placebo A VACCINATION 2021-01-06T15:50:002021-03-03 AB9C4591001SEC4591001 1066 10661429A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-07-26 B9BC4591001SEC4591001 1066 10661429A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-26 2021-07-26T10:35:00BBC4591001SEC4591001 1066 10661429APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-26T10:35:002021-08-16 BBC4591001SEC4591001 1066 10661430ASCRN Screening ASCREENING 2021-01-07 2021-01-07T08:00:00AAC4591001SEC4591001 1066 10661430A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T08:00:002021-03-02 AB7C4591001SEC4591001 1066 10661430A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-07-27 B7BC4591001SEC4591001 1066 10661431ASCRN Screening ASCREENING 2021-01-07 2021-01-07T12:05:00AAC4591001SEC4591001 1066 10661431A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T12:05:002021-03-03 AB8C4591001SEC4591001 1066 10661431A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-07-28 B8BC4591001SEC4591001 1066 10661432ASCRN Screening ASCREENING 2021-01-07 2021-01-07T12:20:00AAC4591001SEC4591001 1066 10661432A VAXP Placebo A VACCINATION 2021-01-07T12:20:002021-03-03 AB8C4591001SEC4591001 1066 10661432A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-05-18 B8BC4591001SEC4591001 1066 10661432A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T10:45:00BBC4591001SEC4591001 1066 10661432APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T10:45:002021-07-14 BBC4591001SEC4591001 1066 10661432A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-07-14 BBC4591001SEC4591001 1066 10661433ASCRN Screening ASCREENING 2021-01-07 2021-01-07T16:00:00AAC4591001SEC4591001 1066 10661433A VAXP Placebo A VACCINATION 2021-01-07T16:00:002021-03-01 AB6C4591001SEC4591001 1066 10661433A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-05-19 B6BC4591001SEC4591001 1066 10661433A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T09:45:00BBC4591001SEC4591001 1066 10661433APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T09:45:002021-07-08 BBC4591001SEC4591001 1066 10661433A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1066 10661434ASCRN Screening ASCREENING 2021-01-12 2021-01-12T12:25:00AAC4591001SEC4591001 1066 10661434A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T12:25:002021-03-09 AB9C4591001SEC4591001 1066 10661434A0FUP Follow-up A0FOLLOW-UP 2021-03-09 2021-07-30 B9BC4591001SEC4591001 1066 10661435ASCRN Screening ASCREENING 2021-01-12 2021-01-12T12:24:00AAC4591001SEC4591001 1066 10661435A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T12:24:002021-03-09 AB9C4591001SEC4591001 1066 10661435A0FUP Follow-up A0FOLLOW-UP 2021-03-09 2021-07-30 B9BC4591001SEC4591001 1077 10771274ASCRN Screening ASCREENING 2020-12-03 2020-12-03T15:02:00AAC4591001SEC4591001 1077 10771274A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-03T15:02:002021-01-19 AB0C4591001SEC4591001 1077 10771274A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-06-15 B0BC4591001SEC4591001 1077 10771275ASCRN Screening ASCREENING 2020-12-03 2020-12-03T15:03:00AAC4591001SEC4591001 1077 10771275A VAXP Placebo A VACCINATION 2020-12-03T15:03:002021-01-19 AB0C4591001SEC4591001 1077 10771275A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-05-17 B0BC4591001SEC4591001 1077 10771275A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T14:15:00BBC4591001SEC4591001 1077 10771275APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T14:15:002021-07-07 BBC4591001SEC4591001 1077 10771275A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1077 10771277ASCRN Screening ASCREENING 2020-12-04 2020-12-04T09:47:00AAC4591001SEC4591001 1077 10771277A VAXP Placebo A VACCINATION 2020-12-04T09:47:002021-01-22 AB2C4591001SEC4591001 1077 10771277A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-05-24 B2BC4591001SEC4591001 1077 10771277A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T12:12:00BBC4591001SEC4591001 1077 10771277APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T12:12:002021-07-20 BBC4591001SEC4591001 1077 10771277A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-20 2021-07-20 BBC4591001SEC4591001 1077 10771278ASCRN Screening ASCREENING 2020-12-04 2020-12-04T09:45:00AAC4591001SEC4591001 1077 10771278A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-04T09:45:002021-01-22 AB2C4591001SEC4591001 1077 10771278A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-06-16 B2BC4591001SEC4591001 1077 10771279ASCRN Screening ASCREENING 2020-12-14 2020-12-14T09:13:00AAC4591001SEC4591001 1077 10771279A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T09:13:002021-02-02 AB3C4591001SEC4591001 1077 10771279A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-06-30 B3BC4591001SEC4591001 1077 10771280ASCRN Screening ASCREENING 2020-12-14 2020-12-14T09:10:00AAC4591001SEC4591001 1077 10771280A VAXP Placebo A VACCINATION 2020-12-14T09:10:002021-02-02 AB3C4591001SEC4591001 1077 10771280A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-28 B3BC4591001SEC4591001 1077 10771280A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-28 2021-05-28T12:58:00BBC4591001SEC4591001 1077 10771280APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-28T12:58:002021-07-16 BBC4591001SEC4591001 1077 10771280A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-16 2021-07-16 BBC4591001SEC4591001 1077 10771281ASCRN Screening ASCREENING 2020-12-14 2020-12-14T09:55:00AAC4591001SEC4591001 1077 10771281A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T09:55:002021-02-02 AB3C4591001SEC4591001 1077 10771281A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-07-08 B3BC4591001SEC4591001 1077 10771282ASCRN Screening ASCREENING 2020-12-14 2020-12-14T17:08:00AAC4591001SEC4591001 1077 10771282A VAXP Placebo A VACCINATION 2020-12-14T17:08:002021-02-04 AB5C4591001SEC4591001 1077 10771282A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-17 B5BC4591001SEC4591001 1077 10771283ASCRN Screening ASCREENING 2020-12-15 2020-12-15T09:18:00AAC4591001SEC4591001 1077 10771283A VAXP Placebo A VACCINATION 2020-12-15T09:18:002021-02-03 AB3C4591001SEC4591001 1077 10771283A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-05-17 B3BC4591001SEC4591001 1077 10771283A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T08:27:00BBC4591001SEC4591001 1077 10771283APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T08:27:002021-07-07 BBC4591001SEC4591001 1077 10771283A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1077 10771284ASCRN Screening ASCREENING 2020-12-15 2020-12-15T09:16:00AAC4591001SEC4591001 1077 10771284A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T09:16:002021-02-03 AB3C4591001SEC4591001 1077 10771284A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-28 B3BC4591001SEC4591001 1077 10771285ASCRN Screening ASCREENING 2020-12-15 2020-12-15T09:20:00AAC4591001SEC4591001 1077 10771285A VAXP Placebo A VACCINATION 2020-12-15T09:20:002021-02-05 AB5C4591001SEC4591001 1077 10771285A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-18 B5BC4591001SEC4591001 1077 10771285A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T08:08:00BBC4591001SEC4591001 1077 10771285APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T08:08:002021-07-07 BBC4591001SEC4591001 1077 10771285A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1077 10771286ASCRN Screening ASCREENING 2020-12-15 2020-12-15T14:03:00AAC4591001SEC4591001 1077 10771286A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T14:03:002021-02-03 AB3C4591001SEC4591001 1077 10771286A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-02 B3BC4591001SEC4591001 1077 10771287ASCRN Screening ASCREENING 2020-12-15 2020-12-15T14:25:00AAC4591001SEC4591001 1077 10771287A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T14:25:002021-02-15 AB?C4591001SEC4591001 1077 10771287A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-06 B?BC4591001SEC4591001 1077 10771288ASCRN Screening ASCREENING 2020-12-16 2020-12-16T15:30:00AAC4591001SEC4591001 1077 10771288A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T15:30:002021-02-04 AB3C4591001SEC4591001 1077 10771288A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-07-12 B3BC4591001SEC4591001 1077 10771289ASCRN Screening ASCREENING 2020-12-18 2020-12-18T15:05:00AAC4591001SEC4591001 1077 10771289A VAXP Placebo A VACCINATION 2020-12-18T15:05:002021-02-12 AB9C4591001SEC4591001 1077 10771289A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-05-14 B9BC4591001SEC4591001 1077 10771290ASCRN Screening ASCREENING 2020-12-18 2020-12-18T15:06:00AAC4591001SEC4591001 1077 10771290A VAXP Placebo A VACCINATION 2020-12-18T15:06:002021-02-12 AB9C4591001SEC4591001 1077 10771290A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-05-14 B9BC4591001SEC4591001 1077 10771291ASCRN Screening ASCREENING 2020-12-18 2020-12-18T16:10:00AAC4591001SEC4591001 1077 10771291A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T16:10:002021-02-10 AB7C4591001SEC4591001 1077 10771291A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-06-30 B7BC4591001SEC4591001 1077 10771292ASCRN Screening ASCREENING 2020-12-18 2020-12-18T16:11:00AAC4591001SEC4591001 1077 10771292A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T16:11:002021-02-10 AB7C4591001SEC4591001 1077 10771292A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-18 B7BC4591001SEC4591001 1077 10771293ASCRN Screening ASCREENING 2020-12-18 2020-12-18 AAC4591001SEC4591001 1077 10771294ASCRN Screening ASCREENING 2020-12-28 2020-12-28T13:31:00AAC4591001SEC4591001 1077 10771294A VAXP Placebo A VACCINATION 2020-12-28T13:31:002021-02-22 AB9C4591001SEC4591001 1077 10771294A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-24 B9BC4591001SEC4591001 1077 10771294A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T14:48:00BBC4591001SEC4591001 1077 10771294APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T14:48:002021-07-16 BBC4591001SEC4591001 1077 10771294A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-16 2021-07-16 BBC4591001SEC4591001 1077 10771295ASCRN Screening ASCREENING 2020-12-28 2020-12-28T14:07:00AAC4591001SEC4591001 1077 10771295A VAXP Placebo A VACCINATION 2020-12-28T14:07:002021-02-17 AB4C4591001SEC4591001 1077 10771295A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-02-25 B4B<C4591001SEC4591001 1077 10771295A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-25 2021-02-25T15:55:00B<B<C4591001SEC4591001 1077 10771295APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-25T15:55:002021-04-14 B<BlC4591001SEC4591001 1077 10771295A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-14 2021-04-14 BlBlC4591001SEC4591001 1077 10771296ASCRN Screening ASCREENING 2020-12-29 2020-12-29T12:00:00AAC4591001SEC4591001 1077 10771296A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T12:00:002021-02-17 AB3C4591001SEC4591001 1077 10771296A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-07 B3BC4591001SEC4591001 1077 10771297ASCRN Screening ASCREENING 2021-01-06 2021-01-06T14:46:00AAC4591001SEC4591001 1077 10771297A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T14:46:002021-02-25 AB3C4591001SEC4591001 1077 10771297A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-07-30 B3BC4591001SEC4591001 1077 10771298ASCRN Screening ASCREENING 2021-01-07 2021-01-07T12:20:00AAC4591001SEC4591001 1077 10771298A VAXP Placebo A VACCINATION 2021-01-07T12:20:002021-02-24 AB1C4591001SEC4591001 1077 10771298A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-14 B1BC4591001SEC4591001 1077 10771298A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T16:18:00BBC4591001SEC4591001 1077 10771298APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T16:18:002021-07-07 BBC4591001SEC4591001 1077 10771298A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1077 10771299ASCRN Screening ASCREENING 2021-01-07 2021-01-07T14:29:00AAC4591001SEC4591001 1077 10771299A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T14:29:002021-02-26 AB3C4591001SEC4591001 1077 10771299A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-21 B3BC4591001SEC4591001 1077 10771300ASCRN Screening ASCREENING 2021-01-07 2021-01-07T16:38:00AAC4591001SEC4591001 1077 10771300A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T16:38:002021-02-24 AB1C4591001SEC4591001 1077 10771300A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-22 B1BC4591001SEC4591001 1084 10841541ASCRN Screening ASCREENING 2020-12-11 2020-12-11T10:05:00AAC4591001SEC4591001 1084 10841541A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-11T10:05:002021-01-29 AB2C4591001SEC4591001 1084 10841541A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-08-30 B2CpC4591001SEC4591001 1084 10841542ASCRN Screening ASCREENING 2020-12-11 2020-12-11T12:05:00AAC4591001SEC4591001 1084 10841542A VAXP Placebo A VACCINATION 2020-12-11T12:05:002021-01-29 AB2C4591001SEC4591001 1084 10841542A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-07-01 B2BC4591001SEC4591001 1084 10841543ASCRN Screening ASCREENING 2020-12-18 2020-12-18T16:31:00AAC4591001SEC4591001 1084 10841543A VAXP Placebo A VACCINATION 2020-12-18T16:31:002021-02-05 AB2C4591001SEC4591001 1084 10841543A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-17 B2BC4591001SEC4591001 1084 10841543A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T16:17:00BBC4591001SEC4591001 1084 10841543APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T16:17:002021-07-05 BBC4591001SEC4591001 1084 10841543A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-05 2021-07-05 BBC4591001SEC4591001 1084 10841544ASCRN Screening ASCREENING 2020-12-18 2020-12-18T17:19:00AAC4591001SEC4591001 1084 10841544A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T17:19:002021-02-05 AB2C4591001SEC4591001 1084 10841544A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-06-30 B2BC4591001SEC4591001 1084 10841545ASCRN Screening ASCREENING 2020-12-18 2020-12-18T17:25:00AAC4591001SEC4591001 1084 10841545A VAXP Placebo A VACCINATION 2020-12-18T17:25:002021-02-05 AB2C4591001SEC4591001 1084 10841545A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-18 B2BC4591001SEC4591001 1084 10841545A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T16:29:00BBC4591001SEC4591001 1084 10841545APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T16:29:002021-07-06 BBC4591001SEC4591001 1084 10841545A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1084 10841546ASCRN Screening ASCREENING 2020-12-18 2020-12-18T17:30:00AAC4591001SEC4591001 1084 10841546A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T17:30:002021-02-05 AB2C4591001SEC4591001 1084 10841546A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-06-30 B2BC4591001SEC4591001 1084 10841547ASCRN Screening ASCREENING 2020-12-21 2020-12-21T10:00:00AAC4591001SEC4591001 1084 10841547A VAXP Placebo A VACCINATION 2020-12-21T10:00:002021-02-10 AB4C4591001SEC4591001 1084 10841547A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-21 B4BC4591001SEC4591001 1084 10841547A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T09:07:00BBC4591001SEC4591001 1084 10841547APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T09:07:002021-07-07 BBC4591001SEC4591001 1084 10841547A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1084 10841548ASCRN Screening ASCREENING 2020-12-21 2020-12-21T14:36:00AAC4591001SEC4591001 1084 10841548A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T14:36:002021-02-12 AB6C4591001SEC4591001 1084 10841548A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-09 B6BC4591001SEC4591001 1084 10841549ASCRN Screening ASCREENING 2020-12-21 2020-12-21T11:52:00AAC4591001SEC4591001 1084 10841549A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T11:52:002021-02-10 AB4C4591001SEC4591001 1084 10841549A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-12 B4BC4591001SEC4591001 1084 10841550ASCRN Screening ASCREENING 2020-12-21 2020-12-21T14:41:00AAC4591001SEC4591001 1084 10841550A VAXP Placebo A VACCINATION 2020-12-21T14:41:002021-02-12 AB6C4591001SEC4591001 1084 10841550A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-08-02 B6BC4591001SEC4591001 1084 10841550A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-08-02 2021-08-02T13:59:00BBC4591001SEC4591001 1084 10841550APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-08-02T13:59:002021-08-25 BBC4591001SEC4591001 1084 10841551ASCRN Screening ASCREENING 2020-12-21 2020-12-21T14:47:00AAC4591001SEC4591001 1084 10841551A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T14:47:002021-02-12 AB6C4591001SEC4591001 1084 10841551A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-08-02 B6BC4591001SEC4591001 1084 10841552ASCRN Screening ASCREENING 2020-12-21 2020-12-21T14:53:00AAC4591001SEC4591001 1084 10841552A VAXP Placebo A VACCINATION 2020-12-21T14:53:002021-02-08 AB2C4591001SEC4591001 1084 10841552A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-24 B2BC4591001SEC4591001 1084 10841552A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T16:46:00BBC4591001SEC4591001 1084 10841552APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T16:46:002021-07-13 BBC4591001SEC4591001 1084 10841552A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1084 10841553ASCRN Screening ASCREENING 2020-12-21 2020-12-21T16:13:00AAC4591001SEC4591001 1084 10841553A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T16:13:002021-02-10 AB4C4591001SEC4591001 1084 10841553A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-07 B4BC4591001SEC4591001 1084 10841555ASCRN Screening ASCREENING 2020-12-21 2020-12-21T16:30:00AAC4591001SEC4591001 1084 10841555A VAXP Placebo A VACCINATION 2020-12-21T16:30:002021-02-08 AB2C4591001SEC4591001 1084 10841555A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-30 B2BC4591001SEC4591001 1084 10841555A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-30 2021-07-30T15:39:00BBC4591001SEC4591001 1084 10841555APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-30T15:39:002021-08-20 BBC4591001SEC4591001 1084 10841556ASCRN Screening ASCREENING 2020-12-28 2020-12-28T11:10:00AAC4591001SEC4591001 1084 10841556A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T11:10:002021-02-22 AB9C4591001SEC4591001 1084 10841556A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-19 B9BC4591001SEC4591001 1084 10841557ASCRN Screening ASCREENING 2020-12-28 2020-12-28T10:31:00AAC4591001SEC4591001 1084 10841557A VAXP Placebo A VACCINATION 2020-12-28T10:31:002021-02-25 AB<C4591001SEC4591001 1084 10841557A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-13 B<BC4591001SEC4591001 1084 10841558ASCRN Screening ASCREENING 2020-12-28 2020-12-28T13:14:00AAC4591001SEC4591001 1084 10841558A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T13:14:002021-02-22 AB9C4591001SEC4591001 1084 10841558A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-12 B9BC4591001SEC4591001 1084 10841559ASCRN Screening ASCREENING 2020-12-28 2020-12-28T13:43:00AAC4591001SEC4591001 1084 10841559A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T13:43:002021-02-22 AB9C4591001SEC4591001 1084 10841559A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-12 B9BC4591001SEC4591001 1084 10841560ASCRN Screening ASCREENING 2020-12-28 2020-12-28T12:50:00AAC4591001SEC4591001 1084 10841560A VAXP Placebo A VACCINATION 2020-12-28T12:50:002021-02-25 AB<C4591001SEC4591001 1084 10841560A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-28 B<BC4591001SEC4591001 1084 10841560A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-28 2021-05-28T14:50:00BBC4591001SEC4591001 1084 10841560APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-28T14:50:002021-07-19 BBC4591001SEC4591001 1084 10841560A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-19 BBC4591001SEC4591001 1084 10841561ASCRN Screening ASCREENING 2020-12-28 2020-12-28T13:52:00AAC4591001SEC4591001 1084 10841561A VAXP Placebo A VACCINATION 2020-12-28T13:52:002021-02-22 AB9C4591001SEC4591001 1084 10841561A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-17 B9BC4591001SEC4591001 1084 10841561A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T16:22:00BBC4591001SEC4591001 1084 10841561APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T16:22:002021-07-05 BBC4591001SEC4591001 1084 10841561A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-05 2021-07-05 BBC4591001SEC4591001 1084 10841562ASCRN Screening ASCREENING 2020-12-28 2020-12-28T16:00:00AAC4591001SEC4591001 1084 10841562A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T16:00:002021-02-22 AB9C4591001SEC4591001 1084 10841562A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-12 B9BC4591001SEC4591001 1084 10841563ASCRN Screening ASCREENING 2020-12-30 2020-12-30T11:06:00AAC4591001SEC4591001 1084 10841563A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T11:06:002021-02-22 AB7C4591001SEC4591001 1084 10841563A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-12 B7BC4591001SEC4591001 1084 10841564ASCRN Screening ASCREENING 2020-12-30 2020-12-30T11:09:00AAC4591001SEC4591001 1084 10841564A VAXP Placebo A VACCINATION 2020-12-30T11:09:002021-02-22 AB7C4591001SEC4591001 1084 10841564A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-21 B7BC4591001SEC4591001 1084 10841564A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T13:53:00BBC4591001SEC4591001 1084 10841564APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T13:53:002021-08-05 BBC4591001SEC4591001 1084 10841564A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-05 2021-08-05 BBC4591001SEC4591001 1084 10841565ASCRN Screening ASCREENING 2020-12-30 2020-12-30T12:11:00AAC4591001SEC4591001 1084 10841565A VAXP Placebo A VACCINATION 2020-12-30T12:11:002021-02-22 AB7C4591001SEC4591001 1084 10841565A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-21 B7BC4591001SEC4591001 1084 10841565A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T09:09:00BBC4591001SEC4591001 1084 10841565APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T09:09:002021-07-07 BBC4591001SEC4591001 1084 10841565A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1084 10841566ASCRN Screening ASCREENING 2020-12-30 2020-12-30T13:41:00AAC4591001SEC4591001 1084 10841566A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T13:41:002021-02-22 AB7C4591001SEC4591001 1084 10841566A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-26 B7BC4591001SEC4591001 1084 10841567ASCRN Screening ASCREENING 2020-12-30 2020-12-30T14:19:00AAC4591001SEC4591001 1084 10841567A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T14:19:002021-02-24 AB9C4591001SEC4591001 1084 10841567A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-12 B9BC4591001SEC4591001 1084 10841568ASCRN Screening ASCREENING 2020-12-30 2020-12-30T15:21:00AAC4591001SEC4591001 1084 10841568A VAXP Placebo A VACCINATION 2020-12-30T15:21:002021-03-08 ABEC4591001SEC4591001 1084 10841568A0FUP Follow-up A0FOLLOW-UP 2021-03-08 2021-06-15 BEBC4591001SEC4591001 1084 10841569ASCRN Screening ASCREENING 2020-12-30 2020-12-30T16:33:00AAC4591001SEC4591001 1084 10841569A VAXP Placebo A VACCINATION 2020-12-30T16:33:002021-02-22 AB7C4591001SEC4591001 1084 10841569A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-21 B7BC4591001SEC4591001 1084 10841569A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T16:42:00BBC4591001SEC4591001 1084 10841569APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T16:42:002021-07-07 BBC4591001SEC4591001 1084 10841569A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1084 10841570ASCRN Screening ASCREENING 2020-12-30 2020-12-30T16:36:00AAC4591001SEC4591001 1084 10841570A VAXP Placebo A VACCINATION 2020-12-30T16:36:002021-02-22 AB7C4591001SEC4591001 1084 10841570A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-21 B7BC4591001SEC4591001 1084 10841570A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T16:44:00BBC4591001SEC4591001 1084 10841570APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T16:44:002021-07-07 BBC4591001SEC4591001 1084 10841570A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1084 10841571ASCRN Screening ASCREENING 2020-12-30 2020-12-30T16:43:00AAC4591001SEC4591001 1084 10841571A VAXP Placebo A VACCINATION 2020-12-30T16:43:002021-02-22 AB7C4591001SEC4591001 1084 10841571A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-21 B7BC4591001SEC4591001 1084 10841571A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T14:40:00BBC4591001SEC4591001 1084 10841571APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T14:40:002021-09-01 BBC4591001SEC4591001 1084 10841571A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-09-01 2021-09-01 BBC4591001SEC4591001 1084 10841572ASCRN Screening ASCREENING 2021-01-04 2021-01-04T10:12:00AAC4591001SEC4591001 1084 10841572A VAXP Placebo A VACCINATION 2021-01-04T10:12:002021-02-24 AB4C4591001SEC4591001 1084 10841572A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-28 B4BC4591001SEC4591001 1084 10841572A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-28 2021-05-28T15:59:00BBC4591001SEC4591001 1084 10841572APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-28T15:59:002021-07-16 BBC4591001SEC4591001 1084 10841572A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-16 2021-07-16 BBC4591001SEC4591001 1084 10841573ASCRN Screening ASCREENING 2021-01-04 2021-01-04T16:30:00AAC4591001SEC4591001 1084 10841573A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T16:30:002021-02-26 AB6C4591001SEC4591001 1084 10841573A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-28 B6BC4591001SEC4591001 1084 10841574ASCRN Screening ASCREENING 2021-01-04 2021-01-04T16:38:00AAC4591001SEC4591001 1084 10841574A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T16:38:002021-02-26 AB6C4591001SEC4591001 1084 10841574A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-28 B6BC4591001SEC4591001 1084 10841575ASCRN Screening ASCREENING 2021-01-04 2021-01-04T16:57:00AAC4591001SEC4591001 1084 10841575A VAXP Placebo A VACCINATION 2021-01-04T16:57:002021-02-26 AB6C4591001SEC4591001 1084 10841575A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-04-16 B6BgC4591001SEC4591001 1084 10841575A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-16 2021-04-16T16:45:00BgBgC4591001SEC4591001 1084 10841575APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-16T16:45:002021-06-30 BgBC4591001SEC4591001 1084 10841575A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-30 2021-06-30 BBC4591001SEC4591001 1084 10841576ASCRN Screening ASCREENING 2021-01-06 2021-01-06T09:58:00AAC4591001SEC4591001 1084 10841576A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T09:58:002021-02-22 AB0C4591001SEC4591001 1084 10841576A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-19 B0BC4591001SEC4591001 1084 10841577ASCRN Screening ASCREENING 2021-01-06 2021-01-06T12:51:00AAC4591001SEC4591001 1084 10841577A VAXP Placebo A VACCINATION 2021-01-06T12:51:002021-02-24 AB2C4591001SEC4591001 1084 10841577A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-20 B2BC4591001SEC4591001 1084 10841577A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T16:18:00BBC4591001SEC4591001 1084 10841577APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T16:18:002021-07-07 BBC4591001SEC4591001 1084 10841577A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1084 10841578ASCRN Screening ASCREENING 2021-01-06 2021-01-06T12:53:00AAC4591001SEC4591001 1084 10841578A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T12:53:002021-02-24 AB2C4591001SEC4591001 1084 10841578A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-28 B2BC4591001SEC4591001 1084 10841579ASCRN Screening ASCREENING 2021-01-06 2021-01-06T14:17:00AAC4591001SEC4591001 1084 10841579A VAXP Placebo A VACCINATION 2021-01-06T14:17:002021-02-25 AB3C4591001SEC4591001 1084 10841579A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-24 B3BC4591001SEC4591001 1084 10841580ASCRN Screening ASCREENING 2021-01-06 2021-01-06T14:20:00AAC4591001SEC4591001 1084 10841580A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T14:20:002021-02-25 AB3C4591001SEC4591001 1084 10841580A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-07-23 B3BC4591001SEC4591001 1084 10841581ASCRN Screening ASCREENING 2021-01-06 2021-01-06T15:40:00AAC4591001SEC4591001 1084 10841581A VAXP Placebo A VACCINATION 2021-01-06T15:40:002021-02-24 AB2C4591001SEC4591001 1084 10841581A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-17 B2BC4591001SEC4591001 1084 10841581A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T12:09:00BBC4591001SEC4591001 1084 10841581APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T12:09:002021-07-06 BBC4591001SEC4591001 1084 10841581A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-08-04 BBC4591001SEC4591001 1084 10841582ASCRN Screening ASCREENING 2021-01-06 2021-01-06T15:54:00AAC4591001SEC4591001 1084 10841582A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T15:54:002021-02-26 AB4C4591001SEC4591001 1084 10841582A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-26 B4BC4591001SEC4591001 1084 10841583ASCRN Screening ASCREENING 2021-01-08 2021-01-08T10:47:00AAC4591001SEC4591001 1084 10841583A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T10:47:002021-02-26 AB2C4591001SEC4591001 1084 10841583A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-04 B2BC4591001SEC4591001 1084 10841584ASCRN Screening ASCREENING 2021-01-08 2021-01-08T11:20:00AAC4591001SEC4591001 1084 10841584A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T11:20:002021-03-01 AB5C4591001SEC4591001 1084 10841584A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-26 B5BC4591001SEC4591001 1084 10841586ASCRN Screening ASCREENING 2021-01-08 2021-01-08T12:16:00AAC4591001SEC4591001 1084 10841586A VAXP Placebo A VACCINATION 2021-01-08T12:16:002021-02-26 AB2C4591001SEC4591001 1084 10841586A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-20 B2BC4591001SEC4591001 1084 10841586A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T14:51:00BBC4591001SEC4591001 1084 10841586APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T14:51:002021-07-07 BBC4591001SEC4591001 1084 10841586A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1084 10841587ASCRN Screening ASCREENING 2021-01-08 2021-01-08T13:01:00AAC4591001SEC4591001 1084 10841587A VAXP Placebo A VACCINATION 2021-01-08T13:01:002021-02-26 AB2C4591001SEC4591001 1084 10841587A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-20 B2BC4591001SEC4591001 1084 10841587A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T14:46:00BBC4591001SEC4591001 1084 10841587APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T14:46:002021-07-07 BBC4591001SEC4591001 1084 10841587A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1084 10841588ASCRN Screening ASCREENING 2021-01-08 2021-01-08T13:42:00AAC4591001SEC4591001 1084 10841588A VAXP Placebo A VACCINATION 2021-01-08T13:42:002021-02-26 AB2C4591001SEC4591001 1084 10841588A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-21 B2BC4591001SEC4591001 1084 10841588A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T16:39:00BBC4591001SEC4591001 1084 10841588APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T16:39:002021-07-07 BBC4591001SEC4591001 1084 10841588A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1084 10841589ASCRN Screening ASCREENING 2021-01-08 2021-01-08T13:24:00AAC4591001SEC4591001 1084 10841589A VAXP Placebo A VACCINATION 2021-01-08T13:24:002021-02-26 AB2C4591001SEC4591001 1084 10841589A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-23 B2BC4591001SEC4591001 1084 10841590ASCRN Screening ASCREENING 2021-01-08 2021-01-08T14:59:00AAC4591001SEC4591001 1084 10841590A VAXP Placebo A VACCINATION 2021-01-08T14:59:002021-03-01 AB5C4591001SEC4591001 1084 10841590A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-05-17 B5BC4591001SEC4591001 1084 10841590A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T13:16:00BBC4591001SEC4591001 1084 10841590APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T13:16:002021-07-07 BBC4591001SEC4591001 1084 10841590A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1084 10841591ASCRN Screening ASCREENING 2021-01-08 2021-01-08T14:56:00AAC4591001SEC4591001 1084 10841591A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T14:56:002021-03-01 AB5C4591001SEC4591001 1084 10841591A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-23 B5BC4591001SEC4591001 1084 10841592ASCRN Screening ASCREENING 2021-01-08 2021-01-08T14:29:00AAC4591001SEC4591001 1084 10841592A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T14:29:002021-03-03 AB7C4591001SEC4591001 1084 10841592A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-07-30 B7BC4591001SEC4591001 1084 10841593ASCRN Screening ASCREENING 2021-01-08 2021-01-08T15:29:00AAC4591001SEC4591001 1084 10841593A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T15:29:002021-02-26 AB2C4591001SEC4591001 1084 10841593A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-23 B2BC4591001SEC4591001 1084 10841594ASCRN Screening ASCREENING 2021-01-08 2021-01-08T16:21:00AAC4591001SEC4591001 1084 10841594A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T16:21:002021-02-26 AB2C4591001SEC4591001 1084 10841594A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-30 B2BC4591001SEC4591001 1084 10841595ASCRN Screening ASCREENING 2021-01-08 2021-01-08T16:29:00AAC4591001SEC4591001 1084 10841595A VAXP Placebo A VACCINATION 2021-01-08T16:29:002021-02-24 AB0C4591001SEC4591001 1084 10841595A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-17 B0BC4591001SEC4591001 1084 10841595A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T16:41:00BBC4591001SEC4591001 1084 10841595APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T16:41:002021-07-05 BBC4591001SEC4591001 1084 10841595A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-05 2021-07-05 BBC4591001SEC4591001 1084 10841596ASCRN Screening ASCREENING 2021-01-08 2021-01-08T16:35:00AAC4591001SEC4591001 1084 10841596A VAXP Placebo A VACCINATION 2021-01-08T16:35:002021-02-26 AB2C4591001SEC4591001 1084 10841596A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-17 B2BC4591001SEC4591001 1084 10841596A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T12:18:00BBC4591001SEC4591001 1084 10841596APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T12:18:002021-07-06 BBC4591001SEC4591001 1084 10841596A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1084 10841597ASCRN Screening ASCREENING 2021-01-08 2021-01-08T16:42:00AAC4591001SEC4591001 1084 10841597A VAXP Placebo A VACCINATION 2021-01-08T16:42:002021-02-26 AB2C4591001SEC4591001 1084 10841597A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-07 B2BxC4591001SEC4591001 1084 10841597A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-07 2021-05-07T14:17:00BxBxC4591001SEC4591001 1084 10841597APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-07T14:17:002021-06-29 BxBC4591001SEC4591001 1084 10841597A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-29 2021-06-29 BBC4591001SEC4591001 1091 10911394ASCRN Screening ASCREENING 2020-12-02 2020-12-02T13:29:00AAC4591001SEC4591001 1091 10911394A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T13:29:002021-01-20 AB2C4591001SEC4591001 1091 10911394A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-17 B2BC4591001SEC4591001 1091 10911395ASCRN Screening ASCREENING 2020-12-02 2020-12-02T13:27:00AAC4591001SEC4591001 1091 10911395A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T13:27:002021-01-20 AB2C4591001SEC4591001 1091 10911395A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-17 B2BC4591001SEC4591001 1091 10911396ASCRN Screening ASCREENING 2020-12-02 2020-12-02T16:14:00AAC4591001SEC4591001 1091 10911396A VAXP Placebo A VACCINATION 2020-12-02T16:14:002021-01-18 AB0C4591001SEC4591001 1091 10911396A0FUP Follow-up A0FOLLOW-UP 2021-01-18 2021-05-12 B0BC4591001SEC4591001 1091 10911396A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-12 2021-05-12T09:27:00BBC4591001SEC4591001 1091 10911396APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-12T09:27:002021-07-01 BBC4591001SEC4591001 1091 10911396A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1091 10911399ASCRN Screening ASCREENING 2020-12-04 2020-12-04T10:55:00AAC4591001SEC4591001 1091 10911399A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-04T10:55:002021-02-04 AB?C4591001SEC4591001 1091 10911399A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-07-21 B?BC4591001SEC4591001 1091 10911400ASCRN Screening ASCREENING 2020-12-04 2020-12-04T11:26:00AAC4591001SEC4591001 1091 10911400A VAXP Placebo A VACCINATION 2020-12-04T11:26:002021-01-27 AB7C4591001SEC4591001 1091 10911400A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-01 B7BC4591001SEC4591001 1091 10911400A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T14:57:00BBC4591001SEC4591001 1091 10911400APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T14:57:002021-08-24 BCC4591001SEC4591001 1091 10911400A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-24 2021-08-24 CCC4591001SEC4591001 1091 10911402ASCRN Screening ASCREENING 2020-12-07 2020-12-07T10:08:00AAC4591001SEC4591001 1091 10911402A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T10:08:002021-01-27 AB4C4591001SEC4591001 1091 10911402A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-30 B4BC4591001SEC4591001 1091 10911403ASCRN Screening ASCREENING 2020-12-07 2020-12-07T11:39:00AAC4591001SEC4591001 1091 10911403A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T11:39:002021-01-26 AB3C4591001SEC4591001 1091 10911403A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-06-22 B3BC4591001SEC4591001 1091 10911404ASCRN Screening ASCREENING 2020-12-07 2020-12-07T13:39:00AAC4591001SEC4591001 1091 10911404A VAXP Placebo A VACCINATION 2020-12-07T13:39:002021-02-09 ABAC4591001SEC4591001 1091 10911404A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-07-14 BABC4591001SEC4591001 1091 10911405ASCRN Screening ASCREENING 2020-12-07 2020-12-07T15:54:00AAC4591001SEC4591001 1091 10911405A VAXP Placebo A VACCINATION 2020-12-07T15:54:002021-01-28 AB5C4591001SEC4591001 1091 10911405A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-05-27 B5BC4591001SEC4591001 1091 10911405A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-27 2021-05-27T12:11:00BBC4591001SEC4591001 1091 10911405APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-27T12:11:002021-07-21 BBC4591001SEC4591001 1091 10911405A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-21 2021-07-21 BBC4591001SEC4591001 1091 10911406ASCRN Screening ASCREENING 2020-12-07 2020-12-07T16:37:00AAC4591001SEC4591001 1091 10911406A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T16:37:002021-01-25 AB2C4591001SEC4591001 1091 10911406A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-06-15 B2BC4591001SEC4591001 1091 10911407ASCRN Screening ASCREENING 2020-12-08 2020-12-08T15:53:00AAC4591001SEC4591001 1091 10911407A VAXP Placebo A VACCINATION 2020-12-08T15:53:002021-01-25 AB1C4591001SEC4591001 1091 10911407A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-07-14 B1BC4591001SEC4591001 1091 10911407A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-14 2021-07-14T14:38:00BBC4591001SEC4591001 1091 10911407APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-14T14:38:002021-08-31 BCC4591001SEC4591001 1091 10911407A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-31 2021-08-31 CCC4591001SEC4591001 1091 10911408ASCRN Screening ASCREENING 2020-12-08 2020-12-08T15:55:00AAC4591001SEC4591001 1091 10911408A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T15:55:002021-01-28 AB4C4591001SEC4591001 1091 10911408A0FUP Follow-up A0FOLLOW-UP 2021-01-28 2021-06-28 B4BC4591001SEC4591001 1091 10911409ASCRN Screening ASCREENING 2020-12-09 2020-12-09T10:43:00AAC4591001SEC4591001 1091 10911409A VAXP Placebo A VACCINATION 2020-12-09T10:43:002021-02-01 AB7C4591001SEC4591001 1091 10911409A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-26 B7BC4591001SEC4591001 1091 10911410ASCRN Screening ASCREENING 2020-12-09 2020-12-09T11:54:00AAC4591001SEC4591001 1091 10911410A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T11:54:002021-01-27 AB2C4591001SEC4591001 1091 10911410A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-24 B2BC4591001SEC4591001 1091 10911411ASCRN Screening ASCREENING 2020-12-09 2020-12-09T11:58:00AAC4591001SEC4591001 1091 10911411A VAXP Placebo A VACCINATION 2020-12-09T11:58:002021-01-27 AB2C4591001SEC4591001 1091 10911411A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-01 B2BC4591001SEC4591001 1091 10911411A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T11:00:00BBC4591001SEC4591001 1091 10911411APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T11:00:002021-07-26 BBC4591001SEC4591001 1091 10911411A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-26 2021-08-03 BBC4591001SEC4591001 1091 10911412ASCRN Screening ASCREENING 2020-12-09 2020-12-09T16:17:00AAC4591001SEC4591001 1091 10911412A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T16:17:002021-01-27 AB2C4591001SEC4591001 1091 10911412A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-23 B2BC4591001SEC4591001 1091 10911413ASCRN Screening ASCREENING 2020-12-09 2020-12-09T16:13:00AAC4591001SEC4591001 1091 10911413A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T16:13:002021-02-09 AB?C4591001SEC4591001 1091 10911413A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-07-01 B?BC4591001SEC4591001 1091 10911414ASCRN Screening ASCREENING 2020-12-09 2020-12-09T16:15:00AAC4591001SEC4591001 1091 10911414A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T16:15:002021-02-09 AB?C4591001SEC4591001 1091 10911414A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-07-01 B?BC4591001SEC4591001 1091 10911415ASCRN Screening ASCREENING 2020-12-10 2020-12-10T11:03:00AAC4591001SEC4591001 1091 10911415A VAXP Placebo A VACCINATION 2020-12-10T11:03:002021-01-27 AB1C4591001SEC4591001 1091 10911415A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-01 B1BC4591001SEC4591001 1091 10911415A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T16:25:00BBC4591001SEC4591001 1091 10911415APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T16:25:002021-07-22 BBC4591001SEC4591001 1091 10911415A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-22 2021-07-22 BBC4591001SEC4591001 1091 10911416ASCRN Screening ASCREENING 2020-12-10 2020-12-10T12:48:00AAC4591001SEC4591001 1091 10911416A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T12:48:002021-01-27 AB1C4591001SEC4591001 1091 10911416A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-07-07 B1BC4591001SEC4591001 1091 10911417ASCRN Screening ASCREENING 2020-12-10 2020-12-10T12:49:00AAC4591001SEC4591001 1091 10911417A VAXP Placebo A VACCINATION 2020-12-10T12:49:002021-01-27 AB1C4591001SEC4591001 1091 10911417A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-17 B1BC4591001SEC4591001 1091 10911417A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-18T08:44:00BBC4591001SEC4591001 1091 10911417APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T08:44:002021-08-04 BBC4591001SEC4591001 1091 10911417A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-04 2021-08-04 BBC4591001SEC4591001 1091 10911418ASCRN Screening ASCREENING 2020-12-10 2020-12-10T12:08:00AAC4591001SEC4591001 1091 10911418A VAXP Placebo A VACCINATION 2020-12-10T12:08:002021-01-27 AB1C4591001SEC4591001 1091 10911418A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-17 B1BC4591001SEC4591001 1091 10911418A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T17:35:00BBC4591001SEC4591001 1091 10911418APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T17:35:002021-07-06 BBC4591001SEC4591001 1091 10911418A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-08-17 BBC4591001SEC4591001 1091 10911419ASCRN Screening ASCREENING 2020-12-10 2020-12-10T15:49:00AAC4591001SEC4591001 1091 10911419A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T15:49:002021-01-27 AB1C4591001SEC4591001 1091 10911419A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-23 B1BC4591001SEC4591001 1091 10911420ASCRN Screening ASCREENING 2020-12-10 2020-12-10T15:45:00AAC4591001SEC4591001 1091 10911420A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T15:45:002021-01-27 AB1C4591001SEC4591001 1091 10911420A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-28 B1BC4591001SEC4591001 1091 10911421ASCRN Screening ASCREENING 2020-12-10 2020-12-10T15:46:00AAC4591001SEC4591001 1091 10911421A VAXP Placebo A VACCINATION 2020-12-10T15:46:002021-01-27 AB1C4591001SEC4591001 1091 10911421A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-20 B1BC4591001SEC4591001 1091 10911421A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T18:43:00BBC4591001SEC4591001 1091 10911421APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T18:43:002021-07-06 BBC4591001SEC4591001 1091 10911421A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1091 10911422ASCRN Screening ASCREENING 2020-12-14 2020-12-14T10:31:00AAC4591001SEC4591001 1091 10911422A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T10:31:002021-02-03 AB4C4591001SEC4591001 1091 10911422A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-06 B4BC4591001SEC4591001 1091 10911423ASCRN Screening ASCREENING 2020-12-14 2020-12-14T10:32:00AAC4591001SEC4591001 1091 10911423A VAXP Placebo A VACCINATION 2020-12-14T10:32:002021-02-10 AB;C4591001SEC4591001 1091 10911423A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-06-30 B;BC4591001SEC4591001 1091 10911423A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-30 2021-06-30T14:46:00BBC4591001SEC4591001 1091 10911423APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-30T14:46:002021-08-23 BBC4591001SEC4591001 1091 10911423A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-23 2021-08-23 BBC4591001SEC4591001 1091 10911424ASCRN Screening ASCREENING 2020-12-15 2020-12-15T11:29:00AAC4591001SEC4591001 1091 10911424A VAXP Placebo A VACCINATION 2020-12-15T11:29:002021-02-01 AB1C4591001SEC4591001 1091 10911424A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-19 B1BC4591001SEC4591001 1091 10911424A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T08:41:00BBC4591001SEC4591001 1091 10911424APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T08:41:002021-07-07 BBC4591001SEC4591001 1091 10911424A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1091 10911425ASCRN Screening ASCREENING 2020-12-15 2020-12-15T12:35:00AAC4591001SEC4591001 1091 10911425A VAXP Placebo A VACCINATION 2020-12-15T12:35:002021-02-02 AB2C4591001SEC4591001 1091 10911425A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-24 B2BC4591001SEC4591001 1091 10911425A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T16:34:00BBC4591001SEC4591001 1091 10911425APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T16:34:002021-07-12 BBC4591001SEC4591001 1091 10911425A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1091 10911426ASCRN Screening ASCREENING 2020-12-16 2020-12-16T13:28:00AAC4591001SEC4591001 1091 10911426A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T13:28:002021-02-04 AB3C4591001SEC4591001 1091 10911426A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-07-01 B3BC4591001SEC4591001 1091 10911427ASCRN Screening ASCREENING 2020-12-16 2020-12-16T14:39:00AAC4591001SEC4591001 1091 10911427A VAXP Placebo A VACCINATION 2020-12-16T14:39:002021-02-10 AB9C4591001SEC4591001 1091 10911427A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-09 B9BC4591001SEC4591001 1091 10911428ASCRN Screening ASCREENING 2020-12-16 2020-12-16T14:41:00AAC4591001SEC4591001 1091 10911428A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T14:41:002021-02-10 AB9C4591001SEC4591001 1091 10911428A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-06-30 B9BC4591001SEC4591001 1091 10911429ASCRN Screening ASCREENING 2020-12-16 2020-12-16T15:26:00AAC4591001SEC4591001 1091 10911429A VAXP Placebo A VACCINATION 2020-12-16T15:26:002021-02-04 AB3C4591001SEC4591001 1091 10911429A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-04-01 B3BkC4591001SEC4591001 1091 10911429A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-01 2021-04-01T10:40:00BkBkC4591001SEC4591001 1091 10911429APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-01T10:40:002021-05-27 BkBC4591001SEC4591001 1091 10911429A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-27 2021-05-27 BBC4591001SEC4591001 1091 10911430ASCRN Screening ASCREENING 2020-12-16 2020-12-16T15:59:00AAC4591001SEC4591001 1091 10911430A VAXP Placebo A VACCINATION 2020-12-16T15:59:002021-02-02 AB1C4591001SEC4591001 1091 10911430A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-17 B1BC4591001SEC4591001 1091 10911430A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-20T18:00:00BBC4591001SEC4591001 1091 10911430APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T18:00:002021-07-07 BBC4591001SEC4591001 1091 10911430A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1091 10911431ASCRN Screening ASCREENING 2020-12-17 2020-12-17T10:29:00AAC4591001SEC4591001 1091 10911431A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T10:29:002021-02-11 AB9C4591001SEC4591001 1091 10911431A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-07-01 B9BC4591001SEC4591001 1091 10911432ASCRN Screening ASCREENING 2020-12-17 2020-12-17T10:27:00AAC4591001SEC4591001 1091 10911432A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T10:27:002021-02-02 AB0C4591001SEC4591001 1091 10911432A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-06-21 B0BC4591001SEC4591001 1091 10911433ASCRN Screening ASCREENING 2020-12-17 2020-12-17T15:30:00AAC4591001SEC4591001 1091 10911433A VAXP Placebo A VACCINATION 2020-12-17T15:30:002021-02-08 AB6C4591001SEC4591001 1091 10911433A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-25 B6BC4591001SEC4591001 1091 10911434ASCRN Screening ASCREENING 2020-12-17 2020-12-17T15:28:00AAC4591001SEC4591001 1091 10911434A VAXP Placebo A VACCINATION 2020-12-17T15:28:002021-02-04 AB2C4591001SEC4591001 1091 10911434A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-20 B2BC4591001SEC4591001 1091 10911434A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T10:58:00BBC4591001SEC4591001 1091 10911434APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T10:58:002021-07-12 BBC4591001SEC4591001 1091 10911434A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1091 10911435ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:50:00AAC4591001SEC4591001 1091 10911435A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T16:50:002021-02-04 AB2C4591001SEC4591001 1091 10911435A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-07-01 B2BC4591001SEC4591001 1091 10911436ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:53:00AAC4591001SEC4591001 1091 10911436A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T16:53:002021-02-04 AB2C4591001SEC4591001 1091 10911436A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-06-30 B2BC4591001SEC4591001 1091 10911437ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:54:00AAC4591001SEC4591001 1091 10911437A VAXP Placebo A VACCINATION 2020-12-17T16:54:002021-02-04 AB2C4591001SEC4591001 1091 10911437A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-26 B2BC4591001SEC4591001 1091 10911437A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T16:22:00BBC4591001SEC4591001 1091 10911437APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T16:22:002021-07-14 BBC4591001SEC4591001 1091 10911437A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-07-14 BBC4591001SEC4591001 1091 10911438ASCRN Screening ASCREENING 2020-12-18 2020-12-18T10:42:00AAC4591001SEC4591001 1091 10911438A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T10:42:002021-02-12 AB9C4591001SEC4591001 1091 10911438A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-06 B9BC4591001SEC4591001 1091 10911439ASCRN Screening ASCREENING 2020-12-18 2020-12-18T10:44:00AAC4591001SEC4591001 1091 10911439A VAXP Placebo A VACCINATION 2020-12-18T10:44:002021-02-12 AB9C4591001SEC4591001 1091 10911439A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-06-02 B9BC4591001SEC4591001 1091 10911439A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-02 2021-06-02T14:16:00BBC4591001SEC4591001 1091 10911439APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-02T14:16:002021-07-21 BBC4591001SEC4591001 1091 10911439A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-21 2021-07-21 BBC4591001SEC4591001 1091 10911440ASCRN Screening ASCREENING 2020-12-18 2020-12-18T11:05:00AAC4591001SEC4591001 1091 10911440A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T11:05:002021-02-08 AB5C4591001SEC4591001 1091 10911440A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-06 B5BC4591001SEC4591001 1091 10911441ASCRN Screening ASCREENING 2020-12-18 2020-12-18T11:08:00AAC4591001SEC4591001 1091 10911441A VAXP Placebo A VACCINATION 2020-12-18T11:08:002021-02-08 AB5C4591001SEC4591001 1091 10911441A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-18 B5BC4591001SEC4591001 1091 10911441A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T10:48:00BBC4591001SEC4591001 1091 10911441APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T10:48:002021-06-08 BBC4591001SEC4591001 1091 10911442ASCRN Screening ASCREENING 2020-12-18 2020-12-18T11:10:00AAC4591001SEC4591001 1091 10911442A VAXP Placebo A VACCINATION 2020-12-18T11:10:002021-02-08 AB5C4591001SEC4591001 1091 10911442A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-18 B5BC4591001SEC4591001 1091 10911442A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T10:49:00BBC4591001SEC4591001 1091 10911442APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T10:49:002021-06-08 BBC4591001SEC4591001 1091 10911443ASCRN Screening ASCREENING 2020-12-21 2020-12-21T15:14:00AAC4591001SEC4591001 1091 10911443A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T15:14:002021-02-12 AB6C4591001SEC4591001 1091 10911443A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-08-12 B6BC4591001SEC4591001 1091 10911444ASCRN Screening ASCREENING 2020-12-21 2020-12-21T14:51:00AAC4591001SEC4591001 1091 10911444A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T14:51:002021-02-08 AB2C4591001SEC4591001 1091 10911444A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-12 B2BC4591001SEC4591001 1091 10911445ASCRN Screening ASCREENING 2020-12-21 2020-12-21T15:16:00AAC4591001SEC4591001 1091 10911445A VAXP Placebo A VACCINATION 2020-12-21T15:16:002021-02-22 AB@C4591001SEC4591001 1091 10911445A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-20 B@BC4591001SEC4591001 1091 10911445A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T18:45:00BBC4591001SEC4591001 1091 10911445APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T18:45:002021-07-12 BBC4591001SEC4591001 1091 10911445A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1091 10911446ASCRN Screening ASCREENING 2020-12-22 2020-12-22T09:38:00AAC4591001SEC4591001 1091 10911446A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T09:38:002021-02-10 AB3C4591001SEC4591001 1091 10911446A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-08-31 B3BC4591001SEC4591001 1091 10911447ASCRN Screening ASCREENING 2020-12-22 2020-12-22T10:41:00AAC4591001SEC4591001 1091 10911447A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T10:41:002021-02-15 AB8C4591001SEC4591001 1091 10911447A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-08 B8BC4591001SEC4591001 1091 10911448ASCRN Screening ASCREENING 2020-12-22 2020-12-22T10:42:00AAC4591001SEC4591001 1091 10911448A VAXP Placebo A VACCINATION 2020-12-22T10:42:002021-02-15 AB8C4591001SEC4591001 1091 10911448A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-17 B8BC4591001SEC4591001 1091 10911448A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-18T08:29:00BBC4591001SEC4591001 1091 10911448APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T08:29:002021-07-06 BBC4591001SEC4591001 1091 10911448A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1091 10911449ASCRN Screening ASCREENING 2020-12-22 2020-12-22T11:29:00AAC4591001SEC4591001 1091 10911449A VAXP Placebo A VACCINATION 2020-12-22T11:29:002021-02-08 AB1C4591001SEC4591001 1091 10911449A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-14 B1BC4591001SEC4591001 1091 10911450ASCRN Screening ASCREENING 2020-12-22 2020-12-22T15:22:00AAC4591001SEC4591001 1091 10911450A VAXP Placebo A VACCINATION 2020-12-22T15:22:002021-02-17 AB:C4591001SEC4591001 1091 10911450A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-21 B:BC4591001SEC4591001 1091 10911450A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T09:31:00BBC4591001SEC4591001 1091 10911450APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T09:31:002021-07-07 BBC4591001SEC4591001 1091 10911450A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1091 10911451ASCRN Screening ASCREENING 2020-12-22 2021-01-04 AAC4591001SEC4591001 1091 10911452ASCRN Screening ASCREENING 2020-12-22 2020-12-22T16:41:00AAC4591001SEC4591001 1091 10911452A VAXP Placebo A VACCINATION 2020-12-22T16:41:002021-02-10 AB3C4591001SEC4591001 1091 10911452A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-20 B3BC4591001SEC4591001 1091 10911452A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T17:57:00BBC4591001SEC4591001 1091 10911452APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T17:57:002021-07-12 BBC4591001SEC4591001 1091 10911452A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1091 10911453ASCRN Screening ASCREENING 2020-12-22 2020-12-22T16:13:00AAC4591001SEC4591001 1091 10911453A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T16:13:002021-02-17 AB:C4591001SEC4591001 1091 10911453A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-13 B:BC4591001SEC4591001 1091 10911454ASCRN Screening ASCREENING 2020-12-28 2020-12-28T15:55:00AAC4591001SEC4591001 1091 10911454A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T15:55:002021-02-15 AB2C4591001SEC4591001 1091 10911454A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-21 B2BC4591001SEC4591001 1091 10911455ASCRN Screening ASCREENING 2020-12-29 2020-12-29T10:38:00AAC4591001SEC4591001 1091 10911455A VAXP Placebo A VACCINATION 2020-12-29T10:38:002021-02-26 AB<C4591001SEC4591001 1091 10911455A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-26 B<BC4591001SEC4591001 1091 10911456ASCRN Screening ASCREENING 2020-12-29 2020-12-29T16:52:00AAC4591001SEC4591001 1091 10911456A VAXP Placebo A VACCINATION 2020-12-29T16:52:002021-02-15 AB1C4591001SEC4591001 1091 10911456A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-15 B1BC4591001SEC4591001 1091 10911457ASCRN Screening ASCREENING 2020-12-29 2020-12-29T16:53:00AAC4591001SEC4591001 1091 10911457A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T16:53:002021-02-15 AB1C4591001SEC4591001 1091 10911457A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-15 B1BC4591001SEC4591001 1091 10911458ASCRN Screening ASCREENING 2020-12-29 2020-12-29T16:48:00AAC4591001SEC4591001 1091 10911458A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T16:48:002021-02-18 AB4C4591001SEC4591001 1091 10911458A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-07-13 B4BC4591001SEC4591001 1091 10911459ASCRN Screening ASCREENING 2020-12-29 2020-12-29T16:49:00AAC4591001SEC4591001 1091 10911459A VAXP Placebo A VACCINATION 2020-12-29T16:49:002021-02-18 AB4C4591001SEC4591001 1091 10911459A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-05-20 B4BC4591001SEC4591001 1091 10911459A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T16:41:00BBC4591001SEC4591001 1091 10911459APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T16:41:002021-07-13 BBC4591001SEC4591001 1091 10911459A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1091 10911460ASCRN Screening ASCREENING 2020-12-30 2020-12-30T12:15:00AAC4591001SEC4591001 1091 10911460A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T12:15:002021-02-17 AB2C4591001SEC4591001 1091 10911460A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-13 B2BC4591001SEC4591001 1091 10911461ASCRN Screening ASCREENING 2020-12-30 2020-12-30T12:16:00AAC4591001SEC4591001 1091 10911461A VAXP Placebo A VACCINATION 2020-12-30T12:16:002021-02-17 AB2C4591001SEC4591001 1091 10911461A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-13 B2BC4591001SEC4591001 1091 10911462ASCRN Screening ASCREENING 2021-01-04 2021-01-04T11:30:00AAC4591001SEC4591001 1091 10911462A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T11:30:002021-02-24 AB4C4591001SEC4591001 1091 10911462A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-27 B4BC4591001SEC4591001 1091 10911463ASCRN Screening ASCREENING 2021-01-04 2021-01-04T16:35:00AAC4591001SEC4591001 1091 10911463A VAXP Placebo A VACCINATION 2021-01-04T16:35:002021-02-25 AB5C4591001SEC4591001 1091 10911463A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-17 B5BC4591001SEC4591001 1091 10911463A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T17:37:00BBC4591001SEC4591001 1091 10911463APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T17:37:002021-07-07 BBC4591001SEC4591001 1091 10911463A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1091 10911464ASCRN Screening ASCREENING 2021-01-04 2021-01-04T16:37:00AAC4591001SEC4591001 1091 10911464A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T16:37:002021-02-25 AB5C4591001SEC4591001 1091 10911464A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-07-29 B5BC4591001SEC4591001 1091 10911465ASCRN Screening ASCREENING 2021-01-05 2021-01-05T11:32:00AAC4591001SEC4591001 1091 10911465A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T11:32:002021-02-24 AB3C4591001SEC4591001 1091 10911465A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-08-02 B3BC4591001SEC4591001 1091 10911466ASCRN Screening ASCREENING 2021-01-11 2021-01-11T15:19:00AAC4591001SEC4591001 1091 10911466A VAXP Placebo A VACCINATION 2021-01-11T15:19:002021-03-08 AB9C4591001SEC4591001 1091 10911466A0FUP Follow-up A0FOLLOW-UP 2021-03-08 2021-05-17 B9BC4591001SEC4591001 1091 10911466A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-18T17:05:00BBC4591001SEC4591001 1091 10911466APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T17:05:002021-07-20 BBC4591001SEC4591001 1091 10911466A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-20 2021-07-20 BBC4591001SEC4591001 1123 11231422ASCRN Screening ASCREENING 2020-12-01 2020-12-01T09:44:00AAC4591001SEC4591001 1123 11231422A VAXP Placebo A VACCINATION 2020-12-01T09:44:002021-01-18 AB1C4591001SEC4591001 1123 11231422A0FUP Follow-up A0FOLLOW-UP 2021-01-18 2021-06-09 B1BC4591001SEC4591001 1123 11231425ASCRN Screening ASCREENING 2020-12-02 2020-12-02T09:38:00AAC4591001SEC4591001 1123 11231425A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T09:38:002021-01-18 AB0C4591001SEC4591001 1123 11231425A0FUP Follow-up A0FOLLOW-UP 2021-01-18 2021-06-28 B0BC4591001SEC4591001 1123 11231428ASCRN Screening ASCREENING 2020-12-03 2020-12-03T15:10:00AAC4591001SEC4591001 1123 11231428A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-03T15:10:002021-01-19 AB0C4591001SEC4591001 1123 11231428A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-06-15 B0BC4591001SEC4591001 1123 11231431ASCRN Screening ASCREENING 2020-12-04 2020-12-04T09:41:00AAC4591001SEC4591001 1123 11231431A VAXP Placebo A VACCINATION 2020-12-04T09:41:002021-01-25 AB5C4591001SEC4591001 1123 11231431A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-05-18 B5BC4591001SEC4591001 1123 11231431A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T16:36:00BBC4591001SEC4591001 1123 11231431APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T16:36:002021-07-07 BBC4591001SEC4591001 1123 11231431A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1123 11231432ASCRN Screening ASCREENING 2020-12-04 2020-12-04T09:39:00AAC4591001SEC4591001 1123 11231432A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-04T09:39:002021-01-25 AB5C4591001SEC4591001 1123 11231432A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-06-18 B5BC4591001SEC4591001 1123 11231434ASCRN Screening ASCREENING 2020-12-07 2020-12-07T10:15:00AAC4591001SEC4591001 1123 11231434A VAXP Placebo A VACCINATION 2020-12-07T10:15:002021-01-29 AB6C4591001SEC4591001 1123 11231434A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-05-13 B6BC4591001SEC4591001 1123 11231438ASCRN Screening ASCREENING 2020-12-08 2020-12-08T10:33:00AAC4591001SEC4591001 1123 11231438A VAXP Placebo A VACCINATION 2020-12-08T10:33:002021-02-04 AB;C4591001SEC4591001 1123 11231438A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-06-15 B;BC4591001SEC4591001 1123 11231439ASCRN Screening ASCREENING 2020-12-08 2020-12-08T10:31:00AAC4591001SEC4591001 1123 11231439A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T10:31:002021-02-04 AB;C4591001SEC4591001 1123 11231439A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-07-07 B;BC4591001SEC4591001 1123 11231440ASCRN Screening ASCREENING 2020-12-09 2020-12-09T09:38:00AAC4591001SEC4591001 1123 11231440A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T09:38:002021-01-25 AB0C4591001SEC4591001 1123 11231440A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-06-28 B0BC4591001SEC4591001 1123 11231441ASCRN Screening ASCREENING 2020-12-09 2020-12-09T11:58:00AAC4591001SEC4591001 1123 11231441A VAXP Placebo A VACCINATION 2020-12-09T11:58:002021-02-05 AB;C4591001SEC4591001 1123 11231441A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-10 B;BC4591001SEC4591001 1123 11231442ASCRN Screening ASCREENING 2020-12-09 2020-12-09T12:33:00AAC4591001SEC4591001 1123 11231442A VAXP Placebo A VACCINATION 2020-12-09T12:33:002021-02-01 AB7C4591001SEC4591001 1123 11231442A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-26 B7BC4591001SEC4591001 1123 11231442A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T15:00:00BBC4591001SEC4591001 1123 11231442APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T15:00:002021-07-23 BBC4591001SEC4591001 1123 11231442A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-23 2021-07-23 BBC4591001SEC4591001 1123 11231443ASCRN Screening ASCREENING 2020-12-09 2020-12-09T12:31:00AAC4591001SEC4591001 1123 11231443A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T12:31:002021-02-01 AB7C4591001SEC4591001 1123 11231443A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-07-06 B7BC4591001SEC4591001 1123 11231445ASCRN Screening ASCREENING 2020-12-09 2020-12-09T14:35:00AAC4591001SEC4591001 1123 11231445A VAXP Placebo A VACCINATION 2020-12-09T14:35:002021-01-27 AB2C4591001SEC4591001 1123 11231445A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-10 B2BC4591001SEC4591001 1123 11231446ASCRN Screening ASCREENING 2020-12-09 2020-12-09T14:55:00AAC4591001SEC4591001 1123 11231446A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-09T14:55:002021-01-27 AB2C4591001SEC4591001 1123 11231446A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-30 B2BC4591001SEC4591001 1123 11231447ASCRN Screening ASCREENING 2020-12-10 2020-12-10T15:13:00AAC4591001SEC4591001 1123 11231447A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T15:13:002021-02-01 AB6C4591001SEC4591001 1123 11231447A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-06-30 B6BC4591001SEC4591001 1123 11231448ASCRN Screening ASCREENING 2020-12-11 2020-12-11T09:05:00AAC4591001SEC4591001 1123 11231448A VAXP Placebo A VACCINATION 2020-12-11T09:05:002021-02-03 AB7C4591001SEC4591001 1123 11231448A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-04-20 B7BC4591001SEC4591001 1123 11231449ASCRN Screening ASCREENING 2020-12-11 2020-12-11T10:14:00AAC4591001SEC4591001 1123 11231449A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-11T10:14:002021-01-29 AB2C4591001SEC4591001 1123 11231449A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-08-27 B2C@C4591001SEC4591001 1123 11231450ASCRN Screening ASCREENING 2020-12-11 2020-12-11T10:43:00AAC4591001SEC4591001 1123 11231450A VAXP Placebo A VACCINATION 2020-12-11T10:43:002021-01-29 AB2C4591001SEC4591001 1123 11231450A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-05-26 B2BC4591001SEC4591001 1123 11231450A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T15:45:00BBC4591001SEC4591001 1123 11231450APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T15:45:002021-07-14 BBC4591001SEC4591001 1123 11231450A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-07-14 BBC4591001SEC4591001 1123 11231451ASCRN Screening ASCREENING 2020-12-15 2020-12-15T09:45:00AAC4591001SEC4591001 1123 11231451A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T09:45:002021-02-04 AB4C4591001SEC4591001 1123 11231451A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-06-28 B4BC4591001SEC4591001 1123 11231452ASCRN Screening ASCREENING 2020-12-15 2020-12-15T14:58:00AAC4591001SEC4591001 1123 11231452A VAXP Placebo A VACCINATION 2020-12-15T14:58:002021-02-01 AB1C4591001SEC4591001 1123 11231452A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-07 B1BC4591001SEC4591001 1123 11231452A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-07 2021-05-07T11:37:00BBC4591001SEC4591001 1123 11231452APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-07T11:37:002021-06-30 BBC4591001SEC4591001 1123 11231452A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-30 2021-06-30 BBC4591001SEC4591001 1123 11231453ASCRN Screening ASCREENING 2020-12-15 2020-12-15T15:13:00AAC4591001SEC4591001 1123 11231453A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T15:13:002021-02-08 AB8C4591001SEC4591001 1123 11231453A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-13 B8BC4591001SEC4591001 1123 11231454ASCRN Screening ASCREENING 2020-12-15 2020-12-15T15:15:00AAC4591001SEC4591001 1123 11231454A VAXP Placebo A VACCINATION 2020-12-15T15:15:002021-02-08 AB8C4591001SEC4591001 1123 11231454A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-02-20 B8BDC4591001SEC4591001 1123 11231454A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-20 2021-02-20T12:32:00BDBDC4591001SEC4591001 1123 11231454APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-20T12:32:002021-04-12 BDBwC4591001SEC4591001 1123 11231454A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-12 2021-04-12 BwBwC4591001SEC4591001 1123 11231455ASCRN Screening ASCREENING 2020-12-15 2020-12-15T17:09:00AAC4591001SEC4591001 1123 11231455A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T17:09:002021-02-02 AB2C4591001SEC4591001 1123 11231455A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-06-29 B2BC4591001SEC4591001 1123 11231456ASCRN Screening ASCREENING 2020-12-16 2020-12-16T09:53:00AAC4591001SEC4591001 1123 11231456A VAXP Placebo A VACCINATION 2020-12-16T09:53:002021-02-02 AB1C4591001SEC4591001 1123 11231456A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-18 B1BC4591001SEC4591001 1123 11231456A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T09:31:00BBC4591001SEC4591001 1123 11231456APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T09:31:002021-07-06 BBC4591001SEC4591001 1123 11231456A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1123 11231457ASCRN Screening ASCREENING 2020-12-16 2020-12-16T12:56:00AAC4591001SEC4591001 1123 11231457A VAXP Placebo A VACCINATION 2020-12-16T12:56:002021-02-01 AB0C4591001SEC4591001 1123 11231457A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-14 B0BC4591001SEC4591001 1123 11231457A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T10:45:00BBC4591001SEC4591001 1123 11231457APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T10:45:002021-07-02 BBC4591001SEC4591001 1123 11231457A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1123 11231458ASCRN Screening ASCREENING 2020-12-16 2020-12-16T14:41:00AAC4591001SEC4591001 1123 11231458A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T14:41:002021-02-01 AB0C4591001SEC4591001 1123 11231458A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-08-11 B0BC4591001SEC4591001 1123 11231459ASCRN Screening ASCREENING 2020-12-16 2020-12-16T15:43:00AAC4591001SEC4591001 1123 11231459A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T15:43:002021-02-01 AB0C4591001SEC4591001 1123 11231459A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-07-12 B0BC4591001SEC4591001 1123 11231460ASCRN Screening ASCREENING 2020-12-17 2020-12-17T12:41:00AAC4591001SEC4591001 1123 11231460A VAXP Placebo A VACCINATION 2020-12-17T12:41:002021-02-05 AB3C4591001SEC4591001 1123 11231460A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-02-17 B3B?C4591001SEC4591001 1123 11231460A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-17 2021-02-17T17:01:00B?B?C4591001SEC4591001 1123 11231460APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-17T17:01:002021-04-08 B?BqC4591001SEC4591001 1123 11231460A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-08 2021-04-08 BqBqC4591001SEC4591001 1123 11231461ASCRN Screening ASCREENING 2020-12-17 2020-12-17T12:59:00AAC4591001SEC4591001 1123 11231461A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T12:59:002021-02-03 AB1C4591001SEC4591001 1123 11231461A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-29 B1BC4591001SEC4591001 1123 11231462ASCRN Screening ASCREENING 2020-12-17 2020-12-17T15:18:00AAC4591001SEC4591001 1123 11231462A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T15:18:002021-02-08 AB6C4591001SEC4591001 1123 11231462A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-02 B6BC4591001SEC4591001 1123 11231463ASCRN Screening ASCREENING 2020-12-18 2020-12-18T12:52:00AAC4591001SEC4591001 1123 11231463A VAXP Placebo A VACCINATION 2020-12-18T12:52:002021-02-04 AB1C4591001SEC4591001 1123 11231463A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-26 B1BC4591001SEC4591001 1123 11231463A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T14:31:00BBC4591001SEC4591001 1123 11231463APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T14:31:002021-07-16 BBC4591001SEC4591001 1123 11231463A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-16 2021-07-16 BBC4591001SEC4591001 1123 11231465ASCRN Screening ASCREENING 2020-12-18 2020-12-18T14:38:00AAC4591001SEC4591001 1123 11231465A VAXP Placebo A VACCINATION 2020-12-18T14:38:002021-02-10 AB7C4591001SEC4591001 1123 11231465A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-21 B7BC4591001SEC4591001 1123 11231465A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T14:10:00BBC4591001SEC4591001 1123 11231465APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T14:10:002021-07-07 BBC4591001SEC4591001 1123 11231465A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1123 11231466ASCRN Screening ASCREENING 2020-12-18 2020-12-18T15:24:00AAC4591001SEC4591001 1123 11231466A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T15:24:002021-02-03 AB0C4591001SEC4591001 1123 11231466A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-30 B0BC4591001SEC4591001 1123 11231467ASCRN Screening ASCREENING 2020-12-21 2020-12-21T09:18:00AAC4591001SEC4591001 1123 11231467A VAXP Placebo A VACCINATION 2020-12-21T09:18:002021-02-15 AB9C4591001SEC4591001 1123 11231467A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-14 B9BC4591001SEC4591001 1123 11231467A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T10:59:00BBC4591001SEC4591001 1123 11231467APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T10:59:002021-06-30 BBC4591001SEC4591001 1123 11231467A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-30 2021-06-30 BBC4591001SEC4591001 1123 11231468ASCRN Screening ASCREENING 2020-12-21 2020-12-21T09:21:00AAC4591001SEC4591001 1123 11231468A VAXP Placebo A VACCINATION 2020-12-21T09:21:002021-02-09 AB3C4591001SEC4591001 1123 11231468A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-06-04 B3BC4591001SEC4591001 1123 11231468A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-04 2021-06-04T10:06:00BBC4591001SEC4591001 1123 11231468APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-04T10:06:002021-07-23 BBC4591001SEC4591001 1123 11231468A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-23 2021-08-13 BBC4591001SEC4591001 1123 11231469ASCRN Screening ASCREENING 2020-12-21 2020-12-21T11:29:00AAC4591001SEC4591001 1123 11231469A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T11:29:002021-02-11 AB5C4591001SEC4591001 1123 11231469A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-07-16 B5BC4591001SEC4591001 1123 11231470ASCRN Screening ASCREENING 2020-12-21 2020-12-21T12:14:00AAC4591001SEC4591001 1123 11231470A VAXP Placebo A VACCINATION 2020-12-21T12:14:002021-02-10 AB4C4591001SEC4591001 1123 11231470A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-26 B4BC4591001SEC4591001 1123 11231470A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T14:06:00BBC4591001SEC4591001 1123 11231470APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T14:06:002021-07-15 BBC4591001SEC4591001 1123 11231470A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-15 2021-07-15 BBC4591001SEC4591001 1123 11231472ASCRN Screening ASCREENING 2020-12-21 2020-12-21T12:49:00AAC4591001SEC4591001 1123 11231472A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T12:49:002021-02-16 AB:C4591001SEC4591001 1123 11231472A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-07-06 B:BC4591001SEC4591001 1123 11231473ASCRN Screening ASCREENING 2020-12-21 2020-12-21T12:53:00AAC4591001SEC4591001 1123 11231473A VAXP Placebo A VACCINATION 2020-12-21T12:53:002021-02-09 AB3C4591001SEC4591001 1123 11231473A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-05-18 B3BC4591001SEC4591001 1123 11231473A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T16:57:00BBC4591001SEC4591001 1123 11231473APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T16:57:002021-07-06 BBC4591001SEC4591001 1123 11231473A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1123 11231474ASCRN Screening ASCREENING 2020-12-21 2020-12-21T15:03:00AAC4591001SEC4591001 1123 11231474A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T15:03:002021-02-15 AB9C4591001SEC4591001 1123 11231474A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-18 B9BC4591001SEC4591001 1123 11231475ASCRN Screening ASCREENING 2020-12-21 2020-12-21T15:01:00AAC4591001SEC4591001 1123 11231475A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T15:01:002021-02-15 AB9C4591001SEC4591001 1123 11231475A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-18 B9BC4591001SEC4591001 1123 11231476ASCRN Screening ASCREENING 2020-12-21 2020-12-21T15:35:00AAC4591001SEC4591001 1123 11231476A VAXP Placebo A VACCINATION 2020-12-21T15:35:002021-02-08 AB2C4591001SEC4591001 1123 11231476A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-14 B2BC4591001SEC4591001 1123 11231476A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T12:15:00BBC4591001SEC4591001 1123 11231476APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T12:15:002021-06-30 BBC4591001SEC4591001 1123 11231476A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-30 2021-06-30 BBC4591001SEC4591001 1123 11231477ASCRN Screening ASCREENING 2020-12-21 2020-12-21T16:33:00AAC4591001SEC4591001 1123 11231477A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T16:33:002021-02-08 AB2C4591001SEC4591001 1123 11231477A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-19 B2BC4591001SEC4591001 1123 11231478ASCRN Screening ASCREENING 2020-12-21 2020-12-21T16:35:00AAC4591001SEC4591001 1123 11231478A VAXP Placebo A VACCINATION 2020-12-21T16:35:002021-02-08 AB2C4591001SEC4591001 1123 11231478A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-06-09 B2BC4591001SEC4591001 1123 11231479ASCRN Screening ASCREENING 2020-12-21 2020-12-21T15:58:00AAC4591001SEC4591001 1123 11231479A VAXP Placebo A VACCINATION 2020-12-21T15:58:002021-02-15 AB9C4591001SEC4591001 1123 11231479A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-14 B9BC4591001SEC4591001 1123 11231481ASCRN Screening ASCREENING 2020-12-21 2020-12-21T17:02:00AAC4591001SEC4591001 1123 11231481A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T17:02:002021-02-10 AB4C4591001SEC4591001 1123 11231481A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-08-03 B4BC4591001SEC4591001 1123 11231482ASCRN Screening ASCREENING 2020-12-22 2020-12-22T09:20:00AAC4591001SEC4591001 1123 11231482A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T09:20:002021-02-12 AB5C4591001SEC4591001 1123 11231482A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-09 B5BC4591001SEC4591001 1123 11231483ASCRN Screening ASCREENING 2020-12-22 2020-12-22T09:54:00AAC4591001SEC4591001 1123 11231483A VAXP Placebo A VACCINATION 2020-12-22T09:54:002021-02-09 AB2C4591001SEC4591001 1123 11231483A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-06-10 B2BC4591001SEC4591001 1123 11231484ASCRN Screening ASCREENING 2020-12-22 2020-12-22T10:18:00AAC4591001SEC4591001 1123 11231484A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T10:18:002021-02-12 AB5C4591001SEC4591001 1123 11231484A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-16 B5BC4591001SEC4591001 1123 11231485ASCRN Screening ASCREENING 2020-12-22 2020-12-22T11:19:00AAC4591001SEC4591001 1123 11231485A VAXP Placebo A VACCINATION 2020-12-22T11:19:002021-02-09 AB2C4591001SEC4591001 1123 11231485A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-06-02 B2BC4591001SEC4591001 1123 11231485A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-02 2021-06-02T09:53:00BBC4591001SEC4591001 1123 11231485APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-02T09:53:002021-07-23 BBC4591001SEC4591001 1123 11231485A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-23 2021-07-23 BBC4591001SEC4591001 1123 11231486ASCRN Screening ASCREENING 2020-12-22 2020-12-22T11:43:00AAC4591001SEC4591001 1123 11231486A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T11:43:002021-02-08 AB1C4591001SEC4591001 1123 11231486A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-21 B1BC4591001SEC4591001 1123 11231487ASCRN Screening ASCREENING 2020-12-22 2020-12-22T11:22:00AAC4591001SEC4591001 1123 11231487A VAXP Placebo A VACCINATION 2020-12-22T11:22:002021-02-10 AB3C4591001SEC4591001 1123 11231487A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-26 B3BC4591001SEC4591001 1123 11231487A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T16:13:00BBC4591001SEC4591001 1123 11231487APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T16:13:002021-07-15 BBC4591001SEC4591001 1123 11231487A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-15 2021-07-15 BBC4591001SEC4591001 1123 11231488ASCRN Screening ASCREENING 2020-12-22 2020-12-22T14:48:00AAC4591001SEC4591001 1123 11231488A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T14:48:002021-02-17 AB:C4591001SEC4591001 1123 11231488A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-12 B:BC4591001SEC4591001 1123 11231489ASCRN Screening ASCREENING 2020-12-22 2020-12-22T15:22:00AAC4591001SEC4591001 1123 11231489A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T15:22:002021-02-12 AB5C4591001SEC4591001 1123 11231489A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-25 B5BC4591001SEC4591001 1123 11231491ASCRN Screening ASCREENING 2020-12-22 2020-12-22T16:02:00AAC4591001SEC4591001 1123 11231491A VAXP Placebo A VACCINATION 2020-12-22T16:02:002021-02-12 AB5C4591001SEC4591001 1123 11231491A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-06-09 B5BC4591001SEC4591001 1123 11231492ASCRN Screening ASCREENING 2020-12-23 2020-12-23T10:13:00AAC4591001SEC4591001 1123 11231492A VAXP Placebo A VACCINATION 2020-12-23T10:13:002021-02-11 AB3C4591001SEC4591001 1123 11231492A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-05-18 B3BC4591001SEC4591001 1123 11231492A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T16:30:00BBC4591001SEC4591001 1123 11231492APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T16:30:002021-07-07 BBC4591001SEC4591001 1123 11231492A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1123 11231493ASCRN Screening ASCREENING 2020-12-23 2020-12-23T10:51:00AAC4591001SEC4591001 1123 11231493A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T10:51:002021-02-12 AB4C4591001SEC4591001 1123 11231493A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-14 B4BC4591001SEC4591001 1123 11231494ASCRN Screening ASCREENING 2020-12-23 2020-12-23T11:28:00AAC4591001SEC4591001 1123 11231494A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T11:28:002021-02-11 AB3C4591001SEC4591001 1123 11231494A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-07-12 B3BC4591001SEC4591001 1123 11231495ASCRN Screening ASCREENING 2020-12-23 2020-12-23T12:04:00AAC4591001SEC4591001 1123 11231495A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T12:04:002021-02-10 AB2C4591001SEC4591001 1123 11231495A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-15 B2BC4591001SEC4591001 1123 11231496ASCRN Screening ASCREENING 2020-12-23 2020-12-23T12:03:00AAC4591001SEC4591001 1123 11231496A VAXP Placebo A VACCINATION 2020-12-23T12:03:002021-02-10 AB2C4591001SEC4591001 1123 11231496A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-25 B2BC4591001SEC4591001 1123 11231496A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T16:01:00BBC4591001SEC4591001 1123 11231496APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T16:01:002021-07-14 BBC4591001SEC4591001 1123 11231496A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-07-14 BBC4591001SEC4591001 1123 11231497ASCRN Screening ASCREENING 2020-12-23 2020-12-23T12:53:00AAC4591001SEC4591001 1123 11231497A VAXP Placebo A VACCINATION 2020-12-23T12:53:002021-02-18 AB:C4591001SEC4591001 1123 11231497A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-05-28 B:BC4591001SEC4591001 1123 11231497A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-28 2021-05-28T16:24:00BBC4591001SEC4591001 1123 11231497APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-28T16:24:002021-07-20 BBC4591001SEC4591001 1123 11231497A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-20 2021-07-20 BBC4591001SEC4591001 1123 11231499ASCRN Screening ASCREENING 2020-12-28 2020-12-28T10:13:00AAC4591001SEC4591001 1123 11231499A VAXP Placebo A VACCINATION 2020-12-28T10:13:002021-02-15 AB2C4591001SEC4591001 1123 11231499A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-14 B2BC4591001SEC4591001 1123 11231499A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T10:05:00BBC4591001SEC4591001 1123 11231499APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T10:05:002021-06-30 BBC4591001SEC4591001 1123 11231499A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-30 2021-06-30 BBC4591001SEC4591001 1123 11231500ASCRN Screening ASCREENING 2020-12-28 2020-12-28T10:39:00AAC4591001SEC4591001 1123 11231500A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T10:39:002021-02-15 AB2C4591001SEC4591001 1123 11231500A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-06-15 B2BC4591001SEC4591001 1123 11231501ASCRN Screening ASCREENING 2020-12-28 2020-12-28T12:31:00AAC4591001SEC4591001 1123 11231501A VAXP Placebo A VACCINATION 2020-12-28T12:31:002021-03-22 ABUC4591001SEC4591001 1123 11231501A0FUP Follow-up A0FOLLOW-UP 2021-03-22 2021-05-21 BUBC4591001SEC4591001 1123 11231501A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T15:44:00BBC4591001SEC4591001 1123 11231501APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T15:44:002021-07-09 BBC4591001SEC4591001 1123 11231501A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1123 11231502ASCRN Screening ASCREENING 2020-12-28 2020-12-28T12:33:00AAC4591001SEC4591001 1123 11231502A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T12:33:002021-02-18 AB5C4591001SEC4591001 1123 11231502A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-07-13 B5BC4591001SEC4591001 1123 11231503ASCRN Screening ASCREENING 2020-12-28 2020-12-28T12:20:00AAC4591001SEC4591001 1123 11231503A VAXP Placebo A VACCINATION 2020-12-28T12:20:002021-02-18 AB5C4591001SEC4591001 1123 11231503A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-05-21 B5BC4591001SEC4591001 1123 11231503A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T14:10:00BBC4591001SEC4591001 1123 11231503APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T14:10:002021-07-08 BBC4591001SEC4591001 1123 11231503A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1123 11231504ASCRN Screening ASCREENING 2020-12-28 2020-12-28T15:30:00AAC4591001SEC4591001 1123 11231504A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T15:30:002021-02-17 AB4C4591001SEC4591001 1123 11231504A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-19 B4BC4591001SEC4591001 1123 11231505ASCRN Screening ASCREENING 2020-12-28 2020-12-28T15:31:00AAC4591001SEC4591001 1123 11231505A VAXP Placebo A VACCINATION 2020-12-28T15:31:002021-02-17 AB4C4591001SEC4591001 1123 11231505A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-06-01 B4BC4591001SEC4591001 1123 11231505A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-01 2021-06-01T10:48:00BBC4591001SEC4591001 1123 11231505APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-01T10:48:002021-07-20 BBC4591001SEC4591001 1123 11231505A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-20 2021-07-20 BBC4591001SEC4591001 1123 11231506ASCRN Screening ASCREENING 2020-12-28 2020-12-28T16:01:00AAC4591001SEC4591001 1123 11231506A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T16:01:002021-02-15 AB2C4591001SEC4591001 1123 11231506A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-08-31 B2BC4591001SEC4591001 1123 11231507ASCRN Screening ASCREENING 2020-12-28 2020-12-28T16:52:00AAC4591001SEC4591001 1123 11231507A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T16:52:002021-02-16 AB3C4591001SEC4591001 1123 11231507A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-05-26 B3BC4591001SEC4591001 1123 11231508ASCRN Screening ASCREENING 2020-12-28 2020-12-28T16:53:00AAC4591001SEC4591001 1123 11231508A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T16:53:002021-02-19 AB6C4591001SEC4591001 1123 11231508A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-07-14 B6BC4591001SEC4591001 1123 11231509ASCRN Screening ASCREENING 2020-12-29 2020-12-29T12:04:00AAC4591001SEC4591001 1123 11231509A VAXP Placebo A VACCINATION 2020-12-29T12:04:002021-02-25 AB;C4591001SEC4591001 1123 11231509A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-26 B;BC4591001SEC4591001 1123 11231509A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T16:17:00BBC4591001SEC4591001 1123 11231509APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T16:17:002021-07-15 BBC4591001SEC4591001 1123 11231509A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-15 2021-07-15 BBC4591001SEC4591001 1123 11231510ASCRN Screening ASCREENING 2020-12-29 2020-12-29T12:42:00AAC4591001SEC4591001 1123 11231510A VAXP Placebo A VACCINATION 2020-12-29T12:42:002021-02-17 AB3C4591001SEC4591001 1123 11231510A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-25 B3BC4591001SEC4591001 1123 11231510A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T15:23:00BBC4591001SEC4591001 1123 11231510APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T15:23:002021-07-15 BBC4591001SEC4591001 1123 11231510A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-15 2021-07-15 BBC4591001SEC4591001 1123 11231511ASCRN Screening ASCREENING 2020-12-30 2020-12-30T10:16:00AAC4591001SEC4591001 1123 11231511A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T10:16:002021-02-22 AB7C4591001SEC4591001 1123 11231511A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-10 B7BC4591001SEC4591001 1123 11231512ASCRN Screening ASCREENING 2020-12-30 2020-12-30T10:17:00AAC4591001SEC4591001 1123 11231512A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T10:17:002021-02-22 AB7C4591001SEC4591001 1123 11231512A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-10 B7BC4591001SEC4591001 1123 11231513ASCRN Screening ASCREENING 2020-12-30 2020-12-30T10:40:00AAC4591001SEC4591001 1123 11231513A VAXP Placebo A VACCINATION 2020-12-30T10:40:002021-02-23 AB8C4591001SEC4591001 1123 11231513A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-06-11 B8BC4591001SEC4591001 1123 11231513A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-11 2021-06-11T10:58:00BBC4591001SEC4591001 1123 11231513APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-11T10:58:002021-07-28 BBC4591001SEC4591001 1123 11231513A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-28 2021-07-28 BBC4591001SEC4591001 1123 11231514ASCRN Screening ASCREENING 2020-12-30 2020-12-30T14:10:00AAC4591001SEC4591001 1123 11231514A VAXP Placebo A VACCINATION 2020-12-30T14:10:002021-02-18 AB3C4591001SEC4591001 1123 11231514A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-05-25 B3BC4591001SEC4591001 1123 11231514A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T11:23:00BBC4591001SEC4591001 1123 11231514APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T11:23:002021-07-15 BBC4591001SEC4591001 1123 11231514A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-15 2021-07-15 BBC4591001SEC4591001 1123 11231515ASCRN Screening ASCREENING 2020-12-30 2020-12-30T15:53:00AAC4591001SEC4591001 1123 11231515A VAXP Placebo A VACCINATION 2020-12-30T15:53:002021-02-15 AB0C4591001SEC4591001 1123 11231515A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-28 B0BC4591001SEC4591001 1123 11231516ASCRN Screening ASCREENING 2020-12-30 2020-12-30T16:18:00AAC4591001SEC4591001 1123 11231516A VAXP Placebo A VACCINATION 2020-12-30T16:18:002021-02-18 AB3C4591001SEC4591001 1123 11231516A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-06-15 B3BC4591001SEC4591001 1123 11231516A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-15 2021-06-15T16:04:00BBC4591001SEC4591001 1123 11231516APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-15T16:04:002021-08-12 BBC4591001SEC4591001 1123 11231516A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-12 2021-08-12 BBC4591001SEC4591001 1123 11231517ASCRN Screening ASCREENING 2020-12-30 2020-12-30T15:35:00AAC4591001SEC4591001 1123 11231517A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T15:35:002021-02-19 AB4C4591001SEC4591001 1123 11231517A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-07-14 B4BC4591001SEC4591001 1123 11231518ASCRN Screening ASCREENING 2020-12-30 2020-12-30T16:17:00AAC4591001SEC4591001 1123 11231518A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T16:17:002021-02-18 AB3C4591001SEC4591001 1123 11231518A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-07-14 B3BC4591001SEC4591001 1123 11231519ASCRN Screening ASCREENING 2020-12-30 2020-12-30T16:57:00AAC4591001SEC4591001 1123 11231519A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T16:57:002021-02-17 AB2C4591001SEC4591001 1123 11231519A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-14 B2BC4591001SEC4591001 1123 11231520ASCRN Screening ASCREENING 2020-12-30 2020-12-30T17:14:00AAC4591001SEC4591001 1123 11231520A VAXP Placebo A VACCINATION 2020-12-30T17:14:002021-02-15 AB0C4591001SEC4591001 1123 11231520A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-21 B0BC4591001SEC4591001 1123 11231520A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T15:57:00BBC4591001SEC4591001 1123 11231520APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T15:57:002021-07-12 BBC4591001SEC4591001 1123 11231520A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1123 11231521ASCRN Screening ASCREENING 2020-12-30 2020-12-30T17:14:00AAC4591001SEC4591001 1123 11231521A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T17:14:002021-02-15 AB0C4591001SEC4591001 1123 11231521A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-12 B0BC4591001SEC4591001 1123 11231522ASCRN Screening ASCREENING 2021-01-05 2021-01-05T13:59:00AAC4591001SEC4591001 1123 11231522A VAXP Placebo A VACCINATION 2021-01-05T13:59:002021-02-25 AB4C4591001SEC4591001 1123 11231522A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-18 B4BC4591001SEC4591001 1123 11231522A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T12:00:00BBC4591001SEC4591001 1123 11231522APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T12:00:002021-07-07 BBC4591001SEC4591001 1123 11231522A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1123 11231523ASCRN Screening ASCREENING 2021-01-05 2021-01-05T13:59:00AAC4591001SEC4591001 1123 11231523A VAXP Placebo A VACCINATION 2021-01-05T13:59:002021-02-25 AB4C4591001SEC4591001 1123 11231523A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-18 B4BC4591001SEC4591001 1123 11231523A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T12:05:00BBC4591001SEC4591001 1123 11231523APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T12:05:002021-07-07 BBC4591001SEC4591001 1123 11231523A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1123 11231524ASCRN Screening ASCREENING 2021-01-05 2021-01-05T15:44:00AAC4591001SEC4591001 1123 11231524A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T15:44:002021-02-25 AB4C4591001SEC4591001 1123 11231524A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-07-22 B4BC4591001SEC4591001 1123 11231525ASCRN Screening ASCREENING 2021-01-07 2021-01-07T16:34:00AAC4591001SEC4591001 1123 11231525A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T16:34:002021-03-04 AB9C4591001SEC4591001 1123 11231525A0FUP Follow-up A0FOLLOW-UP 2021-03-04 2021-07-28 B9BC4591001SEC4591001 1123 11231526ASCRN Screening ASCREENING 2021-01-08 2021-01-08T09:33:00AAC4591001SEC4591001 1123 11231526A VAXP Placebo A VACCINATION 2021-01-08T09:33:002021-03-03 AB7C4591001SEC4591001 1123 11231526A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-05-25 B7BC4591001SEC4591001 1123 11231526A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T15:52:00BBC4591001SEC4591001 1123 11231526APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T15:52:002021-06-30 BBC4591001SEC4591001 1124 11241236ASCRN Screening ASCREENING 2020-12-14 2020-12-14T11:17:00AAC4591001SEC4591001 1124 11241236A VAXP Placebo A VACCINATION 2020-12-14T11:17:002021-02-01 AB2C4591001SEC4591001 1124 11241236A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-06-01 B2BC4591001SEC4591001 1124 11241238ASCRN Screening ASCREENING 2020-12-14 2020-12-14T15:16:00AAC4591001SEC4591001 1124 11241238A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T15:16:002021-02-03 AB4C4591001SEC4591001 1124 11241238A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-30 B4BC4591001SEC4591001 1124 11241239ASCRN Screening ASCREENING 2020-12-14 2020-12-14T15:21:00AAC4591001SEC4591001 1124 11241239A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T15:21:002021-02-03 AB4C4591001SEC4591001 1124 11241239A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-30 B4BC4591001SEC4591001 1124 11241240ASCRN Screening ASCREENING 2020-12-14 2020-12-14T15:58:00AAC4591001SEC4591001 1124 11241240A VAXP Placebo A VACCINATION 2020-12-14T15:58:002021-02-03 AB4C4591001SEC4591001 1124 11241240A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-05-17 B4BC4591001SEC4591001 1124 11241240A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T16:02:00BBC4591001SEC4591001 1124 11241240APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T16:02:002021-07-14 BBC4591001SEC4591001 1124 11241240A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-07-14 BBC4591001SEC4591001 1124 11241241ASCRN Screening ASCREENING 2020-12-14 2020-12-14T15:57:00AAC4591001SEC4591001 1124 11241241A VAXP Placebo A VACCINATION 2020-12-14T15:57:002021-02-03 AB4C4591001SEC4591001 1124 11241241A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-05-17 B4BC4591001SEC4591001 1124 11241241A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T16:00:00BBC4591001SEC4591001 1124 11241241APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T16:00:002021-07-14 BBC4591001SEC4591001 1124 11241241A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-07-14 BBC4591001SEC4591001 1124 11241242ASCRN Screening ASCREENING 2020-12-14 2020-12-14T17:03:00AAC4591001SEC4591001 1124 11241242A VAXP Placebo A VACCINATION 2020-12-14T17:03:002021-02-04 AB5C4591001SEC4591001 1124 11241242A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-06-21 B5BC4591001SEC4591001 1124 11241243ASCRN Screening ASCREENING 2020-12-15 2020-12-15T13:39:00AAC4591001SEC4591001 1124 11241243A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T13:39:002021-02-09 AB9C4591001SEC4591001 1124 11241243A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-06-29 B9BC4591001SEC4591001 1124 11241244ASCRN Screening ASCREENING 2020-12-15 2020-12-15T14:29:00AAC4591001SEC4591001 1124 11241244A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T14:29:002021-02-08 AB8C4591001SEC4591001 1124 11241244A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-06-29 B8BC4591001SEC4591001 1124 11241245ASCRN Screening ASCREENING 2020-12-15 2020-12-15T17:12:00AAC4591001SEC4591001 1124 11241245A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T17:12:002021-02-11 AB;C4591001SEC4591001 1124 11241245A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-07-14 B;BC4591001SEC4591001 1124 11241246ASCRN Screening ASCREENING 2020-12-15 2020-12-15T17:10:00AAC4591001SEC4591001 1124 11241246A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T17:10:002021-02-11 AB;C4591001SEC4591001 1124 11241246A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-06-30 B;BC4591001SEC4591001 1124 11241247ASCRN Screening ASCREENING 2020-12-16 2020-12-16T09:40:00AAC4591001SEC4591001 1124 11241247A VAXP Placebo A VACCINATION 2020-12-16T09:40:002021-02-10 AB9C4591001SEC4591001 1124 11241247A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-06-29 B9BC4591001SEC4591001 1124 11241247A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-29 2021-06-29T16:56:00BBC4591001SEC4591001 1124 11241247APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-29T16:56:002021-07-22 BBC4591001SEC4591001 1124 11241248ASCRN Screening ASCREENING 2020-12-16 2020-12-16T10:40:00AAC4591001SEC4591001 1124 11241248A VAXP Placebo A VACCINATION 2020-12-16T10:40:002021-02-03 AB2C4591001SEC4591001 1124 11241248A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-05-17 B2BC4591001SEC4591001 1124 11241248A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T15:37:00BBC4591001SEC4591001 1124 11241248APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T15:37:002021-07-08 BBC4591001SEC4591001 1124 11241248A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1124 11241249ASCRN Screening ASCREENING 2020-12-16 2020-12-16T14:24:00AAC4591001SEC4591001 1124 11241249A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T14:24:002021-02-08 AB7C4591001SEC4591001 1124 11241249A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-21 B7BC4591001SEC4591001 1124 11241250ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:15:00AAC4591001SEC4591001 1124 11241250A VAXP Placebo A VACCINATION 2020-12-17T16:15:002021-02-04 AB2C4591001SEC4591001 1124 11241250A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-17 B2BC4591001SEC4591001 1124 11241250A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T16:10:00BBC4591001SEC4591001 1124 11241250APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T16:10:002021-07-06 BBC4591001SEC4591001 1124 11241250A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1124 11241251ASCRN Screening ASCREENING 2020-12-18 2020-12-18T09:49:00AAC4591001SEC4591001 1124 11241251A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T09:49:002021-02-05 AB2C4591001SEC4591001 1124 11241251A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-16 B2BC4591001SEC4591001 1124 11241252ASCRN Screening ASCREENING 2020-12-18 2020-12-18T09:42:00AAC4591001SEC4591001 1124 11241252A VAXP Placebo A VACCINATION 2020-12-18T09:42:002021-02-05 AB2C4591001SEC4591001 1124 11241252A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-18 B2BC4591001SEC4591001 1124 11241252A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T14:35:00BBC4591001SEC4591001 1124 11241252APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T14:35:002021-07-08 BBC4591001SEC4591001 1124 11241252A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1124 11241253ASCRN Screening ASCREENING 2020-12-18 2020-12-18T14:56:00AAC4591001SEC4591001 1124 11241253A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T14:56:002021-02-10 AB7C4591001SEC4591001 1124 11241253A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-23 B7BC4591001SEC4591001 1124 11241254ASCRN Screening ASCREENING 2020-12-18 2020-12-18T14:53:00AAC4591001SEC4591001 1124 11241254A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T14:53:002021-02-10 AB7C4591001SEC4591001 1124 11241254A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-30 B7BC4591001SEC4591001 1124 11241255ASCRN Screening ASCREENING 2020-12-18 2020-12-18T16:52:00AAC4591001SEC4591001 1124 11241255A VAXP Placebo A VACCINATION 2020-12-18T16:52:002021-02-10 AB7C4591001SEC4591001 1124 11241255A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-19 B7BC4591001SEC4591001 1124 11241255A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T15:48:00BBC4591001SEC4591001 1124 11241255APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T15:48:002021-07-12 BBC4591001SEC4591001 1124 11241255A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1124 11241256ASCRN Screening ASCREENING 2020-12-21 2020-12-21T12:23:00AAC4591001SEC4591001 1124 11241256A VAXP Placebo A VACCINATION 2020-12-21T12:23:002021-02-10 AB4C4591001SEC4591001 1124 11241256A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-21 B4BC4591001SEC4591001 1124 11241257ASCRN Screening ASCREENING 2020-12-22 2020-12-22T16:08:00AAC4591001SEC4591001 1124 11241257A VAXP Placebo A VACCINATION 2020-12-22T16:08:002021-02-15 AB8C4591001SEC4591001 1124 11241257A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-17 B8BC4591001SEC4591001 1124 11241257A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T17:06:00BBC4591001SEC4591001 1124 11241257APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T17:06:002021-07-07 BBC4591001SEC4591001 1124 11241257A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1124 11241258ASCRN Screening ASCREENING 2020-12-23 2020-12-23T11:55:00AAC4591001SEC4591001 1124 11241258A VAXP Placebo A VACCINATION 2020-12-23T11:55:002021-02-11 AB3C4591001SEC4591001 1124 11241258A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-05-17 B3BC4591001SEC4591001 1124 11241258A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T15:56:00BBC4591001SEC4591001 1124 11241258APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T15:56:002021-07-06 BBC4591001SEC4591001 1124 11241258A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1124 11241259ASCRN Screening ASCREENING 2020-12-23 2020-12-23T11:51:00AAC4591001SEC4591001 1124 11241259A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T11:51:002021-02-11 AB3C4591001SEC4591001 1124 11241259A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-07-14 B3BC4591001SEC4591001 1124 11241260ASCRN Screening ASCREENING 2020-12-23 2020-12-23T12:00:00AAC4591001SEC4591001 1124 11241260A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T12:00:002021-02-10 AB2C4591001SEC4591001 1124 11241260A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-09 B2BC4591001SEC4591001 1124 11241261ASCRN Screening ASCREENING 2020-12-23 2020-12-23T12:42:00AAC4591001SEC4591001 1124 11241261A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T12:42:002021-02-10 AB2C4591001SEC4591001 1124 11241261A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-06-23 B2BC4591001SEC4591001 1124 11241262ASCRN Screening ASCREENING 2020-12-23 2020-12-23T14:42:00AAC4591001SEC4591001 1124 11241262A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T14:42:002021-02-17 AB9C4591001SEC4591001 1124 11241262A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-09 B9BC4591001SEC4591001 1124 11241263ASCRN Screening ASCREENING 2020-12-29 2020-12-29T10:04:00AAC4591001SEC4591001 1124 11241263A VAXP Placebo A VACCINATION 2020-12-29T10:04:002021-02-18 AB4C4591001SEC4591001 1124 11241263A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-05-18 B4BC4591001SEC4591001 1124 11241263A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T14:38:00BBC4591001SEC4591001 1124 11241263APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T14:38:002021-07-12 BBC4591001SEC4591001 1124 11241263A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1124 11241264ASCRN Screening ASCREENING 2020-12-29 2020-12-29T10:05:00AAC4591001SEC4591001 1124 11241264A VAXP Placebo A VACCINATION 2020-12-29T10:05:002021-02-18 AB4C4591001SEC4591001 1124 11241264A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-05-18 B4BC4591001SEC4591001 1124 11241264A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T14:40:00BBC4591001SEC4591001 1124 11241264APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T14:40:002021-07-12 BBC4591001SEC4591001 1124 11241264A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1124 11241265ASCRN Screening ASCREENING 2020-12-29 2020-12-29T12:24:00AAC4591001SEC4591001 1124 11241265A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T12:24:002021-02-17 AB3C4591001SEC4591001 1124 11241265A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-20 B3BC4591001SEC4591001 1124 11241266ASCRN Screening ASCREENING 2020-12-29 2020-12-29T12:28:00AAC4591001SEC4591001 1124 11241266A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T12:28:002021-02-17 AB3C4591001SEC4591001 1124 11241266A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-19 B3BC4591001SEC4591001 1124 11241267ASCRN Screening ASCREENING 2020-12-29 2020-12-29T12:31:00AAC4591001SEC4591001 1124 11241267A VAXP Placebo A VACCINATION 2020-12-29T12:31:002021-02-17 AB3C4591001SEC4591001 1124 11241267A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-17 B3BC4591001SEC4591001 1124 11241267A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T17:04:00BBC4591001SEC4591001 1124 11241267APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T17:04:002021-07-06 BBC4591001SEC4591001 1124 11241267A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1124 11241268ASCRN Screening ASCREENING 2021-01-04 2021-01-04T13:56:00AAC4591001SEC4591001 1124 11241268A VAXP Placebo A VACCINATION 2021-01-04T13:56:002021-03-03 AB;C4591001SEC4591001 1124 11241268A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-05-18 B;BC4591001SEC4591001 1124 11241268A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T14:52:00BBC4591001SEC4591001 1124 11241268APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T14:52:002021-07-06 BBC4591001SEC4591001 1124 11241268A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1124 11241269ASCRN Screening ASCREENING 2021-01-04 2021-01-04T16:28:00AAC4591001SEC4591001 1124 11241269A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T16:28:002021-02-24 AB4C4591001SEC4591001 1124 11241269A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-20 B4BC4591001SEC4591001 1124 11241270ASCRN Screening ASCREENING 2021-01-05 2021-01-05T16:03:00AAC4591001SEC4591001 1124 11241270A VAXP Placebo A VACCINATION 2021-01-05T16:03:002021-02-23 AB2C4591001SEC4591001 1124 11241270A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-02-23 B2B2C4591001SEC4591001 1124 11241270A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-23 2021-02-23T15:46:00B2B2C4591001SEC4591001 1124 11241270APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-23T15:46:002021-04-13 B2BcC4591001SEC4591001 1124 11241270A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-13 2021-04-13 BcBcC4591001SEC4591001 1124 11241271ASCRN Screening ASCREENING 2021-01-05 2021-01-05T16:53:00AAC4591001SEC4591001 1124 11241271A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T16:53:002021-02-23 AB2C4591001SEC4591001 1124 11241271A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-21 B2BC4591001SEC4591001 1124 11241272ASCRN Screening ASCREENING 2021-01-05 2021-01-05T17:10:00AAC4591001SEC4591001 1124 11241272A VAXP Placebo A VACCINATION 2021-01-05T17:10:002021-03-02 AB9C4591001SEC4591001 1124 11241272A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-18 B9BC4591001SEC4591001 1124 11241272A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T16:43:00BBC4591001SEC4591001 1124 11241272APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T16:43:002021-07-13 BBC4591001SEC4591001 1124 11241272A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1124 11241273ASCRN Screening ASCREENING 2021-01-06 2021-01-06T17:37:00AAC4591001SEC4591001 1124 11241273A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T17:37:002021-02-24 AB2C4591001SEC4591001 1124 11241273A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-21 B2BC4591001SEC4591001 1124 11241274ASCRN Screening ASCREENING 2021-01-06 2021-01-06T17:34:00AAC4591001SEC4591001 1124 11241274A VAXP Placebo A VACCINATION 2021-01-06T17:34:002021-02-24 AB2C4591001SEC4591001 1124 11241274A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-19 B2BC4591001SEC4591001 1124 11241274A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T15:50:00BBC4591001SEC4591001 1124 11241274APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T15:50:002021-07-14 BBC4591001SEC4591001 1124 11241274A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-07-14 BBC4591001SEC4591001 1124 11241275ASCRN Screening ASCREENING 2021-01-08 2021-01-08T15:18:00AAC4591001SEC4591001 1124 11241275A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T15:18:002021-02-26 AB2C4591001SEC4591001 1124 11241275A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-11 B2BC4591001SEC4591001 1125 11251241ASCRN Screening ASCREENING 2020-12-07 2020-12-07T09:06:00AAC4591001SEC4591001 1125 11251241A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T09:06:002021-01-27 AB4C4591001SEC4591001 1125 11251241A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-25 B4BC4591001SEC4591001 1125 11251242ASCRN Screening ASCREENING 2020-12-07 2020-12-07T09:29:00AAC4591001SEC4591001 1125 11251242A VAXP Placebo A VACCINATION 2020-12-07T09:29:002021-02-01 AB9C4591001SEC4591001 1125 11251242A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-17 B9BC4591001SEC4591001 1125 11251242A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T17:57:00BBC4591001SEC4591001 1125 11251242APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T17:57:002021-07-12 BBC4591001SEC4591001 1125 11251242A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1125 11251244ASCRN Screening ASCREENING 2020-12-08 2020-12-08T18:31:00AAC4591001SEC4591001 1125 11251244A VAXP Placebo A VACCINATION 2020-12-08T18:31:002021-01-29 AB5C4591001SEC4591001 1125 11251244A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-06-17 B5BC4591001SEC4591001 1125 11251244A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-17 2021-06-17T11:14:00BBC4591001SEC4591001 1125 11251244APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-17T11:14:002021-08-06 BBC4591001SEC4591001 1125 11251244A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-06 2021-08-06 BBC4591001SEC4591001 1125 11251246ASCRN Screening ASCREENING 2020-12-10 2020-12-10T10:10:00AAC4591001SEC4591001 1125 11251246A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T10:10:002021-01-27 AB1C4591001SEC4591001 1125 11251246A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-23 B1BC4591001SEC4591001 1125 11251248ASCRN Screening ASCREENING 2020-12-11 2020-12-11T14:25:00AAC4591001SEC4591001 1125 11251248A VAXP Placebo A VACCINATION 2020-12-11T14:25:002021-01-27 AB0C4591001SEC4591001 1125 11251248A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-07-01 B0BC4591001SEC4591001 1125 11251249ASCRN Screening ASCREENING 2020-12-11 2020-12-11T15:05:00AAC4591001SEC4591001 1125 11251249A VAXP Placebo A VACCINATION 2020-12-11T15:05:002021-01-29 AB2C4591001SEC4591001 1125 11251249A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-05-17 B2BC4591001SEC4591001 1125 11251249A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T17:46:00BBC4591001SEC4591001 1125 11251249APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T17:46:002021-07-12 BBC4591001SEC4591001 1125 11251249A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1125 11251250ASCRN Screening ASCREENING 2020-12-14 2020-12-14T12:01:00AAC4591001SEC4591001 1125 11251250A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T12:01:002021-02-03 AB4C4591001SEC4591001 1125 11251250A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-30 B4BC4591001SEC4591001 1125 11251251ASCRN Screening ASCREENING 2020-12-14 2020-12-14T12:31:00AAC4591001SEC4591001 1125 11251251A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T12:31:002021-02-03 AB4C4591001SEC4591001 1125 11251251A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-30 B4BC4591001SEC4591001 1125 11251252ASCRN Screening ASCREENING 2020-12-16 2020-12-16T14:46:00AAC4591001SEC4591001 1125 11251252A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T14:46:002021-02-12 AB;C4591001SEC4591001 1125 11251252A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-08 B;BC4591001SEC4591001 1125 11251253ASCRN Screening ASCREENING 2020-12-16 2020-12-16T16:06:00AAC4591001SEC4591001 1125 11251253A VAXP Placebo A VACCINATION 2020-12-16T16:06:002021-02-10 AB9C4591001SEC4591001 1125 11251253A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-25 B9BC4591001SEC4591001 1125 11251253A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T10:33:00BBC4591001SEC4591001 1125 11251253APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T10:33:002021-07-20 BBC4591001SEC4591001 1125 11251253A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-20 2021-07-20 BBC4591001SEC4591001 1125 11251254ASCRN Screening ASCREENING 2020-12-28 2020-12-28T11:54:00AAC4591001SEC4591001 1125 11251254A VAXP Placebo A VACCINATION 2020-12-28T11:54:002021-02-19 AB6C4591001SEC4591001 1125 11251254A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-05-18 B6BC4591001SEC4591001 1125 11251254A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T16:10:00BBC4591001SEC4591001 1125 11251254APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T16:10:002021-07-12 BBC4591001SEC4591001 1125 11251254A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1125 11251255ASCRN Screening ASCREENING 2021-01-06 2021-01-06T17:04:00AAC4591001SEC4591001 1125 11251255A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T17:04:002021-02-24 AB2C4591001SEC4591001 1125 11251255A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-26 B2BC4591001SEC4591001 1126 11261229ASCRN Screening ASCREENING 2020-11-30 2020-11-30T13:43:00AAC4591001SEC4591001 1126 11261229A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-11-30T13:43:002021-01-18 AB2C4591001SEC4591001 1126 11261229A0FUP Follow-up A0FOLLOW-UP 2021-01-18 2021-06-16 B2BC4591001SEC4591001 1126 11261230ASCRN Screening ASCREENING 2020-11-30 2020-11-30T16:10:00AAC4591001SEC4591001 1126 11261230A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-11-30T16:10:002021-01-20 AB4C4591001SEC4591001 1126 11261230A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-08-26 B4CC4591001SEC4591001 1126 11261233ASCRN Screening ASCREENING 2020-12-01 2020-12-01T11:55:00AAC4591001SEC4591001 1126 11261233A VAXP Placebo A VACCINATION 2020-12-01T11:55:002021-01-21 AB4C4591001SEC4591001 1126 11261233A0FUP Follow-up A0FOLLOW-UP 2021-01-21 2021-05-19 B4BC4591001SEC4591001 1126 11261233A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T10:25:00BBC4591001SEC4591001 1126 11261233APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T10:25:002021-07-07 BBC4591001SEC4591001 1126 11261233A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1126 11261235ASCRN Screening ASCREENING 2020-12-01 2020-12-01T15:41:00AAC4591001SEC4591001 1126 11261235A VAXP Placebo A VACCINATION 2020-12-01T15:41:002021-01-20 AB3C4591001SEC4591001 1126 11261235A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-05-18 B3BC4591001SEC4591001 1126 11261235A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T10:18:00BBC4591001SEC4591001 1126 11261235APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T10:18:002021-07-09 BBC4591001SEC4591001 1126 11261235A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1126 11261239ASCRN Screening ASCREENING 2020-12-02 2020-12-02T10:00:00AAC4591001SEC4591001 1126 11261239A VAXP Placebo A VACCINATION 2020-12-02T10:00:002021-01-19 AB1C4591001SEC4591001 1126 11261239A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-05-17 B1BC4591001SEC4591001 1126 11261239A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T12:04:00BBC4591001SEC4591001 1126 11261239APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T12:04:002021-07-12 BBC4591001SEC4591001 1126 11261239A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1126 11261240ASCRN Screening ASCREENING 2020-12-02 2020-12-02T10:01:00AAC4591001SEC4591001 1126 11261240A VAXP Placebo A VACCINATION 2020-12-02T10:01:002021-01-19 AB1C4591001SEC4591001 1126 11261240A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-05-21 B1BC4591001SEC4591001 1126 11261240A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T13:58:00BBC4591001SEC4591001 1126 11261240APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T13:58:002021-07-12 BBC4591001SEC4591001 1126 11261240A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1126 11261241ASCRN Screening ASCREENING 2020-12-02 2020-12-02T11:23:00AAC4591001SEC4591001 1126 11261241A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T11:23:002021-01-20 AB2C4591001SEC4591001 1126 11261241A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-08-13 B2BC4591001SEC4591001 1126 11261243ASCRN Screening ASCREENING 2020-12-02 2020-12-02T12:37:00AAC4591001SEC4591001 1126 11261243A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T12:37:002021-01-22 AB4C4591001SEC4591001 1126 11261243A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-07-28 B4BC4591001SEC4591001 1126 11261246ASCRN Screening ASCREENING 2020-12-02 2020-12-02T15:19:00AAC4591001SEC4591001 1126 11261246A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T15:19:002021-01-20 AB2C4591001SEC4591001 1126 11261246A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-22 B2BC4591001SEC4591001 1126 11261249ASCRN Screening ASCREENING 2020-12-02 2020-12-02T17:48:00AAC4591001SEC4591001 1126 11261249A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-02T17:48:002021-01-22 AB4C4591001SEC4591001 1126 11261249A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-06-18 B4BC4591001SEC4591001 1126 11261250ASCRN Screening ASCREENING 2020-12-02 2020-12-02T17:51:00AAC4591001SEC4591001 1126 11261250A VAXP Placebo A VACCINATION 2020-12-02T17:51:002021-01-22 AB4C4591001SEC4591001 1126 11261250A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-05-19 B4BC4591001SEC4591001 1126 11261250A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T12:07:00BBC4591001SEC4591001 1126 11261250APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T12:07:002021-07-16 BBC4591001SEC4591001 1126 11261250A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-16 2021-07-16 BBC4591001SEC4591001 1126 11261253ASCRN Screening ASCREENING 2020-12-03 2020-12-03T12:39:00AAC4591001SEC4591001 1126 11261253A VAXP Placebo A VACCINATION 2020-12-03T12:39:002021-01-20 AB1C4591001SEC4591001 1126 11261253A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-05-17 B1BC4591001SEC4591001 1126 11261253A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T10:03:00BBC4591001SEC4591001 1126 11261253APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T10:03:002021-07-06 BBC4591001SEC4591001 1126 11261253A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1126 11261254ASCRN Screening ASCREENING 2020-12-03 2020-12-03T15:42:00AAC4591001SEC4591001 1126 11261254A VAXP Placebo A VACCINATION 2020-12-03T15:42:002021-02-24 ABTC4591001SEC4591001 1126 11261254A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-06-22 BTBC4591001SEC4591001 1126 11261254A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-22 2021-06-22T14:42:00BBC4591001SEC4591001 1126 11261254APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-22T14:42:002021-08-09 BBC4591001SEC4591001 1126 11261254A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-09 2021-08-19 BC@C4591001SEC4591001 1126 11261255ASCRN Screening ASCREENING 2020-12-03 2020-12-03T15:46:00AAC4591001SEC4591001 1126 11261255A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-03T15:46:002021-01-26 AB7C4591001SEC4591001 1126 11261255A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-08-03 B7BC4591001SEC4591001 1126 11261258ASCRN Screening ASCREENING 2020-12-03 2020-12-03T17:45:00AAC4591001SEC4591001 1126 11261258A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-03T17:45:002021-01-21 AB2C4591001SEC4591001 1126 11261258A0FUP Follow-up A0FOLLOW-UP 2021-01-21 2021-08-31 B2CC4591001SEC4591001 1126 11261262ASCRN Screening ASCREENING 2020-12-04 2020-12-04T16:09:00AAC4591001SEC4591001 1126 11261262A VAXP Placebo A VACCINATION 2020-12-04T16:09:002021-01-20 AB0C4591001SEC4591001 1126 11261262A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-02-10 B0BEC4591001SEC4591001 1126 11261262A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-10 2021-02-10T14:58:00BEBEC4591001SEC4591001 1126 11261262APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-10T14:58:002021-03-31 BEBvC4591001SEC4591001 1126 11261262A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-03-31 2021-03-31 BvBvC4591001SEC4591001 1126 11261263ASCRN Screening ASCREENING 2020-12-04 2020-12-04T16:51:00AAC4591001SEC4591001 1126 11261263A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-04T16:51:002021-01-20 AB0C4591001SEC4591001 1126 11261263A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-06-24 B0BC4591001SEC4591001 1126 11261264ASCRN Screening ASCREENING 2020-12-04 2020-12-04T17:51:00AAC4591001SEC4591001 1126 11261264A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-04T17:51:002021-01-25 AB5C4591001SEC4591001 1126 11261264A0FUP Follow-up A0FOLLOW-UP 2021-01-25 2021-06-25 B5BC4591001SEC4591001 1126 11261265ASCRN Screening ASCREENING 2020-12-14 2020-12-14T18:09:00AAC4591001SEC4591001 1126 11261265A VAXP Placebo A VACCINATION 2020-12-14T18:09:002021-02-01 AB2C4591001SEC4591001 1126 11261265A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-19 B2BC4591001SEC4591001 1126 11261265A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T13:52:00BBC4591001SEC4591001 1126 11261265APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T13:52:002021-07-12 BBC4591001SEC4591001 1126 11261265A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1126 11261266ASCRN Screening ASCREENING 2020-12-14 2020-12-14T09:34:00AAC4591001SEC4591001 1126 11261266A VAXP Placebo A VACCINATION 2020-12-14T09:34:002021-02-01 AB2C4591001SEC4591001 1126 11261266A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-19 B2BC4591001SEC4591001 1126 11261266A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T13:52:00BBC4591001SEC4591001 1126 11261266APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T13:52:002021-07-12 BBC4591001SEC4591001 1126 11261266A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1126 11261267ASCRN Screening ASCREENING 2020-12-14 2020-12-14T10:18:00AAC4591001SEC4591001 1126 11261267A VAXP Placebo A VACCINATION 2020-12-14T10:18:002021-02-03 AB4C4591001SEC4591001 1126 11261267A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-05-21 B4BC4591001SEC4591001 1126 11261267A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T15:49:00BBC4591001SEC4591001 1126 11261267APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T15:49:002021-07-12 BBC4591001SEC4591001 1126 11261267A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1126 11261268ASCRN Screening ASCREENING 2020-12-14 2020-12-14T11:08:00AAC4591001SEC4591001 1126 11261268A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T11:08:002021-02-05 AB6C4591001SEC4591001 1126 11261268A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-07 B6BC4591001SEC4591001 1126 11261269ASCRN Screening ASCREENING 2020-12-14 2020-12-14T13:04:00AAC4591001SEC4591001 1126 11261269A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T13:04:002021-02-03 AB4C4591001SEC4591001 1126 11261269A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-12 B4BC4591001SEC4591001 1126 11261270ASCRN Screening ASCREENING 2020-12-14 2020-12-14T14:48:00AAC4591001SEC4591001 1126 11261270A VAXP Placebo A VACCINATION 2020-12-14T14:48:002021-02-03 AB4C4591001SEC4591001 1126 11261270A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-05-20 B4BC4591001SEC4591001 1126 11261270A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T16:08:00BBC4591001SEC4591001 1126 11261270APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T16:08:002021-07-08 BBC4591001SEC4591001 1126 11261270A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1126 11261271ASCRN Screening ASCREENING 2020-12-14 2020-12-14T16:16:00AAC4591001SEC4591001 1126 11261271A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T16:16:002021-02-03 AB4C4591001SEC4591001 1126 11261271A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-07-16 B4BC4591001SEC4591001 1126 11261273ASCRN Screening ASCREENING 2020-12-14 2020-12-14T17:54:00AAC4591001SEC4591001 1126 11261273A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T17:54:002021-02-09 AB:C4591001SEC4591001 1126 11261273A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-07-13 B:BC4591001SEC4591001 1126 11261274ASCRN Screening ASCREENING 2020-12-15 2020-12-15T12:09:00AAC4591001SEC4591001 1126 11261274A VAXP Placebo A VACCINATION 2020-12-15T12:09:002021-02-03 AB3C4591001SEC4591001 1126 11261274A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-05-20 B3BC4591001SEC4591001 1126 11261274A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T16:24:00BBC4591001SEC4591001 1126 11261274APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T16:24:002021-07-13 BBC4591001SEC4591001 1126 11261274A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-13 2021-07-13 BBC4591001SEC4591001 1126 11261275ASCRN Screening ASCREENING 2020-12-15 2020-12-15T16:25:00AAC4591001SEC4591001 1126 11261275A VAXP Placebo A VACCINATION 2020-12-15T16:25:002021-02-08 AB8C4591001SEC4591001 1126 11261275A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-02-08 B8B8C4591001SEC4591001 1126 11261275A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-08 2021-02-08T16:00:00B8B8C4591001SEC4591001 1126 11261275APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-08T16:00:002021-04-05 B8BpC4591001SEC4591001 1126 11261275A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-05 2021-08-26 BpBC4591001SEC4591001 1126 11261276ASCRN Screening ASCREENING 2020-12-15 2020-12-15T16:26:00AAC4591001SEC4591001 1126 11261276A VAXP Placebo A VACCINATION 2020-12-15T16:26:002021-02-08 AB8C4591001SEC4591001 1126 11261276A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-02-08 B8B8C4591001SEC4591001 1126 11261276A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-08 2021-02-08T16:01:00B8B8C4591001SEC4591001 1126 11261276APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-08T16:01:002021-04-05 B8BpC4591001SEC4591001 1126 11261276A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-05 2021-08-26 BpBC4591001SEC4591001 1126 11261277ASCRN Screening ASCREENING 2020-12-15 2020-12-15T17:02:00AAC4591001SEC4591001 1126 11261277A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T17:02:002021-02-02 AB2C4591001SEC4591001 1126 11261277A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-07-13 B2BC4591001SEC4591001 1126 11261278ASCRN Screening ASCREENING 2020-12-15 2020-12-15T17:53:00AAC4591001SEC4591001 1126 11261278A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T17:53:002021-02-02 AB2C4591001SEC4591001 1126 11261278A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-07-13 B2BC4591001SEC4591001 1126 11261279ASCRN Screening ASCREENING 2020-12-16 2020-12-16T09:55:00AAC4591001SEC4591001 1126 11261279A VAXP Placebo A VACCINATION 2020-12-16T09:55:002021-02-04 AB3C4591001SEC4591001 1126 11261279A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-20 B3BC4591001SEC4591001 1126 11261279A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T14:12:00BBC4591001SEC4591001 1126 11261279APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T14:12:002021-07-09 BBC4591001SEC4591001 1126 11261279A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1126 11261280ASCRN Screening ASCREENING 2020-12-16 2020-12-16T09:58:00AAC4591001SEC4591001 1126 11261280A VAXP Placebo A VACCINATION 2020-12-16T09:58:002021-02-04 AB3C4591001SEC4591001 1126 11261280A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-20 B3BC4591001SEC4591001 1126 11261280A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T14:14:00BBC4591001SEC4591001 1126 11261280APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T14:14:002021-07-09 BBC4591001SEC4591001 1126 11261280A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1126 11261281ASCRN Screening ASCREENING 2020-12-16 2020-12-16T11:43:00AAC4591001SEC4591001 1126 11261281A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T11:43:002021-02-12 AB;C4591001SEC4591001 1126 11261281A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-15 B;BC4591001SEC4591001 1126 11261282ASCRN Screening ASCREENING 2020-12-16 2020-12-16T12:10:00AAC4591001SEC4591001 1126 11261282A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T12:10:002021-02-03 AB2C4591001SEC4591001 1126 11261282A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-30 B2BC4591001SEC4591001 1126 11261283ASCRN Screening ASCREENING 2020-12-16 2020-12-16T14:19:00AAC4591001SEC4591001 1126 11261283A VAXP Placebo A VACCINATION 2020-12-16T14:19:002021-02-10 AB9C4591001SEC4591001 1126 11261283A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-17 B9BC4591001SEC4591001 1126 11261283A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T16:24:00BBC4591001SEC4591001 1126 11261283APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T16:24:002021-07-07 BBC4591001SEC4591001 1126 11261283A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1126 11261284ASCRN Screening ASCREENING 2020-12-16 2020-12-16T15:04:00AAC4591001SEC4591001 1126 11261284A VAXP Placebo A VACCINATION 2020-12-16T15:04:002021-02-03 AB2C4591001SEC4591001 1126 11261284A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-05-17 B2BC4591001SEC4591001 1126 11261284A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T15:38:00BBC4591001SEC4591001 1126 11261284APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T15:38:002021-07-09 BBC4591001SEC4591001 1126 11261284A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1126 11261285ASCRN Screening ASCREENING 2020-12-16 2020-12-16T17:02:00AAC4591001SEC4591001 1126 11261285A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T17:02:002021-02-03 AB2C4591001SEC4591001 1126 11261285A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-30 B2BC4591001SEC4591001 1126 11261286ASCRN Screening ASCREENING 2020-12-16 2020-12-16T17:06:00AAC4591001SEC4591001 1126 11261286A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T17:06:002021-02-10 AB9C4591001SEC4591001 1126 11261286A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-07 B9BC4591001SEC4591001 1126 11261287ASCRN Screening ASCREENING 2020-12-16 2020-12-16T17:08:00AAC4591001SEC4591001 1126 11261287A VAXP Placebo A VACCINATION 2020-12-16T17:08:002021-02-10 AB9C4591001SEC4591001 1126 11261287A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-20 B9BC4591001SEC4591001 1126 11261287A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T11:54:00BBC4591001SEC4591001 1126 11261287APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T11:54:002021-07-08 BBC4591001SEC4591001 1126 11261287A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1126 11261288ASCRN Screening ASCREENING 2020-12-16 2020-12-16T17:25:00AAC4591001SEC4591001 1126 11261288A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T17:25:002021-02-04 AB3C4591001SEC4591001 1126 11261288A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-07-06 B3BC4591001SEC4591001 1126 11261289ASCRN Screening ASCREENING 2020-12-17 2020-12-17T13:19:00AAC4591001SEC4591001 1126 11261289A VAXP Placebo A VACCINATION 2020-12-17T13:19:002021-02-03 AB1C4591001SEC4591001 1126 11261289A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-05-17 B1BC4591001SEC4591001 1126 11261289A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T14:48:00BBC4591001SEC4591001 1126 11261289APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T14:48:002021-07-07 BBC4591001SEC4591001 1126 11261289A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1126 11261290ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:12:00AAC4591001SEC4591001 1126 11261290A VAXP Placebo A VACCINATION 2020-12-17T16:12:002021-02-02 AB0C4591001SEC4591001 1126 11261290A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-18 B0BC4591001SEC4591001 1126 11261290A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T15:30:00BBC4591001SEC4591001 1126 11261290APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T15:30:002021-07-16 BBC4591001SEC4591001 1126 11261290A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-16 2021-07-16 BBC4591001SEC4591001 1126 11261291ASCRN Screening ASCREENING 2020-12-17 2020-12-17T15:34:00AAC4591001SEC4591001 1126 11261291A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T15:34:002021-02-04 AB2C4591001SEC4591001 1126 11261291A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-07-15 B2BC4591001SEC4591001 1126 11261292ASCRN Screening ASCREENING 2020-12-17 2020-12-17T17:21:00AAC4591001SEC4591001 1126 11261292A VAXP Placebo A VACCINATION 2020-12-17T17:21:002021-02-04 AB2C4591001SEC4591001 1126 11261292A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-17 B2BC4591001SEC4591001 1126 11261292A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T13:27:00BBC4591001SEC4591001 1126 11261292APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T13:27:002021-07-08 BBC4591001SEC4591001 1126 11261292A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1126 11261293ASCRN Screening ASCREENING 2020-12-18 2020-12-18T09:08:00AAC4591001SEC4591001 1126 11261293A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T09:08:002021-02-05 AB2C4591001SEC4591001 1126 11261293A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-17 B2BC4591001SEC4591001 1126 11261294ASCRN Screening ASCREENING 2020-12-18 2020-12-18T11:53:00AAC4591001SEC4591001 1126 11261294A VAXP Placebo A VACCINATION 2020-12-18T11:53:002021-02-05 AB2C4591001SEC4591001 1126 11261294A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-16 B2BC4591001SEC4591001 1126 11261294A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-16 2021-07-16T12:13:00BBC4591001SEC4591001 1126 11261294APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-16T12:13:002021-08-06 BBC4591001SEC4591001 1126 11261295ASCRN Screening ASCREENING 2020-12-18 2020-12-18T13:45:00AAC4591001SEC4591001 1126 11261295A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T13:45:002021-02-05 AB2C4591001SEC4591001 1126 11261295A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-07 B2BC4591001SEC4591001 1126 11261296ASCRN Screening ASCREENING 2020-12-18 2020-12-18T15:35:00AAC4591001SEC4591001 1126 11261296A VAXP Placebo A VACCINATION 2020-12-18T15:35:002021-02-05 AB2C4591001SEC4591001 1126 11261296A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-04-07 B2BoC4591001SEC4591001 1126 11261296A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-07 2021-04-07T10:39:00BoBoC4591001SEC4591001 1126 11261296APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-07T10:39:002021-05-24 BoBC4591001SEC4591001 1126 11261296A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-24 2021-05-24 BBC4591001SEC4591001 1126 11261297ASCRN Screening ASCREENING 2020-12-18 2020-12-18T15:34:00AAC4591001SEC4591001 1126 11261297A VAXP Placebo A VACCINATION 2020-12-18T15:34:002021-02-05 AB2C4591001SEC4591001 1126 11261297A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-19 B2BC4591001SEC4591001 1126 11261297A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T16:36:00BBC4591001SEC4591001 1126 11261297APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T16:36:002021-07-14 BBC4591001SEC4591001 1126 11261297A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-07-14 BBC4591001SEC4591001 1126 11261298ASCRN Screening ASCREENING 2020-12-18 2020-12-18T16:16:00AAC4591001SEC4591001 1126 11261298A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T16:16:002021-02-10 AB7C4591001SEC4591001 1126 11261298A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-01 B7BC4591001SEC4591001 1126 11261299ASCRN Screening ASCREENING 2020-12-21 2020-12-21T12:31:00AAC4591001SEC4591001 1126 11261299A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T12:31:002021-02-09 AB3C4591001SEC4591001 1126 11261299A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-07-19 B3BC4591001SEC4591001 1126 11261300ASCRN Screening ASCREENING 2020-12-22 2020-12-22T08:30:00AAC4591001SEC4591001 1126 11261300A VAXP Placebo A VACCINATION 2020-12-22T08:30:002021-02-08 AB1C4591001SEC4591001 1126 11261300A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-19 B1BC4591001SEC4591001 1126 11261300A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T09:46:00BBC4591001SEC4591001 1126 11261300APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T09:46:002021-07-09 BBC4591001SEC4591001 1126 11261300A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1126 11261301ASCRN Screening ASCREENING 2020-12-22 2020-12-22T13:30:00AAC4591001SEC4591001 1126 11261301A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T13:30:002021-02-12 AB5C4591001SEC4591001 1126 11261301A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-08 B5BC4591001SEC4591001 1126 11261302ASCRN Screening ASCREENING 2020-12-23 2020-12-23T13:43:00AAC4591001SEC4591001 1126 11261302A VAXP Placebo A VACCINATION 2020-12-23T13:43:002021-02-18 AB:C4591001SEC4591001 1126 11261302A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-05-21 B:BC4591001SEC4591001 1126 11261302A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T16:11:00BBC4591001SEC4591001 1126 11261302APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T16:11:002021-07-09 BBC4591001SEC4591001 1126 11261302A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1126 11261303ASCRN Screening ASCREENING 2020-12-29 2020-12-29T11:14:00AAC4591001SEC4591001 1126 11261303A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T11:14:002021-02-16 AB2C4591001SEC4591001 1126 11261303A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-07-12 B2BC4591001SEC4591001 1126 11261304ASCRN Screening ASCREENING 2020-12-29 2020-12-29T11:21:00AAC4591001SEC4591001 1126 11261304A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T11:21:002021-02-16 AB2C4591001SEC4591001 1126 11261304A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-07-12 B2BC4591001SEC4591001 1126 11261305ASCRN Screening ASCREENING 2020-12-30 2020-12-30T11:37:00AAC4591001SEC4591001 1126 11261305A VAXP Placebo A VACCINATION 2020-12-30T11:37:002021-02-24 AB9C4591001SEC4591001 1126 11261305A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-02-24 B9B9C4591001SEC4591001 1126 11261305A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-24 2021-02-24T11:36:00B9B9C4591001SEC4591001 1126 11261305APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-24T11:36:002021-04-16 B9BlC4591001SEC4591001 1126 11261305A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-16 2021-04-16 BlBlC4591001SEC4591001 1126 11261306ASCRN Screening ASCREENING 2020-12-30 2020-12-30T11:40:00AAC4591001SEC4591001 1126 11261306A VAXP Placebo A VACCINATION 2020-12-30T11:40:002021-02-24 AB9C4591001SEC4591001 1126 11261306A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-18 B9BC4591001SEC4591001 1126 11261306A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T10:01:00BBC4591001SEC4591001 1126 11261306APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T10:01:002021-07-06 BBC4591001SEC4591001 1126 11261306A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1126 11261307ASCRN Screening ASCREENING 2021-01-04 2021-01-04T16:26:00AAC4591001SEC4591001 1126 11261307A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T16:26:002021-02-22 AB2C4591001SEC4591001 1126 11261307A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-07-21 B2BC4591001SEC4591001 1126 11261308ASCRN Screening ASCREENING 2021-01-04 2021-01-04T16:31:00AAC4591001SEC4591001 1126 11261308A VAXP Placebo A VACCINATION 2021-01-04T16:31:002021-02-22 AB2C4591001SEC4591001 1126 11261308A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-06-18 B2BC4591001SEC4591001 1126 11261308A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-18 2021-06-18T09:46:00BBC4591001SEC4591001 1126 11261308APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-18T09:46:002021-08-06 BBC4591001SEC4591001 1126 11261308A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-06 2021-08-06 BBC4591001SEC4591001 1126 11261309ASCRN Screening ASCREENING 2021-01-04 2021-01-04T16:34:00AAC4591001SEC4591001 1126 11261309A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T16:34:002021-02-22 AB2C4591001SEC4591001 1126 11261309A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-08-09 B2BC4591001SEC4591001 1126 11261310ASCRN Screening ASCREENING 2021-01-05 2021-01-05T10:23:00AAC4591001SEC4591001 1126 11261310A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T10:23:002021-02-26 AB5C4591001SEC4591001 1126 11261310A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-20 B5BC4591001SEC4591001 1126 11261311ASCRN Screening ASCREENING 2021-01-05 2021-01-05T15:11:00AAC4591001SEC4591001 1126 11261311A VAXP Placebo A VACCINATION 2021-01-05T15:11:002021-02-24 AB3C4591001SEC4591001 1126 11261311A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-06-02 B3BC4591001SEC4591001 1126 11261311A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-02 2021-06-02T16:18:00BBC4591001SEC4591001 1126 11261311APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-02T16:18:002021-07-22 BBC4591001SEC4591001 1126 11261311A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-22 2021-07-22 BBC4591001SEC4591001 1126 11261312ASCRN Screening ASCREENING 2021-01-05 2021-01-05T15:43:00AAC4591001SEC4591001 1126 11261312A VAXP Placebo A VACCINATION 2021-01-05T15:43:002021-02-22 AB1C4591001SEC4591001 1126 11261312A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-18 B1BC4591001SEC4591001 1126 11261312A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T12:50:00BBC4591001SEC4591001 1126 11261312APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T12:50:002021-07-12 BBC4591001SEC4591001 1126 11261312A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1126 11261313ASCRN Screening ASCREENING 2021-01-06 2021-01-06T14:31:00AAC4591001SEC4591001 1126 11261313A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T14:31:002021-03-03 AB9C4591001SEC4591001 1126 11261313A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-07-26 B9BC4591001SEC4591001 1126 11261314ASCRN Screening ASCREENING 2021-01-06 2021-01-06T14:20:00AAC4591001SEC4591001 1126 11261314A VAXP Placebo A VACCINATION 2021-01-06T14:20:002021-03-03 AB9C4591001SEC4591001 1126 11261314A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-05-19 B9BC4591001SEC4591001 1126 11261314A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T11:52:00BBC4591001SEC4591001 1126 11261314APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T11:52:002021-07-07 BBC4591001SEC4591001 1126 11261314A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1126 11261315ASCRN Screening ASCREENING 2021-01-06 2021-01-06T17:48:00AAC4591001SEC4591001 1126 11261315A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-06T17:48:002021-02-26 AB4C4591001SEC4591001 1126 11261315A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-23 B4BC4591001SEC4591001 1126 11261316ASCRN Screening ASCREENING 2021-01-07 2021-01-07T09:54:00AAC4591001SEC4591001 1126 11261316A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T09:54:002021-02-24 AB1C4591001SEC4591001 1126 11261316A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-23 B1BC4591001SEC4591001 1126 11261317ASCRN Screening ASCREENING 2021-01-07 2021-01-07T09:57:00AAC4591001SEC4591001 1126 11261317A VAXP Placebo A VACCINATION 2021-01-07T09:57:002021-02-24 AB1C4591001SEC4591001 1126 11261317A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-17 B1BC4591001SEC4591001 1126 11261317A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T10:28:00BBC4591001SEC4591001 1126 11261317APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T10:28:002021-07-12 BBC4591001SEC4591001 1126 11261317A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-08-30 BBC4591001SEC4591001 1126 11261318ASCRN Screening ASCREENING 2021-01-07 2021-01-07T13:15:00AAC4591001SEC4591001 1126 11261318A VAXP Placebo A VACCINATION 2021-01-07T13:15:002021-02-25 AB2C4591001SEC4591001 1126 11261318A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-08-05 B2BC4591001SEC4591001 1126 11261318A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-08-05 2021-08-05T09:30:00BBC4591001SEC4591001 1126 11261318APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-08-05T09:30:002021-08-24 BBC4591001SEC4591001 1126 11261319ASCRN Screening ASCREENING 2021-01-07 2021-01-07T15:20:00AAC4591001SEC4591001 1126 11261319A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T15:20:002021-02-24 AB1C4591001SEC4591001 1126 11261319A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-08-04 B1BC4591001SEC4591001 1126 11261320ASCRN Screening ASCREENING 2021-01-07 2021-01-07T16:55:00AAC4591001SEC4591001 1126 11261320A VAXP Placebo A VACCINATION 2021-01-07T16:55:002021-02-25 AB2C4591001SEC4591001 1126 11261320A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-18 B2BC4591001SEC4591001 1126 11261320A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T14:48:00BBC4591001SEC4591001 1126 11261320APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T14:48:002021-07-06 BBC4591001SEC4591001 1126 11261320A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1126 11261321ASCRN Screening ASCREENING 2021-01-07 2021-01-07T17:55:00AAC4591001SEC4591001 1126 11261321A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T17:55:002021-03-01 AB6C4591001SEC4591001 1126 11261321A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-22 B6BC4591001SEC4591001 1126 11261322ASCRN Screening ASCREENING 2021-01-07 2021-01-07T17:57:00AAC4591001SEC4591001 1126 11261322A VAXP Placebo A VACCINATION 2021-01-07T17:57:002021-03-01 AB6C4591001SEC4591001 1126 11261322A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-05-24 B6BC4591001SEC4591001 1126 11261322A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-24 2021-05-24T16:45:00BBC4591001SEC4591001 1126 11261322APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-24T16:45:002021-07-12 BBC4591001SEC4591001 1126 11261322A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1126 11261323ASCRN Screening ASCREENING 2021-01-08 2021-01-08T16:46:00AAC4591001SEC4591001 1126 11261323A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T16:46:002021-03-01 AB5C4591001SEC4591001 1126 11261323A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-26 B5BC4591001SEC4591001 1126 11261324ASCRN Screening ASCREENING 2021-01-08 2021-01-08T16:48:00AAC4591001SEC4591001 1126 11261324A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T16:48:002021-03-01 AB5C4591001SEC4591001 1126 11261324A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-26 B5BC4591001SEC4591001 1126 11261325ASCRN Screening ASCREENING 2021-01-08 2021-01-08T17:29:00AAC4591001SEC4591001 1126 11261325A VAXP Placebo A VACCINATION 2021-01-08T17:29:002021-03-02 AB6C4591001SEC4591001 1126 11261325A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-18 B6BC4591001SEC4591001 1126 11261325A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T14:06:00BBC4591001SEC4591001 1126 11261325APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T14:06:002021-07-06 BBC4591001SEC4591001 1126 11261325A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1131 11311275ASCRN Screening ASCREENING 2020-12-04 2020-12-04T11:17:00AAC4591001SEC4591001 1131 11311275A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-04T11:17:002021-01-20 AB0C4591001SEC4591001 1131 11311275A0FUP Follow-up A0FOLLOW-UP 2021-01-20 2021-08-31 B0CC4591001SEC4591001 1131 11311277ASCRN Screening ASCREENING 2020-12-08 2020-12-08T12:32:00AAC4591001SEC4591001 1131 11311277A VAXP Placebo A VACCINATION 2020-12-08T12:32:002021-01-26 AB2C4591001SEC4591001 1131 11311277A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-07-01 B2BC4591001SEC4591001 1131 11311278ASCRN Screening ASCREENING 2020-12-08 2020-12-08T17:15:00AAC4591001SEC4591001 1131 11311278A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T17:15:002021-01-27 AB3C4591001SEC4591001 1131 11311278A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-28 B3BC4591001SEC4591001 1131 11311279ASCRN Screening ASCREENING 2020-12-17 2020-12-21T14:16:00@AC4591001SEC4591001 1131 11311279A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T14:16:002021-02-17 AB;C4591001SEC4591001 1131 11311279A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-12 B;BC4591001SEC4591001 1131 11311280ASCRN Screening ASCREENING 2020-12-17 2020-12-17T18:24:00AAC4591001SEC4591001 1131 11311280A VAXP Placebo A VACCINATION 2020-12-17T18:24:002021-02-04 AB2C4591001SEC4591001 1131 11311280A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-07-08 B2BC4591001SEC4591001 1131 11311280A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-08 2021-07-08T16:35:00BBC4591001SEC4591001 1131 11311280APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-08T16:35:002021-09-02 BC@C4591001SEC4591001 1131 11311280A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-09-02 2021-09-02 C@C@C4591001SEC4591001 1131 11311281ASCRN Screening ASCREENING 2020-12-21 2020-12-21T16:23:00AAC4591001SEC4591001 1131 11311281A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T16:23:002021-02-08 AB2C4591001SEC4591001 1131 11311281A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-07-09 B2BC4591001SEC4591001 1131 11311282ASCRN Screening ASCREENING 2020-12-22 2020-12-22T11:01:00AAC4591001SEC4591001 1131 11311282A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T11:01:002021-02-11 AB4C4591001SEC4591001 1131 11311282A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-07-13 B4BC4591001SEC4591001 1131 11311283ASCRN Screening ASCREENING 2020-12-22 2020-12-22T16:59:00AAC4591001SEC4591001 1131 11311283A VAXP Placebo A VACCINATION 2020-12-22T16:59:002021-02-15 AB8C4591001SEC4591001 1131 11311283A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-26 B8BC4591001SEC4591001 1131 11311283A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T15:19:00BBC4591001SEC4591001 1131 11311283APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T15:19:002021-07-16 BBC4591001SEC4591001 1131 11311283A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-16 2021-07-16 BBC4591001SEC4591001 1131 11311285ASCRN Screening ASCREENING 2020-12-23 2020-12-23T11:47:00AAC4591001SEC4591001 1131 11311285A VAXP Placebo A VACCINATION 2020-12-23T11:47:002021-02-12 AB4C4591001SEC4591001 1131 11311285A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-06-14 B4BC4591001SEC4591001 1131 11311285A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-14 2021-06-14T14:43:00BBC4591001SEC4591001 1131 11311285APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-14T14:43:002021-08-04 BBC4591001SEC4591001 1131 11311285A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-04 2021-08-04 BBC4591001SEC4591001 1131 11311286ASCRN Screening ASCREENING 2020-12-29 2020-12-29T10:32:00AAC4591001SEC4591001 1131 11311286A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T10:32:002021-02-15 AB1C4591001SEC4591001 1131 11311286A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-12 B1BC4591001SEC4591001 1131 11311287ASCRN Screening ASCREENING 2020-12-29 2020-12-29T11:35:00AAC4591001SEC4591001 1131 11311287A VAXP Placebo A VACCINATION 2020-12-29T11:35:002021-02-15 AB1C4591001SEC4591001 1131 11311287A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-25 B1BC4591001SEC4591001 1131 11311287A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T13:19:00BBC4591001SEC4591001 1131 11311287APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T13:19:002021-07-14 BBC4591001SEC4591001 1131 11311287A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-07-14 BBC4591001SEC4591001 1131 11311288ASCRN Screening ASCREENING 2020-12-29 2020-12-29T11:37:00AAC4591001SEC4591001 1131 11311288A VAXP Placebo A VACCINATION 2020-12-29T11:37:002021-02-15 AB1C4591001SEC4591001 1131 11311288A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-25 B1BC4591001SEC4591001 1131 11311288A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-25 2021-05-25T13:21:00BBC4591001SEC4591001 1131 11311288APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-25T13:21:002021-07-14 BBC4591001SEC4591001 1131 11311288A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-14 2021-07-14 BBC4591001SEC4591001 1131 11311289ASCRN Screening ASCREENING 2020-12-30 2020-12-30T12:23:00AAC4591001SEC4591001 1131 11311289A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T12:23:002021-02-22 AB7C4591001SEC4591001 1131 11311289A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-08-31 B7BC4591001SEC4591001 1131 11311290ASCRN Screening ASCREENING 2020-12-30 2020-12-30T12:46:00AAC4591001SEC4591001 1131 11311290A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T12:46:002021-02-23 AB8C4591001SEC4591001 1131 11311290A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-14 B8BC4591001SEC4591001 1131 11311291ASCRN Screening ASCREENING 2020-12-30 2020-12-30T14:45:00AAC4591001SEC4591001 1131 11311291A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-30T14:45:002021-02-17 AB2C4591001SEC4591001 1131 11311291A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-14 B2BC4591001SEC4591001 1131 11311292ASCRN Screening ASCREENING 2021-01-04 2021-01-04T16:05:00AAC4591001SEC4591001 1131 11311292A VAXP Placebo A VACCINATION 2021-01-04T16:05:002021-03-31 ABWC4591001SEC4591001 1131 11311292A0FUP Follow-up A0FOLLOW-UP 2021-03-31 2021-08-30 BWBC4591001SEC4591001 1131 11311292A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-08-30 2021-08-30T12:37:00BBC4591001SEC4591001 1131 11311292APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-08-30T12:37:002021-08-30 BBC4591001SEC4591001 1131 11311293ASCRN Screening ASCREENING 2021-01-04 2021-01-04T17:20:00AAC4591001SEC4591001 1131 11311293A VAXP Placebo A VACCINATION 2021-01-04T17:20:002021-02-25 AB5C4591001SEC4591001 1131 11311293A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-07-13 B5BC4591001SEC4591001 1131 11311293A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-07-13 2021-07-13T10:06:00BBC4591001SEC4591001 1131 11311293APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-07-13T10:06:002021-09-02 BBC4591001SEC4591001 1131 11311293A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-09-02 2021-09-02 BBC4591001SEC4591001 1131 11311294ASCRN Screening ASCREENING 2021-01-05 2021-01-05T18:13:00AAC4591001SEC4591001 1131 11311294A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T18:13:002021-02-26 AB5C4591001SEC4591001 1131 11311294A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-20 B5BC4591001SEC4591001 1131 11311295ASCRN Screening ASCREENING 2021-01-07 2021-01-07T14:07:00AAC4591001SEC4591001 1131 11311295A VAXP Placebo A VACCINATION 2021-01-07T14:07:002021-03-01 AB6C4591001SEC4591001 1131 11311295A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-05-18 B6BC4591001SEC4591001 1131 11311295A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T15:36:00BBC4591001SEC4591001 1131 11311295APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T15:36:002021-07-12 BBC4591001SEC4591001 1131 11311295A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1131 11311296ASCRN Screening ASCREENING 2021-01-08 2021-01-08T11:40:00AAC4591001SEC4591001 1131 11311296A VAXP Placebo A VACCINATION 2021-01-08T11:40:002021-02-24 AB0C4591001SEC4591001 1131 11311296A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-04-09 B0B\C4591001SEC4591001 1131 11311296A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-09 2021-04-09T12:05:00B\B\C4591001SEC4591001 1131 11311296APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-09T12:05:002021-05-28 B\BC4591001SEC4591001 1131 11311296A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-28 2021-05-28 BBC4591001SEC4591001 1131 11311297ASCRN Screening ASCREENING 2021-01-08 2021-01-08T11:43:00AAC4591001SEC4591001 1131 11311297A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T11:43:002021-02-24 AB0C4591001SEC4591001 1131 11311297A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-08-02 B0BC4591001SEC4591001 1131 11311298ASCRN Screening ASCREENING 2021-01-08 2021-01-08T11:43:00AAC4591001SEC4591001 1131 11311298A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T11:43:002021-03-05 AB9C4591001SEC4591001 1131 11311298A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-07-23 B9BC4591001SEC4591001 1131 11311299ASCRN Screening ASCREENING 2021-01-08 2021-01-08T17:45:00AAC4591001SEC4591001 1131 11311299A VAXP Placebo A VACCINATION 2021-01-08T17:45:002021-03-03 AB7C4591001SEC4591001 1131 11311299A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-05-20 B7BC4591001SEC4591001 1131 11311299A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T13:38:00BBC4591001SEC4591001 1131 11311299APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T13:38:002021-07-08 BBC4591001SEC4591001 1131 11311299A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1131 11311300ASCRN Screening ASCREENING 2021-01-08 2021-01-08T17:47:00AAC4591001SEC4591001 1131 11311300A VAXP Placebo A VACCINATION 2021-01-08T17:47:002021-03-03 AB7C4591001SEC4591001 1131 11311300A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-05-20 B7BC4591001SEC4591001 1131 11311300A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T13:37:00BBC4591001SEC4591001 1131 11311300APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T13:37:002021-07-08 BBC4591001SEC4591001 1131 11311300A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1131 11311301ASCRN Screening ASCREENING 2021-01-11 2021-01-11T14:50:00AAC4591001SEC4591001 1131 11311301A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T14:50:002021-03-12 AB=C4591001SEC4591001 1131 11311301A0FUP Follow-up A0FOLLOW-UP 2021-03-12 2021-08-09 B=BC4591001SEC4591001 1131 11311302ASCRN Screening ASCREENING 2021-01-11 2021-01-11T17:49:00AAC4591001SEC4591001 1131 11311302A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T17:49:002021-03-01 AB2C4591001SEC4591001 1131 11311302A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-08-05 B2BC4591001SEC4591001 1139 11391144ASCRN Screening ASCREENING 2020-12-01 2020-12-11T15:51:00AC4591001SEC4591001 1139 11391144A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-11T15:51:002021-01-27 AB0C4591001SEC4591001 1139 11391144A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-06-24 B0BC4591001SEC4591001 1139 11391145ASCRN Screening ASCREENING 2020-12-01 2020-12-01T11:33:00AAC4591001SEC4591001 1139 11391145A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-01T11:33:002021-01-19 AB2C4591001SEC4591001 1139 11391145A0FUP Follow-up A0FOLLOW-UP 2021-01-19 2021-06-29 B2BC4591001SEC4591001 1139 11391151ASCRN Screening ASCREENING 2020-12-04 2020-12-04T14:27:00AAC4591001SEC4591001 1139 11391151A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-04T14:27:002021-01-22 AB2C4591001SEC4591001 1139 11391151A0FUP Follow-up A0FOLLOW-UP 2021-01-22 2021-06-18 B2BC4591001SEC4591001 1139 11391152ASCRN Screening ASCREENING 2020-12-04 2020-12-04T17:25:00AAC4591001SEC4591001 1139 11391152A VAXP Placebo A VACCINATION 2020-12-04T17:25:002021-01-27 AB7C4591001SEC4591001 1139 11391152A0FUP Follow-up A0FOLLOW-UP 2021-01-27 2021-05-13 B7BC4591001SEC4591001 1139 11391152A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T13:42:00BBC4591001SEC4591001 1139 11391152APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T13:42:002021-07-01 BBC4591001SEC4591001 1139 11391152A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1139 11391154ASCRN Screening ASCREENING 2020-12-04 2020-12-04T17:34:00AAC4591001SEC4591001 1139 11391154A VAXP Placebo A VACCINATION 2020-12-04T17:34:002021-01-29 AB9C4591001SEC4591001 1139 11391154A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-05-13 B9BC4591001SEC4591001 1139 11391154A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T13:05:00BBC4591001SEC4591001 1139 11391154APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T13:05:002021-07-01 BBC4591001SEC4591001 1139 11391154A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1139 11391155ASCRN Screening ASCREENING 2020-12-04 2020-12-04T17:38:00AAC4591001SEC4591001 1139 11391155A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-04T17:38:002021-01-29 AB9C4591001SEC4591001 1139 11391155A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-08-17 B9CC4591001SEC4591001 1139 11391156ASCRN Screening ASCREENING 2020-12-07 2020-12-07T11:03:00AAC4591001SEC4591001 1139 11391156A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-07T11:03:002021-02-01 AB9C4591001SEC4591001 1139 11391156A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-06-22 B9BC4591001SEC4591001 1139 11391157ASCRN Screening ASCREENING 2020-12-08 2020-12-08T11:25:00AAC4591001SEC4591001 1139 11391157A VAXP Placebo A VACCINATION 2020-12-08T11:25:002021-01-26 AB2C4591001SEC4591001 1139 11391157A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-03-15 B2BbC4591001SEC4591001 1139 11391157A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-03-15 2021-03-15T13:38:00BbBbC4591001SEC4591001 1139 11391157APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-03-15T13:38:002021-05-04 BbBC4591001SEC4591001 1139 11391157A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-05-04 2021-05-04 BBC4591001SEC4591001 1139 11391158ASCRN Screening ASCREENING 2020-12-08 2020-12-08T15:18:00AAC4591001SEC4591001 1139 11391158A VAXP Placebo A VACCINATION 2020-12-08T15:18:002021-01-26 AB2C4591001SEC4591001 1139 11391158A0FUP Follow-up A0FOLLOW-UP 2021-01-26 2021-05-14 B2BC4591001SEC4591001 1139 11391158A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T13:38:00BBC4591001SEC4591001 1139 11391158APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T13:38:002021-07-01 BBC4591001SEC4591001 1139 11391158A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1139 11391159ASCRN Screening ASCREENING 2020-12-08 2020-12-08T14:58:00AAC4591001SEC4591001 1139 11391159A VAXP Placebo A VACCINATION 2020-12-08T14:58:002021-01-29 AB5C4591001SEC4591001 1139 11391159A0FUP Follow-up A0FOLLOW-UP 2021-01-29 2021-05-20 B5BC4591001SEC4591001 1139 11391159A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T13:20:00BBC4591001SEC4591001 1139 11391159APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T13:20:002021-08-12 BBC4591001SEC4591001 1139 11391159A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-12 2021-08-12 BBC4591001SEC4591001 1139 11391161ASCRN Screening ASCREENING 2020-12-08 2020-12-08T16:07:00AAC4591001SEC4591001 1139 11391161A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T16:07:002021-02-01 AB8C4591001SEC4591001 1139 11391161A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-06-23 B8BC4591001SEC4591001 1139 11391162ASCRN Screening ASCREENING 2020-12-08 2020-12-08T16:11:00AAC4591001SEC4591001 1139 11391162A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-08T16:11:002021-02-01 AB8C4591001SEC4591001 1139 11391162A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-06-22 B8BC4591001SEC4591001 1139 11391163ASCRN Screening ASCREENING 2020-12-08 2020-12-08T16:15:00AAC4591001SEC4591001 1139 11391163A VAXP Placebo A VACCINATION 2020-12-08T16:15:002021-02-01 AB8C4591001SEC4591001 1139 11391163A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-14 B8BC4591001SEC4591001 1139 11391163A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T14:56:00BBC4591001SEC4591001 1139 11391163APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T14:56:002021-07-08 BBC4591001SEC4591001 1139 11391163A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1139 11391165ASCRN Screening ASCREENING 2020-12-11 2020-12-11T15:59:00AAC4591001SEC4591001 1139 11391165A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-11T15:59:002021-02-03 AB7C4591001SEC4591001 1139 11391165A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-06-08 B7BC4591001SEC4591001 1139 11391166ASCRN Screening ASCREENING 2020-12-11 2020-12-11T16:06:00AAC4591001SEC4591001 1139 11391166A VAXP Placebo A VACCINATION 2020-12-11T16:06:002021-02-09 AB=C4591001SEC4591001 1139 11391166A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-02-16 B=BDC4591001SEC4591001 1139 11391166A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-16 2021-02-16T12:38:00BDBDC4591001SEC4591001 1139 11391166APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-16T12:38:002021-04-14 BDB}C4591001SEC4591001 1139 11391166A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-14 2021-04-14 B}B}C4591001SEC4591001 1139 11391168ASCRN Screening ASCREENING 2020-12-11 2020-12-11T16:15:00AAC4591001SEC4591001 1139 11391168A VAXP Placebo A VACCINATION 2020-12-11T16:15:002021-02-01 AB5C4591001SEC4591001 1139 11391168A0FUP Follow-up A0FOLLOW-UP 2021-02-01 2021-05-20 B5BC4591001SEC4591001 1139 11391168A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T13:38:00BBC4591001SEC4591001 1139 11391168APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T13:38:002021-08-12 BBC4591001SEC4591001 1139 11391168A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-12 2021-08-12 BBC4591001SEC4591001 1139 11391169ASCRN Screening ASCREENING 2020-12-15 2020-12-15T11:13:00AAC4591001SEC4591001 1139 11391169A VAXP Placebo A VACCINATION 2020-12-15T11:13:002021-02-17 ABAC4591001SEC4591001 1139 11391169A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-08 BABC4591001SEC4591001 1139 11391170ASCRN Screening ASCREENING 2020-12-15 2020-12-15T11:18:00AAC4591001SEC4591001 1139 11391170A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T11:18:002021-02-17 ABAC4591001SEC4591001 1139 11391170A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-08 BABC4591001SEC4591001 1139 11391171ASCRN Screening ASCREENING 2020-12-15 2020-12-15T11:24:00AAC4591001SEC4591001 1139 11391171A VAXP Placebo A VACCINATION 2020-12-15T11:24:002021-03-10 ABVC4591001SEC4591001 1139 11391171A0FUP Follow-up A0FOLLOW-UP 2021-03-10 2021-08-27 BVCC4591001SEC4591001 1139 11391172ASCRN Screening ASCREENING 2020-12-15 2020-12-15T15:48:00AAC4591001SEC4591001 1139 11391172A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T15:48:002021-02-08 AB8C4591001SEC4591001 1139 11391172A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-31 B8BC4591001SEC4591001 1139 11391173ASCRN Screening ASCREENING 2020-12-15 2020-12-15T17:24:00AAC4591001SEC4591001 1139 11391173A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-15T17:24:002021-02-10 AB:C4591001SEC4591001 1139 11391173A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-16 B:BC4591001SEC4591001 1139 11391174ASCRN Screening ASCREENING 2020-12-15 2020-12-15T17:28:00AAC4591001SEC4591001 1139 11391174A VAXP Placebo A VACCINATION 2020-12-15T17:28:002021-02-10 AB:C4591001SEC4591001 1139 11391174A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-06-18 B:BC4591001SEC4591001 1139 11391174A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-18 2021-06-18T13:10:00BBC4591001SEC4591001 1139 11391174APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-18T13:10:002021-08-18 BBC4591001SEC4591001 1139 11391174A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-18 2021-08-18 BBC4591001SEC4591001 1139 11391175ASCRN Screening ASCREENING 2020-12-15 2020-12-15T17:15:00AAC4591001SEC4591001 1139 11391175A VAXP Placebo A VACCINATION 2020-12-15T17:15:002021-02-02 AB2C4591001SEC4591001 1139 11391175A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-14 B2BC4591001SEC4591001 1139 11391175A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T14:10:00BBC4591001SEC4591001 1139 11391175APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T14:10:002021-07-01 BBC4591001SEC4591001 1139 11391175A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1139 11391177ASCRN Screening ASCREENING 2020-12-17 2020-12-17T11:50:00AAC4591001SEC4591001 1139 11391177A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T11:50:002021-02-12 AB:C4591001SEC4591001 1139 11391177A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-19 B:BC4591001SEC4591001 1139 11391178ASCRN Screening ASCREENING 2020-12-18 2020-12-18T12:58:00AAC4591001SEC4591001 1139 11391178A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T12:58:002021-02-05 AB2C4591001SEC4591001 1139 11391178A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-08-27 B2BC4591001SEC4591001 1139 11391179ASCRN Screening ASCREENING 2020-12-18 2020-12-18T15:03:00AAC4591001SEC4591001 1139 11391179A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T15:03:002021-02-05 AB2C4591001SEC4591001 1139 11391179A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-08-28 B2BC4591001SEC4591001 1139 11391180ASCRN Screening ASCREENING 2020-12-18 2020-12-18T15:20:00AAC4591001SEC4591001 1139 11391180A VAXP Placebo A VACCINATION 2020-12-18T15:20:002021-02-08 AB5C4591001SEC4591001 1139 11391180A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-14 B5BC4591001SEC4591001 1139 11391180A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T12:48:00BBC4591001SEC4591001 1139 11391180APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T12:48:002021-07-07 BBC4591001SEC4591001 1139 11391180A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1139 11391181ASCRN Screening ASCREENING 2020-12-18 2020-12-18T15:02:00AAC4591001SEC4591001 1139 11391181A VAXP Placebo A VACCINATION 2020-12-18T15:02:002021-02-03 AB0C4591001SEC4591001 1139 11391181A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-02-15 B0B<C4591001SEC4591001 1139 11391181A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-15 2021-02-15T13:05:00B<B<C4591001SEC4591001 1139 11391181APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-15T13:05:002021-04-08 B<BpC4591001SEC4591001 1139 11391181A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-08 2021-04-08 BpBpC4591001SEC4591001 1139 11391182ASCRN Screening ASCREENING 2020-12-18 2020-12-18T15:27:00AAC4591001SEC4591001 1139 11391182A VAXP Placebo A VACCINATION 2020-12-18T15:27:002021-02-12 AB9C4591001SEC4591001 1139 11391182A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-05-14 B9BC4591001SEC4591001 1139 11391182A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T12:54:00BBC4591001SEC4591001 1139 11391182APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T12:54:002021-07-08 BBC4591001SEC4591001 1139 11391182A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1139 11391183ASCRN Screening ASCREENING 2020-12-18 2020-12-18T16:56:00AAC4591001SEC4591001 1139 11391183A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-18T16:56:002021-02-05 AB2C4591001SEC4591001 1139 11391183A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-07-15 B2BC4591001SEC4591001 1139 11391185ASCRN Screening ASCREENING 2020-12-18 2020-12-18T17:00:00AAC4591001SEC4591001 1139 11391185A VAXP Placebo A VACCINATION 2020-12-18T17:00:002021-02-10 AB7C4591001SEC4591001 1139 11391185A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-13 B7BC4591001SEC4591001 1139 11391185A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T12:38:00BBC4591001SEC4591001 1139 11391185APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T12:38:002021-07-07 BBC4591001SEC4591001 1139 11391185A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1139 11391186ASCRN Screening ASCREENING 2020-12-21 2020-12-21T11:53:00AAC4591001SEC4591001 1139 11391186A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T11:53:002021-02-12 AB6C4591001SEC4591001 1139 11391186A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-07-09 B6BC4591001SEC4591001 1139 11391187ASCRN Screening ASCREENING 2020-12-21 2020-12-21T11:58:00AAC4591001SEC4591001 1139 11391187A VAXP Placebo A VACCINATION 2020-12-21T11:58:002021-02-09 AB3C4591001SEC4591001 1139 11391187A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-05-21 B3BC4591001SEC4591001 1139 11391187A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T12:57:00BBC4591001SEC4591001 1139 11391187APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T12:57:002021-08-12 BBC4591001SEC4591001 1139 11391187A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-12 2021-08-12 BBC4591001SEC4591001 1139 11391188ASCRN Screening ASCREENING 2020-12-21 2020-12-21T12:15:00AAC4591001SEC4591001 1139 11391188A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T12:15:002021-02-15 AB9C4591001SEC4591001 1139 11391188A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-19 B9BC4591001SEC4591001 1139 11391189ASCRN Screening ASCREENING 2020-12-21 2020-12-21T16:15:00AAC4591001SEC4591001 1139 11391189A VAXP Placebo A VACCINATION 2020-12-21T16:15:002021-02-10 AB4C4591001SEC4591001 1139 11391189A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-13 B4BC4591001SEC4591001 1139 11391190ASCRN Screening ASCREENING 2020-12-21 2020-12-21T16:32:00AAC4591001SEC4591001 1139 11391190A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T16:32:002021-02-10 AB4C4591001SEC4591001 1139 11391190A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-15 B4BC4591001SEC4591001 1139 11391191ASCRN Screening ASCREENING 2020-12-21 2020-12-21T16:37:00AAC4591001SEC4591001 1139 11391191A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T16:37:002021-02-10 AB4C4591001SEC4591001 1139 11391191A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-15 B4BC4591001SEC4591001 1139 11391192ASCRN Screening ASCREENING 2020-12-21 2020-12-21T16:27:00AAC4591001SEC4591001 1139 11391192A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T16:27:002021-02-10 AB4C4591001SEC4591001 1139 11391192A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-14 B4BC4591001SEC4591001 1139 11391193ASCRN Screening ASCREENING 2020-12-21 2020-12-21T16:21:00AAC4591001SEC4591001 1139 11391193A VAXP Placebo A VACCINATION 2020-12-21T16:21:002021-02-10 AB4C4591001SEC4591001 1139 11391193A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-13 B4BC4591001SEC4591001 1139 11391193A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T15:04:00BBC4591001SEC4591001 1139 11391193APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T15:04:002021-07-01 BBC4591001SEC4591001 1139 11391193A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1139 11391195ASCRN Screening ASCREENING 2020-12-21 2020-12-21T16:43:00AAC4591001SEC4591001 1139 11391195A VAXP Placebo A VACCINATION 2020-12-21T16:43:002021-02-10 AB4C4591001SEC4591001 1139 11391195A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-14 B4BC4591001SEC4591001 1139 11391195A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T16:51:00BBC4591001SEC4591001 1139 11391195APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T16:51:002021-07-27 BBC4591001SEC4591001 1139 11391195A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-27 2021-07-27 BBC4591001SEC4591001 1139 11391196ASCRN Screening ASCREENING 2020-12-21 2020-12-21T16:49:00AAC4591001SEC4591001 1139 11391196A VAXP Placebo A VACCINATION 2020-12-21T16:49:002021-02-10 AB4C4591001SEC4591001 1139 11391196A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-14 B4BC4591001SEC4591001 1139 11391196A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T16:05:00BBC4591001SEC4591001 1139 11391196APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T16:05:002021-07-27 BBC4591001SEC4591001 1139 11391196A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-27 2021-07-27 BBC4591001SEC4591001 1139 11391197ASCRN Screening ASCREENING 2020-12-22 2020-12-22T12:05:00AAC4591001SEC4591001 1139 11391197A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T12:05:002021-02-11 AB4C4591001SEC4591001 1139 11391197A0FUP Follow-up A0FOLLOW-UP 2021-02-11 2021-07-12 B4BC4591001SEC4591001 1139 11391198ASCRN Screening ASCREENING 2020-12-22 2020-12-22T11:55:00AAC4591001SEC4591001 1139 11391198A VAXP Placebo A VACCINATION 2020-12-22T11:55:002021-02-23 AB@C4591001SEC4591001 1139 11391198A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-05-21 B@BC4591001SEC4591001 1139 11391198A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T15:24:00BBC4591001SEC4591001 1139 11391198APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T15:24:002021-08-13 BBC4591001SEC4591001 1139 11391198A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-13 2021-08-13 BBC4591001SEC4591001 1139 11391199ASCRN Screening ASCREENING 2020-12-22 2020-12-22T11:48:00AAC4591001SEC4591001 1139 11391199A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T11:48:002021-02-26 ABCC4591001SEC4591001 1139 11391199A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-08 BCBC4591001SEC4591001 1139 11391200ASCRN Screening ASCREENING 2020-12-22 2020-12-22T12:01:00AAC4591001SEC4591001 1139 11391200A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T12:01:002021-02-09 AB2C4591001SEC4591001 1139 11391200A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-07-06 B2BC4591001SEC4591001 1139 11391201ASCRN Screening ASCREENING 2020-12-22 2020-12-22T15:02:00AAC4591001SEC4591001 1139 11391201A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T15:02:002021-02-12 AB5C4591001SEC4591001 1139 11391201A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-08-04 B5BC4591001SEC4591001 1139 11391202ASCRN Screening ASCREENING 2020-12-22 2020-12-22T15:06:00AAC4591001SEC4591001 1139 11391202A VAXP Placebo A VACCINATION 2020-12-22T15:06:002021-02-12 AB5C4591001SEC4591001 1139 11391202A0FUP Follow-up A0FOLLOW-UP 2021-02-12 2021-05-26 B5BC4591001SEC4591001 1139 11391202A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T14:13:00BBC4591001SEC4591001 1139 11391202APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T14:13:002021-08-12 BBC4591001SEC4591001 1139 11391202A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-12 2021-08-12 BBC4591001SEC4591001 1139 11391203ASCRN Screening ASCREENING 2020-12-22 2020-12-22T16:50:00AAC4591001SEC4591001 1139 11391203A VAXP Placebo A VACCINATION 2020-12-22T16:50:002021-02-16 AB9C4591001SEC4591001 1139 11391203A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-04-06 B9BjC4591001SEC4591001 1139 11391203A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-06 2021-04-06T15:00:00BjBjC4591001SEC4591001 1139 11391203APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-06T15:00:002021-04-27 BjBC4591001SEC4591001 1139 11391204ASCRN Screening ASCREENING 2020-12-22 2020-12-22T16:55:00AAC4591001SEC4591001 1139 11391204A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T16:55:002021-02-16 AB9C4591001SEC4591001 1139 11391204A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-05-12 B9BC4591001SEC4591001 1139 11391205ASCRN Screening ASCREENING 2020-12-22 2020-12-22T16:29:00AAC4591001SEC4591001 1139 11391205A VAXP Placebo A VACCINATION 2020-12-22T16:29:002021-02-10 AB3C4591001SEC4591001 1139 11391205A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-06-18 B3BC4591001SEC4591001 1139 11391205A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-06-18 2021-06-18T13:31:00BBC4591001SEC4591001 1139 11391205APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-06-18T13:31:002021-08-18 BBC4591001SEC4591001 1139 11391205A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-18 2021-08-18 BBC4591001SEC4591001 1139 11391206ASCRN Screening ASCREENING 2020-12-22 2020-12-22T16:34:00AAC4591001SEC4591001 1139 11391206A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T16:34:002021-02-09 AB2C4591001SEC4591001 1139 11391206A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-07-15 B2BC4591001SEC4591001 1139 11391207ASCRN Screening ASCREENING 2020-12-22 2020-12-22T16:39:00AAC4591001SEC4591001 1139 11391207A VAXP Placebo A VACCINATION 2020-12-22T16:39:002021-02-10 AB3C4591001SEC4591001 1139 11391207A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-20 B3BC4591001SEC4591001 1139 11391207A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T13:08:00BBC4591001SEC4591001 1139 11391207APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T13:08:002021-08-12 BBC4591001SEC4591001 1139 11391207A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-12 2021-08-12 BBC4591001SEC4591001 1139 11391208ASCRN Screening ASCREENING 2020-12-22 2020-12-22T16:44:00AAC4591001SEC4591001 1139 11391208A VAXP Placebo A VACCINATION 2020-12-22T16:44:002021-02-10 AB3C4591001SEC4591001 1139 11391208A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-20 B3BC4591001SEC4591001 1139 11391208A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T13:07:00BBC4591001SEC4591001 1139 11391208APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T13:07:002021-08-12 BBC4591001SEC4591001 1139 11391208A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-12 2021-08-12 BBC4591001SEC4591001 1139 11391209ASCRN Screening ASCREENING 2020-12-22 2020-12-23T10:40:00AC4591001SEC4591001 1139 11391209A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T10:40:002021-02-17 AB9C4591001SEC4591001 1139 11391209A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-28 B9BC4591001SEC4591001 1139 11391210ASCRN Screening ASCREENING 2020-12-28 2020-12-28T12:21:00AAC4591001SEC4591001 1139 11391210A VAXP Placebo A VACCINATION 2020-12-28T12:21:002021-02-15 AB2C4591001SEC4591001 1139 11391210A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-26 B2BC4591001SEC4591001 1139 11391210A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T15:41:00BBC4591001SEC4591001 1139 11391210APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T15:41:002021-08-12 BBC4591001SEC4591001 1139 11391210A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-12 2021-08-12 BBC4591001SEC4591001 1139 11391211ASCRN Screening ASCREENING 2020-12-28 2020-12-28T13:05:00AAC4591001SEC4591001 1139 11391211A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T13:05:002021-02-16 AB3C4591001SEC4591001 1139 11391211A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-07-14 B3BC4591001SEC4591001 1139 11391212ASCRN Screening ASCREENING 2020-12-28 2020-12-28T12:59:00AAC4591001SEC4591001 1139 11391212A VAXP Placebo A VACCINATION 2020-12-28T12:59:002021-02-19 AB6C4591001SEC4591001 1139 11391212A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-02-19 B6B6C4591001SEC4591001 1139 11391212A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-19 2021-02-19T15:56:00B6B6C4591001SEC4591001 1139 11391212APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-19T15:56:002021-04-14 B6BlC4591001SEC4591001 1139 11391212A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-14 2021-04-14 BlBlC4591001SEC4591001 1139 11391213ASCRN Screening ASCREENING 2020-12-28 2020-12-28T13:48:00AAC4591001SEC4591001 1139 11391213A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T13:48:002021-02-22 AB9C4591001SEC4591001 1139 11391213A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-08-03 B9BC4591001SEC4591001 1139 11391214ASCRN Screening ASCREENING 2020-12-28 2020-12-28T15:13:00AAC4591001SEC4591001 1139 11391214A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T15:13:002021-02-19 AB6C4591001SEC4591001 1139 11391214A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-07-19 B6BC4591001SEC4591001 1139 11391215ASCRN Screening ASCREENING 2020-12-29 2020-12-29T12:05:00AAC4591001SEC4591001 1139 11391215A VAXP Placebo A VACCINATION 2020-12-29T12:05:002021-02-19 AB5C4591001SEC4591001 1139 11391215A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-05-14 B5BC4591001SEC4591001 1139 11391215A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T16:55:00BBC4591001SEC4591001 1139 11391215APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T16:55:002021-07-06 BBC4591001SEC4591001 1139 11391215A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1139 11391216ASCRN Screening ASCREENING 2020-12-29 2020-12-29T12:01:00AAC4591001SEC4591001 1139 11391216A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T12:01:002021-02-22 AB8C4591001SEC4591001 1139 11391216A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-08-04 B8BC4591001SEC4591001 1139 11391217ASCRN Screening ASCREENING 2020-12-29 2020-12-29T12:59:00AAC4591001SEC4591001 1139 11391217A VAXP Placebo A VACCINATION 2020-12-29T12:59:002021-02-17 AB3C4591001SEC4591001 1139 11391217A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-20 B3BC4591001SEC4591001 1139 11391217A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T16:17:00BBC4591001SEC4591001 1139 11391217APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T16:17:002021-07-08 BBC4591001SEC4591001 1139 11391217A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1139 11391218ASCRN Screening ASCREENING 2020-12-29 2020-12-29T15:48:00AAC4591001SEC4591001 1139 11391218A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T15:48:002021-02-17 AB3C4591001SEC4591001 1139 11391218A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-08-18 B3BC4591001SEC4591001 1139 11391219ASCRN Screening ASCREENING 2020-12-29 2020-12-29T15:42:00AAC4591001SEC4591001 1139 11391219A VAXP Placebo A VACCINATION 2020-12-29T15:42:002021-02-17 AB3C4591001SEC4591001 1139 11391219A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-13 B3BC4591001SEC4591001 1139 11391219A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T14:23:00BBC4591001SEC4591001 1139 11391219APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T14:23:002021-07-02 BBC4591001SEC4591001 1139 11391219A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-02 2021-07-02 BBC4591001SEC4591001 1139 11391220ASCRN Screening ASCREENING 2020-12-29 2020-12-29T15:52:00AAC4591001SEC4591001 1139 11391220A VAXP Placebo A VACCINATION 2020-12-29T15:52:002021-02-24 AB:C4591001SEC4591001 1139 11391220A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-20 B:BC4591001SEC4591001 1139 11391220A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T13:55:00BBC4591001SEC4591001 1139 11391220APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T13:55:002021-08-13 BBC4591001SEC4591001 1139 11391220A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-13 2021-08-13 BBC4591001SEC4591001 1139 11391221ASCRN Screening ASCREENING 2021-01-04 2021-01-04T13:06:00AAC4591001SEC4591001 1139 11391221A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T13:06:002021-02-24 AB4C4591001SEC4591001 1139 11391221A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-08-02 B4BC4591001SEC4591001 1139 11391222ASCRN Screening ASCREENING 2021-01-04 2021-01-04T13:32:00AAC4591001SEC4591001 1139 11391222A VAXP Placebo A VACCINATION 2021-01-04T13:32:002021-02-24 AB4C4591001SEC4591001 1139 11391222A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-05-20 B4BC4591001SEC4591001 1139 11391222A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T15:39:00BBC4591001SEC4591001 1139 11391222APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T15:39:002021-08-13 BBC4591001SEC4591001 1139 11391222A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-13 2021-08-13 BBC4591001SEC4591001 1139 11391223ASCRN Screening ASCREENING 2021-01-04 2021-01-04T12:57:00AAC4591001SEC4591001 1139 11391223A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T12:57:002021-02-26 AB6C4591001SEC4591001 1139 11391223A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-20 B6BC4591001SEC4591001 1139 11391224ASCRN Screening ASCREENING 2021-01-04 2021-01-04T14:43:00AAC4591001SEC4591001 1139 11391224A VAXP Placebo A VACCINATION 2021-01-04T14:43:002021-02-23 AB3C4591001SEC4591001 1139 11391224A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-05-13 B3BC4591001SEC4591001 1139 11391224A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T13:25:00BBC4591001SEC4591001 1139 11391224APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T13:25:002021-07-07 BBC4591001SEC4591001 1139 11391224A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1139 11391225ASCRN Screening ASCREENING 2021-01-04 2021-01-04T13:26:00AAC4591001SEC4591001 1139 11391225A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-04T13:26:002021-03-05 AB=C4591001SEC4591001 1139 11391225A0FUP Follow-up A0FOLLOW-UP 2021-03-05 2021-08-02 B=BC4591001SEC4591001 1139 11391226ASCRN Screening ASCREENING 2021-01-05 2021-01-05T12:12:00AAC4591001SEC4591001 1139 11391226A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T12:12:002021-02-25 AB4C4591001SEC4591001 1139 11391226A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-08-05 B4BC4591001SEC4591001 1139 11391227ASCRN Screening ASCREENING 2021-01-05 2021-01-05T12:15:00AAC4591001SEC4591001 1139 11391227A VAXP Placebo A VACCINATION 2021-01-05T12:15:002021-02-25 AB4C4591001SEC4591001 1139 11391227A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-05-21 B4BC4591001SEC4591001 1139 11391227A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T14:52:00BBC4591001SEC4591001 1139 11391227APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T14:52:002021-07-16 BBC4591001SEC4591001 1139 11391227A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-16 2021-07-16 BBC4591001SEC4591001 1139 11391228ASCRN Screening ASCREENING 2021-01-05 2021-01-05T12:31:00AAC4591001SEC4591001 1139 11391228A VAXP Placebo A VACCINATION 2021-01-05T12:31:002021-03-01 AB8C4591001SEC4591001 1139 11391228A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-05-20 B8BC4591001SEC4591001 1139 11391228A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T14:00:00BBC4591001SEC4591001 1139 11391228APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T14:00:002021-08-13 BBC4591001SEC4591001 1139 11391228A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-13 2021-08-13 BBC4591001SEC4591001 1139 11391229ASCRN Screening ASCREENING 2021-01-05 2021-01-05T12:21:00AAC4591001SEC4591001 1139 11391229A VAXP Placebo A VACCINATION 2021-01-05T12:21:002021-03-03 AB:C4591001SEC4591001 1139 11391229A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-05-20 B:BC4591001SEC4591001 1139 11391229A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T14:10:00BBC4591001SEC4591001 1139 11391229APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T14:10:002021-08-13 BBC4591001SEC4591001 1139 11391229A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-13 2021-08-13 BBC4591001SEC4591001 1139 11391230ASCRN Screening ASCREENING 2021-01-05 2021-01-05T12:27:00AAC4591001SEC4591001 1139 11391230A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T12:27:002021-02-23 AB2C4591001SEC4591001 1139 11391230A0FUP Follow-up A0FOLLOW-UP 2021-02-23 2021-07-27 B2BC4591001SEC4591001 1139 11391231ASCRN Screening ASCREENING 2021-01-05 2021-01-05T16:28:00AAC4591001SEC4591001 1139 11391231A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T16:28:002021-02-24 AB3C4591001SEC4591001 1139 11391231A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-21 B3BC4591001SEC4591001 1139 11391232ASCRN Screening ASCREENING 2021-01-05 2021-01-05T16:33:00AAC4591001SEC4591001 1139 11391232A VAXP Placebo A VACCINATION 2021-01-05T16:33:002021-02-24 AB3C4591001SEC4591001 1139 11391232A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-08-23 B3BC4591001SEC4591001 1139 11391233ASCRN Screening ASCREENING 2021-01-05 2021-01-05T16:38:00AAC4591001SEC4591001 1139 11391233A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T16:38:002021-02-24 AB3C4591001SEC4591001 1139 11391233A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-21 B3BC4591001SEC4591001 1139 11391235ASCRN Screening ASCREENING 2021-01-05 2021-01-05T16:47:00AAC4591001SEC4591001 1139 11391235A VAXP Placebo A VACCINATION 2021-01-05T16:47:002021-02-15 AB*C4591001SEC4591001 1139 11391235A0SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-15 2021-02-15T15:33:00B*B*C4591001SEC4591001 1139 11391235A@VAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-15T15:33:002021-04-05 B*B[C4591001SEC4591001 1139 11391235APFUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-05 2021-04-05 B[B[C4591001SEC4591001 1139 11391236ASCRN Screening ASCREENING 2021-01-05 2021-01-05T16:52:00AAC4591001SEC4591001 1139 11391236A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-05T16:52:002021-02-24 AB3C4591001SEC4591001 1139 11391236A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-07-28 B3BC4591001SEC4591001 1139 11391237ASCRN Screening ASCREENING 2021-01-07 2021-01-07T16:46:00AAC4591001SEC4591001 1139 11391237A VAXP Placebo A VACCINATION 2021-01-07T16:46:002021-03-02 AB7C4591001SEC4591001 1139 11391237A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-26 B7BC4591001SEC4591001 1139 11391237A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-26 2021-05-26T13:45:00BBC4591001SEC4591001 1139 11391237APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-26T13:45:002021-07-15 BBC4591001SEC4591001 1139 11391237A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-15 2021-07-15 BBC4591001SEC4591001 1139 11391238ASCRN Screening ASCREENING 2021-01-07 2021-01-07T16:38:00AAC4591001SEC4591001 1139 11391238A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-07T16:38:002021-02-26 AB3C4591001SEC4591001 1139 11391238A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-16 B3BC4591001SEC4591001 1139 11391239ASCRN Screening ASCREENING 2021-01-07 2021-01-07T16:52:00AAC4591001SEC4591001 1139 11391239A VAXP Placebo A VACCINATION 2021-01-07T16:52:002021-02-22 AB/C4591001SEC4591001 1139 11391239A0FUP Follow-up A0FOLLOW-UP 2021-02-22 2021-05-21 B/BC4591001SEC4591001 1139 11391239A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T16:02:00BBC4591001SEC4591001 1139 11391239APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T16:02:002021-08-16 BBC4591001SEC4591001 1139 11391239A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-16 2021-08-16 BBC4591001SEC4591001 1139 11391240ASCRN Screening ASCREENING 2021-01-08 2021-01-08T13:57:00AAC4591001SEC4591001 1139 11391240A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T13:57:002021-02-25 AB1C4591001SEC4591001 1139 11391240A0FUP Follow-up A0FOLLOW-UP 2021-02-25 2021-07-30 B1BC4591001SEC4591001 1139 11391241ASCRN Screening ASCREENING 2021-01-08 2021-01-08T16:24:00AAC4591001SEC4591001 1139 11391241A VAXP Placebo A VACCINATION 2021-01-08T16:24:002021-03-03 AB7C4591001SEC4591001 1139 11391241A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-05-20 B7BC4591001SEC4591001 1139 11391241A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T16:40:00BBC4591001SEC4591001 1139 11391241APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T16:40:002021-08-16 BBC4591001SEC4591001 1139 11391241A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-16 2021-08-16 BBC4591001SEC4591001 1139 11391242ASCRN Screening ASCREENING 2021-01-08 2021-01-08T16:42:00AAC4591001SEC4591001 1139 11391242A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T16:42:002021-02-26 AB2C4591001SEC4591001 1139 11391242A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-23 B2BC4591001SEC4591001 1139 11391243ASCRN Screening ASCREENING 2021-01-08 2021-01-08T16:32:00AAC4591001SEC4591001 1139 11391243A VAXP Placebo A VACCINATION 2021-01-08T16:32:002021-02-26 AB2C4591001SEC4591001 1139 11391243A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-20 B2BC4591001SEC4591001 1139 11391243A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T14:55:00BBC4591001SEC4591001 1139 11391243APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T14:55:002021-07-12 BBC4591001SEC4591001 1139 11391243A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1139 11391244ASCRN Screening ASCREENING 2021-01-08 2021-01-08T16:36:00AAC4591001SEC4591001 1139 11391244A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T16:36:002021-02-26 AB2C4591001SEC4591001 1139 11391244A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-08-18 B2BC4591001SEC4591001 1139 11391245ASCRN Screening ASCREENING 2021-01-08 2021-01-08T17:24:00AAC4591001SEC4591001 1139 11391245A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T17:24:002021-03-08 AB<C4591001SEC4591001 1139 11391245A0FUP Follow-up A0FOLLOW-UP 2021-03-08 2021-08-11 B<BC4591001SEC4591001 1139 11391246ASCRN Screening ASCREENING 2021-01-08 2021-01-08T16:52:00AAC4591001SEC4591001 1139 11391246A VAXP Placebo A VACCINATION 2021-01-08T16:52:002021-02-26 AB2C4591001SEC4591001 1139 11391246A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-20 B2BC4591001SEC4591001 1139 11391246A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T16:48:00BBC4591001SEC4591001 1139 11391246APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T16:48:002021-08-16 BBC4591001SEC4591001 1139 11391246A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-16 2021-08-16 BBC4591001SEC4591001 1139 11391247ASCRN Screening ASCREENING 2021-01-08 2021-01-08T17:04:00AAC4591001SEC4591001 1139 11391247A VAXP Placebo A VACCINATION 2021-01-08T17:04:002021-03-03 AB7C4591001SEC4591001 1139 11391247A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-05-13 B7B~C4591001SEC4591001 1139 11391247A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T16:37:00B~B~C4591001SEC4591001 1139 11391247APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T16:37:002021-07-01 B~BC4591001SEC4591001 1139 11391247A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1139 11391248ASCRN Screening ASCREENING 2021-01-08 2021-01-08T17:09:00AAC4591001SEC4591001 1139 11391248A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-08T17:09:002021-03-22 ABJC4591001SEC4591001 1139 11391248A0FUP Follow-up A0FOLLOW-UP 2021-03-22 2021-07-23 BJBC4591001SEC4591001 1139 11391249ASCRN Screening ASCREENING 2021-01-11 2021-01-11T14:19:00AAC4591001SEC4591001 1139 11391249A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T14:19:002021-03-03 AB4C4591001SEC4591001 1139 11391249A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-08-25 B4BC4591001SEC4591001 1139 11391250ASCRN Screening ASCREENING 2021-01-11 2021-01-11T15:47:00AAC4591001SEC4591001 1139 11391250A VAXP Placebo A VACCINATION 2021-01-11T15:47:002021-03-04 AB5C4591001SEC4591001 1139 11391250A0FUP Follow-up A0FOLLOW-UP 2021-03-04 2021-04-20 B5BdC4591001SEC4591001 1139 11391250A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-04-20 2021-04-20T14:30:00BdBdC4591001SEC4591001 1139 11391250APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-04-20T14:30:002021-06-08 BdBC4591001SEC4591001 1139 11391250A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-06-08 2021-06-08 BBC4591001SEC4591001 1139 11391251ASCRN Screening ASCREENING 2021-01-11 2021-01-11T13:41:00AAC4591001SEC4591001 1139 11391251A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T13:41:002021-03-02 AB3C4591001SEC4591001 1139 11391251A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-08-22 B3BC4591001SEC4591001 1139 11391252ASCRN Screening ASCREENING 2021-01-11 2021-01-11T13:46:00AAC4591001SEC4591001 1139 11391252A VAXP Placebo A VACCINATION 2021-01-11T13:46:002021-03-02 AB3C4591001SEC4591001 1139 11391252A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-13 B3B{C4591001SEC4591001 1139 11391252A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-13 2021-05-13T14:48:00B{B{C4591001SEC4591001 1139 11391252APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-13T14:48:002021-07-01 B{BC4591001SEC4591001 1139 11391252A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-01 2021-07-01 BBC4591001SEC4591001 1139 11391253ASCRN Screening ASCREENING 2021-01-11 2021-01-11T15:53:00AAC4591001SEC4591001 1139 11391253A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T15:53:002021-02-26 AB/C4591001SEC4591001 1139 11391253A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-07-30 B/BC4591001SEC4591001 1139 11391254ASCRN Screening ASCREENING 2021-01-11 2021-01-11T15:58:00AAC4591001SEC4591001 1139 11391254A VAXP Placebo A VACCINATION 2021-01-11T15:58:002021-02-26 AB/C4591001SEC4591001 1139 11391254A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-14 B/B|C4591001SEC4591001 1139 11391254A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T15:30:00B|B|C4591001SEC4591001 1139 11391254APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T15:30:002021-07-23 B|BC4591001SEC4591001 1139 11391254A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-23 2021-07-23 BBC4591001SEC4591001 1139 11391255ASCRN Screening ASCREENING 2021-01-11 2021-01-11T16:07:00AAC4591001SEC4591001 1139 11391255A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-11T16:07:002021-03-01 AB2C4591001SEC4591001 1139 11391255A0FUP Follow-up A0FOLLOW-UP 2021-03-01 2021-07-26 B2BC4591001SEC4591001 1139 11391256ASCRN Screening ASCREENING 2021-01-12 2021-01-12T14:38:00AAC4591001SEC4591001 1139 11391256A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T14:38:002021-03-02 AB2C4591001SEC4591001 1139 11391256A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-07-27 B2BC4591001SEC4591001 1139 11391257ASCRN Screening ASCREENING 2021-01-12 2021-01-12T12:35:00AAC4591001SEC4591001 1139 11391257A VAXP Placebo A VACCINATION 2021-01-12T12:35:002021-03-02 AB2C4591001SEC4591001 1139 11391257A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-21 B2BC4591001SEC4591001 1139 11391257A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T12:36:00BBC4591001SEC4591001 1139 11391257APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T12:36:002021-08-16 BBC4591001SEC4591001 1139 11391257A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-16 2021-08-16 BBC4591001SEC4591001 1139 11391258ASCRN Screening ASCREENING 2021-01-12 2021-01-12T16:12:00AAC4591001SEC4591001 1139 11391258A VAXP Placebo A VACCINATION 2021-01-12T16:12:002021-03-02 AB2C4591001SEC4591001 1139 11391258A0FUP Follow-up A0FOLLOW-UP 2021-03-02 2021-05-14 B2B{C4591001SEC4591001 1139 11391258A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-14 2021-05-14T12:42:00B{B{C4591001SEC4591001 1139 11391258APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-14T12:42:002021-07-23 B{BC4591001SEC4591001 1139 11391258A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-23 2021-07-23 BBC4591001SEC4591001 1139 11391259ASCRN Screening ASCREENING 2021-01-12 2021-01-12T12:43:00AAC4591001SEC4591001 1139 11391259A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T12:43:002021-03-08 AB8C4591001SEC4591001 1139 11391259A0FUP Follow-up A0FOLLOW-UP 2021-03-08 2021-08-02 B8BC4591001SEC4591001 1139 11391260ASCRN Screening ASCREENING 2021-01-12 2021-01-12T16:22:00AAC4591001SEC4591001 1139 11391260A VAXP Placebo A VACCINATION 2021-01-12T16:22:002021-03-03 AB3C4591001SEC4591001 1139 11391260A0FUP Follow-up A0FOLLOW-UP 2021-03-03 2021-05-21 B3BC4591001SEC4591001 1139 11391260A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T13:46:00BBC4591001SEC4591001 1139 11391260APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T13:46:002021-08-16 BBC4591001SEC4591001 1139 11391260A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-08-16 2021-08-16 BBC4591001SEC4591001 1139 11391261ASCRN Screening ASCREENING 2021-01-12 2021-01-12T16:08:00AAC4591001SEC4591001 1139 11391261A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T16:08:002021-02-24 AB,C4591001SEC4591001 1139 11391261A0FUP Follow-up A0FOLLOW-UP 2021-02-24 2021-08-03 B,BC4591001SEC4591001 1139 11391262ASCRN Screening ASCREENING 2021-01-12 2021-01-12T17:00:00AAC4591001SEC4591001 1139 11391262A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2021-01-12T17:00:002021-03-10 AB:C4591001SEC4591001 1139 11391262A0FUP Follow-up A0FOLLOW-UP 2021-03-10 2021-08-04 B:BC4591001SEC4591001 1139 11391263ASCRN Screening ASCREENING 2021-01-12 2021-01-12T17:12:00AAC4591001SEC4591001 1139 11391263A VAXP Placebo A VACCINATION 2021-01-12T17:12:002021-02-19 AB'C4591001SEC4591001 1139 11391263A0SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-02-19 2021-02-19T16:16:00B'B'C4591001SEC4591001 1139 11391263A@VAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-02-19T16:16:002021-04-12 B'B[C4591001SEC4591001 1139 11391263APFUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-04-12 2021-04-12 B[B[C4591001SEC4591001 1140 11401323ASCRN Screening ASCREENING 2020-12-10 2020-12-10T14:15:00AAC4591001SEC4591001 1140 11401323A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T14:15:002021-02-10 AB?C4591001SEC4591001 1140 11401323A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-09 B?BC4591001SEC4591001 1140 11401324ASCRN Screening ASCREENING 2020-12-10 2020-12-10T14:20:00AAC4591001SEC4591001 1140 11401324A VAXP Placebo A VACCINATION 2020-12-10T14:20:002021-02-10 AB?C4591001SEC4591001 1140 11401324A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-21 B?BC4591001SEC4591001 1140 11401324A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T15:45:00BBC4591001SEC4591001 1140 11401324APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T15:45:002021-07-09 BBC4591001SEC4591001 1140 11401324A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1140 11401325ASCRN Screening ASCREENING 2020-12-10 2020-12-10T15:02:00AAC4591001SEC4591001 1140 11401325A VAXP Placebo A VACCINATION 2020-12-10T15:02:002021-02-10 AB?C4591001SEC4591001 1140 11401325A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-08-04 B?BC4591001SEC4591001 1140 11401325A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-08-04 2021-08-04T11:21:00BBC4591001SEC4591001 1140 11401325APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-08-04T11:21:002021-08-23 BCC4591001SEC4591001 1140 11401326ASCRN Screening ASCREENING 2020-12-10 2020-12-10T15:07:00AAC4591001SEC4591001 1140 11401326A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-10T15:07:002021-02-10 AB?C4591001SEC4591001 1140 11401326A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-02 B?BC4591001SEC4591001 1140 11401327ASCRN Screening ASCREENING 2020-12-11 2020-12-11T14:46:00AAC4591001SEC4591001 1140 11401327A VAXP Placebo A VACCINATION 2020-12-11T14:46:002021-02-02 AB6C4591001SEC4591001 1140 11401327A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-05-17 B6BC4591001SEC4591001 1140 11401327A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T14:32:00BBC4591001SEC4591001 1140 11401327APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T14:32:002021-07-12 BBC4591001SEC4591001 1140 11401327A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-12 2021-07-12 BBC4591001SEC4591001 1140 11401328ASCRN Screening ASCREENING 2020-12-14 2020-12-14T14:08:00AAC4591001SEC4591001 1140 11401328A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T14:08:002021-02-05 AB6C4591001SEC4591001 1140 11401328A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-06-30 B6BC4591001SEC4591001 1140 11401329ASCRN Screening ASCREENING 2020-12-14 2020-12-14T15:53:00AAC4591001SEC4591001 1140 11401329A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-14T15:53:002021-02-02 AB3C4591001SEC4591001 1140 11401329A0FUP Follow-up A0FOLLOW-UP 2021-02-02 2021-07-12 B3BC4591001SEC4591001 1140 11401330ASCRN Screening ASCREENING 2020-12-15 2020-12-15T10:32:00AAC4591001SEC4591001 1140 11401330A VAXP Placebo A VACCINATION 2020-12-15T10:32:002021-02-05 AB5C4591001SEC4591001 1140 11401330A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-17 B5BC4591001SEC4591001 1140 11401330A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T15:58:00BBC4591001SEC4591001 1140 11401330APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T15:58:002021-07-06 BBC4591001SEC4591001 1140 11401330A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1140 11401331ASCRN Screening ASCREENING 2020-12-16 2020-12-16T11:21:00AAC4591001SEC4591001 1140 11401331A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T11:21:002021-02-03 AB2C4591001SEC4591001 1140 11401331A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-08-27 B2BC4591001SEC4591001 1140 11401332ASCRN Screening ASCREENING 2020-12-16 2020-12-16T11:25:00AAC4591001SEC4591001 1140 11401332A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-16T11:25:002021-02-03 AB2C4591001SEC4591001 1140 11401332A0FUP Follow-up A0FOLLOW-UP 2021-02-03 2021-08-02 B2BC4591001SEC4591001 1140 11401333ASCRN Screening ASCREENING 2020-12-16 2020-12-16T16:03:00AAC4591001SEC4591001 1140 11401333A VAXP Placebo A VACCINATION 2020-12-16T16:03:002021-02-05 AB4C4591001SEC4591001 1140 11401333A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-18 B4BC4591001SEC4591001 1140 11401333A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T15:04:00BBC4591001SEC4591001 1140 11401333APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T15:04:002021-07-07 BBC4591001SEC4591001 1140 11401333A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1140 11401334ASCRN Screening ASCREENING 2020-12-16 2020-12-16T16:07:00AAC4591001SEC4591001 1140 11401334A VAXP Placebo A VACCINATION 2020-12-16T16:07:002021-02-05 AB4C4591001SEC4591001 1140 11401334A0FUP Follow-up A0FOLLOW-UP 2021-02-05 2021-05-18 B4BC4591001SEC4591001 1140 11401334A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T15:00:00BBC4591001SEC4591001 1140 11401334APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T15:00:002021-07-07 BBC4591001SEC4591001 1140 11401334A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1140 11401335ASCRN Screening ASCREENING 2020-12-17 2020-12-17T13:29:00AAC4591001SEC4591001 1140 11401335A VAXP Placebo A VACCINATION 2020-12-17T13:29:002021-02-10 AB8C4591001SEC4591001 1140 11401335A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-17 B8BC4591001SEC4591001 1140 11401335A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T13:48:00BBC4591001SEC4591001 1140 11401335APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T13:48:002021-07-07 BBC4591001SEC4591001 1140 11401335A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1140 11401336ASCRN Screening ASCREENING 2020-12-17 2020-12-17T13:54:00AAC4591001SEC4591001 1140 11401336A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T13:54:002021-02-09 AB7C4591001SEC4591001 1140 11401336A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-07-09 B7BC4591001SEC4591001 1140 11401337ASCRN Screening ASCREENING 2020-12-17 2020-12-17T15:23:00AAC4591001SEC4591001 1140 11401337A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-17T15:23:002021-02-09 AB7C4591001SEC4591001 1140 11401337A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-06-29 B7BC4591001SEC4591001 1140 11401338ASCRN Screening ASCREENING 2020-12-17 2020-12-17T16:09:00AAC4591001SEC4591001 1140 11401338A VAXP Placebo A VACCINATION 2020-12-17T16:09:002021-02-04 AB2C4591001SEC4591001 1140 11401338A0FUP Follow-up A0FOLLOW-UP 2021-02-04 2021-05-17 B2BC4591001SEC4591001 1140 11401338A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T10:00:00BBC4591001SEC4591001 1140 11401338APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T10:00:002021-07-07 BBC4591001SEC4591001 1140 11401338A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1140 11401340ASCRN Screening ASCREENING 2020-12-21 2020-12-21T09:29:00AAC4591001SEC4591001 1140 11401340A VAXP Placebo A VACCINATION 2020-12-21T09:29:002021-02-10 AB4C4591001SEC4591001 1140 11401340A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-21 B4BC4591001SEC4591001 1140 11401340A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T10:09:00BBC4591001SEC4591001 1140 11401340APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T10:09:002021-07-07 BBC4591001SEC4591001 1140 11401340A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1140 11401343ASCRN Screening ASCREENING 2020-12-21 2020-12-21T15:19:00AAC4591001SEC4591001 1140 11401343A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T15:19:002021-02-10 AB4C4591001SEC4591001 1140 11401343A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-16 B4BC4591001SEC4591001 1140 11401344ASCRN Screening ASCREENING 2020-12-21 2020-12-21T15:21:00AAC4591001SEC4591001 1140 11401344A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-21T15:21:002021-02-10 AB4C4591001SEC4591001 1140 11401344A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-16 B4BC4591001SEC4591001 1140 11401345ASCRN Screening ASCREENING 2020-12-22 2020-12-22T09:36:00AAC4591001SEC4591001 1140 11401345A VAXP Placebo A VACCINATION 2020-12-22T09:36:002021-02-15 AB8C4591001SEC4591001 1140 11401345A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-05-18 B8BC4591001SEC4591001 1140 11401345A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T15:30:00BBC4591001SEC4591001 1140 11401345APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T15:30:002021-07-06 BBC4591001SEC4591001 1140 11401345A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1140 11401346ASCRN Screening ASCREENING 2020-12-22 2020-12-22 AAC4591001SEC4591001 1140 11401347ASCRN Screening ASCREENING 2020-12-22 2020-12-22T10:08:00AAC4591001SEC4591001 1140 11401347A VAXP Placebo A VACCINATION 2020-12-22T10:08:002021-02-17 AB:C4591001SEC4591001 1140 11401347A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-19 B:BC4591001SEC4591001 1140 11401347A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T14:22:00BBC4591001SEC4591001 1140 11401347APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T14:22:002021-07-07 BBC4591001SEC4591001 1140 11401347A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1140 11401348ASCRN Screening ASCREENING 2020-12-22 2020-12-22T10:12:00AAC4591001SEC4591001 1140 11401348A VAXP Placebo A VACCINATION 2020-12-22T10:12:002021-02-17 AB:C4591001SEC4591001 1140 11401348A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-19 B:BC4591001SEC4591001 1140 11401348A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T14:24:00BBC4591001SEC4591001 1140 11401348APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T14:24:002021-07-07 BBC4591001SEC4591001 1140 11401348A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1140 11401349ASCRN Screening ASCREENING 2020-12-22 2020-12-22T10:33:00AAC4591001SEC4591001 1140 11401349A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T10:33:002021-02-16 AB9C4591001SEC4591001 1140 11401349A0FUP Follow-up A0FOLLOW-UP 2021-02-16 2021-07-14 B9BC4591001SEC4591001 1140 11401350ASCRN Screening ASCREENING 2020-12-22 2020-12-22T12:21:00AAC4591001SEC4591001 1140 11401350A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T12:21:002021-02-17 AB:C4591001SEC4591001 1140 11401350A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-13 B:BC4591001SEC4591001 1140 11401351ASCRN Screening ASCREENING 2020-12-22 2020-12-22T12:24:00AAC4591001SEC4591001 1140 11401351A VAXP Placebo A VACCINATION 2020-12-22T12:24:002021-02-17 AB:C4591001SEC4591001 1140 11401351A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-08-03 B:BC4591001SEC4591001 1140 11401351A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-08-03 2021-08-03T13:40:00BBC4591001SEC4591001 1140 11401351APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-08-03T13:40:002021-08-23 BBC4591001SEC4591001 1140 11401352ASCRN Screening ASCREENING 2020-12-22 2020-12-22T12:27:00AAC4591001SEC4591001 1140 11401352A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-22T12:27:002021-02-17 AB:C4591001SEC4591001 1140 11401352A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-13 B:BC4591001SEC4591001 1140 11401353ASCRN Screening ASCREENING 2020-12-22 2020-12-22T14:58:00AAC4591001SEC4591001 1140 11401353A VAXP Placebo A VACCINATION 2020-12-22T14:58:002021-02-09 AB2C4591001SEC4591001 1140 11401353A0FUP Follow-up A0FOLLOW-UP 2021-02-09 2021-05-21 B2BC4591001SEC4591001 1140 11401353A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T15:55:00BBC4591001SEC4591001 1140 11401353APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T15:55:002021-07-09 BBC4591001SEC4591001 1140 11401353A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-28 BBC4591001SEC4591001 1140 11401354ASCRN Screening ASCREENING 2020-12-23 2020-12-23T09:56:00AAC4591001SEC4591001 1140 11401354A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T09:56:002021-02-15 AB7C4591001SEC4591001 1140 11401354A0FUP Follow-up A0FOLLOW-UP 2021-02-15 2021-07-07 B7BC4591001SEC4591001 1140 11401356ASCRN Screening ASCREENING 2020-12-23 2020-12-23T13:30:00AAC4591001SEC4591001 1140 11401356A VAXP Placebo A VACCINATION 2020-12-23T13:30:002021-02-10 AB2C4591001SEC4591001 1140 11401356A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-05-20 B2BC4591001SEC4591001 1140 11401356A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-20 2021-05-20T10:11:00BBC4591001SEC4591001 1140 11401356APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-20T10:11:002021-07-15 BBC4591001SEC4591001 1140 11401356A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-15 2021-07-15 BBC4591001SEC4591001 1140 11401357ASCRN Screening ASCREENING 2020-12-23 2020-12-23T14:07:00AAC4591001SEC4591001 1140 11401357A VAXP Placebo A VACCINATION 2020-12-23T14:07:002021-02-08 AB0C4591001SEC4591001 1140 11401357A0FUP Follow-up A0FOLLOW-UP 2021-02-08 2021-05-14 B0BC4591001SEC4591001 1140 11401358ASCRN Screening ASCREENING 2020-12-23 2020-12-23T15:49:00AAC4591001SEC4591001 1140 11401358A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T15:49:002021-02-10 AB2C4591001SEC4591001 1140 11401358A0FUP Follow-up A0FOLLOW-UP 2021-02-10 2021-07-07 B2BC4591001SEC4591001 1140 11401359ASCRN Screening ASCREENING 2020-12-23 2020-12-23T15:45:00AAC4591001SEC4591001 1140 11401359A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-23T15:45:002021-02-17 AB9C4591001SEC4591001 1140 11401359A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-19 B9BC4591001SEC4591001 1140 11401361ASCRN Screening ASCREENING 2020-12-28 2020-12-28T11:58:00AAC4591001SEC4591001 1140 11401361A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T11:58:002021-02-18 AB5C4591001SEC4591001 1140 11401361A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-07-15 B5BC4591001SEC4591001 1140 11401362ASCRN Screening ASCREENING 2020-12-28 2020-12-28T12:04:00AAC4591001SEC4591001 1140 11401362A VAXP Placebo A VACCINATION 2020-12-28T12:04:002021-02-18 AB5C4591001SEC4591001 1140 11401362A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-05-17 B5BC4591001SEC4591001 1140 11401362A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T13:51:00BBC4591001SEC4591001 1140 11401362APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T13:51:002021-07-07 BBC4591001SEC4591001 1140 11401362A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1140 11401363ASCRN Screening ASCREENING 2020-12-28 2020-12-28T12:59:00AAC4591001SEC4591001 1140 11401363A VAXP Placebo A VACCINATION 2020-12-28T12:59:002021-02-26 AB=C4591001SEC4591001 1140 11401363A0FUP Follow-up A0FOLLOW-UP 2021-02-26 2021-05-21 B=BC4591001SEC4591001 1140 11401363A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T15:39:00BBC4591001SEC4591001 1140 11401363APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T15:39:002021-07-09 BBC4591001SEC4591001 1140 11401363A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1140 11401364ASCRN Screening ASCREENING 2020-12-28 2020-12-28T14:08:00AAC4591001SEC4591001 1140 11401364A VAXP Placebo A VACCINATION 2020-12-28T14:08:002021-02-19 AB6C4591001SEC4591001 1140 11401364A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-05-21 B6BC4591001SEC4591001 1140 11401364A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T10:24:00BBC4591001SEC4591001 1140 11401364APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T10:24:002021-07-08 BBC4591001SEC4591001 1140 11401364A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1140 11401365ASCRN Screening ASCREENING 2020-12-28 2020-12-28T14:05:00AAC4591001SEC4591001 1140 11401365A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T14:05:002021-02-19 AB6C4591001SEC4591001 1140 11401365A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-07-30 B6BC4591001SEC4591001 1140 11401366ASCRN Screening ASCREENING 2020-12-28 2020-12-28T14:12:00AAC4591001SEC4591001 1140 11401366A VAXP Placebo A VACCINATION 2020-12-28T14:12:002021-02-19 AB6C4591001SEC4591001 1140 11401366A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-05-21 B6BC4591001SEC4591001 1140 11401366A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T10:26:00BBC4591001SEC4591001 1140 11401366APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T10:26:002021-07-08 BBC4591001SEC4591001 1140 11401366A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1140 11401367ASCRN Screening ASCREENING 2020-12-28 2020-12-28T15:38:00AAC4591001SEC4591001 1140 11401367A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-28T15:38:002021-02-17 AB4C4591001SEC4591001 1140 11401367A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-16 B4BC4591001SEC4591001 1140 11401369ASCRN Screening ASCREENING 2020-12-29 2020-12-29T11:11:00AAC4591001SEC4591001 1140 11401369A VAXP Placebo A VACCINATION 2020-12-29T11:11:002021-02-17 AB3C4591001SEC4591001 1140 11401369A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-19 B3BC4591001SEC4591001 1140 11401369A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-19 2021-05-19T15:51:00BBC4591001SEC4591001 1140 11401369APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-19T15:51:002021-07-06 BBC4591001SEC4591001 1140 11401369A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-06 2021-07-06 BBC4591001SEC4591001 1140 11401370ASCRN Screening ASCREENING 2020-12-29 2020-12-29T12:12:00AAC4591001SEC4591001 1140 11401370A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T12:12:002021-02-18 AB4C4591001SEC4591001 1140 11401370A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-07-16 B4BC4591001SEC4591001 1140 11401371ASCRN Screening ASCREENING 2020-12-29 2020-12-29T12:31:00AAC4591001SEC4591001 1140 11401371A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T12:31:002021-02-17 AB3C4591001SEC4591001 1140 11401371A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-19 B3BC4591001SEC4591001 1140 11401372ASCRN Screening ASCREENING 2020-12-29 2020-12-29T12:34:00AAC4591001SEC4591001 1140 11401372A VAXP Placebo A VACCINATION 2020-12-29T12:34:002021-02-17 AB3C4591001SEC4591001 1140 11401372A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-18 B3BC4591001SEC4591001 1140 11401372A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-18 2021-05-18T14:16:00BBC4591001SEC4591001 1140 11401372APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-18T14:16:002021-07-08 BBC4591001SEC4591001 1140 11401372A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-08 2021-07-08 BBC4591001SEC4591001 1140 11401373ASCRN Screening ASCREENING 2020-12-29 2020-12-29T12:56:00AAC4591001SEC4591001 1140 11401373A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T12:56:002021-02-19 AB5C4591001SEC4591001 1140 11401373A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-07-16 B5BC4591001SEC4591001 1140 11401374ASCRN Screening ASCREENING 2020-12-29 2020-12-29T13:38:00AAC4591001SEC4591001 1140 11401374A VAXP Placebo A VACCINATION 2020-12-29T13:38:002021-02-19 AB5C4591001SEC4591001 1140 11401374A0FUP Follow-up A0FOLLOW-UP 2021-02-19 2021-05-28 B5BC4591001SEC4591001 1140 11401374A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-28 2021-05-28T11:21:00BBC4591001SEC4591001 1140 11401374APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-28T11:21:002021-07-19 BBC4591001SEC4591001 1140 11401374A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-19 2021-07-19 BBC4591001SEC4591001 1140 11401375ASCRN Screening ASCREENING 2020-12-29 2020-12-29T15:00:00AAC4591001SEC4591001 1140 11401375A VAXP Placebo A VACCINATION 2020-12-29T15:00:002021-02-17 AB3C4591001SEC4591001 1140 11401375A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-21 B3BC4591001SEC4591001 1140 11401375A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T14:21:00BBC4591001SEC4591001 1140 11401375APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T14:21:002021-07-07 BBC4591001SEC4591001 1140 11401375A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1140 11401376ASCRN Screening ASCREENING 2020-12-29 2020-12-29T14:52:00AAC4591001SEC4591001 1140 11401376A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T14:52:002021-02-17 AB3C4591001SEC4591001 1140 11401376A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-07-14 B3BC4591001SEC4591001 1140 11401377ASCRN Screening ASCREENING 2020-12-29 2020-12-29T14:56:00AAC4591001SEC4591001 1140 11401377A VAXP Placebo A VACCINATION 2020-12-29T14:56:002021-02-17 AB3C4591001SEC4591001 1140 11401377A0FUP Follow-up A0FOLLOW-UP 2021-02-17 2021-05-21 B3BC4591001SEC4591001 1140 11401377A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-21 2021-05-21T14:19:00BBC4591001SEC4591001 1140 11401377APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-21T14:19:002021-07-07 BBC4591001SEC4591001 1140 11401377A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-07 2021-07-07 BBC4591001SEC4591001 1140 11401378ASCRN Screening ASCREENING 2020-12-29 2020-12-29T15:20:00AAC4591001SEC4591001 1140 11401378A VAXB2_30BNT162b2 (30 mcg) A VACCINATION 2020-12-29T15:20:002021-02-18 AB4C4591001SEC4591001 1140 11401378A0FUP Follow-up A0FOLLOW-UP 2021-02-18 2021-07-14 B4BC4591001SEC4591001 1140 11401379ASCRN Screening ASCREENING 2020-12-30 2020-12-30T10:03:00AAC4591001SEC4591001 1140 11401379A VAXP Placebo A VACCINATION 2020-12-30T10:03:002021-03-16 ABMC4591001SEC4591001 1140 11401379A0FUP Follow-up A0FOLLOW-UP 2021-03-16 2021-05-17 BMBC4591001SEC4591001 1140 11401379A@SCRNOL Screening Open LabelA@REPEAT SCREENING 1 2021-05-17 2021-05-17T14:46:00BBC4591001SEC4591001 1140 11401379APVAXB2_30BNT162b2 (30 mcg) APOPEN LABEL TREATMENT2021-05-17T14:46:002021-07-09 BBC4591001SEC4591001 1140 11401379A`FUPOL Follow-up Open LabelA`OPEN LABEL FOLLOW-UP2021-07-09 2021-07-09 BBC4591001SEC4591001 1140 11401380ASCRN Screening ASCREENING 2020-12-30 2020-12-30T10:13:00AAC4591001SEC4591001 1140 11401380A VAXB2_30BNT162b2 (30 mcg) A